SENS News

Stock Exchange News Service (SENS)

Report on proceedings at the annual general meeting EPE CAPITAL PARTNERS LTD INCORPORATED IN THE REPUBLIC OF MAURITIUS REGISTRATION NUMBER: C138883 C1/GBL ISIN: MU0522S00005 SHARE CODE: EPE ("ETHOS CAPITAL" OR "THE COMPANY") REPORT ON PROCEEDINGS AT THE ANNUAL GENERAL MEETING At the 2nd Annual General Meeting ("AGM") of the shareholders of Ethos Capital held on, Tuesday 13th November 2018, all but one of the ordinary and special resolutions which were proposed, were approved by the requisite majority of votes; ordinary resolution 12 was not approved. In this regard, the Company confirms the voting statistics from the AGM as follows: Resolutions Votes carried disclosed as a percentage in Number of Shares voted disclosed as Shares abstained relation to the total number of shares voted shares voted a percentage in relation disclosed as a percentage at the meeting to the total issued share in relation to the total capital* issued share capital* For Against Ordinary resolution number 1: Approval of the audited Annual Financial Statements 99.99% 0.01% 129,396,549 69.01% 0.01% Ordinary resolution number 2: Reappointment of Deloitte (South Africa) 98.46% 1.54% 129,396,549 69.01% 0.01% Ordinary resolution number 3: Reappointment of Deloitte (Mauritius) 98.46% 1.54% 129,396,549 69.01% 0.01% Ordinary resolution number 4: Re-election of Mr Derek Prout-Jones as a Director 99.97% 0.03% 129,396,549 69.01% 0.01% Ordinary resolution number 5: Re-election of Mr Yuvraj Juwaheer as a Director 99.97% 0.03% 129,396,549 69.01% 0.01% Ordinary resolution number 6: Re-election of Mr Derek Prout-Jones as a member of the Audit and Risk Committee 99.97% 0.03% 129,396,549 69.01% 0.01% Ordinary resolution number 7: Re-election of Mr Kevin Allagapen as a member and chairperson of the Audit and Risk Committee 99.89% 0.11% 129,396,549 69.01% 0.01% Ordinary resolution number 8: Re-election of Mr Yuvraj Juwaheer as a member of the Audit and Risk Committee 99.97% 0.03% 129,396,549 69.01% 0.01% Ordinary resolution number 9: Approval of Non-Executive Directors' remuneration 90.15% 9.85% 129,394,549 69.01% 0.01% Ordinary resolution number 10: Endorsement of the remuneration policy 98.46% 1.54% 129,394,549 69.01% 0.01% Ordinary resolution number 11: Endorsement of the implementation report on the remuneration policy 98.46% 1.54% 129,394,549 69.01% 0.01% Ordinary resolution number 12: Approval of general authority to issue shares and/or other convertible securities for cash, limited to repurchased shares held in treasury 72.06% 27.94% 129,396,549 69.01% 0.01% up to c.10% of the shares in issue at the date of the notice of AGM Special resolution number 1: Approval of general authority to acquire or repurchase the Company's shares, up to 5% of 100.00% 0.00% 129,396,549 69.01% 0.01% the shares in issue at the beginning of the 2019 financial year *Total issued share capital is 179,342,298 (net of repurchased shares held in treasury) Ebene, Mauritius (with simultaneous circulation in Johannesburg) 15 November 2018 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 15/11/2018 11:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Repurchases Of Shares LONG4LIFE LIMITED (Incorporated in the Republic of South Africa) (Registration number 2016/216015/06) Share code: L4L ISIN: ZAE000243119 ("Long4Life" or "the Company" or "the Group") REPURCHASE OF SHARES 1. INTRODUCTION In terms of paragraph 5.79 and 11.27 of the Listings Requirements of the JSE Limited, shareholders are advised that the Company has purchased 27 710 396 of its own ordinary shares, which is 3% of the Company's issued share capital as at the time of the general authority granted by shareholders at the Company's annual general meeting held on 27 August 2018 (the "General Repurchase"). The General Repurchase was effected through the order book operated by the JSE trading system without any prior understanding or arrangement between Long4Life and the counter parties. No shares were repurchased during any prohibited period. The General Repurchase was funded from available cash resources. 2. DETAILS OF THE REPURCHASE Dates of repurchase of securities: Between 26 July 2018 and 13 November 2018 Average price paid per share: R4,39 Lowest price paid per share: R4,24 Highest price paid per share: R4,85 Number of shares repurchased: 27 710 396 Total value of Shares repurchased: R121 697 046 Number of treasury shares (after repurchase): 28 249 615 A portion of the repurchased shares will be used for purposes of the Group's Forfeitable Share Plan. 3. STATEMENT BY THE DIRECTORS The Directors of Long4Life confirm that, after considering the effect of the General Repurchase, for a period of 12 months after the date of this announcement: - The Company and its subsidiaries will be able to pay its debts in the ordinary course of business. - The assets of the Company and the Group will be in excess of the liabilities of the Company and the group. For this purpose, the assets and liabilities were recognised and measured in accordance with the accounting policies used in the latest audited annual group financial statements. - The share capital and reserves of the Company and the Group will be adequate for ordinary business purposes. - The working capital of the Company and the Group will be adequate for ordinary business purposes. - The Company and the Group have passed the solvency and liquidity test and since the test was performed, there have been no material changes to the financial position of the Group. 4. IMPACT OF THE GENERAL REPURCHASE ON THE FINANCIAL INFORMATION OF THE COMPANY The Company's cash balances decreased by R121,7 million as a result of the Repurchase. Johannesburg 15 November 2018 Sponsor: The Standard Bank of South Africa Limited Date: 15/11/2018 11:12:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Partial Redemption of STANPROP Securities STANLIB Collective Investments Limited (Registration number: 1969/003468/06) ("STANLIB" or "the Manager") (being the manager of the STANLIB ETF) STANLIB SA PROPERTY ETF (being a portfolio under the STANLIB Collective Investment Scheme registered in the Republic of South Africa in terms of the Collective Investment Schemes Control Act) Share Code: STPROP ISIN: ZAE000175576 Abbreviated Name: STANPROP Partial Redemption of STANPROP Securities Participants are advised that the JSE Limited has approved the redemption and delisting of 40 000 participatory interests at a price of 5259.314 cents per security with effect from 15 November 2018, following which the total issued number of securities will be 1 481 000. Johannesburg 15 November 2018 Investment Bank and Sponsor The Standard Bank of South Africa Limited Date: 15/11/2018 11:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Results of annual general meeting and details of engagement with shareholders York Timber Holdings Limited Incorporated in the Republic of South Africa Registration number: 1916/004890/06 JSE share code: YRK ISIN: ZAE000133450 ("York" or the "Company") RESULTS OF ANNUAL GENERAL MEETING AND DETAILS OF ENGAGEMENT WITH SHAREHOLDERS York shareholders ("Shareholders") are advised that at the annual general meeting ("AGM") of Shareholders held on Wednesday, 14 November 2018, all the ordinary and special resolutions, were approved by the requisite majority of Shareholders present or represented by proxy. All resolutions proposed at the AGM, together with the percentage of shares abstained, as well as the percentage of votes carried for and against each resolution, are as follows: Ordinary resolution number 1: Adoption of the annual financial statements Shares Voted Abstained For Against 256 888 202 0.06% 100.00% 0.00% 77.55% Ordinary resolution number 2: Re-election of directors who retire by rotation (by separate resolutions) Ordinary resolution number 2.1: Shakeel Meer Shares Voted Abstained For Against 256 868 202 0.07% 100.00% 0.00% 77.55% Ordinary resolution number 2.2: Dinga Mncube Shares Voted Abstained For Against 256 972 454 0.03% 100.00% 0.00% 77.58% Ordinary resolution number 2.3: Thabo Mokgatlha Shares Voted Abstained For Against 256 888 202 0.06% 82.79% 17.21% 77.55% Ordinary resolution number 2.4: Gavin Tipper Shares Voted Abstained For Against 212 680 034 13.41% 100% 0.00% 64.21% Ordinary resolution number 2.5: To ratify the appointment of Gerald Stoltz who was appointed by the Board as an executive director of the Company with effect from 1 December 2017 Shares Voted Abstained For Against 256 888 202 0.06% 100% 0.00% 77.55% Ordinary resolution number 3: Appointment of external auditor Shares Voted Abstained For Against 256 888 202 0.06% 100.00% 0.00% 77.55% Ordinary resolution number 4: Election of Audit Committee members (by separate resolutions) Ordinary resolution number 4.1: Gavin Tipper Shares Voted Abstained For Against 212 680 034 13.41% 100.00% 0.00% 64.21% Ordinary resolution number 4.2: Dr Azar Jammine Shares Voted Abstained For Against 256 868 202 0.07% 100.00% 0.00% 77.55% Ordinary resolution number 4.3: Thabo Mokgatlha Shares Voted Abstained For Against 256 888 202 0.06% 82.79% 17.21% 77.55% Ordinary resolution number 5.1: Endorsement of York's remuneration policy Shares Voted Abstained For Against 256 962 454 0.04% 40.56% 59.44% 77.58% Ordinary resolution number 5.2: Endorsement of York's remuneration implementation report Shares Voted Abstained For Against 256 972 454 0.03% 40.56% 59.44% 77.58% *As a result of more than 25% of the votes cast against ordinary resolutions number 5.1 and 5.2, York invites those Shareholders who voted against either of these resolutions to engage with the Company. Further details of the method of engagement are set out at the end of this announcement. Ordinary resolution number 6: General authority to issue shares for cash Shares Voted Abstained For Against 256 888 202 0.06% 94.56% 5.44% 77.55% Ordinary resolution number 7: Placing authorised but unissued shares under the control of the Board Shares Voted Abstained For Against 256 888 202 0.06% 94.56% 5.44% 77.55% Special resolution number 1: General authority to acquire (repurchase) shares Shares Voted Abstained For Against 256 888 202 0.06% 99.32% 0.68% 77.55% Special resolution number 2: Remuneration of non-executive directors for the period January 2019 to December 2019 (by separate resolutions) Special resolution number 2.1: Chairman of the Board Shares Voted Abstained For Against 256 887 202 0.06% 99.99% 0.01% 77.55% Special resolution number 2.2: Non-executive directors Shares Voted Abstained For Against 256 887 202 0.06% 99.99% 0.01% 77.55% Special resolution number 2.3**: Chairman and member of the Audit Committee Shares Voted Abstained For Against 230 002 010 0.06% 91.90% 8.10% 69.44% Special resolution number 2.4**: Chairman and member of the Social and Ethics Committee Shares Voted Abstained For Against 227 795 942 0.06% 92.79% 7.21% 68.77% Special resolution number 2.5**: Chairman and member of the Risk and Opportunity Committee Shares Voted Abstained For Against 227 795 942 0.06% 92.79% 7.21% 68.77% Special resolution number 2.6**: Chairman and member of the Remuneration and Nomination Committee Shares Voted Abstained For Against 227 805 942 0.06% 92.79% 7.21% 68.77% ** A modification to special resolutions number 2.3, 2.4, 2.5 and 2.6 was tabled at the AGM prior to proposing the resolutions. In terms of the modifications, the Company will pay the non-executive directors for their services as the respective chairpersons and members of the Company's committees, the fees previously paid in the 2018 calendar year, for the period January 2019 to December 2019. Special resolution number 2.7: Increase in the fees payable to non-executive directors for the period January 2020 to December 2020 Shares Voted Abstained For Against 256 887 202 0.06% 99.99% 0.01% 77.55% Notes - Percentages of shares voted are calculated in relation to the total issued share capital of York. - Percentages of shares for and against are calculated in relation to the total number of shares voted for each resolution. - Abstentions are calculated as a percentage in relation to the total issued share capital of York. *As required in terms of the King IV Report on Corporate Governance for South Africa, 2016 and paragraph 3.84(k) of the JSE Limited Listings Requirements, York invites those Shareholders who voted against ordinary resolutions number 5.1 and 5.2 ("Dissenting Shareholders") to engage with the Company regarding their views on York's remuneration policy and remuneration implementation report. Dissenting Shareholders may forward their concerns / questions regarding York's remuneration policy and the implementation thereof to the company secretary via email at shsieh@york.co.za by 9am on Wednesday, 21 November 2018. Following receipt of written communication by the company secretary, such Dissenting Shareholders will be invited to attend a meeting (and for those who are unable to attend, participate via teleconference) with the Chairman of the Remuneration Committee, Dr Azar Jammine, at 9am on Monday, 26 November 2018 ("Meeting"), to discuss the concerns / questions raised. The venue of the Meeting will be communicated to Dissenting Shareholders who have forwarded their concerns / questions to the company secretary. Sabie, Mpumalanga 15 November 2018 Sponsor One Capital Date: 15/11/2018 10:40:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Tap Issue Announcement Date: 15 November 2018 Stock Code: RED901 REDINK RENTALS (RF) LIMITED Date: 15 November 2018 Stock Code: RED901 Tap Issue Announcement The JSE Limited has granted a listing to REDINK RENTALS (RF) LIMITED on Interest Rate Market with effect from 2 August 2018 under its Secured Note Programme dated 29 May 2015. INSTRUMENT TYPE: FLOATING RATE NOTE Authorised Programme size R 10,000,000,000.00 Total Notes Outstanding R 294,119,830.00 Bond Code RED901 Nominal Issued R 21,916,212.00 Issue Price 100,694% Coupon 11,517% (3 Month JIBAR of 7,017% plus 450 bps) Coupon Indicator Floating Trade Type Price Maturity Date 28 July 2022 Books Close 24 January, 24 April, 24 July, 24 October Interest Payment Date(s) 28 January, 28 April, 28 July, 28 October Last Day to Register By 17:00 on 23 January, 23 April, 23 July, 23 October Issue Date 20 November 2018 Date Convention Following ISIN Code ZAG000152844 The note will be immobilised in the Central Securities Depository ("CSD") and settlement will take place electronically in terms of JSE Rules. Further information on the Note issue please contact: Redinkcapital Charlize Wiederkehr Tel: +27 10 0052014 Email: charlize@red-inc.co.za Date: 15/11/2018 10:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Styldrift Project Reaches 150KTPM Milestone ROYAL BAFOKENG PLATINUM LIMITED Incorporated in the Republic of South Africa) Registration number: 2008/015696/06) JSE share code: RBP ISIN: ZAE000149936 Company code: RBPD Bond code: RBPCB ISIN: ZAE000243853 ("RBPlat" or the "Company") STYLDRIFT PROJECT REACHES 150KTPM MILESTONE RBPlat is pleased to announce the progress made in delivering against our growth strategy by achieving the 150ktpm milestone at Styldrift during the month of October. In addition to achieving the 150ktpm milestone, Silo 4 and the associated ore handling infrastructure required to sustain production above the 150ktpm has also been successfully commissioned. This combined with ongoing construction progress related to establishing 230ktpm infrastructure ensures we remain well positioned to achieve our steady state milestone of 230ktpm by the third quarter of 2020. Styldrift is a mechanised mine which provides access to a high grade, relatively shallow Merensky resource through a twin vertical shaft system and is a key part of the Company's organic growth strategy. Johannesburg 15 November 2018 JSE Sponsor Merrill Lynch South Africa Proprietary Limited For further enquiries, please contact: Investors: Lindiwe Montshiwagae Executive: Investor Relations Tel: +27 (0)10 590 4510 E-mail: lindiwe@bafokengplatinum.co.za Date: 15/11/2018 10:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

FRS184 - Listing of New Financial Instrument FirstRand Bank Limited (Incorporated in the Republic of South Africa) (Registration number: 1929/001225/06) Issuer code: FRII Bond code: FRS184 ISIN: ZAG000155490 (FRB) LISTING OF NEW FINANCIAL INSTRUMENT The JSE Limited has granted FirstRand Bank Limited the listing of its unsecured index-linked notes, in terms of its note programme (the programme) dated 29 November 2011, effective 16 November 2018. Debt security code: FRS184 ISIN: ZAG000155490 Type of debt security: Index-Linked Notes Nominal issued: ZAR 25 000 000.00 Issue date: 16 November 2018 Issue price: 100% Coupon rate: Not applicable Interest commencement date: Not applicable Interest determination date(s): Not applicable First interest payment date: Not applicable Interest payment date(s): Not applicable Last day to register: By 17:00 on 11 November 2023 Books close: 12 November 2023 Business day convention: Following Business Day Maturity date: 16 November 2023 Final maturity amount: The final maturity amount is determined based on the calculation below: ILRA = ANA * (1+2.15 * MAX(IRA - 1,0) * (FXFVD / FXFSD)) The definitions for this formula is as per the pricing supplement Other: The pricing supplement contains additional terms and conditions Summary of additional terms: Please refer to the FX disruption provisions contained in the pricing supplement Programme amount: ZAR 30 000 000 000.00 Total notes in issue under programme: ZAR 16 003 826 229.50 Dealer: FirstRand Bank Limited, acting through its Rand Merchant Bank division The notes will be immobilised in the Central Securities Depository and settlement will take place electronically in terms of JSE Rules. 15 November 2018 Debt Sponsor RAND MERCHANT BANK (a division of FirstRand Bank Limited) Date: 15/11/2018 09:55:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Trading Statement SAFARI INVESTMENTS RSA LIMITED Approved as a REIT by the JSE Limited (Incorporated in the Republic of South Africa) (Registration number 2000/015002/06) Share code: SAR ISIN: ZAE000188280 ("Safari" or "the Company") TRADING STATEMENT In terms of the JSE Limited Listings Requirements, a listed property entity may adopt distribution per share as the applicable criteria for trading statement purposes and is then required to publish a trading statement as soon as it becomes reasonably certain that the distribution per share for the next period to be reported on will differ by 15% or more from the distribution per share for the previous corresponding period. The Company hereby advises that a reasonable degree of certainty exists that for the 6 month period ended 30 September 2018, the distribution per share will be between 24 cents and 28 cents, representing a decrease of between 20% and 31% compared to the distribution per share of 35 cents reported for the 6 month period ended 30 September 2017. The distribution per share decreased firstly due to the fact that the weighted number of shares was used and antecedent dividends (resulting from the 119 552 633 shares issued at R7.60 during the 2018 distribution period) were included to calculate distributable income per share for the 2018 distribution period of which the December 2017 distribution of 35 cents per share was the interim distribution. Secondly, the weaker than expected performance of the Platz Am Meer shopping centre and the delay in the sale of the residential units at the Platz Am Meer development in Swakopmund also limited the distributable income per share for the 6 months ending 30 September 2018. Taking the above into account and the current economic climate in South Africa and Namibia, Safari decided not to distribute from capital reserves as this will ensure long term sustainability. The financial information on which this trading statement is based has not been reviewed or reported on by the auditor of the Company. The unaudited results for the 6 month period ended 30 September 2018 are expected to be published on or about 22 November 2018. Pretoria 15 November 2018 Sponsor PSG Capital Date: 15/11/2018 09:38:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Trading Statement RH Bophelo Limited Incorporated in the Republic of South Africa (Registration number: 2016/533398/06) JSE share code: RHB, ISIN: ZAE000244737 ("RHB" or "the Company") Trading Statement The Company is in the process of finalising its half year results for the interim period ended 31 August 2018, which are scheduled to be released on or about 16 November 2018. Shareholders are advised that the Company expects to report earnings per share and headline per share of between 58 to 66 cents, being an increase of between 43% and 63%, compared to prior interim period of 40,7 cents. The increase in earnings in the current year period were mainly attributable to the increase in interest income of R9 225 272 to R15 832 157 (prior year period: R 6 606 885) and an increase in the fair value valuation of RHB's investee companies of R29 985 263 (prior year period: Nil). The Company acquired African Healthcare ("AHC"), Vryburg Private Hospital ("VPH") on 26 April 2018 and Rondebosch Medical Centre Proprietary Limited ("RMC") on 14 May 2018. The above is based on the weighted average number of shares ("W ANOS") in issue during the current period ended 31 August 2018 of 50 821 918 (prior year period: 13 858 696). The Company issued 49,999,999 ordinary shares on 12 July 2017 upon its listing on the JSE, with a subsequent issue of new shares of 1,250,000 on 26 April 2018. Shares issued in the current period were only included in the calculation of W ANOS for only 120 days. The total number of shares in issue as at 31 August 2018 was 51 250 000. The financial information on which this trading statement has been based has neither been reviewed nor reported on by the Company's external auditors. Johannesburg 15 November 2018 Sponsor: Deloitte & Touche Sponsor Services Proprietary Limited Date: 15/11/2018 09:18:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

MMIG - Notification of an Affirmation of the Credit Rating of the Issuer MMI Group Limited (Incorporated in the Republic of South Africa) (Registration No. 1904/002186/06) Company code: MMIG ("MMIGL" or "the Issuer") NOTIFICATION OF AN AFFIRMATION OF THE CREDIT RATING OF THE ISSUER Bondholders are advised that on 08 November 2018, Moody's Investors Service ("Moody's") released an updated credit opinion on MMIGL that affirms the global scale Insurance Financial Strength ("IFS") rating of Baa2, with a long-term rating of Baa3. Moody's also affirmed the national scale IFS rating of the Issuer at Aaa.za with the long-term issuer rating at Aaa.za and the unsecured subordinated notes rating at Aa2.za. It is worth noting that Moody's national scale rating of Aaa.za is the highest rating in the country. Moody's commented that MMIGL's rating reflects its top tier market position in South Africa, its solid capital position and its flexible product characteristics which serve to reduce the impact on the group from stress related to credit pressures at the sovereign level. The full report has been made available at http://www.mmiholdings.co.za/en/investor- relations/credit-ratings 15 November 2018 Debt Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 15/11/2018 09:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Interest Payment Notification CAPITEC BANK LIMITED Incorporated in the Republic of South Africa (Registration No. 1980/003695/06) Company Code: BICAP Stock Code: CBL28 ISIN Code: ZAG000151333 INTEREST PAYMENT NOTIFICATION Bondholders are advised of the following interest payment due 21 November 2018: Bond code: CBL28 ISIN: ZAG000151333 Coupon: 8.547% Interest period: 21 August 2018 to 20 November 2018 Interest amount due: R10,771,561.64 Payment date: 21 November 2018 Date Convention: Following Business Day 15 November 2018 Stellenbosch Debt Sponsor PSG Capital Date: 15/11/2018 09:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Posting Of Integrated Report, Restatement Of Previously Published Results For Minor Rounding Differences AH-VEST LIMITED (Incorporated in the Republic of South Africa) (Registration number 1989/000100/06) Share code: AHL ISIN code: ZAE000129177 ("AH-Vest" or "the Company") Posting Of Integrated Report, Restatement Of Previously Published Results For Minor Rounding Differences, Notice Of Annual General Meeting And Availability Of Broad-Based Black Economic Empowerment Annual Compliance Report Changes to previously published results Shareholders are advised that the company's integrated annual report incorporating, inter alia, the audited annual financial statements for the year ended 30 June 2018 and a notice of annual general meeting, will be posted to shareholders on or about 15 November 2018 and is available on the company's website www.alljoy.co.za. Shareholders are advised that the JSE Listings Requirements provide for the publication of results where there are any changes to the annual financial statements, even if these amendments are immaterial. Certain line items in the annual financial statements contain minor rounding differences compared to the results for 30 June 2018 as published in the audited consolidated provisional results compared to the announcement of reviewed results published on SENS on 15 October 2018 ("the provisional results"). These changes are immaterial to the published provisional results and do not result in any changes to the earnings and headline earnings per share information previously published. The rounding differences occur in the condensed consolidated statement of financial position, statement of changes in equity, condensed consolidated statements of cash flows and these amended line items as well as the previously published figures (where different), are set out below: Statement of Financial Position as at 30 June 2018 Figures in Rands Published Audited Difference 2017 2017 EQUITY AND LIABILITIES Capital and Reserves 19 562 163 19 562 155 -8 Description Stated capital Share Capital Accumulated loss (1 730 909) (1 730 916) -7 Current Liabilities 42 617 996 42 618 004 8 Trade and other payables 31 406 007 31 406 014 7 Condensed statement of changes in equity Published Audited Difference 2017 2017 R R Accumulated loss Opening balance (3 048 163) (3 048 159) 4 Profit for the year 1 317 243 1 317 247 -4 Consolidated statement of cash flows - 30 June 2018 Published Difference Reviewed Audited Year Ended Year Ended 30 June 30 June 2018 2018 R R Purchase of property, plant and equipment 5 900 750 5 900 744 -6 Cash utilised in investing activities (7 127 233) (7 127 227) 5 Net decrease in cash and cash equivalents (4 335 609) (4 335 603) 6 Cash and cash equivalents at end of year (7 539 281) (7 539 275) 6 Cash flows from operations Increase in trade payables (5 933 330) (5 933 333) -3 Consolidated statement of cash flows - 30 June 2017 Published Audited Difference Year Ended Year Ended 30 June 30 June 2018 2017 R R Cash flows from investing activities Purchase of property plant and equipment (5 095 409) (5 095 408) 1 Cash utilised in investing activities (10 560 751) (10 560 750) 1 Cash flows from financing activities Loans received from shareholder 244 783 244 782 -1 Loans repaid to shareholder (10 312 421) (10 312 422) -1 Cash (utilised in)/generated from financing activities 9 544 224 9 544 223 -1 Cash and cash equivalents at end of year (3 203 672) (3 203 671) -1 Cash flows from operations (Heading changed) Finance costs 3 030 781 3 030 780 -1 3 054 888 3 054 887 1 In addition to the above disclosures the notes on related parties has also been updated as follows: Published Audited Difference Year Ended Year Ended 30 June 30 June 2018 2018 R R R Transactions with Eastern Trading Interest received/ charged 1 145 324 1 142 417 -2 907 Key Management remuneration Executive directors' remuneration 5 152 945 5 070 668 -82 277 Non-executive directors' remuneration 247 500 251 550 4 050 The related party transactions with key management has decreased by R82 277 to exclude leave pay that had been included in error. The non- executive directors' emoluments have increased by R4 050 to include statutory payments that had been excluded. Notice of Annual General Meeting Notice is hereby given that the annual general meeting of ordinary shareholders will be held at 10:00 on Thursday, 13 December 2018 at 15 Misgund Road, Eikenhof, Johannesburg, to transact the business as stated in the notice of annual general meeting forming part of the integrated annual report. The Annual Report will be posted to shareholders on or about 14 November 2018. Record Dates The record date to be on the securities register in order to receive the Annual Report is Friday, 9 November 2018. The record date by which shareholders of the Company must be registered as such in the company's securities register in order to attend and vote at the annual general meeting is Friday, 7 December 2018. The last day to trade in order to be eligible to vote at the annual general meeting will accordingly be Tuesday, 4 December 2018. Broad-Based Black Economic Empowerment Annual Compliance Report Shareholders are hereby notified that in accordance with the JSE Listings Requirements, the Company's annual compliance report in terms of section 13G(2) of the Broad-Based Black Economic Empowerment Act 53 of 2003 read with the Broad-Based Black Economic Empowerment Amendment Act 46 of 2013, the Company's BEE certificate, which is valid for the 2018/2019 period, is available on the Company's website http://www.alljoy.co.za/. Johannesburg 15 November 2018 Designated Advisor Arbor Capital Sponsors Proprietary Limited Date: 15/11/2018 09:19:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Net1 notification to SA shareholders: No change statement regarding first quarter 2019 Form 10-Q filing with the SEC Net 1 UEPS Technologies, Inc. Registered in the state of Florida, USA (IRS Employer Identification No. 98-0171860) Nasdaq share code: UEPS JSE share code: NT1 ISIN: US64107N2062 ("Net1" or "the Company") Net1 notification to South African shareholders: No change statement regarding first quarter 2019 Form 10-Q filing with the SEC The Company's South African shareholders are advised that Net1 filed its Quarterly Report on Form 10-Q with the United States Securities and Exchange Commission ("SEC") on close of business in the United States on November 14, 2018. The Company further advises its South African shareholders that there were no changes to the amounts presented in the condensed consolidated financial statements contained in the SENS announcement released on November 9, 2019, titled "Net 1 UEPS Technologies, Inc. Reports First Quarter 2019 Results". The Form 10-Q for the first quarter of fiscal 2019 is available on the Company's website at http://ir.net1.com/phoenix.zhtml?c=73876&p=irol-reportsOther About Net1 (www.net1.com) Net1 is a leading provider of transaction processing services, financial inclusion products and services and secure payment technology. Net1 operates market-leading payment processors in South Africa and the Republic of Korea. Net1 offers debit, credit and prepaid processing and issuing services for all major payment networks. In South Africa, Net1 provides innovative low-cost financial inclusion products, including banking, lending and insurance, and is a leading distributor of mobile subscriber starter packs for Cell C, a South African mobile network operator. Net1 leverages its strategic equity investments in Finbond and Bank Frick (both regulated banks), and Cell C to introduce products to new customers and geographies. Net1 has a primary listing on NASDAQ (NasdaqGS: UEPS) and a secondary listing on the Johannesburg Stock Exchange (JSE: NT1). Visit www.net1.com for additional information about Net1. Investor Relations Contact: Dhruv Chopra Head of Investor Relations Phone: +1-917-767-6722 Email: dchopra@net1.com Media Relations Contact: Bridget von Holdt Business Director - BCW Phone: +27-82-610-0650 Email: bridget.vonholdt@bm-africa.com Johannesburg November 15, 2018 Sponsor: Rand Merchant Bank, a division of FirstRand Bank Limited Date: 15/11/2018 09:11:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Mediclinic International plc - 2018/19 interim results and declaration of interim cash dividend Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 South African income tax number: 9432434182 ("Mediclinic", the "Company" or the "Group") 15 November 2018 MEDICLINIC INTERNATIONAL PLC - 2018/19 INTERIM RESULTS AND DECLARATION OF INTERIM CASH DIVIDEND - First half Group performance impacted by Hirslanden - Actions taken at Hirslanden to address structural changes across Swiss healthcare environment - Southern Africa and Middle East local currency revenue growth and EBITDA margin improvements - Interim dividend maintained at 3.20 pence per share - No change to full year guidance Mediclinic announces its results for the six months ended 30 September 2018 (the "period" or "1H19"). GROUP FINANCIAL RESULTS - Revenue down 1% to GBP1 387m; up 2% in constant currency terms reflecting growth in Southern Africa and Middle East offset by weak performance in Switzerland - Combined effect of the tariff reductions and less favourable insurance mix caused greater than expected impact on Hirslanden results - Adjusted EBITDA down 8% to GBP213m; reflecting the lower contribution from Hirslanden - Adjusted operating profit down 15% to GBP137m; reported operating profit down 71% to GBP39m, impacted by non-cash Hirslanden impairment charges of GBP98m - Reported loss* of GBP168m (1H18: loss of GBP50m), reflecting a non-cash impairment charge on the equity investment in Spire of GBP164m (1H18: GBP109m) and Hirslanden impairment charges - Adjusted earnings per share down 9% to 10.3 pence - Cash conversion at 69% of adjusted EBITDA (1H18: 91%); impacted by timing differences in Southern Africa and the Middle East and HIT2020 implementation in Switzerland; expect full year cash conversion to be more in line with prior periods - Interim dividend maintained at 3.20 pence per share *Refers to loss attributable to equity holders. Dr Ronnie van der Merwe, CEO of Mediclinic, today commented: "The Group's first half financial results were disappointing. The poor performance in Switzerland more than outweighed the revenue growth and margin expansion delivered by the Southern Africa and Middle East divisions. "The rapidly implemented regulatory changes regarding outpatient tariff adjustments and outmigration of care in Switzerland are significantly impacting the healthcare market in that country. We are acutely focused on adapting Hirslanden to reflect the future healthcare environment in Switzerland. Steps have been taken to improve the current financial performance through securing revenue growth, reducing costs and driving efficiency savings in different areas of the business. These, together with customary seasonal benefits, are expected to support the delivery of improved performance in the second half. "In the medium term, we will improve service differentiation across the insurance categories, address the cost base, drive operational efficiencies, focus on doctor recruitment initiatives and advance Hirslanden's outpatient delivery model to capture the growing requirement for outpatient procedures in a cost-efficient manner. Here we will benefit from the Group's experience of delivering such outpatient solutions successfully in Southern Africa and the Middle East. I am confident that Hirslanden is well positioned than many of its competitors to deal with these challenges and remains profitable and cash generative. "In the Middle East, we continue to gain momentum, supported by revenue growth, selective investment projects that both enhance our facilities and the clinical service offering and strategically expanding our capacity in the region. In September, a key milestone was achieved with the opening of the new 182-bed Mediclinic Parkview Hospital in Dubai, both on time and within budget. In Southern Africa, we continued to deliver excellent operational performance and made progress on our strategic priority to expand across the continuum of care, particularly in the primary care and day clinic settings. "We are highly cognisant of our shareholders' experience during this period of Swiss regulatory change. Underpinned by the continued global demand for healthcare services, I am determined to improve shareholder value and confidence in Mediclinic International through our focus on delivering growth and attractive returns over the medium term." GROUP STRATEGIC OVERVIEW The Group's strategic focus is to deliver cost-effective, high-quality healthcare services and provide an optimal patient experience across the operating divisions in Switzerland, Southern Africa and the Middle East. To this end, Mediclinic continued to invest in its people, clinical facilities and technology during the year. The Group's growing international scale enables it to unlock further value through promoting collaboration and best practice between its operating divisions and to extract further synergies and cost-efficiencies across a complementary service set in the continuum of care. There is a clear underlying long-term demand for Mediclinic's services, across its operating divisions, which is expected to remain robust, underpinned by inter alia ageing population, growing disease burden and technological innovation. However, the expected increase in demand across the operating divisions is contrasted by lower economic growth in some regions and greater competition. In addition, there is an increased focus on the affordability of delivering healthcare which is resulting in changing care delivery models and greater regulatory intervention. This is in line with our philosophy of making long term decisions informed by our core business as well as the changing environment. GROUP FINANCIAL SUMMARY 1H19 1H18 % GBP'm GBP'm variance(4) Revenue 1 387 1 405 (1%) EBITDA 213 232 (8%) Adjusted EBITDA(1) 213 232 (8%) Reported operating profit 39 133 (71%) Adjusted operating profit(1) 137 161 (15%) Reported loss(2) (168) (50) (236%) Adjusted earnings(1) 76 84 (9%) Loss per share (pence) (22.8) (6.8) (235%) Adjusted earnings per share (pence)(1) 10.3 11.3 (9%) Interim dividend per share (pence) 3.20 3.20 0% Net debt(3) 1 787 1 676 7% Cash conversion 69% 91% 1 The Group uses adjusted income statement reporting as non-IFRS measures in evaluating performance and as a method to provide shareholders with clear and consistent reporting. The reconciliations between the statutory and the non-IFRS measures are included in the Financial Review section below. 2 Reported loss refers to loss attributable to equity holders. 3 The comparative for net debt reflects the balance as at 31 March 2018. 4 The percentage variances are calculated in unrounded pounds sterling values and not in millions. Adjusted results The Group's 1H19 revenue was GBP1 387m (1H18: GBP1 405m) and adjusted EBITDA was GBP213m (1H18: GBP232m), down 1% and 8% respectively. In constant currency terms, 1H19 revenue was up 2% and adjusted EBITDA was down 5%, with the Group's adjusted EBITDA margin decreasing to 15.4% (1H18: 16.5%). This was as a result of local currency revenue growth and EBITDA margin expansion in Southern Africa and the Middle East more than offset by a weaker than expected contribution from Hirslanden. Adjusted depreciation and amortisation was up 7% to GBP76m (1H18: GBP71m) in line with the continued investment to support growth and enhancing patient experience and clinical quality. Additional assets contributing to the increase in adjusted depreciation and amortisation included the Linde Hospital in Switzerland and Majid Al Futtaim Clinics in Dubai partially offset by divestments made in the Middle East. Capitalised HIT2020 project costs and the initial depreciation of brands in Switzerland also contributed to the overall increase. Adjusted operating profit was down 15% to GBP137m (1H18: GBP161m), largely arising from the poor Hirslanden contribution which was impacted by recent regulatory changes in the Swiss healthcare market. Adjusted net finance costs were down 31% at GBP27m (1H18: GBP39m), benefiting from the successful October 2017 refinancing in Switzerland as well the capitalisation of borrowing costs on capital projects. Adjusted taxation was GBP26m (1H18: GBP29m) with an adjusted effective tax rate for the period of 23.4% (1H18: 24.0%). Mediclinic's investment in Spire Healthcare Group plc ("Spire") is equity accounted. For the six months ended 30 June 2018, Spire reported a profit after tax of GBP8.2m (30 June 2017: GBP8.9m). After adjusting for the amortisation of intangible assets recognised in the notional purchase price allocation of the equity investment, 1H19 income from associates was GBP1.8m (1H18: GBP1.1m). Adjusted earnings were down 9% to GBP76m (1H18: GBP84m) with adjusted earnings per share down 9% to 10.3 pence (1H18: 11.3 pence). The interim dividend per share is maintained at 3.20 pence (1H18: 3.20 pence), with the Group maintaining its full year dividend policy of 25% to 30% of adjusted earnings per share. Cash flow conversion at 69% (1H18: 91%) was impacted by timing differences of receivables in Mediclinic Southern Africa and Mediclinic Middle East. In addition, the new HIT2020 billing system implementation in Zurich caused a delay in invoicing. By October, invoicing had improved and by year end it is anticipated that Hirslanden receivables will have normalised. The Group expects full year cash conversion to be more in line with prior years. The Group continues to follow a strategy of responsible leverage, largely using its asset base to secure cost efficient borrowings. These are incurred in the same currency as the underlying cash flows of the divisions to avoid foreign exchange fluctuation risks and debt is ring-fenced with no cross guarantees or cross defaults from one division to another. As Hirslanden has the highest value of fixed assets and lowest cost of borrowing across the Group, we follow a deliberate strategy of raising the majority of our funding in Switzerland. On a Group basis, leverage at the end of the period was at 3.6x and we maintain sufficient financing flexibility across the entire Group to fund continued investment in the business and incremental growth all whilst maintaining headroom to our covenants. Reported results Reported revenue was down 1% to GBP1 387m (1H18: GBP1 405m) and EBITDA was down 8% to GBP213m (1H18: GBP232m). Depreciation and amortisation decreased by 19% to GBP76m (1H18: GBP94m), largely due to the accelerated amortisation of GBP23m recognised in the prior period relating to the rebranding of the Al Noor hospitals to Mediclinic. A loss of GBP5m related to the disposal of non-core businesses in Mediclinic Middle East was also recorded in the prior period. Operating profit was down 71% to GBP39m (1H18: GBP133m), reflecting non-cash impairment charges on Hirslanden properties of GBP43m and trade names of GBP55m. Net finance costs decreased by 23% to GBP27m (1H18: GBP35m), benefiting from the successful October 2017 refinancing in Switzerland as well the capitalisation of borrowing costs on capital projects. The market value of the investment in Spire was GBP169m at 30 September 2018, reflecting Spire's half year results announcement including its revised guidance, compared to the carrying value of GBP348m at 31 March 2018. An impairment test was performed at 30 September 2018 by updating the key assumptions applied in the value in use calculation performed at 31 March 2018. As a result, an impairment charge of GBP164m was recorded against the carrying value of the equity accounted investment. The Group's reported effective tax rate is significantly skewed by the exceptional non tax-deductible impairment charge for the Spire equity investment. The reported earnings were a loss of GBP168m (1H18: loss of GBP50m). Group results are subject to movements in foreign currency exchange rates. Refer to the Financial Review section below for exchange rates used to convert the operating divisions' results and financial position to pounds sterling. Details of the 1H19 results investor and analyst audio webcast and conference call are available at the end of this report or visit the Group's website at www.mediclinic.com. OPERATIONAL RESULTS Hirslanden - Revenue up 1% to CHF826m - Adjusted EBITDA down 17% to CHF118m - Adjusted EBITDA margin of 14.3% (1H18: 17.4%) - Disappointing performance at Hirslanden where recent regulatory changes have significantly impacted the tariff environment and inpatient insurance mix; affected key inputs to the impairment review giving rise to impairment charges on Hirslanden properties of GBP43m and trade names of GBP55m - Continue to take actions to improve the current financial performance through securing revenue growth, reducing costs and driving efficiency savings; additional medium term actions include improving service differentiation across insurance categories, doctor recruitment initiatives and advancing the outpatient delivery model - Customary seasonality in the second half and additional cost saving and efficiency initiatives anticipated to deliver improved sequential performance - Announced the combination of Hirslanden La Colline and Clinique des Grangettes, to strengthen the leading market position of Hirslanden in the attractive Geneva market Southern Africa - Revenue up 5% to ZAR7 958m - Adjusted EBITDA up 6% to ZAR1 684m - Adjusted EBITDA margin of 21.2% (1H18: 21.0%) - EBITDA margin improvement was supported by excellent operational performance despite weaker than expected second quarter volumes as a result of fewer winter flu related cases - In line with the strategy to expand across the continuum of care, Mediclinic Southern Africa completed the investment in the Welkom Medical Centre in August 2018 and the investment in Intercare day clinic business in November 2018 whilst opening the new Mediclinic Newcastle Day Clinic in October 2018 Middle East - Revenue up 5% to AED1 495m, adjusting 1H18 revenue by AED46m to reflect IFRS 15 - Adjusted EBITDA up 13% to AED141m benefiting from operating leverage; adjusted EBITDA margin of 9.4% (reflecting IFRS 15 1H18: 8.8%) - Excluding costs associated with the start-up of Mediclinic Parkview Hospital, adjusted EBITDA margin improved to 10.7% (reflecting IFRS 15 1H18: 8.8%) - Delivered gradual improvement in revenue and EBITDA margin expansion as benefits from business and operational alignment initiatives in Abu Dhabi materialise; anticipate stronger growth in the second half of the year - The 182-bed Mediclinic Parkview Hospital in Dubai opened in September on time and within budget; the hospital will be a key contributor to the growth of the division as it ramps up over the coming years HIRSLANDEN Variance 1H19 1H18 % Inpatient admissions (000's) 49.3 47.6 3.6% Movement in inpatient revenue per admission (2.8%) (0.8%) Revenue (CHFm) 826 820 1% Adjusted EBITDA (CHFm) 118 143 (17%) Adjusted EBITDA margin 14.3% 17.4% Expansion capex (CHFm) 14 15 (7%) Maintenance capex (CHFm) 18 26 (31%) Adjusted EBITDA converted to cash 51% 91% Average GBP/CHF exchange rate 1.31 1.26 4% Revenue (GBPm) 631 651 (3%) Adjusted EBITDA (GBPm) 90 113 (20%) Financial review As at the end of the reporting period, Hirslanden operated 17 hospitals and 4 outpatient clinics with a total of 1 817 inpatient beds and 9 510 employees (7 513 full-time equivalents). It is the largest private acute care hospital group in Switzerland servicing approximately one third of inpatients treated in Swiss private hospitals. Hirslanden accounted for 46% of the Group's revenues (1H18: 46%) and 42% of its adjusted EBITDA (1H18: 49%). Hirslanden's disappointing first half financial performance was a direct result of recent regulatory changes in the Swiss healthcare market which has impacted all providers. These changes included the implementation of national outpatient tariff ("TARMED") reductions effective from 1 January 2018 and the outmigration of identified clinical treatments transferring from an inpatient to an outpatient tariff across many cantons. The outmigration of care continues to unfold with the Federal list and its more restrictive exclusion criteria being implemented from 1 January 2019. This creates further uncertainty, which will be mitigated by the actions being taken by management to accelerate the changes required to adapt the business to the new operating environment. Including the contribution from the Linde acquisition in July 2017, first half revenue increased 1% to CHF826m (1H18: CHF820m). Inpatient revenue was up 1%. Outpatient revenue, which contributed some 19% to total revenue in the period, was up 2% reflecting additional cases from the outmigration of certain treatments to an outpatient tariff offset by the TARMED tariff reduction. Inpatient admissions were up 3.6% but average occupancy was down in the period to 68.5% (1H18: 69.6%) due to lower average length of stay. Inpatient revenue per case was down 2.8% as a result of the less favourable insurance mix (proportion of general insured patients 1H19: 49.4% compared to 1H18: 46.9%). Despite cost savings and efficiency gains, the significant effect of the tariff reductions and less favourable insurance mix resulted in a greater than expected impact on adjusted EBITDA which declined 17% to CHF118m (1H18: CHF143m). The adjusted EBITDA margin was materially lower at 14.3% (1H18: 17.4%). Depreciation and amortisation increased by 16% to CHF61m (1H18: CHF52m), reflecting the incorporation of Linde and ongoing fixed asset investments. Operating profit decreased by 176% to an operating loss of CHF68m (1H18: CHF90m). Net finance costs decreased by 28% to CHF25m (1H18: CHF35m). This was mainly as a result of the refinancing completed in October 2017 for borrowings totalling CHF2.0bn, with a 25bps reduction in the cost of debt on a like for like basis and an extended maturity profile to at least 2024. Hirslanden contributed GBP27m to the Group's adjusted earnings (representing 35%) compared to GBP43m (representing 51%) in the prior year. Hirslanden converted 51% (1H18: 91%) of adjusted EBITDA into cash generated from operations, down from 91% in 1H18 due to an increase in trade receivables largely caused by the new HIT2020 billing system implementation in Zurich. By October, invoicing had improved and by year end it is anticipated that Hirslanden receivables will have normalised and that cash conversion will be in line with prior years. In line with the requirements of IFRS, non-financial assets are considered for impairment when impairment indicators are identified at an individual cash-generating unit ("CGU") level. In Switzerland, the changes in the market and regulatory environment continued to affect key inputs to the review and gave rise to impairment charges recorded against properties and trade names of GBP43m and GBP55m, respectively. The impairment charges are non-cash and excluded from the adjusted earnings metrics. The remaining trade name will be amortised over its respective estimated useful life. The impairment calculations remain sensitive to reasonably possible changes in key assumptions, including cash flow projections and long-term growth and discount rates. Regulatory update On 1 January 2018, the previously announced reductions to the TARMED became effective. After mitigating actions, including improved utilisation and increased efficiencies, Hirslanden expects the annualised impact on adjusted EBITDA to be around CHF25m. The Federal Government has also been preparing a national framework for the outmigration of certain medical treatments from an inpatient to an outpatient tariff, which is expected to be implemented from 1 January 2019. In the Canton of Lucerne, similar measures were implemented on 1 July 2017, in four further Cantons (Zurich, Zug, Schaffhausen and Aargau) on 1 January 2018 and in Basel and St. Gallen on 1 July 2018. The effect of these tariff changes on Hirslanden was further impacted by two factors out of the control of the division. Firstly, although the Federal Government is expected to implement a national framework from 1 January 2019, several insurance companies in Switzerland are already applying elements of the framework in some cantons that have not yet officially implemented outmigration. Secondly, different outmigration exclusion criteria are being applied across cantons which takes account of factors including age and comorbidities. Adapting to the current market and regulatory trends Hirslanden continues to adapt its business model to address the current trends in inpatient and outpatient activity driven by the recent regulatory changes to the healthcare market whilst maintaining excellent clinical performance. The recent tariff reductions as a result of these regulatory changes require Hirslanden to accelerate, in the near-term, the cost reduction programme to drive further operational efficiencies. In the first half of the year, the management team at Hirslanden was able to offset some of the revenue impact resulting from the tariff reductions through identified cost savings. However, in the second half of the year, plans have been implemented to increase those cost savings delivered in the first half. Therefore, with the additional customary Swiss seasonal benefits in the second half of the year which typically generate higher patient volumes and improved insurance mix compared to the first half, Hirslanden is expecting to deliver an EBITDA margin of around 16% for FY19. However, more substantial changes are being implemented at Hirslanden. The effect on the business in the first half of the year caused by the outmigration of care was a change in the inpatient insurance mix. This was largely due to a greater proportion of lower tariff general insured patients filling spare capacity created by fewer inpatient cases in many cantons. Hirslanden is adapting to the changing inpatient environment making fundamental changes to the service model and cost structure of the division including areas such as supply costs, service differentiation, operational efficiency, doctor recruitment and hospital reconfiguration. Hirslanden is implementing plans to advance its outpatient delivery model to capture the growing requirement for outpatient procedures in a cost-efficient manner. This will include the opening of further Outpatient Surgery Units, medical centres and doctors' consulting rooms and reconfiguring theatres and recovery areas in existing hospitals to treat the growing volume of outpatient cases cost effectively. With the knowledge and experience across Mediclinic of implementing outpatient solutions in Southern Africa and the Middle East, Hirslanden is confident of being able to execute on an effective strategy. Disciplined capital allocation In 1H18, Hirslanden invested CHF14m (down 7% on 1H18) in expansion capital projects and new equipment and CHF18m (down 31% on 1H18) on the replacement of existing equipment and upgrade projects. During the period, the division continued to invest in the HIT2020 project to standardise IT and systems across the group and completed the outpatient medical centre at Klinik Birshof. Hirslanden has reduced its capital investment plans for FY19 by around 15% taking FY19 forecast capex down CHF21m to CHF111m. There will be an ongoing review of capital allocation at Hirslanden during this period of regulatory challenges, whilst ensuring clinical standards and the quality of patient care remain appropriate. Outpatient projects expected to complete in the second half of the year include the Outpatient Surgery Unit at St. Anna Im Bahnhof, doctors' offices at Klinik Hirslanden and Stephanshorn and the new sports medicine centre at Clinique La Colline. The combination of the Hirslanden Clinique La Colline and Clinique des Grangettes in Geneva was announced in September 2018 and will be effective from October 2018. The combination, which included a cash consideration of CHF68m for a 60% controlling interest in the combined entity, strengthens Hirslanden's leading market position in Geneva and will deliver enhanced services for patients in addition to being earnings accretive. The hospital is supported by around 450 affiliated independent doctors and attracts around 92% supplementary insured inpatients and derives around 47% of its revenue from outpatient activities. For the year ended 31 December 2017, Clinique des Grangettes reported net revenue of CHF115m (GBP91m), EBITDA of CHF25m (GBP20m), an EBITDA margin of 21.7% and profit before tax of CHF22m (GBP17m). MEDICLINIC SOUTHERN AFRICA Variance 1H19 1H18 % Movement in bed days sold 0.5% (3.3%) Movement in revenue per bed day sold 4.4% 7.7% Inpatient admissions (000's) 286 289 (0.9%) Revenue (ZARm) 7 958 7 581 5% Adjusted EBITDA (ZARm) 1 684 1 590 6% Adjusted EBITDA margin 21.2% 21.0% Expansion capex (ZARm) 176 228 (23%) Maintenance capex (ZARm) 348 232 50% Adjusted EBITDA converted to cash 79% 90% Average GBP/ZAR exchange rate 17.71 17.08 4% Revenue (GBPm) 449 444 1% Adjusted EBITDA (GBPm) 95 93 2% Financial review In Southern Africa (including South Africa and Namibia), as at the end of the reporting period, Mediclinic operated 51 hospitals and 3 day clinics with a total of 8 157 beds and 15 887 employees (19 838 full-time equivalents). Mediclinic Southern Africa is the third largest private healthcare provider in Southern Africa by number of licensed beds. Mediclinic Southern Africa accounted for 32% of the Group's revenues (1H18: 32%) and 44% of its adjusted EBITDA (1H18: 40%). Revenue in Southern Africa increased by 5% to ZAR7 958m (1H18: ZAR7 581m). The growth was driven by a strong performance in the first quarter offset by fewer pneumonia and bronchitis related cases during the winter. Bed days sold increased by 0.5% and average revenue per bed day increased by 4.4%. Admissions decreased by 0.9%, impacted by second quarter volume weakness and continued decline in surgical day cases as the outmigration trend continues. The average length of stay increased by 1.4% whilst occupancy rates remained flat at 71.2% (1H18: 71.2%). Adjusted EBITDA increased by 6% to ZAR1 684m (1H18: ZAR1 590m) resulting in the adjusted EBITDA margin increasing to 21.2% from 21.0% due to excellent operational performance and cost management initiatives. Depreciation and amortisation increased by 4% to ZAR263m (1H18: ZAR253m) mainly due to increased spend on medical equipment. Operating profit increased by 7% to ZAR1 436m (1H18: ZAR1 338m). Net finance costs decreased by 5% to ZAR252m (1H18: ZAR266m), with lower interest rates supported by interest received on cash balances. Mediclinic Southern Africa contributed GBP37m to the Group's adjusted earnings (representing 49%) compared to GBP34m (representing 40%) in the comparative period. The division converted 79% (1H18: 90%) of adjusted EBITDA into cash generated from operations. The final day of the month being a Sunday impacted the receipt of payment runs from insurers in September. This normalised in October and the conversion rate at year end is expected to be in line with prior years. Investing to support continued long-term growth Mediclinic Southern Africa invested ZAR176m (down 23% on 1H18) on expansion capital projects and new equipment and ZAR348m (up 50% on 1H18) on the replacement of existing equipment and upgrade projects. The total number of licensed beds increased marginally to 8 157 (1H18: 8 095). This comprised of existing hospital expansion work completed in the second half of FY18 at Mediclinic's Thabazimbi and Newcastle hospitals, the addition of 60 beds acquired through the investment in Welkom Medical Centre, and the sale of the 34-bed Mediclinic Barberton Hospital. In FY19, Mediclinic Southern Africa remains committed to investing ZAR452m and ZAR846m on expansion and maintenance capex respectively. In line with Mediclinic's strategic priority to expand across the continuum of care, several existing hospital and day clinic projects are to be completed in FY19 and FY20, adding some 300 additional operational beds. Mediclinic's day clinic roll-out is unique and premised on co-locating the facilities with the main hospitals to adapt to the outmigration of care trend in Southern Africa where admissions across the division have been impacted by declining day cases. In October, Mediclinic opened its fourth day clinic at Mediclinic Newcastle, comprising of 30 beds and 3 theatres. On track for opening in FY20 are the day clinics at Mediclinic Nelspruit, Stellenbosch, Bloemfontein, Pietermaritzburg and Cape Gate. In August 2017, Mediclinic Southern Africa announced it had agreed to an investment in the Intercare group of companies ("Intercare"). The Intercare group was founded in 2000 and currently manages 20 multi-disciplinary primary care medical centres (which includes 15 dental centres), as well as 4 day hospitals, and 4 sub-acute rehabilitation hospitals and a fertility clinic in South Africa, servicing over 1 million patients per annum. The investment in Intercare comprises: a minority shareholding in the multi-disciplinary medical and dental centres which was completed in October 2017; and a controlling shareholding in the day hospitals and sub- acute and rehabilitation hospitals which received Competition Commission approval in August 2018 and completed in November 2018. Intercare will continue to manage all its facilities under the Intercare brand. Mediclinic's proposed acquisition of a controlling shareholding in Matlosana Medical Health Services (Pty) Ltd ("MMHS"), based in Klerksdorp in the North West Province of South Africa, was referred to the Competition Tribunal by the Competition Commission. Following the appeal hearing in June 2018, the closing arguments were due to continue at the end of September 2018. However, these were postponed by the tribunal and it is now expected that closing arguments and a verdict will be delivered in December 2018. Regulatory update The Competition Commission is currently undertaking a market inquiry into the private healthcare sector in South Africa to understand both whether there are features of the sector that prevent, distort or restrict competition and how competition in the sector can be promoted. The inquiry published its Provisional Findings and Recommendations Report on 5 July 2018. Mediclinic supports the process and submitted its responses to the provisional report on 15 October 2018. Mediclinic awaits the final publication which is scheduled to be at the end of November 2018. The South African Government is seeking a phased introduction of a National Health Insurance system over a 14-year period. Following the latest White Paper that was released in June 2017 for consultation, Mediclinic has engaged with the Department of Health with regards to the functioning of the proposed seven institutions, bodies and commissions, submitting comments on the draft guidelines and making nominations to the committees. On 21 June 2018, the government published the National Health Insurance Bill ('NHI Bill'). Mediclinic fully supports the principle of Universal Health Coverage and improving access and affordability of healthcare to all South Africans and will continue to contribute constructively towards achieving these goals. Mediclinic believes that an enhanced healthcare system can be achieved through greater collaboration across the public and private sectors to find common solutions and looks forward to the opportunity to contribute in this regard. Mediclinic's comprehensive comments on the NHI Bill were submitted on 20 September 2018. MEDICLINIC MIDDLE EAST Variance 1H19 1H18 % Movement in inpatient admissions 3.1% (2.2%) Outpatient cases ('000s) 1 347 1 356 (0.8%) Revenue (AEDm) 1 495 1 475 1% Revenue adjusted for IFRS 15(1) 1 495 1 429 5% Adjusted EBITDA (AEDm) 141 125 13% Adjusted EBITDA margin 9.4% 8.5% Adjusted EBITDA margin adjusted for IFRS 15(1) 9.4% 8.8% Expansion capex (AEDm) 256 105 144% Maintenance capex (AEDm) 26 28 (7%) Adjusted EBITDA converted to cash 78% 91% Average GBP/AED exchange rate 4.89 4.75 3% Revenue (GBPm) 307 310 (1%) Adjusted EBITDA (GBPm) 29 27 7% 1 The Group adopted the new IFRS 15 accounting standard (Revenue from Contracts with Customers) from 1 April 2018. IFRS 15 has implications for the Middle East division where disallowances have been reclassified to revenue. In the current period, AED40m was recognised as part of revenue (decreasing the revenue recognised). In the prior period, AED46m was recognised in operating expenses (increasing the revenue recognised). Whilst reported revenue in the prior period will not be re-stated, revenue growth guidance does reflect net revenue (adjusted for IFRS 15) in the prior period. Financial review Mediclinic Middle East, as at the end of the reporting period, operated 7 hospitals and 22 clinics with a total of 934 beds and 6 278 employees (6 278 full-time equivalents). Mediclinic Middle East is one of the leading private healthcare providers in the UAE with the majority of its operations in Dubai and Abu Dhabi (including Al Ain). Mediclinic Middle East accounted for 22% of the Group's revenues (1H18: 22%) and 14% of its adjusted EBITDA (1H18: 12%). The Middle East remains a long-term growth market for the provision of high-quality private healthcare services, driven by a growing expatriate market and ageing local population facing an increased incidence of lifestyle-related medical conditions and a maturing regulatory environment which is increasingly focused on quality and clinical outcomes measures. Mediclinic has confidence in its Middle East growth strategy which includes the opening of new hospitals and clinics in addition to expansion and upgrades to existing facilities. 1H19 revenue was AED1 495m, up 5% (1H18: 1 429m after adjusting for the impact of IFRS 15). Inpatient admissions were up 3.1% whilst outpatient volumes were down 0.8%, reflecting the divestment of non-core facilities and the ongoing insurance mix strategy in Abu Dhabi. This strategy resulted in Thiqa and Enhanced volumes combined increasing 20% and 11% for inpatients and outpatients respectively. Lower tariff Basic volumes over the same period declined 35% and 32% for inpatients and outpatients respectively. Basic plan patients now represent 23% and 22% of the insurance mix in Abu Dhabi for inpatients and outpatients respectively (1H18: 35% and 31% respectively). Including the costs associated with the start-up of the new Mediclinic Parkview Hospital, adjusted EBITDA increased by 13% to AED141m (1H18: AED125m) with the adjusted EBITDA margin increasing to 9.4% (1H18: 8.8% after adjusting for the impact of IFRS 15). Excluding the costs associated with the start-up of the new Mediclinic Parkview Hospital, adjusted EBITDA increased by 26% to AED160m (1H18: AED127m) with the adjusted EBITDA margin increasing to 10.7%. Adjusted depreciation and amortisation decreased by 1% to AED73m (1H18: AED74m), mainly due to the divestment of non-core assets. Net finance costs decreased by 47% to AED9m (1H18: AED17m) mainly due to the capitalisation of borrowing costs on capital projects of AED21m. The division contributed GBP12m to the Group's adjusted earnings (representing 16%) compared to GBP7m (representing 8%) in the prior year. The division converted 78% (1H18: 91%) of adjusted EBITDA into cash generated from operations. This was impacted by the late receipt from one major insurer which subsequently was received in October. For the full year, Mediclinic Middle East expects its conversion ratio compared to be more in line with the prior year. Investing in a dynamic and growing market The Middle East division is now entering an expansionary phase that is expected to drive an increase in revenue and improvement in EBITDA margins over time to around 20%. In Abu Dhabi, the growth will be driven by ongoing performance improved in the existing business and strategic investments at the Mediclinic Airport Road, Mediclinic Al Noor and the new Mediclinic Western Region hospitals. Further, the Abu Dhabi business will benefit from its increasing reputation and brand recognition following the investment made since the combination. Whilst doctor recruitment continues to support the growing business, vacancies have normalised and the focus has shifted to supporting doctors to grow their patient activities within the new remuneration framework that is similar to that established in Dubai. Aligned with this strategy is the target in Abu Dhabi of growing the inpatient volumes, similar to that in Dubai, through the continued investment in doctors, services and facilities. The divestment strategy of non-core assets was concluded in the prior year and aligns the portfolio with the long-term strategic and clinical targets. In Dubai, the ongoing performance of the existing business will benefit from significant growth at the new 182-bed Mediclinic Parkview Hospital which opened in September 2018. The project, Mediclinic's largest value greenfield construction, was completed in two and a half years and within the AED680m original budget. Initially opened with 100-beds supported by 80 doctors, the hospital will ramp up to full capacity over the coming years. The hospital is strategically located to serve the extensive population expansion that has occurred to the south of Dubai. The state-of-the-art hospital will focus on clinical excellence, offering patients a range of comprehensive consultant-led primary, secondary and tertiary level healthcare services and leading technology including comprehensive maternity, Level III Neonatal Intensive Care, 24/7 paediatric specialities and accident and emergency. In November 2018, Mediclinic Middle East announced the acquisition of a minority stake in Bourn Hall International MENA Ltd, the holding company for the Bourn Hall Fertility Centre in the UAE, a pioneering fertility centre established in the Middle East in 2010 and currently the only fertility centre in the Middle East to be accredited by JCI. The acquisition lays the foundation for a partnership focused on a long-term MENA-focused expansion in the field of Assisted Reproduction. In the initial stage, Bourn Hall Fertility Centre will take over operations of Mediclinic Middle East's existing IVF clinic located at Mediclinic Al Ain Hospital and operate it under the Bourn Hall brand. Bourn Hall will continue to operate and manage its IVF business independently and under its existing brand. Bourn Hall's UK founder, Professor Robert Edwards, invented the IVF concept over forty years ago, in 1978, and was subsequently awarded the Nobel Prize in medicine in 2010. The small investment was made from Mediclinic Middle East's available cash and debt and is expected to currently have an immaterial impact on the earnings of the division. In 1H19, Mediclinic Middle East invested AED256m (up 97% on 1H18) on expansion and AED26m (down 7% on 1H18) on maintenance capex. Expansion capex in the period largely related to the costs associated with the new Mediclinic Parkview Hospital and the Electronic Health Record ("EHR"). The EHR is being systematically rolled out across the Mediclinic Middle East division during FY19 and FY20 and is live in the new Mediclinic Parkview Hospital. The EHR is expected to deliver seamless care and improved service quality for patients as well as improved administration efficiency for the division. During the second half of the year, work will continue on the ground floor and mezzanine renovations at the Mediclinic Al Noor Hospital which is expected to be completed in 2019 with plans to address the long-term changes required to enhance the hospital continuing to progress. Looking further ahead, as part of the division's expansionary phase, the Mediclinic Airport Road 100-bed expansion and cancer centre project is progressing as planned towards the FY21 opening. The plans are progressing to construct a new 40-bed hospital in the Western Region of Abu Dhabi, which is due to open in FY22. In May 2018, Mediclinic Middle East completed the acquisition of the Dubai based City Centre Clinics Deira and Me'aisem from Majid Al Futtaim, the leading shopping mall, retail and leisure pioneer across the Middle East and North Africa. Under the terms of the agreement, Mediclinic Middle East has acquired City Centre Clinic Deira, a large outpatient facility which opened in 2013 with two day-care surgery theatres and 18 medical disciplines, and City Centre Clinic Me'aisem, a smaller community clinic focusing on six core disciplines. The clinics serve strategic geographic locations and offer the opportunity to refer higher acuity inpatient cases to existing Mediclinic Middle East hospitals and the Mediclinic Parkview Hospital. Significant potential also exists to attract additional doctors and over time to grow patient volumes and revenues as well as allowing Mediclinic Middle East the opportunity to partner with Majid Al Futtaim in the future. Regulatory update The division continues to maintain an active dialogue with government authorities on regulatory changes within the UAE healthcare sector. Preparations are ongoing for the implementation of Diagnosis Related Groups ("DRG") in Dubai which are still expected to be implemented in early 2019 with Mediclinic continuing to test the systems through a shadow billing process. The Dubai Health Authority ("DHA") is following a collaborative approach in the design and implementation of the DRGs and in addition to sharing and discussing the test version of the DRG methodology with the market, it also shared hospital level results and impact studies. Currently, it is expected that the DRGs will have a revenue neutral impact on the division, as prescribed by the DHA. SPIRE HEALTHCARE GROUP Mediclinic has a 29.9% investment in Spire. Spire's underlying performance for the six months to 30 June 2018 resulted in revenue decreasing 1.1% and EBITDA decreasing 20.6% with the EBITDA margin decreasing to 14.7% (30 June 2017: 18.1%). Adjusted EPS (excluding exceptional and tax one-off items) decreased by 52.9%. Underlying inpatient and day case admissions declined 5.3% driven by volume declines more than offsetting growth in self-pay volumes. Mediclinic's investment in Spire is equity accounted. Spire reported profit after tax of GBP8.2m for the six months ended 30 June 2018 (30 June 2017: GBP8.9m). After adjusting for the amortisation of intangible assets recognised in the notional purchase price allocation of the equity investment, the 1H19 income from associate, reflecting the disappointing financial results, was GBP1.8m (1H18: GBP1.1m). The market value of the investment in Spire was GBP169m at 30 September 2018, reflecting Spire's half year results announcement including its revised guidance, compared to the carrying value of GBP348m at 31 March 2018. An impairment test was performed at 30 September 2018 by updating the key assumptions applied in the value in use calculation performed at 31 March 2018. As a result, an impairment charge of GBP164m was recorded against the carrying value of the equity accounted investment. OUTLOOK The Group provides the following guidance for FY19 which remains unchanged since the October 2018 Trading Update: - Hirslanden: Including the contribution from Clinique des Grangettes, Hirslanden expects to deliver modest revenue growth in FY19. As a result of the regulatory and market trends more than offsetting the benefits of cost savings, efficiency initiatives and seasonal benefits, the FY19 EBITDA margin is expected to be around 16%. - Mediclinic Southern Africa: FY19 revenue growth will be driven by an expected increase in bed days sold of between 1-2%, combined with tariff increases broadly in line with inflation. The EBITDA margin is expected to be broadly in line with recent years. - Mediclinic Middle East: In FY19, the Middle East division is expected to deliver revenue growth (adjusted for the adoption of IFRS 15) in the high single-digit percentage range reflecting the underlying operating performance of the business and additional bed capacity coming online in the second half of the year. The operating leverage in the underlying business offset to some extent by the start-up losses associated with expansion projects is expected to deliver a slightly improved EBITDA margin compared to the prior year (adjusted for the adoption of IFRS 15, FY18: 13.0%). - The Group's capital expenditure budget, in constant currency, for FY19 is expected to increase by 9% to GBP269m (FY18: GBP245m). This comprises GBP86m in Hirslanden (FY18: GBP101m), GBP75m in Mediclinic Southern Africa (FY18: GBP62m), GBP107m in Mediclinic Middle East (FY18: GBP80m) and GBP1m (FY18: GBP2m) for Corporate. The increase is largely driven by expansion in the Middle East and upgrades in Southern Africa. Exchange rates used CHF 1.29; ZAR 17.22; and AED 4.87. BOARD CHANGES The following changes to the Board and its Committees occurred since year-end, as previously announced: - Dr Ronnie van der Merwe (Chief Clinical Officer and Chief Executive Officer ("CEO") Designate) succeeded Mr Danie Meintjes as CEO of the Company on 1 June 2018 and was appointed as an executive director of the Company with effect from that date. - Mr Danie Meintjes was re-elected as a director of the Company at the Annual General Meeting held on 25 July 2018 ("2018 AGM"), continuing to serve in an executive capacity until 31 July 2018 and as a non-executive director from 1 August 2018. - Dr Anja Oswald was appointed as an independent non-executive director and member of the Remuneration Committee and Nomination Committee on 25 July 2018 and Ms Nandi Mandela and Prof Dr Robert Leu retired as non-executive directors of the Company at the conclusion of the 2018 AGM. They also retired from all relevant Board committees at that time. - Effective from 1 April 2018, Dr Felicity Harvey took over from Dr Edwin Hertzog as chair of the Clinical Performance and Sustainability Committee and Dr Muhadditha Al Hashimi joined this committee as an additional member. Dr Hertzog remains a member of the committee. - Various other changes were made to Board committee memberships: Mr Trevor Petersen stepped down as a member of the Nomination Committee, with Dr Felicity Harvey appointed as a new committee member. Mr Danie Meintjes stepped down as a member of the Clinical Performance and Sustainability Committee, with Mr Seamus Keating and Dr Ronnie van der Merwe appointed as new committee members. Mr Seamus Keating stepped down as a member of the Investment Committee, with Dr Ronnie van der Merwe appointed as a new committee member. The Company announces, as further detailed in a separate announcement today, that Mr Desmond Smith will retire as an independent non-executive director and as Senior Independent Director with effect from the conclusion of the 2019 AGM on 24 July 2019. Mr Smith will be succeeded as Senior Independent Director and as Chairman of the Audit and Risk Committee from that date by Mr Alan Grieve. FINANCIAL REVIEW ADJUSTED NON-IFRS FINANCIAL MEASURES The Group uses adjusted income statement reporting as non-IFRS measures in evaluating performance and as a method to provide shareholders with clear and consistent reporting. The adjusted measures are intended to remove volatility associated with certain types of exceptional income and charges from reported earnings. Historically, EBITDA and adjusted EBITDA were disclosed as supplemental non-IFRS financial performance measures because they are regarded as useful metrics to analyse the performance of the business from period to period. Measures like adjusted EBITDA are used by analysts and investors in assessing performance. The rationale for using non-IFRS measures: - it tracks the adjusted operational performance of the Group and its operating segments by separating out exceptional items; - non-IFRS measures are used by management for budgeting, planning and monthly financial reporting; - non-IFRS measures are used by management in presentations and discussions with investment analysts; and - non-IFRS measures are used by the directors in evaluating management's performance and in setting management incentives. The Group's policy is to adjust, inter alia, the following types of significant income and charges from the reported IFRS measures to present adjusted results: - cost associated with major restructuring programmes; - profit/loss on sale of assets and transaction costs incurred during acquisitions; - past service cost charges / credits in relation to pension fund conversion rate changes; - accelerated amortisation charges; - mark-to-market fair value gains / losses, relating to ineffective interest rate swaps; - impairment charges and reversal of impairment charges; - insurance proceeds; and - prior year tax adjustments and tax impact of the above items. EBITDA is defined as operating profit before depreciation and amortisation and impairments of non-financial assets, excluding other gains and losses. Non-IFRS financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with IFRS. The adjusted measures used by the Group are not necessarily comparable with those used by other entities. The Group has consistently applied this definition of adjusted measures as it has reported on its financial performance in the past as the directors believe this additional information is important to allow shareholders to better understand the Group's trading performance for the reporting period. It is the Group's intention to continue to consistently apply this definition in the future. GROUP FINANCIAL PERFORMANCE Group revenue decreased by 1% to GBP1 387m (1H18: GBP1 405m) for the reporting period. In constant currency terms, 1H19 revenue was up 2% due to disappointing revenue growth in Hirslanden and good revenue growth in Southern Africa and the Middle East, compared to the comparative period. EBITDA and adjusted EBITDA was 8% lower at GBP213m (1H18: GBP232m). The EBITDA margin declined from 16.5% to 15.4%. Adjusted depreciation and amortisation was up 7% to GBP76m (1H18: GBP71m) in line with expectations and due to the continued investment to support growth and enhance patient experience and clinical quality. The Group recorded an operating profit of GBP39m in 1H19 (1H18: GBP133m). Adjusted operating profit decreased by 15% to GBP137m (1H18: GBP161m), largely arising from the poor Hirslanden contribution which was impacted by recent regulatory changes in the Swiss healthcare market. Operating profit was adjusted for the following exceptional items: - recognition of an impairment charge to Hirslanden properties. Non-financial assets are considered for impairment when impairment indicators are identified at an individual cash-generating unit ("CGU") level. During the period, CGUs in Hirslanden were tested for impairment. For one CGU in particular, the carrying value was determined to be higher than its recoverable amount and, as a result, an impairment charge of GBP43m was recognised in the income statement; and - recognition of an impairment charge to the Hirslanden trade name and Linde trade name. As part of the CGU impairment testing, the carrying amounts of these trade names were determined to be higher than their recoverable amounts and, as a result, impairments of GBP39m and GBP16m were recognised in the income statement. Adjusted net finance costs were down 31% at GBP27m (1H18: GBP39m) benefiting from the successful October 2017 refinancing in Switzerland as well the capitalisation of borrowing costs on capital projects. The Group's reported effective tax rate of (6%) (1H18: (300%)) is significantly skewed by the exceptional non-deductible impairment charge for the Spire equity investment. Adjusted taxation was GBP26m (1H18: GBP29m) with an adjusted effective tax rate for the period of 23.4% (1H18: 24.0%). After adjusting for the amortisation of intangible assets recognised in the notional purchase price allocation of the equity investment, the 1H19 income from associates was GBP1.8m (1H18: GBP1.1m). The Group recorded loss attributable to equity holders of GBP168m in 1H19 (1H18: loss of GBP50m). Adjusted earnings decreased by 9% to GBP76m (1H18: GBP84m). Adjusted earnings per share were 9% lower at 10.3 pence (1H18: 11.3 pence). Reported loss were adjusted for the following exceptional item in the period (in addition to the Hirslanden impairments above): - recognition of an impairment charge on the equity investment in Spire of GBP164m. During the half year, the Group performed an impairment test updating the key assumptions applied in the value in use calculation performed at 31 March 2018. In particular, the Group adjusted the value in use calculation for the guidance announced by Spire in September 2018 about the current financial performance and about the related impact on short- and medium-term growth rates and revisited other key assumptions in this context. As a result, an impairment loss of GBP164m was recorded against the carrying value. EARNINGS RECONCILIATIONS 30 SEPTEMBER 2018 Total Hirslanden Southern Africa Middle East Spire Corporate GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm Revenue 1 387 631 449 307 - - Operating profit/(loss) 39 (54) 81 14 - (2) (Loss)/profit attributable to equity holders* (168) (53) 37 12 (162) (2) Reconciliations Operating profit/(loss) 39 (54) 81 14 - (2) Add back: - Other gains and losses - - (1) - - 1 - Depreciation and amortisation 76 46 15 15 - - - Impairment of properties 43 43 - - - - - Impairment of intangible assets 55 55 - - - - EBITDA 213 90 95 29 - (1) No adjustments - - - - - - Adjusted EBITDA 213 90 95 29 - (1) Operating profit/(loss) 39 (54) 81 14 - (2) - Impairment of properties 43 43 - - - - - Impairment of intangible assets 55 55 - - - - Adjusted operating profit/(loss) 137 44 81 14 - (2) (Loss)/profit attributable to equity holders* (168) (53) 37 12 (162) (2) Exceptional items - Impairment of properties 43 43 - - - - - Impairment of intangible assets 55 55 - - - - - Impairment of associate 164 - - - 164 - - Tax on exceptional items (18) (18) - - - - Adjusted earnings 76 27 37 12 2 (2) Weighted average number of shares (millions) 737.1 Adjusted earnings per share (pence) 10.3 * Profit attributable to equity holders in Hirslanden and Corporate is shown after the elimination of intercompany loan interest of GBP8m. 30 SEPTEMBER 2017 Total Hirslanden Southern Africa Middle East Spire Corporate GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm Revenue 1 405 651 444 310 - - Operating profit/(loss) 133 72 78 (16) - (1) (Loss)/profit attributable to equity holders* (50) 46 34 (21) (108) (1) Reconciliations Operating profit/(loss) 133 72 78 (16) - (1) Add back: - Other gains and losses 5 - - 5 - - - Depreciation and amortisation 94 41 15 38 - - EBITDA 232 113 93 27 - (1) No adjustments - - - - - - Adjusted EBITDA 232 113 93 27 - (1) Operating profit/(loss) 133 72 78 (16) - (1) Exceptional items - Accelerated amortisation 23 - - 23 - - - Loss on disposal of businesses 5 - - 5 - - Adjusted operating profit/(loss) 161 72 78 12 - (1) (Loss)/profit attributable to equity holders* (50) 46 34 (21) (108) (1) Exceptional items - Accelerated amortisation 23 - - 23 - - - Loss on disposal of businesses 5 - - 5 - - - Fair value gains on ineffective cash flow hedges (4) (4) - - - - - Impairment of associate 109 - - - 109 - - Tax on exceptional items 1 1 - - - - Adjusted earnings 84 43 34 7 1 (1) Weighted average number of shares (millions) 737.1 Adjusted earnings per share (pence) 11.3 * Profit attributable to equity holders in Hirslanden and Corporate is shown after the elimination of intercompany loan interest of GBP8m. FOREIGN EXCHANGE RATES Although the Group reports its results in pounds sterling, the divisional profits are generated in Swiss franc, South African rand and UAE dirham. Consequently, movements in exchange rates affected the reported earnings and reported balances in the statement of financial position. The resulting currency translation difference, which is the amount by which the Group's interest in the equity of the operating divisions increased because of spot rate movements, amounted to GBP169m (1H18: decrease of GBP189m) and was credited (1H18: debited) to the statement of other comprehensive income. The main reason for the increase was the strengthening of period end Swiss franc and UAE dirham rates against pounds sterling. Foreign exchange rate sensitivity: - The impact of a 10% change in the GBP/CHF exchange rate for a sustained period of six months is that reported profit for the period would increase/decrease by GBP3m (1H18: increase/decrease by GBP5m) due to exposure to the GBP/CHF exchange rate. - The impact of a 10% change in the GBP/ZAR exchange rate for a sustained period of six months is that reported profit for the period would increase/decrease by GBP4m (1H18: increase/decrease by GBP5m) due to exposure to the GBP/ZAR exchange rate. - The impact of a 10% change in the GBP/AED exchange rate for a sustained period of six months is that reported profit for the period would increase/decrease by GBP1m (1H18: increase/decrease by GBP2m) due to exposure to the GBP/AED exchange rate. During the reporting period, the average and closing exchange rates were the following: Variance 1H19 1H18 % Average rates Swiss franc 1.31 1.26 4% South African rand 17.71 17.08 4% UAE dirham 4.89 4.75 3% Variance 1H19 FY18 % Period end rates: Swiss franc 1.28 1.34 (4%) South African rand 18.48 16.57 12% UAE dirham 4.78 5.15 (7%) CASH FLOW The Group converted 69% (1H18: 91%) of adjusted EBITDA into cash generated from operations. The receivables of all three operating divisions were impacted by timing differences which are expected to normalise before the end of the financial year. 1H19 1H18 GBP'm GBP'm Cash from operations (a) 146 210 Adjusted EBITDA (b) 213 232 Cash conversion ((a)/(b) x 100) 69% 91% INTEREST-BEARING BORROWINGS Interest-bearing borrowings increased from GBP1 937m at 31 March 2018 to GBP2 029m at 30 September 2018 due to the proceeds from the refinancing transactions in Mediclinic Southern Africa and Mediclinic Middle East. The closing exchange rate differences also increased the closing balances. 1H19 FY18 GBP'm GBP'm Borrowings 2 029 1 937 Less: cash and cash equivalents (242) (261) Net debt 1 787 1 676 Total equity 3 364 3 373 Debt-to-equity capital ratio 53.1% 49.7% ASSETS Property, equipment and vehicles and intangible assets increased from GBP3 590m and GBP1 406m respectively at 31 March 2018 to GBP3 694m and GBP1 459m at 30 September 2018. This included an increase of GBP113m on capital projects and fixed asset additions in line with the continued investment to support growth and enhance patient experience and clinical quality. In addition to the depreciation and amortisation charge, the balances were further reduced by the impairment charges of GBP43m to properties and GBP55m to trade names at Hirslanden. The change in the closing exchange rate increased the closing balances of property, equipment and vehicles. Adjusted depreciation and amortisation was calculated as follows: 1H19 1H18 GBP'm GBP'm Depreciation and amortisation 76 94 Accelerated amortisation - (23) Adjusted depreciation and amortisation 76 71 An impairment charge of GBP164m (1H18: GBP109m) was recognised for the Spire equity investment, reducing the carrying value to GBP181m. All impairment charges have been excluded from the adjusted earnings calculation consistent with prior periods. HIRSLANDEN PENSION PLAN Hirslanden provides defined contribution pension plans in terms of Swiss law to employees, the assets of which are held in separate trustee-administered funds. These plans are funded by payments from employees and Hirslanden, taking into account the recommendations of independent qualified actuaries. Because of the strict definition of defined contribution plans in IAS 19, in terms of IFRS, these plans are classified as defined benefit plans, since the funds are obliged to take some investment and longevity risk in terms of Swiss law. The IAS 19 pension liability was valued by the actuaries at the end of the period and amounted to an asset of GBP24m (31 March 2018: a liability of GBP4m), included under "Retirement benefit obligations" in the Group's statement of financial position. The decrease in the pension liability was largely due to the increase of the discount rate from 0.75% to 0.90% as well as changes in actuarial assumptions. FINANCE COSTS Adjusted net finance costs were down 31% at GBP27m (1H18: GBP39m) benefiting from the successful October 2017 refinancing in Switzerland as well the capitalisation of borrowing costs on capital projects. Adjusted net finance cost was calculated as follows: 1H19 1H18 GBP'm GBP'm Finance cost 31 41 Finance income (4) (6) Net finance cost 27 35 Fair value gains on ineffective cash flow hedges - 4 Adjusted finance cost 27 39 INCOME TAX The Group's effective tax rate for the period under review was (6%) (1H18: (300%)), mainly due to the exceptional non-deductible expenses which include the impairment of the equity investment and accelerated amortisation in the prior period. Excluding these exceptional non-deductible charges, the adjusted effective tax rate would be 23.4% (1H18: 24.0%) for the period ended 30 September 2018. Adjusted income tax was calculated as follows: 1H19 1H18 GBP'm GBP'm Income tax expense 8 30 Tax impact of exceptional items 18 (1) - Impairment of properties 7 - - Impairment of trade names 11 - - Fair value gains on ineffective cash flow hedges - (1) Adjusted income tax expense 26 29 REFINANCING OF DEBT The borrowing facilities in Mediclinic Southern Africa and Mediclinic Middle East were refinanced during the period. In both instances, the terms of the loans were extended with favourable pricing. The effective date for the funding and the closing was 26 September 2018 and 29 August 2018 respectively. In Mediclinic Middle East, a new term loan of GBP192m (AED920m) and revolving loan facility of GBP38m (AED184m) were put in place. DIVIDEND POLICY AND DIVIDEND DECLARATION The Group's dividend policy is to target a pay-out ratio of between 25% and 30% of full year adjusted earnings. The Board may revise the policy at its discretion. The Board declared an interim dividend from retained earnings of 3.20 pence per ordinary share for the six months ended 30 September 2018. Shareholders on the South African register will be paid the ZAR cash equivalent of 59.16800 cents (47.33440 cents net of dividend withholding tax) per share. A dividend withholding tax of 20% will be applicable to all shareholders on the South African register who are not exempt therefrom. The ZAR cash equivalent has been calculated using the following exchange rate: GBP1: ZAR18.49, being the 5-day average ZAR/GBP exchange rate (Bloomberg) on Friday, 9 November 2018 at 3:00pm GMT. The interim dividend will be paid on Tuesday, 18 December 2018 to all ordinary shareholders who are on the register of members at the close of business on the record date of Friday, 7 December 2018. The salient dates for the dividend will be as follows: Dividend announcement date Thursday, 15 November 2018 Last date to trade cum dividend (SA register) Tuesday, 4 December 2018 First date of trading ex-dividend (SA register) Wednesday, 5 December 2018 First date of trading ex-dividend (UK register) Thursday, 6 December 2018 Record date Friday, 7 December 2018 Payment date Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised within Strate from Wednesday, 5 December 2018 to Friday, 7 December 2018, both dates inclusive. No transfers between the UK and SA registers may take place from Thursday, 15 November 2018 to Friday, 7 December 2018, both days inclusive. Tax treatment for shareholders on the South African register South African tax resident shareholders on the South African register: In terms of the Company's Dividend Access Trust structure, the following South African tax resident shareholders on the South African register will receive a component of the dividend from the Dividend Access Trust and therefore regarded as a local South African dividend, with the remaining component from the Company and therefore regarded as a foreign non-South African dividend. For purposes of South African dividend withholding tax, the entire dividend of 59.16800 cents per share is taxable at a rate of 20%, unless an applicable exemption applies: 1. in the case of shares held in certificated form, who are registered on the South African register with an address in South Africa (other than PLC Nominees Proprietary Limited (or any successor entity through which shares held in dematerialised form are held)); and 2. in the case of shares held in dematerialised form, in respect of whom the South African transfer secretaries of the Company have determined, in good faith and by reference to the information provided to them by the eligible shareholders and/or their brokers and/or central securities depository participants, that such eligible shareholders are either (i) tax resident in South Africa or (ii) have an address in South Africa and have not expressly indicated that they are not tax resident in South Africa as at the dividend record date. The component of the dividend payable by the Dividend Access Trust and by the Company will be announced on the JSE's Stock Exchange News Service and on the LSE's Regulatory News Service as soon as possible after the record date, 7 December 2018, of the dividend. Non-South African tax resident shareholders on the South African register: Non-South African tax resident shareholders on the South African register will be paid the dividend by the Company in the usual way and not through the Dividend Access Trust. The entire dividend of 59.16800 cents per share payable to such shareholders will therefore be regarded as a foreign dividend and exempt from South African dividend withholding tax, provided that the relevant exemption forms have been completed and submitted as prescribed. PRINCIPAL RISKS The Board is ultimately accountable for the Group's risk management process and system of internal control. In the first half of the year, regulatory changes in Switzerland have had a material impact on the Group's financial performance. Hirslanden's management team is actively addressing the changes that have impacted all Swiss healthcare providers to enable the division to adapt in order to appropriately address to the future healthcare requirements in Switzerland. Other than the risk discussed above, the principal risks and mitigating factors remained the same as described on pages 44 to 49 of the Group's Annual Report and Financial Statements for the year ended 31 March 2018 (a copy of which is available on the Group's website at www.mediclinic.com). DIRECTORS' RESPONSIBILITIES STATEMENT The Directors confirm that, to the best of their knowledge the unaudited condensed financial information has been prepared in accordance with International Financial Reporting Standards as adopted by the European Union and that this announcement includes a fair review of the information required by the Disclosure Guidance and Transparency Rules 4.2.4, 4.2.7 and 4.2.8. After making enquiries, the Directors considered it appropriate to adopt the going concern basis in preparing the financial information. The names and functions of the Company's directors are listed on the Company's website. By order of the Board. Ronnie van der Merwe Jurgens Myburgh Chief Executive Officer Chief Financial Officer 15 November 2018 CAUTIONARY STATEMENT This announcement contains certain forward-looking statements relating to the business of the Company and its subsidiaries (collectively, the "Group"), including with respect to the progress, timing and completion of the Group's development, the Group's ability to treat, attract, and retain patients and customers, its ability to engage consultants and general practitioners and to operate its business and increase referrals, the integration of prior acquisitions, the Group's estimates for future performance and its estimates regarding anticipated operating results, future revenue, capital requirements, shareholder structure and financing. In addition, even if the Group's actual results or development are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of the Group's results or developments in the future. In some cases, you can identify forward-looking statements by words such as "could," "should," "may," "expects," "aims," "targets," "anticipates," "believes," "intends," "estimates," or similar words. These forward-looking statements are based largely on the Group's current expectations as of the date of this announcement and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievement expressed or implied by these forward-looking statements. In particular, the Group's expectations could be affected by, among other things, uncertainties involved in the integration of acquisitions or new developments, changes in legislation or the regulatory regime governing healthcare in Switzerland, South Africa, Namibia and the UAE and poor performance by healthcare practitioners who practice at our facilities, unexpected regulatory actions or suspensions, competition in general, the impact of global economic changes, and the Group's ability to obtain or maintain accreditation or approval for its facilities or service lines. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements made in this announcement will in fact be realised and no representation or warranty is given as to the completeness or accuracy of the forward-looking statements contained in this announcement. The Group is providing the information in this announcement as of this date, and we disclaim any intention or obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise. INDEPENDENT REVIEW REPORT TO MEDICLINIC INTERNATIONAL PLC Report on the condensed consolidated financial information Our conclusion We have reviewed Mediclinic International plc's condensed consolidated financial information (the "interim financial statements") in the interim results announcement of Mediclinic International plc for the six month period ended 30 September 2018. Based on our review, nothing has come to our attention that causes us to believe that the interim financial statements are not prepared, in all material respects, in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority. What we have reviewed The interim financial statements comprise: - the condensed consolidated statement of financial position at 30 September 2018; - the condensed consolidated income statement and condensed consolidated statement of comprehensive income for the period then ended; - the condensed consolidated statement of cash flows for the period then ended; - the condensed consolidated statement of changes in equity for the period then ended; and - the notes to the interim financial statements. The interim financial statements included in the interim results announcement have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority. As disclosed in note 2 to the interim financial statements, the financial reporting framework that has been applied in the preparation of the full annual financial statements of the Group is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union. Responsibilities for the interim financial statements and the review Our responsibilities and those of the directors The interim results announcement, including the interim financial statements, is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the interim results announcement in accordance with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority. Our responsibility is to express a conclusion on the interim financial statements in the interim results announcement based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of complying with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority and for no other purpose. We do not, in giving this conclusion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. What a review of interim financial statements involves We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We have read the other information contained in the interim results announcement and considered whether it contains any apparent misstatements or material inconsistencies with the information in the interim financial statements. PricewaterhouseCoopers LLP Chartered Accountants London 14 November 2018 a) The maintenance and integrity of the Mediclinic International plc website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the interim financial statements since they were initially presented on the website. b) Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION at 30 September 2018 30 Sept 2018 31 Mar 2018 (Unaudited) (Audited) Notes GBP'm GBP'm ASSETS Non-current assets 5 396 5 382 Property, equipment and vehicles 4 3 694 3 590 Intangible assets 5 1 459 1 406 Equity accounted investments 6 190 357 Retirement benefit asset 8 24 - Other investments and loans 8 7 Derivative financial instruments 1 - Deferred income tax assets 20 22 Current assets 1 042 961 Inventories 91 90 Trade and other receivables 704 607 Other investments and loans 1 1 Current income tax assets 4 1 Cash and cash equivalents 242 261 Assets classified as held for sale - 1 Total assets 6 438 6 343 EQUITY Capital and reserves Share capital 74 74 Share premium reserve 690 690 Treasury shares - (1) Retained earnings 4 872 5 057 Other reserves (2 355) (2 534) Attributable to equity holders of the Company 3 281 3 286 Non-controlling interests 83 87 Total equity 3 364 3 373 LIABILITIES Non-current liabilities 2 531 2 445 Borrowings 7 1 936 1 866 Deferred income tax liabilities 479 467 Retirement benefit obligations 87 86 Provisions 27 23 Derivative financial instruments 1 2 Cash-settled share-based payment liabilities 1 1 Current liabilities 543 525 Trade and other payables 422 424 Borrowings 7 93 71 Provisions 15 15 Retirement benefit obligations 11 10 Current income tax liabilities 2 5 Total liabilities 3 074 2 970 Total equity and liabilities 6 438 6 343 CONDENSED CONSOLIDATED INCOME STATEMENT for the six months ended 30 September 2018 Notes 30 Sept 2018 30 Sept 2017 (Unaudited) (Unaudited) GBP'm GBP'm Revenue 1 387 1 405 Cost of sales (872) (885) Administration and other operating expenses (476) (382) Impairment of properties 4 (43) - Impairment of intangible assets 5 (55) - Other administration and operating expenses (378) (382) Other gains and losses - (5) Operating profit 39 133 Finance income 4 6 Finance cost 9 (31) (41) Share of net profit of equity accounted investments 6 2 1 Impairment of equity accounted investment 6 (164) (109) Loss before tax (150) (10) Income tax expense 10 (8) (30) Loss for the period (158) (40) Attributable to: Equity holders of the Company (168) (50) Non-controlling interests 10 10 (158) (40) Loss per ordinary share attributable to the equity holders of the Company - pence Basic 11 (22.8) (6.8) Diluted 11 (22.8) (6.8) CONDENSED CONSOLIDATED STATEMENT OF OTHER COMPREHENSIVE INCOME for the six months ended 30 September 2018 30 Sept 2018 30 Sept 2017 (Unaudited) (Unaudited) GBP'm GBP'm Loss for the period (158) (40) Other comprehensive income/(loss) Items that may be reclassified to the income statement 171 (189) Currency translation differences 169 (189) Fair value adjustment - cash flow hedges 2 - Items that may not be reclassified to the income statement 20 31 Remeasurements of retirement benefit obligations 20 31 Other comprehensive income/(loss), net of tax 191 (158) Total comprehensive income/(loss) for the period 33 (198) Attributable to: Equity holders of the Company 32 (202) Non-controlling interests 1 4 33 (198) CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY for the six months ended 30 September 2018 Attributable Share- Foreign to equity Capital Share Reverse based currency holders Non- Share redemption premium acquisition Treasury payment translation Hedging Retained of the controlling Total capital reserve reserve reserve shares reserve reserve reserve earnings Company interests equity GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm Balance at 1 April 2018 (audited) 74 6 690 (3 014) (1) 1 468 5 5 057 3 286 87 3 373 IFRS 9 transition adjustment - - - - - - - - (2) (2) - (2) Restated as at 1 April 2018 (unaudited) 74 6 690 (3 014) (1) 1 468 5 5 055 3 284 87 3 371 (Loss)/profit for the period - - - - - - - - (168) (168) 10 (158) Other comprehensive income/(loss) for the period - - - - - - 178 2 20 200 (9) 191 Total comprehensive income/(loss) for the period - - - - - - 178 2 (148) 32 1 33 Transfer to other reserves - - - - - - 7 (7) - - - - Non-controlling shareholders acquired - - - - - - - - - - 2 2 Settlement of Forfeitable Share Plan - - - - 1 (1) - - - - - - Dividends paid - - - - - - - - (35) (35) (7) (42) Balance at 30 September 2018 (unaudited) 74 6 690 (3 014) - - 653 - 4 872 3 281 83 3 364 CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY for the six months ended 30 September 2017 Attributable Share- Foreign to equity Capital Share Reverse based currency holders Non- Share redemption premium acquisition Treasury payment translation Hedging Retained of the controlling Total capital reserve reserve reserve shares reserve reserve reserve earnings Company interests equity GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm Balance at 1 April 2017 (audited) 74 6 690 (3 014) (2) 24 779 4 5 525 4 086 78 4 164 (Loss)/profit for the period - - - - - - - - (50) (50) 10 (40) Other comprehensive (loss)/income for the period - - - - - - (183) - 31 (152) (6) (158) Total comprehensive (loss)/income for the period - - - - - - (183) - (19) (202) 4 (198) Transfer to retained earnings - - - - - (24) - - 24 - - - Treasury shares purchased (Forfeitable Share Plan) - - - - 1 - - - - 1 - 1 Transactions with non-controlling shareholders - - - - - - - - (1) (1) (1) (2) Dividends paid - - - - - - - - (35) (35) (8) (43) Balance at 30 September 2017 (unaudited) 74 6 690 (3 014) (1) - 596 4 5 494 3 849 73 3 922 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS for the six months ended 30 September 2018 Notes 30 Sep 2018 30 Sep 2017 (Unaudited) (Unaudited) GBP'm GBP'm Inflow/ Inflow/ (outflow) (outflow) CASH FLOW FROM OPERATING ACTIVITIES Cash received from customers 1 308 1 477 Cash paid to suppliers and employees (1 162) (1 267) Cash generated from operations 146 210 Interest received 4 6 Interest paid (39) (41) Tax paid (30) (26) Net cash generated from operating activities 81 149 CASH FLOW FROM INVESTMENT ACTIVITIES (131) (182) Investment to maintain operations (47) (62) Investment to expand operations (72) (57) Acquisition of subsidiaries 12 (13) (83) Disposal of subsidiaries - 3 Dividends received from equity accounted investment 3 3 Acquisition of other investments and loans (2) - Investment in short-term deposits - 14 Net cash utilised before financing activities (50) (33) CASH FLOW FROM FINANCING ACTIVITIES 36 (48) Distributions to non-controlling interests (7) (8) Distributions to shareholders 15 (35) (35) Transaction with non-controlling interest 2 3 Proceeds from borrowings 110 2 Repayment of borrowings (31) (10) Refinancing transaction costs (3) - Net decrease in cash and cash equivalents (14) (81) Opening balance of cash and cash equivalents 261 361 Exchange rate fluctuations on foreign cash (5) (18) Closing balance of cash and cash equivalents 242 262 NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL INFORMATION 1. GENERAL INFORMATION Mediclinic is an international private hospital group with operations in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing value-based healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private hospital group. The Company is a public limited company, with a primary listing on the London Stock Exchange and secondary listings on the Johannesburg Stock Exchange and the Namibian Stock Exchange and incorporated and domiciled in the UK (registered number: 08338604). The address of its registered office is 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom. The condensed consolidated financial information for the six months ended 30 September 2018 was approved by the Board on 14 November 2018. 2. BASIS OF PREPARATION The condensed consolidated interim financial information is prepared in accordance with International Financial Reporting Standards ('IFRS') as adopted by the European Union ('EU'), the Companies Act 2006 and Article 4 of the EU IAS Regulations. The results announcement has been prepared applying consistent accounting policies to those applied by the Group in the 31 March 2018 financial year, except for the estimation of income tax in accordance with IAS 34 at 30 September 2018 and subject to the adoption of IFRS 9 and IFRS 15. The Group has prepared the condensed consolidated interim financial information on a going concern basis. The condensed consolidated financial statements has been prepared in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority and with IAS 34 Interim Financial Reporting, as adopted by the EU. They do not include all the information required for full annual financial statements and should be read in conjunction with information contained in the Group's Annual Report and Financial Statements for the year ended 31 March 2018. The condensed consolidated interim financial information has been reviewed, not audited. This results announcement does not constitute statutory accounts of the Group within the meaning of sections 434(3) and 435(3) of the Companies Act 2006. Statutory accounts for the year ended 31 March 2018 were approved by the Board of Directors on 23 May 2018 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not draw attention to any matters by way of emphasis and did not contain statements under sections 498(2) or (3) of the Companies Act 2006. The Group has adopted IFRS 9 and IFRS 15 from 1 April 2018. Refer to note 13 for a description of the changes in accounting policies. The Group will adopt IFRS 16 Leases from 1 April 2019. A key change arising from IFRS 16 is that most operating leases will be accounted for on the statement of financial position of lessees and would recognise a right of use asset and a lease liability. In general, properties are owned by the Group with the exception of the Middle East division where properties are generally leased. Our impact assessment of IFRS 16 is ongoing and we intend to provide an update at year end. Functional and presentation currency The condensed consolidated financial statements are presented in pounds sterling, rounded to the nearest million. The functional currency of the majority of the Group's entities, and the currencies of the primary economic environments in which they operate, is the Swiss franc, South African rand and United Arab Emirates dirham. The United Arab Emirates dirham is pegged against the United States dollar at a rate of 3.6725 per US Dollar. 3. SEGMENTAL REPORT The reportable operating segments are identified as follows: Switzerland, Southern Africa, Middle East and additional segments are shown for the United Kingdom and Corporate. Reportable operating segments Other PERIOD ENDED Southern Middle United 30 SEPTEMBER 2018 Total Switzerland Africa East Kingdom Corporate GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm Revenue 1 387 631 449 307 - - EBITDA 213 90 95 29 - (1) EBITDA before management fee 213 93 98 30 - (8) Management fees included in EBITDA - (3) (3) (1) - 7 Other gains and losses - - 1 - - (1) Depreciation and amortisation (76) (46) (15) (15) - - Impairment of properties (43) (43) - - - - Impairment of intangible assets (55) (55) - - - - Operating profit/(loss) 39 (54) 81 14 - (2) Income from associate 2 - - - 2 - Impairment of associate (164) - - - (164) - Finance income 4 - 4 - - - Finance cost (excluding intersegment loan interest) (31) (11) (18) (2) - - Total finance cost (31) (19) (18) (2) - 8 Elimination of intersegment loan interest - 8 - - - (8) Taxation (8) 12 (20) - - - Segment result (158) (53) 47 12 (162) (2) At 30 September 2018 Investments in associates 185 2 2 - 181 - Investments in joint ventures 5 - 5 - - - Capital expenditure 113 24 30 58 - 1 Total segment assets 6 438 3 572 681 1 962 181 42 Total segment liabilities (excluding intersegment loan) 3 074 2 080 594 400 - - Total liabilities from reportable segment 3 977 2 983 594 400 - - Elimination of intersegment loan (903) (903) - - - - Reportable operating segments Other PERIOD ENDED Southern Middle United 30 SEPTEMBER 2017 Total Switzerland Africa East Kingdom Corporate GBP'm GBP'm GBP'm GBP'm GBP'm GBP'm Revenue 1 405 651 444 310 - - EBITDA 232 113 93 27 - (1) EBITDA before management fee 232 115 95 29 - (7) Management fees included in EBITDA - (2) (2) (2) - 6 Other gains and losses (5) - - (5) - - Depreciation and amortisation (94) (41) (15) (38) - - Operating profit/(loss) 133 72 78 (16) - (1) Income from associate 1 - - - 1 - Impairment of associate (109) - - - (109) - Finance income 6 1 4 1 - - Finance cost (excluding intersegment loan interest) (41) (17) (20) (4) - - Total finance cost (41) (25) (20) (4) - 8 Elimination of intersegment loan interest - 8 - - - (8) Taxation (30) (10) (19) - - (1) Segment result (40) 46 43 (19) (108) (2) At 31 March 2108 Investments in associates 352 2 2 - 348 - Investments in joint venture 5 - 5 - - - Capital expenditure 245 101 62 80 - 2 Total segment assets 6 343 3 448 747 1 757 348 43 Total segment liabilities (excluding intersegment loan) 2 970 1 985 672 309 - 4 Total liabilities from reportable segment 3 827 2 842 672 309 - 4 Elimination of intersegment loan (857) (857) - - - - 4. PROPERTY, EQUIPMENT AND VEHICLES 30 Sep 2018 31 Mar 2018 GBP'm GBP'm Land - cost 902 864 Buildings 2 336 2 184 Capital expenditure in progress 107 181 Equipment 306 306 Furniture and vehicles 43 55 3 694 3 590 Cash generating unit (CGU) impairment indicators Property, equipment and vehicles are considered for impairment if impairment indicators are identified at an individual CGU level. A CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. The Group defines CGUs as combined inter-dependent hospitals and/or clinics or as individual hospitals depending on the geographical location or the degree of integration. The impairment assessment is performed at CGU level and any impairment charge that arises would be allocated to the CGU's goodwill first, followed by other assets (such as property, equipment and vehicles and other intangible assets). Impairment of properties in Switzerland At 30 September 2018, the CGUs in the Switzerland segment were assessed for impairment due to disappointing performance during the first half of the year. The recoverable amounts of the CGUs tested for impairment were based on fair value less cost to sell calculations. In determining the fair value less cost to sell for the CGUs, the cash flows were discounted at rates between 4.9% and 5.1%. Beyond five years, the cash flows were extrapolated using a 1.6% (2017: 1.6%) growth rate. The carrying value of one CGU was determined to be higher than its recoverable amount and as a result an impairment charge of GBP43m was recognised in the income statement relating to properties. Certain CGUs remain sensitive to reasonably possible changes in key assumptions in the fair value less cost to sell calculations, including discount rates, growth rates and cash flow projections. 5. INTANGIBLE ASSETS 30 Sep 2018 31 Mar 2018 GBP'm GBP'm Goodwill 1 351 1 253 Trade names 31 83 Computer software 53 48 Leases 24 22 1 459 1 406 Impairment testing of non financial assets in Switzerland Following the disappointing performance in the Switzerland segment, the recoverable amount of certain Hirslanden CGUs and the Hirslanden trade name were tested for impairment at the end of the period. The recoverable amounts have been determined based on fair value less costs to sell discounted cash flow calculations. The key inputs to its calculations are described below. Forecasts As a result of the continued impact of changes in the regulatory and market environment (including new TARMED tariffs and regulations that require enhanced outmigration of medical treatments) and to reflect actions taken by management to adopt to the new operating environment, the 31 March 2018 forecasted cash flows have been adjusted. Growth rates The terminal growth rate beyond five years is extrapolated using a 1.6% (31 March 2018: 1.6%) growth rate. Discount rates The discount rate applied to cash flow projections is 5.0% (31 March 2018: 5.0%). The carrying amounts of the Hirslanden trade name and the Linde trade name were fully impaired during the period. The impairment loss recognised in the income statement consisted of GBP39m for the impairment of the Hirslanden trade name and GBP16m for the Linde trade name. 6. EQUITY ACCOUNTED INVESTMENTS 30 Sep 2018 31 Mar 2018 GBP'm GBP'm Investment in associates 185 352 Investment in joint venture 5 5 190 357 30 Sep 2018 31 Mar 2018 GBP'm GBP'm Listed investment 181 348 Unlisted investments 4 4 185 352 Reconciliation of carrying value at the beginning and end of the period Opening balance 352 461 IFRS 9 transition adjustment (2) - Additional investment in unlisted associate - 2 Share of net profit of associated companies 2 3 Impairment of listed associate (164) (109) Dividends received from associated companies (3) (5) 185 352 Set out below are details of the associate which is material to the Group: Country of incorporation and place of business % ownership Spire Healthcare Group plc (Spire) United Kingdom 29.9% Spire is listed on the London Stock Exchange. It does not issue publicly available quarterly financial information and has a December year-end. The investment in associate was equity accounted for the 6 months to 30 June 2018 (31 March 2018: 12 months to 31 December 2017). Spire reported its half year results to 30 June 2018 in September 2018 when it provided an update to its earnings guidance on financial performance for the remainder of the financial year. Lower reported revenue, margins and consistent underperformance compared to market expectation in trading during 2018 resulted in a revised outlook for the remainder of financial year and our view on the business. At 30 September 2018, the market value of the investment in Spire was GBP169m, which was below the carrying value. Consequently, the Group performed an impairment test by updating the key assumptions applied in the value in use calculation performed at 31 March 2018. The impairment test was prepared based on the Group's updated expectations of Spire's future trading performance and considered external sources of information, including recent investor analyst valuations and target prices published since the September 2018 announcement by Spire. Accordingly, key assumptions related to cash flow growth rates in the short- and medium-term were adjusted in the value in use calculation. There was no change in key assumptions related to discount rates or long-term growth rates from 31 March 2018. The carrying value of the investment of GBP181m remains sensitive to any reasonable changes in key assumptions. 7. BORROWINGS 30 Sep 2018 31 Mar 2018 GBP'm GBP'm Bank loans 1 746 1 559 Preference shares 97 200 Listed bonds 184 176 Other liabilities 2 2 2 029 1 937 Non-current borrowings 1 936 1 866 Current borrowings 93 71 Total borrowings 2 029 1 937 30 Sep 2018 30 Sep 2018 31 Mar 2018 31 Mar 2018 GBP'm GBP'm GBP'm GBP'm Non-current Current Non-current Current Swiss operations (denominated in Swiss franc) Secured bank loan one These loans bear interest at variable rates linked to the 3M LIBOR plus 1.25%. CHF80m must be redeemed on 21 December 2018. The remaining balances are repayable by 30 September 2024. 1 105 90 1 085 26 Secured bank loan two These loans were acquired as part of the Linde acquisition and bear interest linked to the 3M LIBOR plus 0.92% and are repayable during May 2023. 15 1 13 - Secured bank loan three This fixed interest mortgage loan was acquired as part of the Linde acquisition and bears interest at 0.9% compounded quarterly. The loan is repayable by December 2023. 8 - 7 - Listed bonds The listed bonds consist of CHF145m 1.625% and CHF90m 2% Swiss franc bonds. The bonds are repayable on 25 February 2021 and 25 February 2025 respectively. 184 - 176 - Secured long term finance These liabilities bear interest at variable rates ranging between 1% and 12% and are repayable in equal monthly payments in periods ranging from one to seven years. 1 1 1 1 Middle East operations (denominated in UAE dirham) Secured bank loan one These loans bear interest at variable rates linked to the 3M LIBOR and a margin of 1.85% with a 5-year amortising term, expiring in August 2023. 191 - - - Secured bank loan two These loans bear interest at variable rates linked to the 3M LIBOR and a margin of 2.50%. This liability was extinguished during August 2018 as part of the refinancing. - - 98 39 Balance carried forward 1 504 92 1 380 66 30 Sep 2018 30 Sep 2018 31 Mar 2018 31 Mar 2018 GBP'm GBP'm GBP'm GBP'm Non-current Current Non-current Current Balance carried forward 1 504 92 1 380 66 Southern African operations (denominated in South African rand) Secured bank loan one The loan bears interest at the 3M JIBAR variable rate plus a margin of 1.49% compounded quarterly and is repayable on 26 September 2022. 139 - - - Secured bank loan two The loan bears interest at the 3M JIBAR variable rate plus a margin of 1.59% compounded quarterly and is repayable on 26 September 2023. 192 1 - - Secured bank loan three The loan bears interest at the 3M JIBAR variable rate plus a margin of 1.51% compounded quarterly. This liability was extinguished during September 2018 as part of the refinancing. - - 208 2 Secured bank loan four The loan bears interest at the 3M JIBAR variable rate plus a margin of 1.69% compounded quarterly. This liability was extinguished during September 2018 as part of the refinancing. - - 73 - Secured bank loan five These loans bear interest at variable rates linked to the prime overdraft rate and are repayable in periods ranging between one and twelve years. 4 - 6 2 Preference shares Dividends are payable quarterly at a rate of 72% of 3M JIBAR plus a margin of 1.65%. The outstanding balance will be redeemed on 26 September 2022. 97 - 108 1 Preference shares Dividends are payable semi-annually at a rate of 73% of the prime interest rate (10.0%). The amount was repaid on 26 September 2018 as part of the refinancing. - - 91 - 1 936 93 1 866 71 The borrowing facilities in Mediclinic Southern Africa and Mediclinic Middle East were refinanced during the period. In both instances, the terms of the loans were extended with favourable pricing. The effective date for the funding and the closing was 26 September 2018 and 29 August 2018 respectively. In Mediclinic Middle East, a new term loan of GBP192m (AED920m) and revolving loan facility of GBP38m (AED184m) were put in place. The refinancing agreements in both Mediclinic Southern Africa and Mediclinic Middle East have been treated as extinguishments of the original financial liabilities due to the substantial modifications of the terms (including the terms of the financing and the margins). As a result, the original liabilities were derecognised and new financial liabilities were recognised. The unamortised portion of the capitalised finance cost of the original agreements of GBP2m in Mediclinic Middle East were derecognised as a result of the extinguishment of the liabilities. 8. RETIREMENT BENEFIT OBLIGATIONS The Swiss pension benefit obligation decreased from GBP4m on 31 March 2018 to a net asset of GBP24m at 30 September 2018. The assumptions underlying the valuation of the Swiss pension obligation were reassessed during the period and as a result the discount rate used to value the plan obligation was changed from 0.75% to 0.90%. 9. FINANCE COSTS 30 Sep 2018 30 Sep 2017 GBP'm GBP'm Interest expenses 24 30 Interest rate swaps - 5 Amortisation of capitalised financing costs 4 4 Fair value gains on ineffective cash flow hedges - (4) Preference share dividend 7 7 Less: amounts included in cost of qualifying assets (4) (1) 31 41 10. INCOME TAX EXPENSE 30 Sep 2018 30 Sep 2017 GBP'm GBP'm Current tax Current year 24 27 Previous year - - Deferred tax (16) 3 Taxation per income statement 8 30 Composition UK tax - - Foreign tax 8 30 8 30 The tax charge for the period has been calculated using an estimate of the effective annual rate of tax for the full year per operating division. This rate has been applied to the pre-tax profits for the six months ended 30 September 2018, with adjustments made for non-recurring items in the period. The effective tax rate on the loss before tax was (6%) (1H18: (300%)). The following significant item affecting the effective tax rate for the current period was identified: - Impairment of the listed associate of GBP164m is not deductible for tax purposes. The tax effect amounted to GBP31m (decrease of 21% in effective tax rate). The impairment of the properties (GBP43m) and the impairment of trade names (GBP55m) in Switzerland led to the release of deferred tax liabilities of GBP7m and GBP11m respectively. The impact on the effective tax rate is minimal. The following significant items affecting the effective tax rate for the prior period were identified: - Impairment of the listed associate of GBP109m was not deductible for tax purposes. The tax effect amounted to GBP21m (decrease of 207% in effective tax rate). - Loss on disposal of subsidiaries of GBP5m was not deductible for tax purposes. The tax effect amounted to GBP1m (decrease of 10% in effective tax rate). - Accelerated amortisation of GBP23m was recognised on the Al Noor trade names during the period. The profits earned in the UAE are not subject to income tax. The tax effect amounted to GBP4m (decrease of 44% in effective tax rate). If the abovementioned significant items were excluded from the effective tax rate calculation, the adjusted effective tax rate would be 23.4% (1H18: 24%). The estimated adjusted effective tax rate for the full year is around 21% (1H18: 21%) reflecting expected profit mix from the Group's segments in the second half. 11. EARNINGS PER ORDINARY SHARE 30 Sep 2018 30 Sep 2017 GBP'm GBP'm Loss per ordinary share (pence) Basic (pence) (22.8) (6.8) Diluted (pence) (22.8) (6.8) Earnings reconciliation Loss attributable to equity holders of the Company (168) (50) Adjusted for: No adjustments - - Loss for basic and diluted earnings per share (168) (50) Number of shares reconciliation Weighted average number of ordinary shares in issue for basic earnings per share Number of ordinary shares in issue at the beginning of the year 737 243 810 737 243 810 Weighted average number of treasury shares (66 664) (181 162) Mpilo Trusts (32 330) (32 330) Forfeitable Share Plan (34 334) (148 832) 737 177 146 737 062 648 Weighted average number of ordinary shares in issue for diluted earnings per share Weighted average number of ordinary shares in issue 737 177 146 737 062 648 Weighted average number of treasury shares held not yet released from treasury stock 66 664 181 162 Mpilo Trusts 32 330 32 330 Forfeitable Share Plan 34 334 148 832 737 243 810 737 243 810 Headline earnings per ordinary share The Group is required to calculate headline earnings per share (HEPS) in accordance with the JSE Limited (JSE) Listings Requirements, determined by reference to the South African Institute of Chartered Accountants' circular 04/2018 (Revised) 'Headline Earnings'. The table below sets out a reconciliation of basic EPS and HEPS in accordance with that circular. Disclosure of HEPS is not a requirement of IFRS, but it is a commonly used measure of earnings in South Africa. The table below reconciles the profit for the financial year attributable to equity holders of the parent to headline earnings and summarises the calculation of basic HEPS: 30 Sep 2018 30 Sep 2017 GBP'm GBP'm Headline earnings per share Loss for basic and diluted earnings per share (168) (50) Adjustments Impairment of equity accounted investment 164 109 Impairment of properties and intangible assets 80 - (Profit)/loss on disposal of subsidiaries (1) 5 Associate's impairment of property, plant and equipment 4 - Headline earnings 79 64 Headline earnings per share (pence) 10.7 8.7 Diluted headline earnings per share (pence) 10.7 8.7 12. BUSINESS COMBINATIONS The following business combinations occurred during the period: 30 Sep 2018 30 Sep 2017 GBP'm GBP'm Cash flow on acquisition: City Centre Clinics Deira and Me'aisem (7) - Welkom Medical Centre (6) - Linde Holding Biel/Bienne AG - (74) Rontgeninstitut Cham AG - (9) (13) (83) City Centre Clinics Deira and Me'aisem On 28 June 2018, Mediclinic Middle East acquired 100% of the Dubai based City Centre Clinics Deira and Me'aisem from Majid Al Futtaim for GBP7m (AED30m). City Centre Clinic Deira is a large outpatient facility with two day-care surgery theatres and 18 medical disciplines. City Centre Clinic Me'aisem is a smaller community clinic focusing on six core disciplines. The clinics serve strategic geographic locations and offer the opportunity to refer higher acuity inpatient cases to existing Mediclinic Middle East hospitals as well as the new Mediclinic Parkview Hospital. The goodwill of GBP2m (AED8m) arising from the acquisition is attributable to the acquired workforce and economies of scale expected from combining the operations of Mediclinic Middle East and the City Centre Clinics. The following table summarises the consideration paid for the City Centre Clinics Deira and Me'aisem and the provisional fair value of assets acquired and liabilities assumed at the acquisition date. 30 Sep 2018 GBP'm Recognised amounts of identifiable assets acquired and liabilities assumed Assets Property, equipment and vehicles 5 Total assets 5 Total identifiable net assets at fair value 5 Goodwill 2 Consideration transferred for the business 7 Cash flow on acquisition Cash paid (7) Net cash flow on acquisition (7) Welkom Medical Centre On 17 August 2018, Mediclinic Southern Africa acquired 100% of the share capital of Welkom Medical Centre for GBP6m (ZAR110m). Welkom Medical Centre consists of a day clinic with 20 beds, a sub-acute unit of 20 beds and a mental health unit with a further 20 beds. The goodwill of GBP3m (ZAR47m) arising from the acquisition is attributable to the acquired workforce and economies of scale expected from combining the operations of Welkom Medical Centre and Mediclinic Southern Africa. None of the goodwill recognised is expected to be deductible for income tax purposes. The following table summarises the consideration paid for Welkom Medical Centre and the provisional fair value of assets acquired and liabilities assumed at the acquisition date. 30 Sep 2018 GBP'm Recognised amounts of identifiable assets acquired and liabilities assumed Assets Property, equipment and vehicles 3 Total assets 3 Total identifiable net assets at fair value 3 Goodwill 3 Consideration transferred for the business 6 Cash flow on acquisition Net cash acquired with subsidiary - Cash paid (6) Net cash flow on acquisition (6) 13. CHANGES IN ACCOUNTING POLICIES This note explains the impact of the adoption of IFRS 15 Revenue from Contracts with Customers and IFRS 9 Financial Instruments on the Group's financial statements. 13.1 IFRS 15 Revenue from contracts with customers The Group adopted IFRS 15 from 1 April 2018 which resulted in changes in accounting policies. In accordance with the transitional provisions in the standard, the Group followed the modified retrospective approach. The comparative information is presented based on the requirements of IAS 18 Revenue and no adjustment to opening retained earnings was required. In the Middle East, the normal business process associated with transactions with insurers includes an amount of claims disallowed (disallowance provision) which is not paid by the insurer. These disallowed claims could be for various technical or medical reasons. Disallowance write-offs on rejected claims is a general practice by the insurers in the Middle East. Accordingly, Mediclinic Middle East accepts and expects an amount of consideration that is less than what was originally invoiced. These write-offs constitute variable consideration under IFRS 15. Variable consideration is recognised as revenue to the extent that it is highly probable that a reversal of revenue will not occur. In prior periods, revenue was recognised based on the contract with the insurers and a provision for bad debt was recognised for the rejections based on historical trends. Under IFRS 15, these rejected claims will be recognised as part of revenue (decreasing the revenue recognised). The rejections recognised in the provision for impairment of trade receivables in the prior period will be reclassified to gross debtors on 1 April 2018, refer to note 13.2 below. If IFRS 15 was applied to the prior period results, revenue from the Middle East segment would have been GBP300m compared to the GBP310m recognised under IAS 18 (with a corresponding decrease of GBP10m in expenses). This change has no impact on net profit. The implementation of IFRS 15 did not have a material impact on the Group's other operating divisions. 13.2 IFRS 9 Financial Instruments The accounting policies were changed to comply with IFRS 9 which replaces the provisions of IAS 39 that relate to the recognition, classification and measurement of financial assets and financial liabilities; derecognition of financial instruments; impairment of financial assets; and hedge accounting. The Group has adopted IFRS 9 which resulted in changes in accounting policies and adjustments to the amounts recognised in the financial statements. In accordance with the transitional provisions in the standard, comparative figures have not been restated. The adjustments arising from the new impairment rules are therefore not reflected in the statement of financial position as at 31 March 2018, but are recognised in the opening balance of retained earnings on 1 April 2018. The total impact of the Group's retained earnings due to classification and measurement of financial instruments as at 1 April 2018 is as follows: 1 Apr 2018 GBP'm Opening retained earnings - IAS 39 5 057 Adjustment to retained earnings on adoption of IFRS 9: Increase in provision for impairment of trade receivables* - Impact of IFRS 9 on equity accounted investments (2) Opening retained earnings - IFRS 9 5 055 * Impact is less than GBP0.5m. The Group was required to revise its impairment methodology under IFRS 9 for trade receivables. The Group applied the simplified approach to measure the expected credit losses as prescribed by IFRS 9. The simplified approach requires the use of the lifetime expected loss provision for all trade receivables. The loss allowance for trade receivables as at 31 March 2018 reconcile to the opening loss allowance on 1 April 2018 as follows: GBP'm At 31 March 2018 - calculated under IAS 39 45 Disallowances recognised as bad debt reclassified to gross debtors (32) (IFRS 15 adjustment) Increase in provision for impairment of trade receivables* - Opening loss allowance as at 1 April 2018 - calculated under IFRS 9 13 * Impact is less than GBP0.5m. 14. COMMITMENTS 30 Sep 2018 31 Mar 2018 GBP'm GBP'm Capital commitments Switzerland 31 29 Southern Africa 199 219 Middle East 77 94 307 342 These commitments will be financed from Group and borrowed funds. 15. DIVIDENDS Dividend per 30 Sept 2018 30 Sept 2017 Date paid/payable share (pence) GBP'm GBP'm Dividends declared Period ended 30 September 2018 Interim dividend 18 December 2018 3.20 24 Period ended 30 September 2017 Interim dividend 18 December 2017 3.20 24 Dividends paid Dividends paid during the period 35 35 Under IFRS, dividends are only recognised in the financial statements when authorised by the Board of Directors (for interim dividends) or when authorised by the shareholders (for final dividends). The aggregate amount of the proposed dividend expected to be paid on 18 December 2018 from retained earnings has not been recognised as a liability at 30 September 2018. 16. FINANCIAL INSTRUMENTS Financial instruments that are measured at fair value in the statement of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in the valuation. The fair value hierarchy has the following levels: Level 1 - Quoted prices (unadjusted) in active markets for identical assets and liabilities Level 2 - Input (other than quoted prices included within Level 1) that is observable for the asset or liability, either directly (as prices) or indirectly (derived from prices) Level 3 - Input for the asset or liability that is not based on observable market data (unobservable input). Derivative financial instruments comprise interest rate swaps and are measured at the present value of future cash flows estimated and discounted based on the applicable yield curves derived from quoted interest rates. Based on the degree to which the fair values are observable, the interest rate swaps are grouped as Level 2. The fair value for available-for-sale assets (part of other investments and loans) is based on appropriate valuation methodologies being discounted cash flow or actual net asset value of the investment. These assets are grouped as Level 2. 17. RELATED PARTIES There are no significant changes to the related party transactions for the six months ended 30 September 2018 compared to those disclosed in the Group's annual financial statements for the year ended 31 March 2018. 18. SHARE-BASED PAYMENTS During the six months ended 30 September 2018, the Group made further grants under its existing long-term incentive plan awards ("LTIP") as follows: On 15 June 2018, the Group granted Danie Meintjes, Ronnie van der Merwe and Jurgens Myburgh 209 998, 200 128 and 110 646 phantom shares respectively. On the same date, 677 318 phantom shares were granted to other senior management. The vesting of these shares is subject to continued employment and is conditional upon achievement of performance targets, measured over a three-year period. The performance conditions for the year under review constitute a combination of: absolute total shareholder return ("TSR") (40% weighting) and adjusted earnings per share (60% weighting). For the six months ended 30 September 2018, the total cost recognised in the income statement for the LTIP awards was GBP0.6m (1H18: GBP0.4m). 19. EVENTS AFTER THE REPORTING DATE Effective October 2018, the Group acquired a controlling interest in Clinique des Grangettes in Geneva, Switzerland. After combining Hirslanden Clinique La Colline with Clinique des Grangettes, the Group has a 60% controlling interest in the combined entity. The Group will combine the operating companies of Hirslanden Clinique La Colline and Pidji Healthcare Ltd, the holding company for the Clinique des Grangettes group of companies, and it paid a cash consideration of CHF68m to the previous owner for a 60% interest in the new combined company. The Group and the previous owner will have call and put options respectively on the remaining 40% interest in the combined company. The options are exercisable after 4 years and the consideration on exercise will be determined based on the profitability of the combined company at that time. The Group acquired a controlling interest of 50% plus one share in the day hospitals and sub-acute and rehabilitation hospitals of the Intercare group of companies for a consideration of ZAR32m. This transaction received Competition Commission approval in August 2018 and the effective date of acquisition was on 1 November 2018. ABOUT MEDICLINIC INTERNATIONAL PLC Mediclinic is an international private healthcare services group, established in South Africa in 1983, with current operating divisions in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist- orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group. As at 30 September 2018, Mediclinic comprised 75 hospitals and 29 clinics. Hirslanden operated 17 private hospitals and 4 clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operated 48 hospitals and 3 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operated 7 hospitals and 22 clinics with more than 900 inpatient beds in the United Arab Emirates. Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. AUDIO WEBCAST AND CONFERENCE CALL DETAILS In conjunction with these results Mediclinic is hosting an audio webcast and conference call. A replay facility will be available on the website shortly after the presentation. 09:00 GMT/11:00 SAST Audio webcast: https://edge.media-server.com/m6/p/r4zg98qa To access the call please dial the appropriate number below 5-10 minutes before the start of the event using the conference confirmation code below. UK: +44 (0)330 336 9127 SA: +27 (0)11 844 6054 CH: +41 (0)44 580 7206 UAE toll-free: 8000 3570 2653 US: +1 929 477 0324 Confirmation code: 9603575 CONTACT INFORMATION Investor queries James Arnold, Head of Investor Relations, Mediclinic International plc +44 (0)20 3786 8181 ir@mediclinic.com Media queries FTI Consulting Deborah Scott/Brett Pollard - United Kingdom +44 (0)20 3727 1000 Max Gebhardt - South Africa +27 (0)21 487 9000 Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom Website: www.mediclinic.com Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited) NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Directorate change Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 ("Mediclinic", the "Company" or the "Group") 15 November 2018 DIRECTORATE CHANGE The Company announces that on 14 November 2018, Mr Desmond Smith, the Company's Senior Independent Director, informed the Board of his intention to retire as a director of the Company at the conclusion of the Company's Annual General Meeting ("AGM") scheduled for 24 July 2019 and not seek re-election at the AGM. Mr Smith will also step down from all Board committees at that time. Mr Alan Grieve will succeed Mr Smith as Senior Independent Director of the Company and as Chairman of the Audit and Risk Committee, to be effective from the date of Mr Smith's resignation in 2019. Further changes to the constitution of the Company's committees will be made and announced in due course. Mediclinic's chairman, Dr Edwin Hertzog commented: "On behalf of my colleagues on the Board, I would like to thank Desmond for his commitment and valued contributions to the Board and the Group over many years." This announcement is made in accordance with the requirement of LR 9.6.11. About Mediclinic International plc Mediclinic is an international private healthcare services group with operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group. Mediclinic comprises 76 hospitals and 30 clinics. Hirslanden operates 18 private hospitals and 4 clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operates 48 hospitals and 4 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operates 7 hospitals and 22 clinics with more than 900 inpatient beds in the United Arab Emirates. Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. For further information, please contact: Company Secretary, Link Company Matters Limited Jayne Meacham / Caroline Emmet +44 (0)20 7954 9569 Investor Relations, Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com +44 (0)20 3786 8181 Media queries FTI Consulting Brett Pollard/Debbie Scott - UK +44 (0)20 3727 1000 Sherryn Schooling - South Africa +27 (0)21 487 9000 Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom Website: www.mediclinic.com Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd Date: 15/11/2018 09:01:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Announcement Of Results And Webcast KAAP AGRI LIMITED (Incorporated in the Republic of South Africa) (Registration number 2011/113185/06) ISIN: ZAE000244711 Share code: KAL ("Kaap Agri" or "the Company") ANNOUNCEMENT OF RESULTS AND WEBCAST Shareholders are advised that Kaap Agri intends to release its results for the year ended 30 September 2018 on Thursday, 29 November 2018. The Company will be hosting a webcast at 10:00 am on Thursday, 29 November 2018, to present the results to shareholders and the market. To register for the webcast, please follow the below link. Webcast details: - View and listen mode, with a Q&A facility - Link: www.corpcam.com/KaapAgri29112018 Paarl 15 November 2018 Sponsor PSG Capital Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Unaudited combined consolidated financial results for the six months ended 30 September 2018 Investec Limited Incorporated in the Republic of South Africa Registration number: 1925/002833/06 JSE ordinary share code: INL NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000081949 Investec plc Incorporated in England and Wales (Registration number 3633621) JSE ordinary share code: INP LSE ordinary share code: INVP ISIN: GB00B17BBQ50 Investec plc and Investec Limited (combined results) Unaudited combined consolidated financial results for the six months ended 30 September 2018 Unaudited combined consolidated financial results This announcement covers the statutory results of the Investec group for the six months ended 30 September 2018. Overview of results - The group has delivered a sound operational performance. - This is notwithstanding a challenging operating environment. Rising US interest rates, the threat of trade wars, concerns over global growth prospects, weak economic growth in South Africa and Brexit-related uncertainty in the UK have contributed to this. - The Asset Management and Wealth & Investment businesses have grown funds under management supported by strong net flows of GBP4.8 billion. - The Specialist Banking business saw a substantial reduction in impairments as well as revenue growth supported by reasonable levels of client activity. - The cost to income ratio improved marginally. Revenue growth and cost containment remain priorities. - A solid base of annuity revenue has continued to support earnings through varying market conditions. Overall group performance Operating profit before goodwill, acquired intangibles, non-operating items and taxation and after other non-controlling interests (operating profit) increased 14.2% to GBP359.3 million (2017: GBP314.6 million) - an increase of 17.6% on a currency neutral basis. Overall group results have been negatively impacted by the depreciation of the average Rand: Pounds Sterling exchange rate of approximately 4.1% over the period. The combined South African businesses reported operating profit 5.0% ahead of the prior period (in Rands), whilst the combined UK and Other businesses posted a 40.2% increase in operating profit in Pounds Sterling. Salient features of the period under review are: - Adjusted earnings attributable to shareholders before goodwill, acquired intangibles and non-operating items increased 8.2% to GBP265.3 million (2017: GBP245.3 million) - an increase of 11.1% on a currency neutral basis. - Adjusted earnings per share (EPS) before goodwill, acquired intangibles and non-operating items increased 6.4% from 26.6 pence to 28.3 pence - an increase of 9.4% on a currency neutral basis. - Annuity income as a percentage of total operating income amounted to 75.5% (2017: 76.4%). - The total income statement impairment charge reduced materially to GBP31.0 million (2017: GBP59.6 million). The annualised credit loss charge as a percentage of average gross core loans and advances subject to expected credit losses has improved to 0.34% (2017: 0.52%). - The annualised return on adjusted average shareholders' equity increased to 13.4% from 12.1% at 31 March 2018. - Third party assets under management increased 3.7% to GBP166.5 billion (31 March 2018: GBP160.6 billion) - an increase of 7.2% on a currency neutral basis. - Customer accounts (deposits) decreased 2.1% to GBP30.3 billion (31 March 2018: GBP31.0 billion) - an increase of 4.3% on a currency neutral basis. - Core loans and advances decreased 3.7% to GBP24.2 billion (31 March 2018: GBP25.1 billion) - an increase of 2.4% on a currency neutral basis. - The group maintained a sound capital position with common equity tier one (CET 1) ratios of 10.4% for Investec plc and 10.3% for Investec Limited, ahead of the group's CET 1 ratio target. The group is comfortable with its CET 1 ratio target at a 10% level, as its leverage ratios for both Investec Limited and Investec plc are above 7%. - Liquidity remains strong with cash and near cash balances amounting to GBP12.5 billion. - The board declared a dividend of 11.0 pence per ordinary share (2017: 10.5 pence) resulting in a dividend cover based on the group's adjusted EPS before goodwill and non-operating items of 2.6 times (2017: 2.5 times), consistent with the group's dividend policy. - The proposed demerger and separate listing of Investec Asset Management (still subject to regulatory and shareholder approvals) is progressing well. Fani Titi and Hendrik du Toit, Joint Chief Executive Officers of Investec said: "The outgoing executives have handed over a resilient business with positive momentum and good growth potential. It is now up to us to implement our strategy of simplification and greater focus, involving the demerger and separate listing of the Asset Management business and the positioning of the Specialist Bank and Wealth & Investment businesses for sustainable long- term growth. Revenue growth, capital allocation and cost discipline remain high on our agenda." For further information please contact: Investec +27 (0) 11 286 7070 or +44 (0) 20 7597 5546 Fani Titi, Joint Chief Executive Officer Hendrik du Toit, Joint Chief Executive Officer Ursula Nobrega, Investor Relations (mobile: +27 (0) 82 552 8808) Carly Newton, Investor Relations (+44 (0) 20 7597 4493) Brunswick (SA PR advisers) Marina Bidoli Tel: +27 (0)11 502 7405 / +2783 253 0478 Lansons (UK PR advisers) Tom Baldock Tel: +44 (0)20 7566 9716 Presentation/conference call details A presentation on the results will commence at 9:00 UK time/11:00 SA time. Viewing options as below: - Live on South African TV (Business day TV channel 412 DSTV) - A live and delayed video webcast at www.investec.com - Toll free numbers for the telephone conference facilities - SA participants: 0800 200 648 - UK participants: 0808 162 4061 - rest of Europe and other participants: +800 246 78 700 - Australian participants: 1800 350 100 - USA participants: 1855 481 6362 About Investec Investec is an international specialist bank and asset manager that provides a diverse range of financial products and services to a select client base in three principal markets - the UK and Europe, South Africa and Asia/Australia as well as certain other countries. The group was established in 1974 and currently has approximately 10 300 employees. Investec focuses on delivering distinctive profitable solutions for its clients in three core areas of activity namely, Asset Management, Wealth & Investment and Specialist Banking. In July 2002 the Investec group implemented a dual listed company structure with listings on the London and Johannesburg Stock Exchanges. The combined group's current market capitalisation is approximately GBP5.0 billion. Business unit review Asset Management Asset Management operating profit increased by 10.0% to GBP91.5 million (2017: GBP83.2 million). Strong net inflows of GBP4.1 billion supported the growth in total funds under management to GBP109.2 billion (31 March 2018: GBP103.9 billion). Flows were well spread across client regions. Wealth & Investment Wealth & Investment operating profit decreased by 6.3% to GBP46.4 million (2017: GBP49.5 million). Earnings have been impacted by growth in headcount for IT initiatives, compliance requirements, and continued recruitment of experienced portfolio managers and financial planners to support future revenue growth. The business generated net inflows of GBP650 million. Total funds under management amounted to GBP56.7 billion (31 March 2018: GBP56.0 billion). Specialist Banking Specialist Banking operating profit increased by 18.8% to GBP245.4 million (2017: GBP206.5 million). The South African business reported an increase in operating profit in Rands of 4.2%. A combination of a weak domestic economy and political policy uncertainty has resulted in subdued activity; reflecting in softer loan book growth, client flow trading levels and a weaker performance from the equity and investment property portfolios. We did however, report growth in net interest income supported by higher net margins and continued activity from our private client base. The annualised credit loss ratio on average core loans and advances subject to expected credit losses amounted to 0.30% (2017: 0.30% under the IAS 39 incurred impairment loss model), remaining at the lower end of its long-term average trend. The UK and Other businesses reported a 96.0% increase in operating profit, reflecting a material decrease in impairment charges due to no longer incurring substantial losses on the legacy portfolio. In addition, earnings were supported by strong growth in net interest income and fee income largely driven by the corporate business. With the investment phase in the private bank largely complete, the business has strengthened its focus on client acquisition and has seen sound growth in mortgage lending activity. The bank's overall cost to income ratio improved, notwithstanding an increase in costs driven largely by headcount growth in relation to increased business activity and regulatory requirements. The annualised credit loss ratio on average core loans and advances subject to expected credit losses amounted to 0.41% (2017: 0.84% under the IAS 39 incurred impairment loss model). Further information on key developments within each of the business units is provided in a detailed report published on the group's website: https://www.investec.com Group costs These largely relate to group brand and marketing costs and a portion of executive and support functions which are associated with group level activities. These costs are not incurred by the operating divisions and are necessary to support the operational functioning of the group. These costs amounted to GBP24.0 million (2017: GBP24.7 million). Financial statement analysis Total operating income Total operating income before expected credit loss impairment charges increased by 7.6% to GBP1 281.3 million (2017: GBP1 191.1 million). Net interest income increased by 11.2% to GBP405.0 million (2017: GBP364.3 million) driven by lending activity and endowment impact from rate rises in the UK. Net fee and commission income increased by 5.7% to GBP703.7 million (2017: GBP666.0 million) as a result of higher average funds under management and net inflows in the Asset Management and Wealth Management businesses as well as a good performance from the corporate advisory business in the UK. Investment income amounted to GBP41.5 million (2017: GBP62.1 million) reflecting a weaker performance from the group's listed and unlisted investment portfolio, as well as from the investment property portfolio in South Africa. Share of post taxation profit of associates of GBP20.8 million (2017: GBP23.7 million) reflects earnings in relation to the group's investment in the IEP Group. Trading income arising from customer flow increased by 1.4% to GBP65.1 million (2017: GBP64.2 million) reflecting subdued client flow trading levels given the uncertainty in both geographies. Trading income from balance sheet management and other trading activities increased significantly to GBP39.0 million (2017: GBP5.1 million). The increase is largely reflective of translation gains on foreign currency equity investments in South Africa (partially offsetting the related weaker investment income performance) as well as the unwind of the UK subordinated debt fair value adjustment (recognised on the adoption of IFRS 9) as the instrument pulls to par over its remaining term. Expected credit loss (ECL) impairment charges The total ECL impairment charges amounted to GBP31.0 million, a substantial reduction from GBP59.6 million (under the IAS 39 incurred loss model) in the prior period, primarily reflecting a reduction in legacy impairments. The group's annualised credit loss ratio is now within its long term average range at 0.34% (2017: 0.52%). Since 1 April 2018 gross core loan Stage 3 assets have reduced by GBP141 million to GBP595.0 million largely driven by a reduction of legacy exposures. Stage 3 assets (net of ECL impairment charges) as a percentage of net core loans subject to ECL was 1.7% (1 April 2018: 2.0%). Operating costs The cost to income ratio improved marginally, amounting to 66.6% (2017: 66.9%). Total operating costs grew by 7.2% to GBP854.2 million (2017: GBP797.1 million) largely driven by growth in headcount to support both activity levels and increased regulatory requirements. Taxation The effective tax rate amounted to 16.1% (2017: 14.5%), which remains below the group's historical effective tax rate mainly impacted by the utilisation of tax losses. Profit attributable to non-controlling interests Profit attributable to non-controlling interests mainly comprises: - GBP12.8 million profit attributable to non-controlling interests in the Asset Management business. - GBP36.4 million profit attributable to non-controlling interests in the Investec Property Fund. Balance sheet analysis Since 31 March 2018: - Shareholders equity decreased by 5.9% to GBP4.2 billion primarily as a result of the adoption of IFRS 9 on 1 April 2018 as well as from the depreciation of the closing Rand: Pounds Sterling exchange rate. - Net asset value per share decreased 6.7% to 422.0 pence and net tangible asset value per share (which excludes goodwill and intangible assets) decreased 7.2% to 372.7 pence, primarily as a result of the adoption of IFRS 9 as well as from the depreciation of the closing Rand: Pounds Sterling exchange rate. - The annualised return on adjusted average shareholders' equity increased from 12.1% to 13.4%. Liquidity and funding As at 30 September 2018 the group held GBP12.5 billion in cash and near cash balances (GBP6.5 billion in Investec plc and R110.8 billion in Investec Limited) which amounted to 41.1% of customer deposits. The group continues to focus on maintaining an optimal overall liquidity and funding profile. Loans and advances to customers as a percentage of customer deposits amounted to 78.2% (31 March 2018: 79.6%). The group comfortably exceeds Basel liquidity requirements for the Liquidity Coverage Ratio (LCR) and Net Stable Funding Ratio (NSFR). Investec Bank Limited (solo basis) ended the period to 30 September 2018 with the three-month average of its LCR at 137.4% and an NSFR of 111.3%. Further detail with respect to the bank's LCR and NSFR in South Africa is provided on the website. For Investec plc and Investec Bank plc (solo basis) the LCR is calculated using our own interpretations of the EU Delegated Act. The LCR reported to the PRA at 30 September 2018 was 332% for Investec plc and 339% for Investec Bank plc (solo basis). Ahead of the implementation of the final NSFR rules, the group has applied its own interpretations of regulatory guidance and definitions from the BCBS final guidelines to calculate the NSFR which was 140% for Investec plc and 134% for Investec Bank plc (solo basis). The reported NSFR and LCR may change over time with regulatory developments and guidance. Capital adequacy and leverage ratios The group is targeting a minimum common equity tier 1 capital ratio above 10% and a total capital adequacy ratio range of 14% to 17% on a consolidated basis for each of Investec plc and Investec Limited. The group's anticipated fully loaded Basel III common equity tier 1 (CET 1) ratios in both Investec plc and Investec Limited are reflected in the following table. The group expects to implement the Foundation Internal Ratings-Based (FIRB) approach in South Africa by the end of the 2019 financial year, subject to final regulatory approval. 30 Sept 1 April 31 March 2018 2018 2018 Investec plc^ Capital adequacy ratio 15.4% 15.0% 15.4% Tier 1 ratio 12.2% 12.4% 12.9% Common equity tier 1 ratio 10.4% 10.5% 11.0% Common equity tier 1 ratio ('fully loaded'*) 10.0% 10.3% 11.0% Leverage ratio (current) 7.7% 8.3% 8.5% Leverage ratio ('fully loaded'*) 7.3% 8.0% 8.4% Investec Limited** Capital adequacy ratio 14.7% 14.5% 14.6% Tier 1 ratio 11.1% 10.8% 11.0% Common equity tier 1 ratio 10.3% 10.0% 10.2% Common equity tier 1 ratio ('fully loaded'*) 10.2% 9.8% 10.2% Leverage ratio (current) 7.5% 7.4% 7.5% Leverage ratio ('fully loaded'*) 7.1% 6.9% 7.1% ^ The capital adequacy disclosures follow Investec's normal basis of presentation so as to show a consistent basis of calculation across the jurisdictions in which the group operates. For Investec plc this does not include the deduction of foreseeable charges and dividends when calculating CET 1 capital as required under the Capital Requirements Regulation and European Banking Authority technical standards. The impact of this deduction totalling GBP45 million for Investec plc would lower the CET 1 ratio by 30bps (31 March 2018: 45bps). ** Investec Limited's capital information includes unappropriated profits. If unappropriated profits are excluded from the capital information, Investec Limited's CET 1 ratio would be 27bps (31 March 2018: 25bps) lower. * The CET 1 fully loaded ratio and the fully loaded leverage ratio assume full adoption of IFRS 9 and full adoption of all CRD IV rules or South African Prudential Authority regulations, as applicable in the relevant jurisdictions. As a result of the adoption of IFRS 9 Investec plc elected to designate its subordinated fixed rate medium- term notes due in 2022 at fair value. By the time of full adoption of IFRS 9 in 2023, these subordinated liabilities will have reached final maturity and will be redeemed at par value. The remaining interest rate portion of the fair value adjustment at 30 September 2018 of GBP18 million (post-taxation), has therefore been excluded from the fully loaded ratios as it will be released into profit and loss over the remaining life of the instrument. Additional information - proposed demerger and listing of Investec Asset Management business On 14 September 2018, the board of directors of Investec plc and Investec Limited announced that the Investec Asset Management business would become a separately listed entity. The demerger and the listing of Investec Asset Management is subject to regulatory, shareholder and other approvals, and is expected to be completed during the second half of 2019. Outlook Notwithstanding macro challenges, we believe that our current business momentum and our drive to simplify and focus the business, together with our commitment to cost discipline, will support our long-term growth aspirations. On behalf of the boards of Investec plc and Investec Limited Perry Crosthwaite Fani Titi Hendrik du Toit Chairman Joint Chief Executive Joint Chief Executive Officer Officer 14 November 2018 Notes to the commentary section above Presentation of financial information Investec operates under a Dual Listed Companies (DLC) structure with primary listings of Investec plc on the London Stock Exchange and Investec Limited on the JSE Limited. In terms of the contracts constituting the DLC structure, Investec plc and Investec Limited effectively form a single economic enterprise in which the economic and voting rights of ordinary shareholders of the companies are maintained in equilibrium relative to each other. The directors of the two companies consider that for financial reporting purposes, the fairest presentation is achieved by combining the results and financial position of both companies. Accordingly, the interim results for Investec plc and Investec Limited present the results and financial position of the combined DLC group under International Financial Reporting Standards (IFRS), denominated in Pounds Sterling. In the commentary above, all references to Investec or the group relate to the combined DLC group comprising Investec plc and Investec Limited. Unless the context indicates otherwise, all comparatives included in the commentary above relate to the six months ended 30 September 2017. Amounts represented on a currency neutral basis for income statement items assume that the relevant average exchange rates for the six months to 30 September 2018 remain the same as those in the prior period. Amounts represented on a currency neutral basis for balance sheet items assume that the relevant closing exchange rates at 30 September 2018 remain the same as those at 31 March 2018. Foreign currency impact The group's reporting currency is Pounds Sterling. Certain of the group's operations are conducted by entities outside the UK. The results of operations and the financial position of the individual companies are reported in the local currencies in which they are domiciled, including Rands, Australian Dollars, Euros and US Dollars. These results are then translated into Pounds Sterling at the applicable foreign currency exchange rates for inclusion in the group's combined consolidated financial statements. In the case of the income statement, the weighted average rate for the relevant period is applied and, in the case of the balance sheet, the relevant closing rate is used. The following table sets out the movements in certain relevant exchange rates against Pounds Sterling over the period: Six months to Year to Six months to 30 Sep 2018 31 Mar 2018 30 Sep 2017 Currency per Period Period Period GBP1.00 end Average end Average end Average South African Rand 18.44 17.76 16.62 17.21 18.10 17.06 Australian Dollar 1.80 1.79 1.83 1.72 1.71 1.69 Euro 1.12 1.13 1.14 1.14 1.13 1.14 US Dollar 1.30 1.33 1.40 1.33 1.34 1.30 Exchange rates between local currencies and Pounds Sterling have fluctuated over the period. The most significant impact arises from the volatility of the Rand. The average exchange rate over the period has depreciated by 4.1% and the closing rate has depreciated by 11.0% since 31 March 2018. Accounting policies and disclosures These unaudited summarised combined consolidated financial results have been prepared in terms of the recognition and measurement criteria of International Financial Reporting Standards, and the presentation and disclosure requirements of IAS 34, (Interim Financial Reporting). The accounting policies applied in the preparation of the results for the period to 30 September 2018 are consistent with those adopted in the financial statements for the year ended 31 March 2018 except as noted below. On 1 April 2018 the group adopted IFRS 9 'Financial Instruments' which replaced IAS 39 and sets out the new requirements for the recognition and measurement of financial instruments. These requirements focus primarily on the classification and measurement of financial instruments and measurement of impairment losses based on an expected credit loss (ECL) model as opposed to an incurred loss methodology under IAS 39. Disclosure related to the initial application and the impact of the transition from IAS 39 to IFRS 9 were included in the group's transition disclosures published on 15 June 2018 which can be accessed via the Investec website at www.investec.com. Additionally, on 1 April 2018 the group adopted IFRS 15 'Revenue from contracts with customers' which replaced IAS 18 'Revenue'. IFRS 15 provides a principles-based approach for revenue recognition and introduces the concept of recognising revenue for obligations as they are satisfied. It applies to all contracts with customers except leases, financial instruments and insurance contracts. The group's measurement and recognition principles were aligned to the new standard and hence there has been no material impact on measurement and recognition principles or on disclosure requirements from the adoption of IFRS 15. The financial results have been prepared under the supervision of Glynn Burger, the Group Risk and Finance Director. The financial statements for the six months to 30 September 2018 will be posted to stakeholders on 30 November 2018. These financial results will be available on the group's website on the same date. Proviso - Please note that matters discussed in this announcement may contain forward looking statements which are subject to various risks and uncertainties and other factors, including, but not limited to: - the further development of standards and interpretations under IFRS applicable to past, current and future periods, evolving practices with regard to the interpretation and application of standards under IFRS. - domestic and global economic and business conditions. - market related risks. - A number of these factors are beyond the group's control. - These factors may cause the group's actual future results, performance or achievements in the markets in which it operates to differ from those expressed or implied. - Any forward looking statements made are based on the knowledge of the group at 14 November 2018. - The information in the announcement for the six months ended 30 September 2018, which was approved by the board of directors on 14 November 2018, does not constitute statutory accounts as defined in Section 435 of the UK Companies Act 2006. The 31 March 2018 financial statements were filed with the registrar and were unqualified with the audit report containing no statements in respect of Sections 498(2) or 498(3) of the UK Companies Act. - This announcement is available on the group's website: www.investec.com Financial assistance Shareholders are referred to Special Resolution number 3, which was approved at the annual general meeting held on 8 August 2018, relating to the provision of direct or indirect financial assistance in terms of Section 45 of the South African Companies Act, No 71 of 2008 to related or inter-related companies. Shareholders are hereby notified that in terms of S45(5)(a) of the South African Companies Act, the boards of directors of Investec Limited and Investec Bank Limited provided such financial assistance during the period 1 April 2018 to 30 September 2018 to various group subsidiaries. Financial information Salient financial features Results in Pounds Sterling Results in Rand Neutral currency^ Neutral Six months to Six months to Six months to currency Six months to Six months to 30 September 30 September % 30 September % 30 September 30 September % 2018 2017 change 2018 change 2018 2017 change Operating profit before taxation* (million) 359.3 314.6 14.2% 370.1 17.6% 6 415 5 378 19.3% Earnings attributable to shareholders (million) 279.9 252.4 10.9% 287.5 13.9% 4 983 4 321 15.3% Adjusted earnings attributable to shareholders** (million) 265.3 245.3 8.2% 272.5 11.1% 4 725 4 199 12.5% Adjusted earnings per share** 28.3p 26.6p 6.4% 29.1p 9.4% 504c 455c 10.8% Basic earnings per share 27.6p 25.8p 7.0% 28.4p 10.1% 492c 443c 11.1% Headline earnings per share 27.4p 24.6p 11.4% 28.1p 14.2% 487c 422c 15.4 % Dividends per share 11.0p 10.5p 4.8% n/a n/a 206c 200c 3.0% * Before goodwill, acquired intangibles, non-operating items and after other non-controlling interests. ** Before goodwill, acquired intangibles, non-operating items and after non-controlling interests. ^ For income statement items we have used the average Rand:Pound Sterling exchange rate that was applied in the prior year, i.e. 17.06. Results in Pounds Sterling Actual as Actual as Actual Neutral reported reported as currency^^ Neutral At At reported At currency 30 September 31 March % 30 September % 2018 2018 change 2018 change Net asset value per share 422.0p 452.5p (6.7%) 440.9p (2.6%) Net tangible asset value per share 372.7p 401.5p (7.2%) 391.2p (2.6%) Total equity (million) 5 118 5 428 (5.7%) 5 429 0.0% Total assets (million) 56 137 57 617 (2.6%) 59 918 4.0% Core loans and advances (million) 24 190 25 132 (3.7%) 25 740 2.4% Cash and near cash balances (million) 12 467 12 825 (2.8%) 13 125 2.3% Customer deposits (million) 30 349 30 987 (2.1%) 32 317 4.3% Third party assets under management (million) 166 512 160 576 3.7% 172 180 7.2% Return on average adjusted shareholders' equity 13.4% 12.1% Return on average risk-weighted assets 1.54% 1.45% Loans and advances to customers as a % of customer deposits 78.2% 79.6% Credit loss ratio (expected credit loss impairment charges on gross core loans and advances as a % of average gross core loans and advances) 0.34% 0.61% For balance sheet items we have assumed that the Rand:Pound Sterling exchange rate has remained neutral since March 2018. Condensed combined consolidated income statement Six months to Six months to Year to 30 September 30 September 31 March GBP'000 2018 2017 2018 Interest income 1 285 916 1 225 130 2 491 009 Interest expense (880 902) (860 809) (1 730 611) Net interest income 405 014 364 321 760 398 Fee and commission income 804 249 753 835 1 543 447 Fee and commission expense (100 540) (87 825) (182 240) Investment income 41 472 62 074 130 048 Share of post taxation profit of associates 20 782 23 677 46 823 Trading income/(loss) arising from - customer flow 65 078 64 160 138 226 - balance sheet management and other trading activities 39 031 5 146 (4 307) Other operating income 6 238 5 669 11 115 Total operating income before expected credit losses/impairment losses 1 281 324 1 191 057 2 443 510 Expected credit loss impairment charges* (31 022) - - Impairment losses on loans and advances* - (59 593) (148 556) Operating income 1 250 302 1 131 464 2 294 954 Operating costs (852 982) (795 883) (1 632 740) Depreciation on operating leased assets (1 207) (1 177) (2 421) Operating profit before goodwill and acquired intangibles 396 113 334 404 659 793 Amortisation of acquired intangibles (7 861) (8 142) (16 255) Operating profit 388 252 326 262 643 538 Additional costs on acquisition of subsidiary - - (6 039) Profit before taxation 388 252 326 262 637 499 Taxation on operating profit before goodwill and acquired intangibles (60 301) (44 996) (59 099) Taxation on acquired intangibles and acquisition/disposal/integration of subsidiaries 1 577 1 631 3 253 Profit after taxation 329 528 282 897 581 653 Profit attributable to other non-controlling interests (36 846) (19 800) (52 288) Profit attributable to Asset Management non-controlling interests (12 828) (10 663) (23 817) Earnings attributable to shareholders 279 854 252 434 505 548 Amortisation of acquired intangibles 7 861 8 142 16 255 Additional costs on acquisition of subsidiary - - 6 039 Taxation on acquired intangibles and acquisition/disposal/integration of subsidiaries (1 577) (1 631) (3 253) Preference dividends paid (21 086) (14 101) (32 980) Accrual adjustment on earnings attributable to other equity holders 271 436 (547) Adjusted earnings 265 323 245 280 491 062 Headline adjustments** (8 724) (18 010) (41 415) Headline earnings 256 599 227 270 449 647 Earnings per share (pence) - Basic 27.6 25.8 51.2 - Diluted 26.8 24.9 49.8 Adjusted earnings per share (pence) - Basic 28.3 26.6 53.2 - Diluted 27.5 25.7 51.7 Dividends per share (pence) - Interim 11.0 10.5 10.5 - Final n/a n/a 13.5 Headline earnings per share (pence) - Basic 27.4 24.6 48.7 - Diluted 26.6 23.8 47.4 Number of weighted average shares (million) 937.2 922.9 923.5 * On adoption of IFRS 9, there is a move from an incurred loss model to an expected credit loss methodology. ** The headline earnings adjustments are made up of property revaluations of GBP2.2 million (2017: GBP5.5 million), amortisation of acquired intangibles of GBP7.9 million (2017: GBP8.1 million), gains on available-for-sale instruments recycled to the income statement GBPnil (2017: GBP4.8 million), profit on realisation of associate company of GBPnil (2017: GBP0.8 million), taxation on acquired intangibles and acquisition/disposal/integration of subsidiaries GBP1.6 million (2017: GBP1.6 million) and accrual adjustment on earnings attributable to other equity holders of GBP0.3 million (2017: GBP0.4 million). This line represents the reconciling items from adjusted earnings to headline earnings. Summarised combined consolidated statement of comprehensive income Six months to Six months to Year to 30 September 30 September 31 March GBP'000 2018 2017 2018 Profit after taxation 329 528 282 897 581 653 Other comprehensive income: Items that may be reclassified to the income statement Fair value movements on cash flow hedges taken directly to other comprehensive income* (788) (1 824) (5 746) Gains on debt instruments at FVOCI recycled to the income statement*^ (1 999) - - Fair value movements on debt instruments at FVOCI taken directly to other comprehensive income*^ (12 023) - - Gains on realisation of available-for-sale assets recycled to the income statement*^ - (4 760) (6 676) Fair value movements on available-for-sale assets taken directly to other comprehensive income*^ - 13 816 20 051 Foreign currency adjustments on translating foreign operations (249 312) (220 844) (25 300) Items that will never be reclassified to the income statement Remeasurement of net defined pension liability 69 - 3 938 Gains and losses attributable to own credit risk 10 318 - - Total comprehensive income 75 793 69 285 567 920 Total comprehensive income attributable to ordinary shareholders 70 757 72 485 451 913 Total comprehensive (loss)/income attributable to non-controlling interests (16 050) (17 301) 83 027 Total comprehensive income attributable to perpetual preferred securities 21 086 14 101 32 980 Total comprehensive income 75 793 69 285 567 920 * Net of taxation of (GBP2.1 million) [six months to 30 September 2017: GBP3.0 million, year to 31 March 2018: GBP11.7 million]. ^ On adoption of IFRS 9 on 1 April 2018, the fair value reserve was introduced, replacing the available-for-sale reserve. Summarised combined consolidated cash flow statement Six months to Six months to Year to 30 September 30 September 31 March GBP'000 2018 2017 2018 Cash inflows from operations 404 278 357 998 732 242 Increase in operating assets (1 926 505) (1 009 683) (3 352 869) Increase in operating liabilities 1 845 075 705 103 3 075 779 Net cash inflow from operating activities 322 848 53 418 455 152 Net cash inflow/(outflow) from investing activities 58 190 5 292 (37 799) Net cash (outflow)/inflow from financing activities (203 047) (121 852) 45 383 Effects of exchange rates on cash and cash equivalents (106 538) (144 595) (54 085) Net increase/(decrease) in cash and cash equivalents 71 453 (207 737) 408 651 Cash and cash equivalents at the beginning of the period 6 130 379 5 721 728 5 721 728 Cash and cash equivalents at the end of the period 6 201 832 5 513 991 6 130 379 Cash and cash equivalents is defined as including; cash and balances at central banks, on demand loans and advances to banks and cash equivalent loans and advances to customers (all of which have a maturity profile of less than three months). Condensed combined consolidated balance sheet At 30 September 1 April 31 March 30 September GBP'000 2018 2018* 2018* 2017 Assets Cash and balances at central banks 4 402 571 4 040 010 4 040 512 3 356 259 Loans and advances to banks 2 194 184 2 164 598 2 165 533 2 308 618 Non-sovereign and non-bank cash placements 566 221 599 982 601 243 574 521 Reverse repurchase agreements and cash collateral on securities borrowed 1 641 435 2 207 137 2 207 477 1 690 036 Sovereign debt securities 4 483 385 4 907 624 4 910 027 3 608 316 Bank debt securities 609 522 591 428 587 164 604 511 Other debt securities 1 109 942 898 122 903 603 968 597 Derivative financial instruments 1 098 812 1 345 744 1 352 408 1 201 602 Securities arising from trading activities 1 921 010 1 434 391 1 434 391 1 395 766 Investment portfolio 950 455 956 560 885 499 911 480 Loans and advances to customers 23 739 734 24 410 334 24 673 009 22 351 228 Own originated loans and advances to customers securitised 452 341 458 814 459 088 445 672 Other loans and advances 207 251 345 742 347 809 367 401 Other securitised assets 142 884 148 387 148 387 153 786 Interests in associated undertakings 421 139 467 852 467 852 371 294 Deferred taxation assets 215 388 242 239 157 321 123 435 Other assets 2 006 480 1 875 357 1 876 116 2 016 057 Property and equipment 269 174 233 340 233 340 100 910 Investment properties 1 041 323 1 184 097 1 184 097 1 063 771 Goodwill 367 480 368 803 368 803 366 969 Intangible assets 120 333 125 389 125 389 132 692 47 961 064 49 005 950 49 129 068 44 112 921 Other financial instruments at fair value through profit or loss in respect of liabilities to customers 8 176 040 8 487 776 8 487 776 7 705 206 56 137 104 57 493 726 57 616 844 51 818 127 Liabilities Deposits by banks 3 011 094 2 931 267 2 931 267 2 246 115 Derivative financial instruments 1 402 260 1 471 563 1 471 563 1 169 314 Other trading liabilities 1 006 572 960 166 960 166 968 917 Repurchase agreements and cash collateral on securities lent 488 271 655 840 655 840 730 170 Customer accounts (deposits) 30 348 761 30 985 251 30 987 173 27 966 006 Debt securities in issue 2 734 128 2 717 187 2 717 187 2 549 264 Liabilities arising on securitisation of own originated loans and advances 120 161 136 812 136 812 133 307 Liabilities arising on securitisation of other assets 121 161 127 853 127 853 131 740 Current taxation liabilities 170 794 185 486 185 486 197 244 Deferred taxation liabilities 30 507 32 158 32 158 38 304 Other liabilities 1 812 573 2 019 906 2 012 268 1 827 251 41 246 282 42 223 489 42 217 773 37 957 632 Liabilities to customers under investment contracts 8 172 496 8 484 296 8 484 296 7 702 724 Insurance liabilities, including unit-linked liabilities 3 544 3 480 3 480 2 482 49 422 322 50 711 265 50 705 549 45 662 838 Subordinated liabilities 1 596 958 1 619 878 1 482 987 1 389 091 51 019 280 52 331 143 52 188 536 47 051 929 Equity Ordinary share capital 245 240 240 240 Perpetual preference share capital 31 31 31 31 Share premium 2 490 403 2 416 736 2 416 736 2 404 171 Treasury shares (210 912) (160 132) (160 132) (196 198) Other reserves (530 880) (406 718) (345 606) (460 907) Retained income 2 430 803 2 326 212 2 530 825 2 385 707 Shareholders' equity excluding non-controlling interests 4 179 690 4 176 369 4 442 094 4 133 044 Other Additional Tier 1 securities in issue 298 808 304 150 304 150 30 386 Non-controlling interests 639 326 682 064 682 064 602 768 - Perpetual preferred securities issued by subsidiaries 83 204 92 312 92 312 84 763 - Non-controlling interests in partially held subsidiaries 556 122 589 752 589 752 518 005 Total equity 5 117 824 5 162 583 5 428 308 4 766 198 Total liabilities and equity 56 137 104 57 493 726 57 616 844 51 818 127 * The 1 April 2018 balance sheet has been presented on an IFRS 9 basis and the comparative as at 31 March 2018 on an IAS 39 basis. Summarised combined consolidated statement of changes in equity Six months to Year to Six months to 30 September 31 March 30 September GBP'000 2018 2018 2017 Balance at the beginning of the period 5 428 308 4 808 629 4 808 629 Adoption of IFRS 9 (265 725) - - Total comprehensive income for the period 75 793 567 920 69 285 Share-based payments adjustments 33 084 69 218 34 688 Dividends paid to ordinary shareholders (127 943) (227 908) (123 230) Dividends declared to perpetual preference shareholders (7 528) (15 736) (8 160) Dividends paid to perpetual preference shareholders included in non-controlling interests (13 558) (17 244) (5 941) Dividends paid to non-controlling interests (27 378) (63 688) (29 272) Issue of ordinary shares 103 141 125 240 105 206 Issue of Other Additional Tier 1 security instruments - 271 058 - Issue of equity by subsidiaries - 12 695 - Net equity impact of non-controlling interest movements - 20 057 4 518 Net equity movement of interest in associate undertakings (5 671) - - Movement of treasury shares (74 699) (121 933) (89 525) Balance at the end of the period 5 117 824 5 428 308 4 766 198 Combined consolidated segmental analysis For the six months to 30 September UK and Southern Total GBP'000 Other Africa group Segmental geographical and business analysis of operating profit before goodwill, acquired intangibles, non-operating items, taxation and after other non-controlling interests 2018 Asset Management 56 840 34 686 91 526 Wealth & Investment 32 864 13 544 46 408 Specialist Banking 80 756 164 625 245 381 170 460 212 855 383 315 Group costs (17 227) (6 821) (24 048) Total group 153 233 206 034 359 267 Other non-controlling interest - equity 36 846 Operating profit 396 113 2017 Asset Management 49 949 33 284 83 233 Wealth & Investment 35 441 14 087 49 528 Specialist Banking 41 208 165 291 206 499 126 598 212 662 339 260 Group costs (17 295) (7 361) (24 656) Total group 109 303 205 301 314 604 Other non-controlling interest - equity 19 800 Operating profit 334 404 Analysis of financial assets and liabilities by category of financial instrument Total Total financial Non-financial financial instruments instruments At 30 September 2018 instruments at amortised or scoped GBP'000 at fair value cost out of IFRS 9 Total Assets Cash and balances at central banks 695 4 401 876 - 4 402 571 Loans and advances to banks - 2 194 184 - 2 194 184 Non-sovereign and non-bank cash placements 47 613 518 608 - 566 221 Reverse repurchase agreements and cash collateral on securities borrowed 527 934 1 113 501 - 1 641 435 Sovereign debt securities 4 200 240 283 145 - 4 483 385 Bank debt securities 274 025 335 497 - 609 522 Other debt securities 698 726 411 216 - 1 109 942 Derivative financial instruments 1 098 812 - - 1 098 812 Securities arising from trading activities 1 921 010 - - 1 921 010 Investment portfolio 950 455 - - 950 455 Loans and advances to customers 2 443 852 21 295 882 - 23 739 734 Own originated loans and advances to customers securitised - 452 341 - 452 341 Other loans and advances - 207 251 - 207 251 Other securitised assets 125 814 17 070 - 142 884 Interests in associated undertakings - - 421 139 421 139 Deferred taxation assets - - 215 388 215 388 Other assets 228 394 1 160 686 617 400 2 006 480 Property and equipment - - 269 174 269 174 Investment properties - - 1 041 323 1 041 323 Goodwill - - 367 480 367 480 Intangible assets - - 120 333 120 333 12 517 570 32 391 257 3 052 237 47 961 064 Other financial instruments at fair value through profit or loss in respect of liabilities to customers 8 176 040 - - 8 176 040 20 693 610 32 391 257 3 052 237 56 137 104 Liabilities Deposits by banks - 3 011 094 - 3 011 094 Derivative financial instruments 1 402 260 - - 1 402 260 Other trading liabilities 1 006 572 - - 1 006 572 Repurchase agreements and cash collateral on securities lent 175 187 313 084 - 488 271 Customer accounts (deposits) 2 300 787 28 047 974 - 30 348 761 Debt securities in issue 390 098 2 344 030 - 2 734 128 Liabilities arising on securitisation of own originated loans and advances - 120 161 - 120 161 Liabilities arising on securitisation of other assets 121 161 - - 121 161 Current taxation liabilities - - 170 794 170 794 Deferred taxation liabilities - - 30 507 30 507 Other liabilities 37 059 1 167 966 607 548 1 812 573 5 433 124 35 004 309 808 849 41 246 282 Liabilities to customers under investment contracts 8 172 496 - - 8 172 496 Insurance liabilities, including unit-linked liabilities 3 544 - - 3 544 13 609 164 35 004 309 808 849 49 422 322 Subordinated liabilities 385 060 1 211 898 - 1 596 958 13 994 224 36 216 207 808 849 51 019 280 Financial instruments carried at fair value The table below analyses recurring fair value measurements for financial assets and financial liabilities. These fair value measurements are categorised into different levels in the fair value hierarchy based on the inputs to the valuation technique used. The different levels are identified as follows: Level 1 - quoted (unadjusted) prices in active markets for identical assets or liabilities. Level 2 - inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices) Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs) Fair value category Total financial At 30 September 2018 instruments GBP'000 at fair value Level 1 Level 2 Level 3 Assets Cash and balances at central banks 695 695 - - Non-sovereign and non-bank cash placements 47 613 4 495 43 118 - Reverse repurchase agreements and cash collateral on securities borrowed 527 934 - 527 934 - Sovereign debt securities 4 200 240 4 200 240 - - Bank debt securities 274 025 266 206 7 819 - Other debt securities 698 726 194 776 411 716 92 234 Derivative financial instruments 1 098 812 - 1 060 819 37 993 Securities arising from trading activities 1 921 010 1 917 605 3 405 - Investment portfolio 950 455 182 062 31 590 736 803 Loans and advances to customers 2 443 852 - 970 182 1 473 670 Other securitised assets 125 814 - - 125 814 Other assets 228 394 228 394 - - Other financial instruments at fair value through profit or loss in respect of liabilities to customers 8 176 040 8 176 040 - - 20 693 610 15 170 513 3 056 583 2 466 514 Liabilities Derivative financial instruments 1 402 260 - 1 382 215 20 045 Other trading liabilities 1 006 572 883 181 123 391 - Repurchase agreements and cash collateral on securities lent 175 187 - 175 187 - Customer accounts (deposits) 2 300 787 - 2 300 787 - Debt securities in issue 390 098 - 390 098 - Liabilities arising on securitisation of other assets 121 161 - - 121 161 Other liabilities 37 059 - 37 059 - Subordinated liabilities 385 060 385 060 - - Liabilities to customers under investment contracts 8 172 496 8 172 496 - - Insurance liabilities, including unit-linked liabilities 3 544 3 544 - - 13 994 224 9 444 281 4 408 737 141 206 Net financial assets at fair value 6 699 386 5 726 232 (1 352 154) 2 325 308 Transfers between level 1 and level 2 There were no significant transfers between level 1 and level 2 in the current period. The group transfers between levels within the fair value hierarchy when the significance of the unobservable inputs change or if the valuation methods change. Level 2 financial assets and financial liabilities The following table sets out the group's principal valuation techniques as at 30 September 2018 used in determining the fair value of its financial assets and financial liabilities that are classified within level 2 of the fair value hierarchy. Valuation basis/techniques Main assumptions Assets Non-sovereign and non-bank cash Discounted cash flow model Yield curves placements Reverse repurchase agreements and Discounted cash flow model, Hermite interpolation Yield curves cash collateral on securities borrowed Bank debt securities Discounted cash flow model Yield curves NCD curves Other debt securities Discounted cash flow model Yield curves and NCD curves, external prices, broker quotes Derivative financial instruments Discounted cash flow model, Hermite interpolation, Yield curves, risk free rate, volatilities, forex forward industry standard derivative pricing models including points and spot rates, interest rate swap curves and Black-Scholes credit curves Securities arising from trading activities Interest rate curves, implied bond spreads, equity Standard industry derivative pricing model volatilities Adjusted quoted price Liquidity adjustments Investment portfolio Discounted cash flow model, relative valuation model Discount rate and fund unit price, net assets Comparable quoted inputs Loans and advances to customers Discounted cash flow model Yield curves Liabilities Derivative financial instruments Discounted cash flow model, Hermite interpolation, Yield curves, risk-free rate, volatilities, forex forward industry standard derivative pricing models including points and spot rates, interest rate swap curves and Black-Scholes credit curves Other trading liabilities Discounted cash flow model Yield curves Repurchase agreements and cash Discounted cash flow model, Hermite interpolation Yield curves collateral on securities lent Customer accounts (deposits) Discounted cash flow model Yield curves Debt securities in issue Discounted cash flow model Yield curves Other liabilities Discounted cash flow model Yield curves Net level 3 For the six months to 30 September 2018 financial GBP'000 instruments The following table is a reconciliation of the opening balances to the closing balances for fair value measurements in level 3 of the fair value hierarchy: Balance as at 31 March 2018 776 176 Adoption of IFRS 9 1 341 810 Balance as at 1 April 2018 2 117 986 Total gains or losses 73 464 In the income statement 73 206 In the statement of comprehensive income 258 Purchases 800 061 Sales (348 240) Issues 16 616 Settlements (391 874) Transfers into level 3 12 123 Foreign exchange adjustments 45 172 Balance as at 30 September 2018 2 325 308 For the period ended 30 September 2018, GBP12.1 million has been transferred out of level 2 into level 3 as a result of the inputs to the valuation method becoming unobservable in the market. For the six months to 30 September 2018 GBP'000 Total Realised Unrealised Total gains/(losses) included in the income statement for the period Net interest income 51 731 40 662 11 069 Fee and commission income 9 600 11 512 (1 912) Investment income 7 071 1 334 5 737 Trading income arising from customer flow 4 804 3 734 1 070 73 206 57 242 15 964 Total gains/(losses) included in other comprehensive income for the period Gains on realisation on debt instruments at FVOCI recycled through the income statement 19 757 19 757 - Fair value movements on debt instruments at FVOCI taken directly to other comprehensive income 258 - 258 20 015 19 757 258 Sensitivity of fair values to reasonably possible alternative assumptions by level 3 instrument type The fair value of financial instruments in level 3 are measured using valuation techniques that incorporate assumptions that are not evidenced by prices from observable market data. The following table shows the sensitivity of these fair values to reasonably possible alternative assumptions, determined at a transactional level: Balance sheet Significant Range of Favourable Unfavourable value unobservable unobservable changes changes GBP'000 input input used GBP'000 GBP'000 30 September 2018 Assets Other debt securities 92 234 Potential impact on income statement 7 975 (7 887) Cash flow adjustments CPR 8.6% - (68) Credit spreads 5.1% 140 (136) EBITDA (5%)/5% 348 (348) Other^ ^ 7 487 (7 335) Derivative financial instruments 37 993 Potential impact on income statement 6 964 (9 205) Volatilities 4.0% - 9.0% 212 (212) Cash flow adjustments CPR 7.6% - 11.2% 110 (101) Underlying asset value 5 684 (8 029) EBIDTA (5%)/20% 128 (32) Other^ ^ 830 (831) Investment portfolio 736 803 Potential impact on income statement 122 097 (124 731) Price earnings multiple 4.0 x - 10.3 x 6 117 (5 828) WACC 20.0% 29 594 (35 004) Underlying asset value 9 472 (3 029) EBITDA ^^ 23 602 (19 226) Cash flow adjustments (15%)/25% 3 151 (2 638) Precious and industrial metals prices (10%)/6% 1 139 (1 898) Property values (5%)/5% 9 339 (9 339) Other^ ^ 39 683 (47 769) Loans and advances to customers 1 473 670 Potential impact on income statement 41 750 (54 993) Credit spreads 0.2% - 29.0% 4 202 (6 048) Cash flow adjustments (15%)/5% 1 637 (4 910) Underlying asset value 2 130 (1 715) Other^ ^ 33 781 (42 320) Potential impact on other comprehensive income Credit spreads 0.1% - 5.1% 1 135 (1 615) Other securitised assets* 125 814 Potential impact on income statement Cash flow adjustments CPR 7.7% 723 (728) Total level 3 assets 2 466 514 180 644 (199 159) Liabilities Derivative financial instruments 20 045 Potential impact on income statement (9 085) 7 268 Cash flow adjustments CPR 7.6% - 11.2% (81) 89 Volatilities 8.5% (2) 2 Underlying asset value (9 002) 7 177 Liabilities arising on securitisation of other 121 161 Potential impact on income statement assets* Cash flow adjustments CPR 8.0% (244) 205 Total level 3 liabilities 141 206 (9 329) 7 473 Net level 3 assets 2 325 308 * The sensitivity of the fair value of liabilities arising on securitisation of other assets has been considered together with other securitised assets. ^ Other - The valuation sensitivity has been assessed by adjusting various inputs such as expected cash flows, discount rates, earnings multiples rather than a single input. It is deemed appropriate to reflect the outcome on a portfolio basis for the purposes of this analysis as the sensitivity of the assets cannot be determined through the adjustment of a single input. ^^ The EBITDA has been stressed on an investment by investment basis to obtain a favourable and unfavourable valuation. Underlying asset values calculated by reference to a tangible asset, for example property, aircraft or shares. In determining the value of level 3 financial instruments, the following are the principal inputs that do require judgement: Credit spreads Credit spreads reflect the additional yield that a market participant would demand for taking exposure to the credit risk of an instrument. The credit spread for an instrument forms part of the yield used in a discounted cash flow calculation. In general a significant increase in a credit spread in isolation will result in a movement in fair value that is unfavourable for the holder of a financial instrument. Discount rates (including WACC) Discount rates are used to adjust for the time value of money when using a discounted cash flow valuation method. Where relevant, the discount rate also accounts for illiquidity, market conditions and uncertainty for future cash flows. Volatilities Volatility is a key input in the valuation of derivative products containing optionality. Volatility is a measure of the variability or uncertainty in returns for a given derivative underlying. It represents an estimate of how much a particular underlying instrument, parameter or index will change in value over time. Cash flows Cash flows relate to the future cash flows which can be expected from the instrument and requires judgement. EBITDA The group's earnings before interest, taxes, depreciation and amortisation. This is the main input into a price earnings multiple valuation method. Price earnings multiple The price-to-earnings ratio is an equity valuation multiple. It is a key driver in the valuation of unlisted investments. Precious and industrial metals and property value The price of precious and industrial metals and property value is a key driver of future cash flows on certain investments. Underlying asset value In instances where cash flows have links to referenced assets, the underlying asset value is used to determine the fair value. The underlying asset valuation is derived using observable market prices sourced from broker quotes, specialist valuers or other reliable pricing sources. Fair value of financial assets and liabilities at amortised cost The following table sets out the fair value of financial instruments held at amortised cost where the carrying value is not a reasonable approximation of fair value. At 30 September 2018 Carrying Fair GBP'000 amount value Assets Loans and advances to banks 2 194 184 2 194 749 Reverse repurchase agreements and cash collateral on securities borrowed 1 113 501 1 113 413 Sovereign debt securities 283 145 274 120 Bank debt securities 335 497 334 171 Other debt securities 411 216 406 266 Loans and advances to customers 21 295 882 21 275 003 Other loans and advances 207 251 240 619 Other assets 1 160 686 1 159 535 Liabilities Deposits by banks 3 011 094 3 039 929 Repurchase agreements and cash collateral on securities lent 313 084 309 554 Customer accounts (deposits) 28 047 974 28 035 101 Debt securities in issue 2 344 030 2 372 763 Other liabilities 1 167 966 1 169 085 Subordinated liabilities 1 211 898 1 282 250 Investec Limited Incorporated in the Republic of South Africa Registration number: 1925/002833/06 JSE ordinary share code: INL NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000081949 Ordinary share dividend announcement Declaration of dividend number 126 Notice is hereby given an interim dividend number 126, being a gross dividend of 206 cents (2017: 200 cents) per ordinary share has been declared by the board from income reserves in respect of the six months ended 30 September 2018 payable to shareholders recorded in the shareholders' register of the company at the close of business on Friday, 7 December 2018. The relevant dates for the payment of dividend number 126 are as follows: Last day to trade cum-dividend Tuesday, 4 December 2018 Shares commence trading ex-dividend Wednesday, 5 December 2018 Record date Friday, 7 December 2018 Payment date Wednesday, 19 December 2018 The interim gross dividend of 206 cents per ordinary share has been determined by converting the Investec plc distribution of 11 pence per ordinary share into Rands using the Rand/Pounds Sterling average buy/sell forward rate at 11:00 (SA time) on Wednesday, 14 November 2018. Share certificates may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information to take note of: - Investec Limited South African tax reference number: 9800/181/71/2 - The issued ordinary share capital of Investec Limited is 318 904 709 ordinary shares - The dividend paid by Investec Limited is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - Shareholders who are exempt from paying the Dividend Tax will receive a net dividend of 206 cents per ordinary share - Shareholders who are not exempt from paying the Dividend Tax will receive a net dividend of 164.8 cents per ordinary share (gross dividend of 206 cents per ordinary share less Dividend Tax of 41.200 cents per ordinary share). By order of the board N van Wyk Company Secretary 14 November 2018 Investec Limited Incorporated in the Republic of South Africa Registration number: 1925/002833/06 JSE share Code: INPR NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000063814 Preference share dividend announcement Non-redeemable non-cumulative non-participating preference shares ("preference shares") Declaration of dividend number 28 Notice is hereby given that preference dividend number 28 has been declared by the board from income reserves for the period 1 April 2018 to 30 September 2018 amounting to a gross preference dividend of 389.91534 cents per share payable to holders of the non-redeemable non-cumulative non-participating preference shares as recorded in the books of the company at the close of business on Friday, 14 December 2018. The relevant dates for the payment of dividend number 28 are as follows: Last day to trade cum-dividend Tuesday, 11 December 2018 Shares commence trading ex-dividend Wednesday, 12 December 2018 Record date Friday, 14 December 2018 Payment date Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised between Wednesday, 12 December 2018 and Friday, 14 December 2018, both dates inclusive. Additional information to take note of: - Investec Limited South African tax reference number: 9800/181/71/2 - The issued preference share capital of Investec Limited is 32 214 499 preference shares in this specific class - The dividend paid by Investec Limited is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - The net dividend amounts to 311.93227 cents per preference share for shareholders liable to pay the Dividend Tax and 389.91534 cents per preference share for preference shareholders exempt from paying the Dividend Tax. By order of the board N van Wyk Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales Registration number 3633621 LSE ordinary share code: INVP JSE ordinary share code: INP ISIN: GB00B17BBQ50 Ordinary share dividend announcement In terms of the DLC structure, Investec plc shareholders registered on the United Kingdom share register may receive all or part of their dividend entitlements through dividends declared and paid by Investec plc on their ordinary shares and/or through dividends declared and paid on the SA DAN share issued by Investec Limited. Investec plc shareholders registered on the South African branch register may receive all or part of their dividend entitlements through dividends declared and paid by Investec plc on their ordinary shares and/or through dividends declared and paid on the SA DAS share issued by Investec Limited. Declaration of dividend number 33 Notice is hereby given that an interim dividend number 33, being a gross dividend of 11 pence (2017: 10.5 pence) per ordinary share has been declared by the board from income reserves in respect of the six months ended 30 September 2018 payable to shareholders recorded in the shareholders' register of the company at the close of business on Friday, 7 December 2018. - for Investec plc shareholders, registered on the United Kingdom share register, through a dividend payment by Investec plc from income reserves of 11 pence per ordinary share - for Investec plc shareholders, registered on the South African branch register, through a dividend payment by Investec plc from income reserves of 3 pence per ordinary share and through a dividend paid by Investec Limited, on the SA DAS share, payable from income reserves, equivalent to 8 pence per ordinary share The relevant dates for the payment of dividend number 33 are as follows: Last day to trade cum-dividend On the Johannesburg Stock Exchange (JSE) Tuesday, 4 December 2018 On the London Stock Exchange (LSE) Wednesday, 5 December 2018 Shares commence trading ex-dividend On the Johannesburg Stock Exchange (JSE) Wednesday, 5 December 2018 On the London Stock Exchange (LSE) Thursday, 6 December 2018 Record date (on the JSE and LSE) Friday, 7 December 2018 Payment date (on the JSE and LSE) Wednesday, 19 December 2018 Share certificates on the South African branch register may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive, nor may transfers between the United Kingdom share register and the South African branch register take place between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information for South African resident shareholders of Investec plc - Shareholders registered on the South African branch register are advised that the distribution of 11 pence, equivalent to a gross dividend of 206 cents per share, has been arrived at using the Rand/Pound Sterling average buy/sell forward rate, as determined at 11:00 (SA time) on Wednesday, 14 November 2018 - Investec plc United Kingdom tax reference number: 2683967322360 - The issued ordinary share capital of Investec plc is 681 051 512 ordinary shares - The dividend paid by Investec plc to South African resident shareholders registered on the South African branch register and the dividend paid by Investec Limited to Investec plc shareholders on the SA DAS share are subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - Shareholders registered on the South African branch register who are exempt from paying the Dividend Tax will receive a net dividend of 206 cents per share, comprising 149.81818 cents per share paid by Investec Limited on the SA DAS share and 56.18182 cents per ordinary share paid by Investec plc - Shareholders registered on the South African branch register who are not exempt from paying the Dividend Tax will receive a net dividend of 164.8 cents per share (gross dividend of 206 cents per share less Dividend Tax of 41.2 cents per share) comprising 119.85455 cents per share paid by Investec Limited on the SA DAS share and 44.94545 cents per ordinary share paid by Investec plc. By order of the board D Miller Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales Registration number: 3633621 Share code: INPP ISIN: GB00B19RX541 Preference share dividend announcement Non-redeemable non-cumulative non-participating preference shares ("preference shares") Declaration of dividend number 25 Notice is hereby given that preference dividend number 25 has been declared by the board from income reserves for the period 1 April 2018 to 30 September 2018 amounting to a gross preference dividend of 7.93150 pence per preference share payable to holders of the non-redeemable non- cumulative non-participating preference shares as recorded in the books of the company at the close of business on Friday, 7 December 2018. For shares trading on the Johannesburg Stock Exchange (JSE), the dividend of 7.93150 pence per preference share is equivalent to a gross dividend of 148.73149 cents per share, which has been determined using the Rand/ Pound Sterling average buy/sell forward rate as at 11:00 (SA Time) on Wednesday, 14 November 2018. The relevant dates relating to the payment of dividend number 25 are as follows: Last day to trade cum-dividend On the Johannesburg Stock Exchange (JSE) Tuesday, 4 December 2018 On The International Stock Exchange (TISE) Wednesday, 5 December 2018 Shares commence trading ex-dividend On the Johannesburg Stock Exchange (JSE) Wednesday, 5 December 2018 On The International Stock Exchange (TISE) Thursday, 6 December 2018 Record date (on the JSE and TISE) Friday, 7 December 2018 Payment date (on the JSE and TISE) Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive, nor may transfers between the United Kingdom share register and the South African branch register take place between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information for South African resident shareholders of Investec plc - Investec plc United Kingdom tax reference number: 2683967322360 - The issued preference share capital of Investec plc is 2 754 587 preference shares - The dividend paid by Investec plc to shareholders recorded on the South African branch register is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - The net dividend amounts to 118.98519 cents per preference share for preference shareholders liable to pay the Dividend Tax and 148.73149 cents per preference share for preference shareholders exempt from paying the Dividend Tax. By order of the board D Miller Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales Registration number: 3633621 JSE share code: INPPR ISIN: GB00B4B0Q974 Rand-denominated preference share dividend announcement Rand-denominated non-redeemable non-cumulative non- participating perpetual preference shares ("preference shares") Declaration of dividend number 15 Notice is hereby given that preference dividend number 15 has been declared by the board from income reserves for the period 1 April 2018 to 30 September 2018 amounting to a gross preference dividend of 476.30137 cents per preference share payable to holders of the Rand-denominated non- redeemable non-cumulative non-participating perpetual preference shares as recorded in the books of the company at the close of business on Friday, 7 December 2018. The relevant dates relating to the payment of dividend number 15 are as follows: Last day to trade cum-dividend Tuesday, 4 December 2018 Shares commence trading ex-dividend Wednesday, 5 November 2018 Record date Friday, 7 December 2018 Payment date Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information for South African resident shareholders of Investec plc - Investec plc United Kingdom tax reference number: 2683967322360 - The issued rand denominated preference share capital of Investec plc is 131 447 preference shares - The dividend paid by Investec plc to shareholders recorded on the South African branch register is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - The net dividend amounts to 381.04110 cents per preference share for preference shareholders liable to pay the Dividend Tax and 476.30137 cents per preference share for preference shareholders exempt from paying the Dividend Tax. By order of the board D Miller Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales (Registration number 3633621) JSE ordinary share code: INP LSE ordinary share code: INVP ISIN: GB00B17BBQ50 Registered office: 30 Gresham Street, London EC2V 7QP, United Kingdom Transfer secretaries: Computershare Investor Services (Pty) Ltd Rosebank Towers, 15 Biermann Avenue, Rosebank, 2196 Company Secretary: D Miller Investec Limited Incorporated in the Republic of South Africa (Registration number 1925/002833/06) JSE ordinary share code: INL NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000081949 Registered office: 100 Grayston Drive Sandown, Sandton, 2196 Transfer secretaries: Computershare Investor Services (Pty) Ltd Rosebank Towers, 15 Biermann Avenue, Rosebank, 2196 Company Secretary: N van Wyk Directors: PKO Crosthwaite* (Chairman), HJ du Toit## (Joint Chief Executive Officer) F Titi## (Joint Chief Executive Officer) ZBM Bassa, LC Bowden*, GR Burger##, CA Carolus, D Friedland, PA Hourquebie, CR Jacobs^, B Kantor##, IR Kantor^^, S Koseff##, Lord Malloch-Brown KCMG*, KM McFarland## KL Shuenyane ## Executive *British ^^ Dutch ^Irish Sponsor: Investec Bank Limited Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Unaudited combined consolidated financial results for the six months ended 30 September 2018 Investec Limited Incorporated in the Republic of South Africa Registration number: 1925/002833/06 JSE ordinary share code: INL NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000081949 Investec plc Incorporated in England and Wales (Registration number 3633621) JSE ordinary share code: INP LSE ordinary share code: INVP ISIN: GB00B17BBQ50 Investec plc and Investec Limited (combined results) Unaudited combined consolidated financial results for the six months ended 30 September 2018 Unaudited combined consolidated financial results This announcement covers the statutory results of the Investec group for the six months ended 30 September 2018. Overview of results - The group has delivered a sound operational performance. - This is notwithstanding a challenging operating environment. Rising US interest rates, the threat of trade wars, concerns over global growth prospects, weak economic growth in South Africa and Brexit-related uncertainty in the UK have contributed to this. - The Asset Management and Wealth & Investment businesses have grown funds under management supported by strong net flows of GBP4.8 billion. - The Specialist Banking business saw a substantial reduction in impairments as well as revenue growth supported by reasonable levels of client activity. - The cost to income ratio improved marginally. Revenue growth and cost containment remain priorities. - A solid base of annuity revenue has continued to support earnings through varying market conditions. Overall group performance Operating profit before goodwill, acquired intangibles, non-operating items and taxation and after other non-controlling interests (operating profit) increased 14.2% to GBP359.3 million (2017: GBP314.6 million) - an increase of 17.6% on a currency neutral basis. Overall group results have been negatively impacted by the depreciation of the average Rand: Pounds Sterling exchange rate of approximately 4.1% over the period. The combined South African businesses reported operating profit 5.0% ahead of the prior period (in Rands), whilst the combined UK and Other businesses posted a 40.2% increase in operating profit in Pounds Sterling. Salient features of the period under review are: - Adjusted earnings attributable to shareholders before goodwill, acquired intangibles and non-operating items increased 8.2% to GBP265.3 million (2017: GBP245.3 million) - an increase of 11.1% on a currency neutral basis. - Adjusted earnings per share (EPS) before goodwill, acquired intangibles and non-operating items increased 6.4% from 26.6 pence to 28.3 pence - an increase of 9.4% on a currency neutral basis. - Annuity income as a percentage of total operating income amounted to 75.5% (2017: 76.4%). - The total income statement impairment charge reduced materially to GBP31.0 million (2017: GBP59.6 million). The annualised credit loss charge as a percentage of average gross core loans and advances subject to expected credit losses has improved to 0.34% (2017: 0.52%). - The annualised return on adjusted average shareholders' equity increased to 13.4% from 12.1% at 31 March 2018. - Third party assets under management increased 3.7% to GBP166.5 billion (31 March 2018: GBP160.6 billion) - an increase of 7.2% on a currency neutral basis. - Customer accounts (deposits) decreased 2.1% to GBP30.3 billion (31 March 2018: GBP31.0 billion) - an increase of 4.3% on a currency neutral basis. - Core loans and advances decreased 3.7% to GBP24.2 billion (31 March 2018: GBP25.1 billion) - an increase of 2.4% on a currency neutral basis. - The group maintained a sound capital position with common equity tier one (CET 1) ratios of 10.4% for Investec plc and 10.3% for Investec Limited, ahead of the group's CET 1 ratio target. The group is comfortable with its CET 1 ratio target at a 10% level, as its leverage ratios for both Investec Limited and Investec plc are above 7%. - Liquidity remains strong with cash and near cash balances amounting to GBP12.5 billion. - The board declared a dividend of 11.0 pence per ordinary share (2017: 10.5 pence) resulting in a dividend cover based on the group's adjusted EPS before goodwill and non-operating items of 2.6 times (2017: 2.5 times), consistent with the group's dividend policy. - The proposed demerger and separate listing of Investec Asset Management (still subject to regulatory and shareholder approvals) is progressing well. Fani Titi and Hendrik du Toit, Joint Chief Executive Officers of Investec said: "The outgoing executives have handed over a resilient business with positive momentum and good growth potential. It is now up to us to implement our strategy of simplification and greater focus, involving the demerger and separate listing of the Asset Management business and the positioning of the Specialist Bank and Wealth & Investment businesses for sustainable long- term growth. Revenue growth, capital allocation and cost discipline remain high on our agenda." For further information please contact: Investec +27 (0) 11 286 7070 or +44 (0) 20 7597 5546 Fani Titi, Joint Chief Executive Officer Hendrik du Toit, Joint Chief Executive Officer Ursula Nobrega, Investor Relations (mobile: +27 (0) 82 552 8808) Carly Newton, Investor Relations (+44 (0) 20 7597 4493) Brunswick (SA PR advisers) Marina Bidoli Tel: +27 (0)11 502 7405 / +2783 253 0478 Lansons (UK PR advisers) Tom Baldock Tel: +44 (0)20 7566 9716 Presentation/conference call details A presentation on the results will commence at 9:00 UK time/11:00 SA time. Viewing options as below: - Live on South African TV (Business day TV channel 412 DSTV) - A live and delayed video webcast at www.investec.com - Toll free numbers for the telephone conference facilities - SA participants: 0800 200 648 - UK participants: 0808 162 4061 - rest of Europe and other participants: +800 246 78 700 - Australian participants: 1800 350 100 - USA participants: 1855 481 6362 About Investec Investec is an international specialist bank and asset manager that provides a diverse range of financial products and services to a select client base in three principal markets - the UK and Europe, South Africa and Asia/Australia as well as certain other countries. The group was established in 1974 and currently has approximately 10 300 employees. Investec focuses on delivering distinctive profitable solutions for its clients in three core areas of activity namely, Asset Management, Wealth & Investment and Specialist Banking. In July 2002 the Investec group implemented a dual listed company structure with listings on the London and Johannesburg Stock Exchanges. The combined group's current market capitalisation is approximately GBP5.0 billion. Business unit review Asset Management Asset Management operating profit increased by 10.0% to GBP91.5 million (2017: GBP83.2 million). Strong net inflows of GBP4.1 billion supported the growth in total funds under management to GBP109.2 billion (31 March 2018: GBP103.9 billion). Flows were well spread across client regions. Wealth & Investment Wealth & Investment operating profit decreased by 6.3% to GBP46.4 million (2017: GBP49.5 million). Earnings have been impacted by growth in headcount for IT initiatives, compliance requirements, and continued recruitment of experienced portfolio managers and financial planners to support future revenue growth. The business generated net inflows of GBP650 million. Total funds under management amounted to GBP56.7 billion (31 March 2018: GBP56.0 billion). Specialist Banking Specialist Banking operating profit increased by 18.8% to GBP245.4 million (2017: GBP206.5 million). The South African business reported an increase in operating profit in Rands of 4.2%. A combination of a weak domestic economy and political policy uncertainty has resulted in subdued activity; reflecting in softer loan book growth, client flow trading levels and a weaker performance from the equity and investment property portfolios. We did however, report growth in net interest income supported by higher net margins and continued activity from our private client base. The annualised credit loss ratio on average core loans and advances subject to expected credit losses amounted to 0.30% (2017: 0.30% under the IAS 39 incurred impairment loss model), remaining at the lower end of its long-term average trend. The UK and Other businesses reported a 96.0% increase in operating profit, reflecting a material decrease in impairment charges due to no longer incurring substantial losses on the legacy portfolio. In addition, earnings were supported by strong growth in net interest income and fee income largely driven by the corporate business. With the investment phase in the private bank largely complete, the business has strengthened its focus on client acquisition and has seen sound growth in mortgage lending activity. The bank's overall cost to income ratio improved, notwithstanding an increase in costs driven largely by headcount growth in relation to increased business activity and regulatory requirements. The annualised credit loss ratio on average core loans and advances subject to expected credit losses amounted to 0.41% (2017: 0.84% under the IAS 39 incurred impairment loss model). Further information on key developments within each of the business units is provided in a detailed report published on the group's website: https://www.investec.com Group costs These largely relate to group brand and marketing costs and a portion of executive and support functions which are associated with group level activities. These costs are not incurred by the operating divisions and are necessary to support the operational functioning of the group. These costs amounted to GBP24.0 million (2017: GBP24.7 million). Financial statement analysis Total operating income Total operating income before expected credit loss impairment charges increased by 7.6% to GBP1 281.3 million (2017: GBP1 191.1 million). Net interest income increased by 11.2% to GBP405.0 million (2017: GBP364.3 million) driven by lending activity and endowment impact from rate rises in the UK. Net fee and commission income increased by 5.7% to GBP703.7 million (2017: GBP666.0 million) as a result of higher average funds under management and net inflows in the Asset Management and Wealth Management businesses as well as a good performance from the corporate advisory business in the UK. Investment income amounted to GBP41.5 million (2017: GBP62.1 million) reflecting a weaker performance from the group's listed and unlisted investment portfolio, as well as from the investment property portfolio in South Africa. Share of post taxation profit of associates of GBP20.8 million (2017: GBP23.7 million) reflects earnings in relation to the group's investment in the IEP Group. Trading income arising from customer flow increased by 1.4% to GBP65.1 million (2017: GBP64.2 million) reflecting subdued client flow trading levels given the uncertainty in both geographies. Trading income from balance sheet management and other trading activities increased significantly to GBP39.0 million (2017: GBP5.1 million). The increase is largely reflective of translation gains on foreign currency equity investments in South Africa (partially offsetting the related weaker investment income performance) as well as the unwind of the UK subordinated debt fair value adjustment (recognised on the adoption of IFRS 9) as the instrument pulls to par over its remaining term. Expected credit loss (ECL) impairment charges The total ECL impairment charges amounted to GBP31.0 million, a substantial reduction from GBP59.6 million (under the IAS 39 incurred loss model) in the prior period, primarily reflecting a reduction in legacy impairments. The group's annualised credit loss ratio is now within its long term average range at 0.34% (2017: 0.52%). Since 1 April 2018 gross core loan Stage 3 assets have reduced by GBP141 million to GBP595.0 million largely driven by a reduction of legacy exposures. Stage 3 assets (net of ECL impairment charges) as a percentage of net core loans subject to ECL was 1.7% (1 April 2018: 2.0%). Operating costs The cost to income ratio improved marginally, amounting to 66.6% (2017: 66.9%). Total operating costs grew by 7.2% to GBP854.2 million (2017: GBP797.1 million) largely driven by growth in headcount to support both activity levels and increased regulatory requirements. Taxation The effective tax rate amounted to 16.1% (2017: 14.5%), which remains below the group's historical effective tax rate mainly impacted by the utilisation of tax losses. Profit attributable to non-controlling interests Profit attributable to non-controlling interests mainly comprises: - GBP12.8 million profit attributable to non-controlling interests in the Asset Management business. - GBP36.4 million profit attributable to non-controlling interests in the Investec Property Fund. Balance sheet analysis Since 31 March 2018: - Shareholders equity decreased by 5.9% to GBP4.2 billion primarily as a result of the adoption of IFRS 9 on 1 April 2018 as well as from the depreciation of the closing Rand: Pounds Sterling exchange rate. - Net asset value per share decreased 6.7% to 422.0 pence and net tangible asset value per share (which excludes goodwill and intangible assets) decreased 7.2% to 372.7 pence, primarily as a result of the adoption of IFRS 9 as well as from the depreciation of the closing Rand: Pounds Sterling exchange rate. - The annualised return on adjusted average shareholders' equity increased from 12.1% to 13.4%. Liquidity and funding As at 30 September 2018 the group held GBP12.5 billion in cash and near cash balances (GBP6.5 billion in Investec plc and R110.8 billion in Investec Limited) which amounted to 41.1% of customer deposits. The group continues to focus on maintaining an optimal overall liquidity and funding profile. Loans and advances to customers as a percentage of customer deposits amounted to 78.2% (31 March 2018: 79.6%). The group comfortably exceeds Basel liquidity requirements for the Liquidity Coverage Ratio (LCR) and Net Stable Funding Ratio (NSFR). Investec Bank Limited (solo basis) ended the period to 30 September 2018 with the three-month average of its LCR at 137.4% and an NSFR of 111.3%. Further detail with respect to the bank's LCR and NSFR in South Africa is provided on the website. For Investec plc and Investec Bank plc (solo basis) the LCR is calculated using our own interpretations of the EU Delegated Act. The LCR reported to the PRA at 30 September 2018 was 332% for Investec plc and 339% for Investec Bank plc (solo basis). Ahead of the implementation of the final NSFR rules, the group has applied its own interpretations of regulatory guidance and definitions from the BCBS final guidelines to calculate the NSFR which was 140% for Investec plc and 134% for Investec Bank plc (solo basis). The reported NSFR and LCR may change over time with regulatory developments and guidance. Capital adequacy and leverage ratios The group is targeting a minimum common equity tier 1 capital ratio above 10% and a total capital adequacy ratio range of 14% to 17% on a consolidated basis for each of Investec plc and Investec Limited. The group's anticipated fully loaded Basel III common equity tier 1 (CET 1) ratios in both Investec plc and Investec Limited are reflected in the following table. The group expects to implement the Foundation Internal Ratings-Based (FIRB) approach in South Africa by the end of the 2019 financial year, subject to final regulatory approval. 30 Sept 1 April 31 March 2018 2018 2018 Investec plc^ Capital adequacy ratio 15.4% 15.0% 15.4% Tier 1 ratio 12.2% 12.4% 12.9% Common equity tier 1 ratio 10.4% 10.5% 11.0% Common equity tier 1 ratio ('fully loaded'*) 10.0% 10.3% 11.0% Leverage ratio (current) 7.7% 8.3% 8.5% Leverage ratio ('fully loaded'*) 7.3% 8.0% 8.4% Investec Limited** Capital adequacy ratio 14.7% 14.5% 14.6% Tier 1 ratio 11.1% 10.8% 11.0% Common equity tier 1 ratio 10.3% 10.0% 10.2% Common equity tier 1 ratio ('fully loaded'*) 10.2% 9.8% 10.2% Leverage ratio (current) 7.5% 7.4% 7.5% Leverage ratio ('fully loaded'*) 7.1% 6.9% 7.1% ^ The capital adequacy disclosures follow Investec's normal basis of presentation so as to show a consistent basis of calculation across the jurisdictions in which the group operates. For Investec plc this does not include the deduction of foreseeable charges and dividends when calculating CET 1 capital as required under the Capital Requirements Regulation and European Banking Authority technical standards. The impact of this deduction totalling GBP45 million for Investec plc would lower the CET 1 ratio by 30bps (31 March 2018: 45bps). ** Investec Limited's capital information includes unappropriated profits. If unappropriated profits are excluded from the capital information, Investec Limited's CET 1 ratio would be 27bps (31 March 2018: 25bps) lower. * The CET 1 fully loaded ratio and the fully loaded leverage ratio assume full adoption of IFRS 9 and full adoption of all CRD IV rules or South African Prudential Authority regulations, as applicable in the relevant jurisdictions. As a result of the adoption of IFRS 9 Investec plc elected to designate its subordinated fixed rate medium- term notes due in 2022 at fair value. By the time of full adoption of IFRS 9 in 2023, these subordinated liabilities will have reached final maturity and will be redeemed at par value. The remaining interest rate portion of the fair value adjustment at 30 September 2018 of GBP18 million (post-taxation), has therefore been excluded from the fully loaded ratios as it will be released into profit and loss over the remaining life of the instrument. Additional information - proposed demerger and listing of Investec Asset Management business On 14 September 2018, the board of directors of Investec plc and Investec Limited announced that the Investec Asset Management business would become a separately listed entity. The demerger and the listing of Investec Asset Management is subject to regulatory, shareholder and other approvals, and is expected to be completed during the second half of 2019. Outlook Notwithstanding macro challenges, we believe that our current business momentum and our drive to simplify and focus the business, together with our commitment to cost discipline, will support our long-term growth aspirations. On behalf of the boards of Investec plc and Investec Limited Perry Crosthwaite Fani Titi Hendrik du Toit Chairman Joint Chief Executive Joint Chief Executive Officer Officer 14 November 2018 Notes to the commentary section above Presentation of financial information Investec operates under a Dual Listed Companies (DLC) structure with primary listings of Investec plc on the London Stock Exchange and Investec Limited on the JSE Limited. In terms of the contracts constituting the DLC structure, Investec plc and Investec Limited effectively form a single economic enterprise in which the economic and voting rights of ordinary shareholders of the companies are maintained in equilibrium relative to each other. The directors of the two companies consider that for financial reporting purposes, the fairest presentation is achieved by combining the results and financial position of both companies. Accordingly, the interim results for Investec plc and Investec Limited present the results and financial position of the combined DLC group under International Financial Reporting Standards (IFRS), denominated in Pounds Sterling. In the commentary above, all references to Investec or the group relate to the combined DLC group comprising Investec plc and Investec Limited. Unless the context indicates otherwise, all comparatives included in the commentary above relate to the six months ended 30 September 2017. Amounts represented on a currency neutral basis for income statement items assume that the relevant average exchange rates for the six months to 30 September 2018 remain the same as those in the prior period. Amounts represented on a currency neutral basis for balance sheet items assume that the relevant closing exchange rates at 30 September 2018 remain the same as those at 31 March 2018. Foreign currency impact The group's reporting currency is Pounds Sterling. Certain of the group's operations are conducted by entities outside the UK. The results of operations and the financial position of the individual companies are reported in the local currencies in which they are domiciled, including Rands, Australian Dollars, Euros and US Dollars. These results are then translated into Pounds Sterling at the applicable foreign currency exchange rates for inclusion in the group's combined consolidated financial statements. In the case of the income statement, the weighted average rate for the relevant period is applied and, in the case of the balance sheet, the relevant closing rate is used. The following table sets out the movements in certain relevant exchange rates against Pounds Sterling over the period: Six months to Year to Six months to 30 Sep 2018 31 Mar 2018 30 Sep 2017 Currency per Period Period Period GBP1.00 end Average end Average end Average South African Rand 18.44 17.76 16.62 17.21 18.10 17.06 Australian Dollar 1.80 1.79 1.83 1.72 1.71 1.69 Euro 1.12 1.13 1.14 1.14 1.13 1.14 US Dollar 1.30 1.33 1.40 1.33 1.34 1.30 Exchange rates between local currencies and Pounds Sterling have fluctuated over the period. The most significant impact arises from the volatility of the Rand. The average exchange rate over the period has depreciated by 4.1% and the closing rate has depreciated by 11.0% since 31 March 2018. Accounting policies and disclosures These unaudited summarised combined consolidated financial results have been prepared in terms of the recognition and measurement criteria of International Financial Reporting Standards, and the presentation and disclosure requirements of IAS 34, (Interim Financial Reporting). The accounting policies applied in the preparation of the results for the period to 30 September 2018 are consistent with those adopted in the financial statements for the year ended 31 March 2018 except as noted below. On 1 April 2018 the group adopted IFRS 9 'Financial Instruments' which replaced IAS 39 and sets out the new requirements for the recognition and measurement of financial instruments. These requirements focus primarily on the classification and measurement of financial instruments and measurement of impairment losses based on an expected credit loss (ECL) model as opposed to an incurred loss methodology under IAS 39. Disclosure related to the initial application and the impact of the transition from IAS 39 to IFRS 9 were included in the group's transition disclosures published on 15 June 2018 which can be accessed via the Investec website at www.investec.com. Additionally, on 1 April 2018 the group adopted IFRS 15 'Revenue from contracts with customers' which replaced IAS 18 'Revenue'. IFRS 15 provides a principles-based approach for revenue recognition and introduces the concept of recognising revenue for obligations as they are satisfied. It applies to all contracts with customers except leases, financial instruments and insurance contracts. The group's measurement and recognition principles were aligned to the new standard and hence there has been no material impact on measurement and recognition principles or on disclosure requirements from the adoption of IFRS 15. The financial results have been prepared under the supervision of Glynn Burger, the Group Risk and Finance Director. The financial statements for the six months to 30 September 2018 will be posted to stakeholders on 30 November 2018. These financial results will be available on the group's website on the same date. Proviso - Please note that matters discussed in this announcement may contain forward looking statements which are subject to various risks and uncertainties and other factors, including, but not limited to: - the further development of standards and interpretations under IFRS applicable to past, current and future periods, evolving practices with regard to the interpretation and application of standards under IFRS. - domestic and global economic and business conditions. - market related risks. - A number of these factors are beyond the group's control. - These factors may cause the group's actual future results, performance or achievements in the markets in which it operates to differ from those expressed or implied. - Any forward looking statements made are based on the knowledge of the group at 14 November 2018. - The information in the announcement for the six months ended 30 September 2018, which was approved by the board of directors on 14 November 2018, does not constitute statutory accounts as defined in Section 435 of the UK Companies Act 2006. The 31 March 2018 financial statements were filed with the registrar and were unqualified with the audit report containing no statements in respect of Sections 498(2) or 498(3) of the UK Companies Act. - This announcement is available on the group's website: www.investec.com Financial assistance Shareholders are referred to Special Resolution number 3, which was approved at the annual general meeting held on 8 August 2018, relating to the provision of direct or indirect financial assistance in terms of Section 45 of the South African Companies Act, No 71 of 2008 to related or inter-related companies. Shareholders are hereby notified that in terms of S45(5)(a) of the South African Companies Act, the boards of directors of Investec Limited and Investec Bank Limited provided such financial assistance during the period 1 April 2018 to 30 September 2018 to various group subsidiaries. Financial information Salient financial features Results in Pounds Sterling Results in Rand Neutral currency^ Neutral Six months to Six months to Six months to currency Six months to Six months to 30 September 30 September % 30 September % 30 September 30 September % 2018 2017 change 2018 change 2018 2017 change Operating profit before taxation* (million) 359.3 314.6 14.2% 370.1 17.6% 6 415 5 378 19.3% Earnings attributable to shareholders (million) 279.9 252.4 10.9% 287.5 13.9% 4 983 4 321 15.3% Adjusted earnings attributable to shareholders** (million) 265.3 245.3 8.2% 272.5 11.1% 4 725 4 199 12.5% Adjusted earnings per share** 28.3p 26.6p 6.4% 29.1p 9.4% 504c 455c 10.8% Basic earnings per share 27.6p 25.8p 7.0% 28.4p 10.1% 492c 443c 11.1% Headline earnings per share 27.4p 24.6p 11.4% 28.1p 14.2% 487c 422c 15.4 % Dividends per share 11.0p 10.5p 4.8% n/a n/a 206c 200c 3.0% * Before goodwill, acquired intangibles, non-operating items and after other non-controlling interests. ** Before goodwill, acquired intangibles, non-operating items and after non-controlling interests. ^ For income statement items we have used the average Rand:Pound Sterling exchange rate that was applied in the prior year, i.e. 17.06. Results in Pounds Sterling Actual as Actual as Actual Neutral reported reported as currency^^ Neutral At At reported At currency 30 September 31 March % 30 September % 2018 2018 change 2018 change Net asset value per share 422.0p 452.5p (6.7%) 440.9p (2.6%) Net tangible asset value per share 372.7p 401.5p (7.2%) 391.2p (2.6%) Total equity (million) 5 118 5 428 (5.7%) 5 429 0.0% Total assets (million) 56 137 57 617 (2.6%) 59 918 4.0% Core loans and advances (million) 24 190 25 132 (3.7%) 25 740 2.4% Cash and near cash balances (million) 12 467 12 825 (2.8%) 13 125 2.3% Customer deposits (million) 30 349 30 987 (2.1%) 32 317 4.3% Third party assets under management (million) 166 512 160 576 3.7% 172 180 7.2% Return on average adjusted shareholders' equity 13.4% 12.1% Return on average risk-weighted assets 1.54% 1.45% Loans and advances to customers as a % of customer deposits 78.2% 79.6% Credit loss ratio (expected credit loss impairment charges on gross core loans and advances as a % of average gross core loans and advances) 0.34% 0.61% For balance sheet items we have assumed that the Rand:Pound Sterling exchange rate has remained neutral since March 2018. Condensed combined consolidated income statement Six months to Six months to Year to 30 September 30 September 31 March GBP'000 2018 2017 2018 Interest income 1 285 916 1 225 130 2 491 009 Interest expense (880 902) (860 809) (1 730 611) Net interest income 405 014 364 321 760 398 Fee and commission income 804 249 753 835 1 543 447 Fee and commission expense (100 540) (87 825) (182 240) Investment income 41 472 62 074 130 048 Share of post taxation profit of associates 20 782 23 677 46 823 Trading income/(loss) arising from - customer flow 65 078 64 160 138 226 - balance sheet management and other trading activities 39 031 5 146 (4 307) Other operating income 6 238 5 669 11 115 Total operating income before expected credit losses/impairment losses 1 281 324 1 191 057 2 443 510 Expected credit loss impairment charges* (31 022) - - Impairment losses on loans and advances* - (59 593) (148 556) Operating income 1 250 302 1 131 464 2 294 954 Operating costs (852 982) (795 883) (1 632 740) Depreciation on operating leased assets (1 207) (1 177) (2 421) Operating profit before goodwill and acquired intangibles 396 113 334 404 659 793 Amortisation of acquired intangibles (7 861) (8 142) (16 255) Operating profit 388 252 326 262 643 538 Additional costs on acquisition of subsidiary - - (6 039) Profit before taxation 388 252 326 262 637 499 Taxation on operating profit before goodwill and acquired intangibles (60 301) (44 996) (59 099) Taxation on acquired intangibles and acquisition/disposal/integration of subsidiaries 1 577 1 631 3 253 Profit after taxation 329 528 282 897 581 653 Profit attributable to other non-controlling interests (36 846) (19 800) (52 288) Profit attributable to Asset Management non-controlling interests (12 828) (10 663) (23 817) Earnings attributable to shareholders 279 854 252 434 505 548 Amortisation of acquired intangibles 7 861 8 142 16 255 Additional costs on acquisition of subsidiary - - 6 039 Taxation on acquired intangibles and acquisition/disposal/integration of subsidiaries (1 577) (1 631) (3 253) Preference dividends paid (21 086) (14 101) (32 980) Accrual adjustment on earnings attributable to other equity holders 271 436 (547) Adjusted earnings 265 323 245 280 491 062 Headline adjustments** (8 724) (18 010) (41 415) Headline earnings 256 599 227 270 449 647 Earnings per share (pence) - Basic 27.6 25.8 51.2 - Diluted 26.8 24.9 49.8 Adjusted earnings per share (pence) - Basic 28.3 26.6 53.2 - Diluted 27.5 25.7 51.7 Dividends per share (pence) - Interim 11.0 10.5 10.5 - Final n/a n/a 13.5 Headline earnings per share (pence) - Basic 27.4 24.6 48.7 - Diluted 26.6 23.8 47.4 Number of weighted average shares (million) 937.2 922.9 923.5 * On adoption of IFRS 9, there is a move from an incurred loss model to an expected credit loss methodology. ** The headline earnings adjustments are made up of property revaluations of GBP2.2 million (2017: GBP5.5 million), amortisation of acquired intangibles of GBP7.9 million (2017: GBP8.1 million), gains on available-for-sale instruments recycled to the income statement GBPnil (2017: GBP4.8 million), profit on realisation of associate company of GBPnil (2017: GBP0.8 million), taxation on acquired intangibles and acquisition/disposal/integration of subsidiaries GBP1.6 million (2017: GBP1.6 million) and accrual adjustment on earnings attributable to other equity holders of GBP0.3 million (2017: GBP0.4 million). This line represents the reconciling items from adjusted earnings to headline earnings. Summarised combined consolidated statement of comprehensive income Six months to Six months to Year to 30 September 30 September 31 March GBP'000 2018 2017 2018 Profit after taxation 329 528 282 897 581 653 Other comprehensive income: Items that may be reclassified to the income statement Fair value movements on cash flow hedges taken directly to other comprehensive income* (788) (1 824) (5 746) Gains on debt instruments at FVOCI recycled to the income statement*^ (1 999) - - Fair value movements on debt instruments at FVOCI taken directly to other comprehensive income*^ (12 023) - - Gains on realisation of available-for-sale assets recycled to the income statement*^ - (4 760) (6 676) Fair value movements on available-for-sale assets taken directly to other comprehensive income*^ - 13 816 20 051 Foreign currency adjustments on translating foreign operations (249 312) (220 844) (25 300) Items that will never be reclassified to the income statement Remeasurement of net defined pension liability 69 - 3 938 Gains and losses attributable to own credit risk 10 318 - - Total comprehensive income 75 793 69 285 567 920 Total comprehensive income attributable to ordinary shareholders 70 757 72 485 451 913 Total comprehensive (loss)/income attributable to non-controlling interests (16 050) (17 301) 83 027 Total comprehensive income attributable to perpetual preferred securities 21 086 14 101 32 980 Total comprehensive income 75 793 69 285 567 920 * Net of taxation of (GBP2.1 million) [six months to 30 September 2017: GBP3.0 million, year to 31 March 2018: GBP11.7 million]. ^ On adoption of IFRS 9 on 1 April 2018, the fair value reserve was introduced, replacing the available-for-sale reserve. Summarised combined consolidated cash flow statement Six months to Six months to Year to 30 September 30 September 31 March GBP'000 2018 2017 2018 Cash inflows from operations 404 278 357 998 732 242 Increase in operating assets (1 926 505) (1 009 683) (3 352 869) Increase in operating liabilities 1 845 075 705 103 3 075 779 Net cash inflow from operating activities 322 848 53 418 455 152 Net cash inflow/(outflow) from investing activities 58 190 5 292 (37 799) Net cash (outflow)/inflow from financing activities (203 047) (121 852) 45 383 Effects of exchange rates on cash and cash equivalents (106 538) (144 595) (54 085) Net increase/(decrease) in cash and cash equivalents 71 453 (207 737) 408 651 Cash and cash equivalents at the beginning of the period 6 130 379 5 721 728 5 721 728 Cash and cash equivalents at the end of the period 6 201 832 5 513 991 6 130 379 Cash and cash equivalents is defined as including; cash and balances at central banks, on demand loans and advances to banks and cash equivalent loans and advances to customers (all of which have a maturity profile of less than three months). Condensed combined consolidated balance sheet At 30 September 1 April 31 March 30 September GBP'000 2018 2018* 2018* 2017 Assets Cash and balances at central banks 4 402 571 4 040 010 4 040 512 3 356 259 Loans and advances to banks 2 194 184 2 164 598 2 165 533 2 308 618 Non-sovereign and non-bank cash placements 566 221 599 982 601 243 574 521 Reverse repurchase agreements and cash collateral on securities borrowed 1 641 435 2 207 137 2 207 477 1 690 036 Sovereign debt securities 4 483 385 4 907 624 4 910 027 3 608 316 Bank debt securities 609 522 591 428 587 164 604 511 Other debt securities 1 109 942 898 122 903 603 968 597 Derivative financial instruments 1 098 812 1 345 744 1 352 408 1 201 602 Securities arising from trading activities 1 921 010 1 434 391 1 434 391 1 395 766 Investment portfolio 950 455 956 560 885 499 911 480 Loans and advances to customers 23 739 734 24 410 334 24 673 009 22 351 228 Own originated loans and advances to customers securitised 452 341 458 814 459 088 445 672 Other loans and advances 207 251 345 742 347 809 367 401 Other securitised assets 142 884 148 387 148 387 153 786 Interests in associated undertakings 421 139 467 852 467 852 371 294 Deferred taxation assets 215 388 242 239 157 321 123 435 Other assets 2 006 480 1 875 357 1 876 116 2 016 057 Property and equipment 269 174 233 340 233 340 100 910 Investment properties 1 041 323 1 184 097 1 184 097 1 063 771 Goodwill 367 480 368 803 368 803 366 969 Intangible assets 120 333 125 389 125 389 132 692 47 961 064 49 005 950 49 129 068 44 112 921 Other financial instruments at fair value through profit or loss in respect of liabilities to customers 8 176 040 8 487 776 8 487 776 7 705 206 56 137 104 57 493 726 57 616 844 51 818 127 Liabilities Deposits by banks 3 011 094 2 931 267 2 931 267 2 246 115 Derivative financial instruments 1 402 260 1 471 563 1 471 563 1 169 314 Other trading liabilities 1 006 572 960 166 960 166 968 917 Repurchase agreements and cash collateral on securities lent 488 271 655 840 655 840 730 170 Customer accounts (deposits) 30 348 761 30 985 251 30 987 173 27 966 006 Debt securities in issue 2 734 128 2 717 187 2 717 187 2 549 264 Liabilities arising on securitisation of own originated loans and advances 120 161 136 812 136 812 133 307 Liabilities arising on securitisation of other assets 121 161 127 853 127 853 131 740 Current taxation liabilities 170 794 185 486 185 486 197 244 Deferred taxation liabilities 30 507 32 158 32 158 38 304 Other liabilities 1 812 573 2 019 906 2 012 268 1 827 251 41 246 282 42 223 489 42 217 773 37 957 632 Liabilities to customers under investment contracts 8 172 496 8 484 296 8 484 296 7 702 724 Insurance liabilities, including unit-linked liabilities 3 544 3 480 3 480 2 482 49 422 322 50 711 265 50 705 549 45 662 838 Subordinated liabilities 1 596 958 1 619 878 1 482 987 1 389 091 51 019 280 52 331 143 52 188 536 47 051 929 Equity Ordinary share capital 245 240 240 240 Perpetual preference share capital 31 31 31 31 Share premium 2 490 403 2 416 736 2 416 736 2 404 171 Treasury shares (210 912) (160 132) (160 132) (196 198) Other reserves (530 880) (406 718) (345 606) (460 907) Retained income 2 430 803 2 326 212 2 530 825 2 385 707 Shareholders' equity excluding non-controlling interests 4 179 690 4 176 369 4 442 094 4 133 044 Other Additional Tier 1 securities in issue 298 808 304 150 304 150 30 386 Non-controlling interests 639 326 682 064 682 064 602 768 - Perpetual preferred securities issued by subsidiaries 83 204 92 312 92 312 84 763 - Non-controlling interests in partially held subsidiaries 556 122 589 752 589 752 518 005 Total equity 5 117 824 5 162 583 5 428 308 4 766 198 Total liabilities and equity 56 137 104 57 493 726 57 616 844 51 818 127 * The 1 April 2018 balance sheet has been presented on an IFRS 9 basis and the comparative as at 31 March 2018 on an IAS 39 basis. Summarised combined consolidated statement of changes in equity Six months to Year to Six months to 30 September 31 March 30 September GBP'000 2018 2018 2017 Balance at the beginning of the period 5 428 308 4 808 629 4 808 629 Adoption of IFRS 9 (265 725) - - Total comprehensive income for the period 75 793 567 920 69 285 Share-based payments adjustments 33 084 69 218 34 688 Dividends paid to ordinary shareholders (127 943) (227 908) (123 230) Dividends declared to perpetual preference shareholders (7 528) (15 736) (8 160) Dividends paid to perpetual preference shareholders included in non-controlling interests (13 558) (17 244) (5 941) Dividends paid to non-controlling interests (27 378) (63 688) (29 272) Issue of ordinary shares 103 141 125 240 105 206 Issue of Other Additional Tier 1 security instruments - 271 058 - Issue of equity by subsidiaries - 12 695 - Net equity impact of non-controlling interest movements - 20 057 4 518 Net equity movement of interest in associate undertakings (5 671) - - Movement of treasury shares (74 699) (121 933) (89 525) Balance at the end of the period 5 117 824 5 428 308 4 766 198 Combined consolidated segmental analysis For the six months to 30 September UK and Southern Total GBP'000 Other Africa group Segmental geographical and business analysis of operating profit before goodwill, acquired intangibles, non-operating items, taxation and after other non-controlling interests 2018 Asset Management 56 840 34 686 91 526 Wealth & Investment 32 864 13 544 46 408 Specialist Banking 80 756 164 625 245 381 170 460 212 855 383 315 Group costs (17 227) (6 821) (24 048) Total group 153 233 206 034 359 267 Other non-controlling interest - equity 36 846 Operating profit 396 113 2017 Asset Management 49 949 33 284 83 233 Wealth & Investment 35 441 14 087 49 528 Specialist Banking 41 208 165 291 206 499 126 598 212 662 339 260 Group costs (17 295) (7 361) (24 656) Total group 109 303 205 301 314 604 Other non-controlling interest - equity 19 800 Operating profit 334 404 Analysis of financial assets and liabilities by category of financial instrument Total Total financial Non-financial financial instruments instruments At 30 September 2018 instruments at amortised or scoped GBP'000 at fair value cost out of IFRS 9 Total Assets Cash and balances at central banks 695 4 401 876 - 4 402 571 Loans and advances to banks - 2 194 184 - 2 194 184 Non-sovereign and non-bank cash placements 47 613 518 608 - 566 221 Reverse repurchase agreements and cash collateral on securities borrowed 527 934 1 113 501 - 1 641 435 Sovereign debt securities 4 200 240 283 145 - 4 483 385 Bank debt securities 274 025 335 497 - 609 522 Other debt securities 698 726 411 216 - 1 109 942 Derivative financial instruments 1 098 812 - - 1 098 812 Securities arising from trading activities 1 921 010 - - 1 921 010 Investment portfolio 950 455 - - 950 455 Loans and advances to customers 2 443 852 21 295 882 - 23 739 734 Own originated loans and advances to customers securitised - 452 341 - 452 341 Other loans and advances - 207 251 - 207 251 Other securitised assets 125 814 17 070 - 142 884 Interests in associated undertakings - - 421 139 421 139 Deferred taxation assets - - 215 388 215 388 Other assets 228 394 1 160 686 617 400 2 006 480 Property and equipment - - 269 174 269 174 Investment properties - - 1 041 323 1 041 323 Goodwill - - 367 480 367 480 Intangible assets - - 120 333 120 333 12 517 570 32 391 257 3 052 237 47 961 064 Other financial instruments at fair value through profit or loss in respect of liabilities to customers 8 176 040 - - 8 176 040 20 693 610 32 391 257 3 052 237 56 137 104 Liabilities Deposits by banks - 3 011 094 - 3 011 094 Derivative financial instruments 1 402 260 - - 1 402 260 Other trading liabilities 1 006 572 - - 1 006 572 Repurchase agreements and cash collateral on securities lent 175 187 313 084 - 488 271 Customer accounts (deposits) 2 300 787 28 047 974 - 30 348 761 Debt securities in issue 390 098 2 344 030 - 2 734 128 Liabilities arising on securitisation of own originated loans and advances - 120 161 - 120 161 Liabilities arising on securitisation of other assets 121 161 - - 121 161 Current taxation liabilities - - 170 794 170 794 Deferred taxation liabilities - - 30 507 30 507 Other liabilities 37 059 1 167 966 607 548 1 812 573 5 433 124 35 004 309 808 849 41 246 282 Liabilities to customers under investment contracts 8 172 496 - - 8 172 496 Insurance liabilities, including unit-linked liabilities 3 544 - - 3 544 13 609 164 35 004 309 808 849 49 422 322 Subordinated liabilities 385 060 1 211 898 - 1 596 958 13 994 224 36 216 207 808 849 51 019 280 Financial instruments carried at fair value The table below analyses recurring fair value measurements for financial assets and financial liabilities. These fair value measurements are categorised into different levels in the fair value hierarchy based on the inputs to the valuation technique used. The different levels are identified as follows: Level 1 - quoted (unadjusted) prices in active markets for identical assets or liabilities. Level 2 - inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices) Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs) Fair value category Total financial At 30 September 2018 instruments GBP'000 at fair value Level 1 Level 2 Level 3 Assets Cash and balances at central banks 695 695 - - Non-sovereign and non-bank cash placements 47 613 4 495 43 118 - Reverse repurchase agreements and cash collateral on securities borrowed 527 934 - 527 934 - Sovereign debt securities 4 200 240 4 200 240 - - Bank debt securities 274 025 266 206 7 819 - Other debt securities 698 726 194 776 411 716 92 234 Derivative financial instruments 1 098 812 - 1 060 819 37 993 Securities arising from trading activities 1 921 010 1 917 605 3 405 - Investment portfolio 950 455 182 062 31 590 736 803 Loans and advances to customers 2 443 852 - 970 182 1 473 670 Other securitised assets 125 814 - - 125 814 Other assets 228 394 228 394 - - Other financial instruments at fair value through profit or loss in respect of liabilities to customers 8 176 040 8 176 040 - - 20 693 610 15 170 513 3 056 583 2 466 514 Liabilities Derivative financial instruments 1 402 260 - 1 382 215 20 045 Other trading liabilities 1 006 572 883 181 123 391 - Repurchase agreements and cash collateral on securities lent 175 187 - 175 187 - Customer accounts (deposits) 2 300 787 - 2 300 787 - Debt securities in issue 390 098 - 390 098 - Liabilities arising on securitisation of other assets 121 161 - - 121 161 Other liabilities 37 059 - 37 059 - Subordinated liabilities 385 060 385 060 - - Liabilities to customers under investment contracts 8 172 496 8 172 496 - - Insurance liabilities, including unit-linked liabilities 3 544 3 544 - - 13 994 224 9 444 281 4 408 737 141 206 Net financial assets at fair value 6 699 386 5 726 232 (1 352 154) 2 325 308 Transfers between level 1 and level 2 There were no significant transfers between level 1 and level 2 in the current period. The group transfers between levels within the fair value hierarchy when the significance of the unobservable inputs change or if the valuation methods change. Level 2 financial assets and financial liabilities The following table sets out the group's principal valuation techniques as at 30 September 2018 used in determining the fair value of its financial assets and financial liabilities that are classified within level 2 of the fair value hierarchy. Valuation basis/techniques Main assumptions Assets Non-sovereign and non-bank cash Discounted cash flow model Yield curves placements Reverse repurchase agreements and Discounted cash flow model, Hermite interpolation Yield curves cash collateral on securities borrowed Bank debt securities Discounted cash flow model Yield curves NCD curves Other debt securities Discounted cash flow model Yield curves and NCD curves, external prices, broker quotes Derivative financial instruments Discounted cash flow model, Hermite interpolation, Yield curves, risk free rate, volatilities, forex forward industry standard derivative pricing models including points and spot rates, interest rate swap curves and Black-Scholes credit curves Securities arising from trading activities Interest rate curves, implied bond spreads, equity Standard industry derivative pricing model volatilities Adjusted quoted price Liquidity adjustments Investment portfolio Discounted cash flow model, relative valuation model Discount rate and fund unit price, net assets Comparable quoted inputs Loans and advances to customers Discounted cash flow model Yield curves Liabilities Derivative financial instruments Discounted cash flow model, Hermite interpolation, Yield curves, risk-free rate, volatilities, forex forward industry standard derivative pricing models including points and spot rates, interest rate swap curves and Black-Scholes credit curves Other trading liabilities Discounted cash flow model Yield curves Repurchase agreements and cash Discounted cash flow model, Hermite interpolation Yield curves collateral on securities lent Customer accounts (deposits) Discounted cash flow model Yield curves Debt securities in issue Discounted cash flow model Yield curves Other liabilities Discounted cash flow model Yield curves Net level 3 For the six months to 30 September 2018 financial GBP'000 instruments The following table is a reconciliation of the opening balances to the closing balances for fair value measurements in level 3 of the fair value hierarchy: Balance as at 31 March 2018 776 176 Adoption of IFRS 9 1 341 810 Balance as at 1 April 2018 2 117 986 Total gains or losses 73 464 In the income statement 73 206 In the statement of comprehensive income 258 Purchases 800 061 Sales (348 240) Issues 16 616 Settlements (391 874) Transfers into level 3 12 123 Foreign exchange adjustments 45 172 Balance as at 30 September 2018 2 325 308 For the period ended 30 September 2018, GBP12.1 million has been transferred out of level 2 into level 3 as a result of the inputs to the valuation method becoming unobservable in the market. For the six months to 30 September 2018 GBP'000 Total Realised Unrealised Total gains/(losses) included in the income statement for the period Net interest income 51 731 40 662 11 069 Fee and commission income 9 600 11 512 (1 912) Investment income 7 071 1 334 5 737 Trading income arising from customer flow 4 804 3 734 1 070 73 206 57 242 15 964 Total gains/(losses) included in other comprehensive income for the period Gains on realisation on debt instruments at FVOCI recycled through the income statement 19 757 19 757 - Fair value movements on debt instruments at FVOCI taken directly to other comprehensive income 258 - 258 20 015 19 757 258 Sensitivity of fair values to reasonably possible alternative assumptions by level 3 instrument type The fair value of financial instruments in level 3 are measured using valuation techniques that incorporate assumptions that are not evidenced by prices from observable market data. The following table shows the sensitivity of these fair values to reasonably possible alternative assumptions, determined at a transactional level: Balance sheet Significant Range of Favourable Unfavourable value unobservable unobservable changes changes GBP'000 input input used GBP'000 GBP'000 30 September 2018 Assets Other debt securities 92 234 Potential impact on income statement 7 975 (7 887) Cash flow adjustments CPR 8.6% - (68) Credit spreads 5.1% 140 (136) EBITDA (5%)/5% 348 (348) Other^ ^ 7 487 (7 335) Derivative financial instruments 37 993 Potential impact on income statement 6 964 (9 205) Volatilities 4.0% - 9.0% 212 (212) Cash flow adjustments CPR 7.6% - 11.2% 110 (101) Underlying asset value 5 684 (8 029) EBIDTA (5%)/20% 128 (32) Other^ ^ 830 (831) Investment portfolio 736 803 Potential impact on income statement 122 097 (124 731) Price earnings multiple 4.0 x - 10.3 x 6 117 (5 828) WACC 20.0% 29 594 (35 004) Underlying asset value 9 472 (3 029) EBITDA ^^ 23 602 (19 226) Cash flow adjustments (15%)/25% 3 151 (2 638) Precious and industrial metals prices (10%)/6% 1 139 (1 898) Property values (5%)/5% 9 339 (9 339) Other^ ^ 39 683 (47 769) Loans and advances to customers 1 473 670 Potential impact on income statement 41 750 (54 993) Credit spreads 0.2% - 29.0% 4 202 (6 048) Cash flow adjustments (15%)/5% 1 637 (4 910) Underlying asset value 2 130 (1 715) Other^ ^ 33 781 (42 320) Potential impact on other comprehensive income Credit spreads 0.1% - 5.1% 1 135 (1 615) Other securitised assets* 125 814 Potential impact on income statement Cash flow adjustments CPR 7.7% 723 (728) Total level 3 assets 2 466 514 180 644 (199 159) Liabilities Derivative financial instruments 20 045 Potential impact on income statement (9 085) 7 268 Cash flow adjustments CPR 7.6% - 11.2% (81) 89 Volatilities 8.5% (2) 2 Underlying asset value (9 002) 7 177 Liabilities arising on securitisation of other 121 161 Potential impact on income statement assets* Cash flow adjustments CPR 8.0% (244) 205 Total level 3 liabilities 141 206 (9 329) 7 473 Net level 3 assets 2 325 308 * The sensitivity of the fair value of liabilities arising on securitisation of other assets has been considered together with other securitised assets. ^ Other - The valuation sensitivity has been assessed by adjusting various inputs such as expected cash flows, discount rates, earnings multiples rather than a single input. It is deemed appropriate to reflect the outcome on a portfolio basis for the purposes of this analysis as the sensitivity of the assets cannot be determined through the adjustment of a single input. ^^ The EBITDA has been stressed on an investment by investment basis to obtain a favourable and unfavourable valuation. Underlying asset values calculated by reference to a tangible asset, for example property, aircraft or shares. In determining the value of level 3 financial instruments, the following are the principal inputs that do require judgement: Credit spreads Credit spreads reflect the additional yield that a market participant would demand for taking exposure to the credit risk of an instrument. The credit spread for an instrument forms part of the yield used in a discounted cash flow calculation. In general a significant increase in a credit spread in isolation will result in a movement in fair value that is unfavourable for the holder of a financial instrument. Discount rates (including WACC) Discount rates are used to adjust for the time value of money when using a discounted cash flow valuation method. Where relevant, the discount rate also accounts for illiquidity, market conditions and uncertainty for future cash flows. Volatilities Volatility is a key input in the valuation of derivative products containing optionality. Volatility is a measure of the variability or uncertainty in returns for a given derivative underlying. It represents an estimate of how much a particular underlying instrument, parameter or index will change in value over time. Cash flows Cash flows relate to the future cash flows which can be expected from the instrument and requires judgement. EBITDA The group's earnings before interest, taxes, depreciation and amortisation. This is the main input into a price earnings multiple valuation method. Price earnings multiple The price-to-earnings ratio is an equity valuation multiple. It is a key driver in the valuation of unlisted investments. Precious and industrial metals and property value The price of precious and industrial metals and property value is a key driver of future cash flows on certain investments. Underlying asset value In instances where cash flows have links to referenced assets, the underlying asset value is used to determine the fair value. The underlying asset valuation is derived using observable market prices sourced from broker quotes, specialist valuers or other reliable pricing sources. Fair value of financial assets and liabilities at amortised cost The following table sets out the fair value of financial instruments held at amortised cost where the carrying value is not a reasonable approximation of fair value. At 30 September 2018 Carrying Fair GBP'000 amount value Assets Loans and advances to banks 2 194 184 2 194 749 Reverse repurchase agreements and cash collateral on securities borrowed 1 113 501 1 113 413 Sovereign debt securities 283 145 274 120 Bank debt securities 335 497 334 171 Other debt securities 411 216 406 266 Loans and advances to customers 21 295 882 21 275 003 Other loans and advances 207 251 240 619 Other assets 1 160 686 1 159 535 Liabilities Deposits by banks 3 011 094 3 039 929 Repurchase agreements and cash collateral on securities lent 313 084 309 554 Customer accounts (deposits) 28 047 974 28 035 101 Debt securities in issue 2 344 030 2 372 763 Other liabilities 1 167 966 1 169 085 Subordinated liabilities 1 211 898 1 282 250 Investec Limited Incorporated in the Republic of South Africa Registration number: 1925/002833/06 JSE ordinary share code: INL NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000081949 Ordinary share dividend announcement Declaration of dividend number 126 Notice is hereby given an interim dividend number 126, being a gross dividend of 206 cents (2017: 200 cents) per ordinary share has been declared by the board from income reserves in respect of the six months ended 30 September 2018 payable to shareholders recorded in the shareholders' register of the company at the close of business on Friday, 7 December 2018. The relevant dates for the payment of dividend number 126 are as follows: Last day to trade cum-dividend Tuesday, 4 December 2018 Shares commence trading ex-dividend Wednesday, 5 December 2018 Record date Friday, 7 December 2018 Payment date Wednesday, 19 December 2018 The interim gross dividend of 206 cents per ordinary share has been determined by converting the Investec plc distribution of 11 pence per ordinary share into Rands using the Rand/Pounds Sterling average buy/sell forward rate at 11:00 (SA time) on Wednesday, 14 November 2018. Share certificates may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information to take note of: - Investec Limited South African tax reference number: 9800/181/71/2 - The issued ordinary share capital of Investec Limited is 318 904 709 ordinary shares - The dividend paid by Investec Limited is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - Shareholders who are exempt from paying the Dividend Tax will receive a net dividend of 206 cents per ordinary share - Shareholders who are not exempt from paying the Dividend Tax will receive a net dividend of 164.8 cents per ordinary share (gross dividend of 206 cents per ordinary share less Dividend Tax of 41.200 cents per ordinary share). By order of the board N van Wyk Company Secretary 14 November 2018 Investec Limited Incorporated in the Republic of South Africa Registration number: 1925/002833/06 JSE share Code: INPR NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000063814 Preference share dividend announcement Non-redeemable non-cumulative non-participating preference shares ("preference shares") Declaration of dividend number 28 Notice is hereby given that preference dividend number 28 has been declared by the board from income reserves for the period 1 April 2018 to 30 September 2018 amounting to a gross preference dividend of 389.91534 cents per share payable to holders of the non-redeemable non-cumulative non-participating preference shares as recorded in the books of the company at the close of business on Friday, 14 December 2018. The relevant dates for the payment of dividend number 28 are as follows: Last day to trade cum-dividend Tuesday, 11 December 2018 Shares commence trading ex-dividend Wednesday, 12 December 2018 Record date Friday, 14 December 2018 Payment date Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised between Wednesday, 12 December 2018 and Friday, 14 December 2018, both dates inclusive. Additional information to take note of: - Investec Limited South African tax reference number: 9800/181/71/2 - The issued preference share capital of Investec Limited is 32 214 499 preference shares in this specific class - The dividend paid by Investec Limited is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - The net dividend amounts to 311.93227 cents per preference share for shareholders liable to pay the Dividend Tax and 389.91534 cents per preference share for preference shareholders exempt from paying the Dividend Tax. By order of the board N van Wyk Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales Registration number 3633621 LSE ordinary share code: INVP JSE ordinary share code: INP ISIN: GB00B17BBQ50 Ordinary share dividend announcement In terms of the DLC structure, Investec plc shareholders registered on the United Kingdom share register may receive all or part of their dividend entitlements through dividends declared and paid by Investec plc on their ordinary shares and/or through dividends declared and paid on the SA DAN share issued by Investec Limited. Investec plc shareholders registered on the South African branch register may receive all or part of their dividend entitlements through dividends declared and paid by Investec plc on their ordinary shares and/or through dividends declared and paid on the SA DAS share issued by Investec Limited. Declaration of dividend number 33 Notice is hereby given that an interim dividend number 33, being a gross dividend of 11 pence (2017: 10.5 pence) per ordinary share has been declared by the board from income reserves in respect of the six months ended 30 September 2018 payable to shareholders recorded in the shareholders' register of the company at the close of business on Friday, 7 December 2018. - for Investec plc shareholders, registered on the United Kingdom share register, through a dividend payment by Investec plc from income reserves of 11 pence per ordinary share - for Investec plc shareholders, registered on the South African branch register, through a dividend payment by Investec plc from income reserves of 3 pence per ordinary share and through a dividend paid by Investec Limited, on the SA DAS share, payable from income reserves, equivalent to 8 pence per ordinary share The relevant dates for the payment of dividend number 33 are as follows: Last day to trade cum-dividend On the Johannesburg Stock Exchange (JSE) Tuesday, 4 December 2018 On the London Stock Exchange (LSE) Wednesday, 5 December 2018 Shares commence trading ex-dividend On the Johannesburg Stock Exchange (JSE) Wednesday, 5 December 2018 On the London Stock Exchange (LSE) Thursday, 6 December 2018 Record date (on the JSE and LSE) Friday, 7 December 2018 Payment date (on the JSE and LSE) Wednesday, 19 December 2018 Share certificates on the South African branch register may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive, nor may transfers between the United Kingdom share register and the South African branch register take place between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information for South African resident shareholders of Investec plc - Shareholders registered on the South African branch register are advised that the distribution of 11 pence, equivalent to a gross dividend of 206 cents per share, has been arrived at using the Rand/Pound Sterling average buy/sell forward rate, as determined at 11:00 (SA time) on Wednesday, 14 November 2018 - Investec plc United Kingdom tax reference number: 2683967322360 - The issued ordinary share capital of Investec plc is 681 051 512 ordinary shares - The dividend paid by Investec plc to South African resident shareholders registered on the South African branch register and the dividend paid by Investec Limited to Investec plc shareholders on the SA DAS share are subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - Shareholders registered on the South African branch register who are exempt from paying the Dividend Tax will receive a net dividend of 206 cents per share, comprising 149.81818 cents per share paid by Investec Limited on the SA DAS share and 56.18182 cents per ordinary share paid by Investec plc - Shareholders registered on the South African branch register who are not exempt from paying the Dividend Tax will receive a net dividend of 164.8 cents per share (gross dividend of 206 cents per share less Dividend Tax of 41.2 cents per share) comprising 119.85455 cents per share paid by Investec Limited on the SA DAS share and 44.94545 cents per ordinary share paid by Investec plc. By order of the board D Miller Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales Registration number: 3633621 Share code: INPP ISIN: GB00B19RX541 Preference share dividend announcement Non-redeemable non-cumulative non-participating preference shares ("preference shares") Declaration of dividend number 25 Notice is hereby given that preference dividend number 25 has been declared by the board from income reserves for the period 1 April 2018 to 30 September 2018 amounting to a gross preference dividend of 7.93150 pence per preference share payable to holders of the non-redeemable non- cumulative non-participating preference shares as recorded in the books of the company at the close of business on Friday, 7 December 2018. For shares trading on the Johannesburg Stock Exchange (JSE), the dividend of 7.93150 pence per preference share is equivalent to a gross dividend of 148.73149 cents per share, which has been determined using the Rand/ Pound Sterling average buy/sell forward rate as at 11:00 (SA Time) on Wednesday, 14 November 2018. The relevant dates relating to the payment of dividend number 25 are as follows: Last day to trade cum-dividend On the Johannesburg Stock Exchange (JSE) Tuesday, 4 December 2018 On The International Stock Exchange (TISE) Wednesday, 5 December 2018 Shares commence trading ex-dividend On the Johannesburg Stock Exchange (JSE) Wednesday, 5 December 2018 On The International Stock Exchange (TISE) Thursday, 6 December 2018 Record date (on the JSE and TISE) Friday, 7 December 2018 Payment date (on the JSE and TISE) Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive, nor may transfers between the United Kingdom share register and the South African branch register take place between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information for South African resident shareholders of Investec plc - Investec plc United Kingdom tax reference number: 2683967322360 - The issued preference share capital of Investec plc is 2 754 587 preference shares - The dividend paid by Investec plc to shareholders recorded on the South African branch register is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - The net dividend amounts to 118.98519 cents per preference share for preference shareholders liable to pay the Dividend Tax and 148.73149 cents per preference share for preference shareholders exempt from paying the Dividend Tax. By order of the board D Miller Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales Registration number: 3633621 JSE share code: INPPR ISIN: GB00B4B0Q974 Rand-denominated preference share dividend announcement Rand-denominated non-redeemable non-cumulative non- participating perpetual preference shares ("preference shares") Declaration of dividend number 15 Notice is hereby given that preference dividend number 15 has been declared by the board from income reserves for the period 1 April 2018 to 30 September 2018 amounting to a gross preference dividend of 476.30137 cents per preference share payable to holders of the Rand-denominated non- redeemable non-cumulative non-participating perpetual preference shares as recorded in the books of the company at the close of business on Friday, 7 December 2018. The relevant dates relating to the payment of dividend number 15 are as follows: Last day to trade cum-dividend Tuesday, 4 December 2018 Shares commence trading ex-dividend Wednesday, 5 November 2018 Record date Friday, 7 December 2018 Payment date Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised between Wednesday, 5 December 2018 and Friday, 7 December 2018, both dates inclusive. Additional information for South African resident shareholders of Investec plc - Investec plc United Kingdom tax reference number: 2683967322360 - The issued rand denominated preference share capital of Investec plc is 131 447 preference shares - The dividend paid by Investec plc to shareholders recorded on the South African branch register is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - The net dividend amounts to 381.04110 cents per preference share for preference shareholders liable to pay the Dividend Tax and 476.30137 cents per preference share for preference shareholders exempt from paying the Dividend Tax. By order of the board D Miller Company Secretary 14 November 2018 Investec plc Incorporated in England and Wales (Registration number 3633621) JSE ordinary share code: INP LSE ordinary share code: INVP ISIN: GB00B17BBQ50 Registered office: 30 Gresham Street, London EC2V 7QP, United Kingdom Transfer secretaries: Computershare Investor Services (Pty) Ltd Rosebank Towers, 15 Biermann Avenue, Rosebank, 2196 Company Secretary: D Miller Investec Limited Incorporated in the Republic of South Africa (Registration number 1925/002833/06) JSE ordinary share code: INL NSX ordinary share code: IVD BSE ordinary share code: INVESTEC ISIN: ZAE000081949 Registered office: 100 Grayston Drive Sandown, Sandton, 2196 Transfer secretaries: Computershare Investor Services (Pty) Ltd Rosebank Towers, 15 Biermann Avenue, Rosebank, 2196 Company Secretary: N van Wyk Directors: PKO Crosthwaite* (Chairman), HJ du Toit## (Joint Chief Executive Officer) F Titi## (Joint Chief Executive Officer) ZBM Bassa, LC Bowden*, GR Burger##, CA Carolus, D Friedland, PA Hourquebie, CR Jacobs^, B Kantor##, IR Kantor^^, S Koseff##, Lord Malloch-Brown KCMG*, KM McFarland## KL Shuenyane ## Executive *British ^^ Dutch ^Irish Sponsor: Investec Bank Limited Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Transaction in Own Shares Hammerson plc (Incorporated in England and Wales) (Company number 360632) LSE share code: HMSO JSE share code: HMN ISIN: GB0004065016 ("Hammerson" or "the Company") Transaction in Own Shares 15 November 2018 The Company announces that on 14 November 2018, in accordance with the authority given to the Company by its shareholders and pursuant to a share repurchase programme, it purchased for cancellation from J.P. Morgan Securities plc the following ordinary shares: Highest Lowest VWAP No. of shares Venue price paid price paid paid per share (p) (p) (p) London Stock 227,200 443.3000 435.2000 440.2326 Exchange Total: 440.2326 227,200 These share purchases form part of the Company's share buyback programme (the "Programme"), which is expected to be completed over the period from 24 July 2018 to 19 July 2019, details of which were announced on 24 July 2018. Following cancellation of the above shares repurchased, the Company will have 773,404,019 ordinary shares in issue. In accordance with the Market Abuse Regulation 596/2014/EU, the schedule below contains detailed information about the purchases made as part of the Programme. Verity Pickard Assistant Company Secretary +44 (0) 20 7887 1000 Hammerson has its primary listing on the London Stock Exchange and a secondary inward listing on the Johannesburg Stock Exchange. Sponsor: Investec Bank Limited Transaction details - ordinary shares of 25 pence each: Issuer name: Hammerson plc Classification: 2.4. Acquisition or disposal of the issuer's own shares LEI: 213800G1C9KKVVDN1A60 ISIN: GB0004065016 Intermediary name: J.P. Morgan Securities plc Intermediary Code: JPMSGB2L Timezone: GMT Currency: GBP Schedule of purchases - aggregated information: Date of purchase: 14 November 2018 Number of ordinary shares purchased: 227,200 Volume weighted average price paid per share (p): 440.2326 Schedule of purchases - individual transactions: Transaction Date Price Volume Platform Transaction Reference Number and Time (GBp) 14-Nov-2018 08:03:17 739 439.9000 XLON 01503015000005179-E0bsngalWrg220181114 14-Nov-2018 08:03:17 528 439.8000 XLON 01503015000005074-E0bsngalWrgG20181114 14-Nov-2018 08:03:17 198 439.8000 XLON 01503015000005074-E0bsngalWrg420181114 14-Nov-2018 08:08:56 241 440.4000 XLON 11503115000009031-E0bsngalXDdA20181114 14-Nov-2018 08:12:22 339 442.3000 XLON 11503115000010787-E0bsngalXSUo20181114 14-Nov-2018 08:13:58 858 442.2000 XLON 11503115000011252-E0bsngalXYjK20181114 14-Nov-2018 08:15:31 261 441.9000 XLON 01503015000012243-E0bsngalXg1220181114 14-Nov-2018 08:15:31 614 441.9000 XLON 01503015000012243-E0bsngalXg1020181114 14-Nov-2018 08:15:31 194 441.9000 XLON 01503015000012243-E0bsngalXg1420181114 14-Nov-2018 08:18:28 300 441.9000 XLON 01503015000013692-E0bsngalXqAI20181114 14-Nov-2018 08:18:28 129 441.9000 XLON 01503015000013692-E0bsngalXqAE20181114 14-Nov-2018 08:18:28 458 441.9000 XLON 01503015000013692-E0bsngalXqAG20181114 14-Nov-2018 08:19:08 724 441.4000 XLON 01503015000013065-E0bsngalXsh720181114 14-Nov-2018 08:19:21 661 441.3000 XLON 11503115000012928-E0bsngalXtcb20181114 14-Nov-2018 08:23:18 92 441.2000 XLON 11503115000015899-E0bsngalY8VQ20181114 14-Nov-2018 08:24:01 122 441.2000 XLON 11503115000015899-E0bsngalYBLm20181114 14-Nov-2018 08:24:01 1238 441.2000 XLON 11503115000016253-E0bsngalYBLq20181114 14-Nov-2018 08:24:01 512 441.2000 XLON 11503115000015899-E0bsngalYBLk20181114 14-Nov-2018 08:26:03 100 441.1000 XLON 11503115000016619-E0bsngalYIjv20181114 14-Nov-2018 08:26:03 335 441.1000 XLON 11503115000016619-E0bsngalYIjR20181114 14-Nov-2018 08:26:27 220 441.1000 XLON 11503115000016619-E0bsngalYJcu20181114 14-Nov-2018 08:28:22 792 440.9000 XLON 11503115000017863-E0bsngalYReQ20181114 14-Nov-2018 08:30:22 660 441.3000 XLON 01503015000019012-E0bsngalYY9H20181114 14-Nov-2018 08:30:22 1041 441.4000 XLON 01503015000019192-E0bsngalYY8x20181114 14-Nov-2018 08:32:05 238 441.1000 XLON 11503115000019614-E0bsngalYfeT20181114 14-Nov-2018 08:32:05 488 441.1000 XLON 11503115000019614-E0bsngalYfeR20181114 14-Nov-2018 08:36:29 858 440.5000 XLON 01503015000021637-E0bsngalYx6i20181114 14-Nov-2018 08:37:52 924 439.5000 XLON 01503015000022128-E0bsngalZ2ww20181114 14-Nov-2018 08:39:58 660 438.9000 XLON 01503015000022129-E0bsngalZClE20181114 14-Nov-2018 08:39:58 536 438.9000 XLON 11503115000022039-E0bsngalZClC20181114 14-Nov-2018 08:39:58 190 438.9000 XLON 11503115000022039-E0bsngalZClA20181114 14-Nov-2018 08:43:02 660 438.3000 XLON 01503015000022648-E0bsngalZMQx20181114 14-Nov-2018 08:47:27 793 438.6000 XLON 01503015000025054-E0bsngalZZQ820181114 14-Nov-2018 08:47:58 224 438.5000 XLON 01503015000025130-E0bsngalZapk20181114 14-Nov-2018 08:47:58 700 438.5000 XLON 01503015000025130-E0bsngalZapi20181114 14-Nov-2018 08:49:32 204 438.7000 XLON 11503115000025539-E0bsngalZf4g20181114 14-Nov-2018 08:49:32 588 438.7000 XLON 11503115000025539-E0bsngalZf4d20181114 14-Nov-2018 08:51:04 660 438.6000 XLON 01503015000025616-E0bsngalZjIW20181114 14-Nov-2018 08:52:11 1208 438.4000 XLON 01503015000023989-E0bsngalZmHr20181114 14-Nov-2018 09:01:16 458 439.4000 XLON 11503115000029459-E0bsngalaFuT20181114 14-Nov-2018 09:01:16 406 439.4000 XLON 11503115000029459-E0bsngalaFuN20181114 14-Nov-2018 09:02:59 990 439.9000 XLON 11503115000030035-E0bsngalaLl920181114 14-Nov-2018 09:04:56 660 439.9000 XLON 11503115000030582-E0bsngalaRy120181114 14-Nov-2018 09:04:56 660 439.9000 XLON 01503015000030630-E0bsngalaRxv20181114 14-Nov-2018 09:04:56 90 439.9000 XLON 01503015000030748-E0bsngalaRy520181114 14-Nov-2018 09:04:56 1056 439.9000 XLON 11503115000030608-E0bsngalaRy320181114 14-Nov-2018 09:09:58 766 439.9000 XLON 11503115000032217-E0bsngalajRy20181114 14-Nov-2018 09:09:58 792 440.0000 XLON 11503115000032500-E0bsngalajRa20181114 14-Nov-2018 09:09:58 224 439.9000 XLON 11503115000032217-E0bsngalajRo20181114 14-Nov-2018 09:12:56 726 439.6000 XLON 01503015000033767-E0bsngalaun820181114 14-Nov-2018 09:13:15 319 439.5000 XLON 11503115000033027-E0bsngalavjc20181114 14-Nov-2018 09:13:15 430 439.5000 XLON 11503115000033027-E0bsngalavjj20181114 14-Nov-2018 09:14:29 858 439.5000 XLON 01503015000034315-E0bsngalb03H20181114 14-Nov-2018 09:14:36 387 439.4000 XLON 01503015000034265-E0bsngalb0cC20181114 14-Nov-2018 09:15:09 471 439.4000 XLON 01503015000034265-E0bsngalb42e20181114 14-Nov-2018 09:17:30 716 440.8000 XLON 01503015000035222-E0bsngalbFYK20181114 14-Nov-2018 09:22:58 660 441.2000 XLON 01503015000037069-E0bsngalbZEA20181114 14-Nov-2018 09:27:18 624 441.4000 XLON 11503115000038485-E0bsngalbrAW20181114 14-Nov-2018 09:27:18 223 441.4000 XLON 11503115000038485-E0bsngalbrAY20181114 14-Nov-2018 09:29:42 661 441.7000 XLON 01503015000039306-E0bsngalbyQZ20181114 14-Nov-2018 09:30:02 70 441.7000 XLON 11503115000039441-E0bsngalc26b20181114 14-Nov-2018 09:31:10 23 441.7000 XLON 11503115000039441-E0bsngalc6EE20181114 14-Nov-2018 09:31:10 633 441.7000 XLON 11503115000039441-E0bsngalc6EC20181114 14-Nov-2018 09:31:37 790 442.0000 XLON 11503115000040008-E0bsngalc7TJ20181114 14-Nov-2018 09:32:30 726 441.2000 XLON 11503115000040226-E0bsngalcA6920181114 14-Nov-2018 09:33:02 737 441.2000 XLON 11503115000040428-E0bsngalcCig20181114 14-Nov-2018 09:33:57 660 441.0000 XLON 11503115000040335-E0bsngalcFzp20181114 14-Nov-2018 09:36:49 1487 440.8000 XLON 11503115000041370-E0bsngalcOGa20181114 14-Nov-2018 09:36:49 858 440.7000 XLON 11503115000041063-E0bsngalcOGo20181114 14-Nov-2018 09:38:20 661 440.3000 XLON 01503015000041770-E0bsngalcSDK20181114 14-Nov-2018 09:43:15 714 440.6000 XLON 01503015000043067-E0bsngalcfBS20181114 14-Nov-2018 09:47:42 858 440.7000 XLON 11503115000044174-E0bsngalcsSW20181114 14-Nov-2018 09:48:23 858 440.5000 XLON 01503015000044236-E0bsngalctsV20181114 14-Nov-2018 09:50:39 726 441.0000 XLON 11503115000044792-E0bsngald0nH20181114 14-Nov-2018 09:50:58 1219 440.8000 XLON 11503115000044715-E0bsngald1Xy20181114 14-Nov-2018 09:58:32 1528 441.1000 XLON 01503015000046155-E0bsngaldKIS20181114 14-Nov-2018 09:58:32 570 441.2000 XLON 11503115000046096-E0bsngaldKIE20181114 14-Nov-2018 09:58:32 157 441.2000 XLON 11503115000046096-E0bsngaldKIG20181114 14-Nov-2018 10:00:06 857 441.3000 XLON 01503015000046733-E0bsngaldPyC20181114 14-Nov-2018 10:01:31 726 441.4000 XLON 11503115000046960-E0bsngaldTi820181114 14-Nov-2018 10:02:09 858 441.3000 XLON 11503115000046892-E0bsngaldVTs20181114 14-Nov-2018 10:03:18 545 441.0000 XLON 01503015000047276-E0bsngaldXva20181114 14-Nov-2018 10:03:18 115 441.0000 XLON 01503015000047276-E0bsngaldXvg20181114 14-Nov-2018 10:06:14 350 440.3000 XLON 01503015000047627-E0bsngaldf2o20181114 14-Nov-2018 10:06:14 311 440.3000 XLON 01503015000047627-E0bsngaldf2q20181114 14-Nov-2018 10:09:03 791 440.1000 XLON 11503115000048193-E0bsngaldoW320181114 14-Nov-2018 10:09:49 924 439.8000 XLON 01503015000048426-E0bsngaldr5G20181114 14-Nov-2018 10:14:58 990 439.8000 XLON 11503115000049261-E0bsngale3jQ20181114 14-Nov-2018 10:17:54 726 440.2000 XLON 01503015000049943-E0bsngaleAXh20181114 14-Nov-2018 10:19:28 881 439.8000 XLON 11503115000050084-E0bsngaleDW320181114 14-Nov-2018 10:19:28 109 439.8000 XLON 11503115000050084-E0bsngaleDVz20181114 14-Nov-2018 10:21:13 858 440.0000 XLON 11503115000050480-E0bsngaleHzO20181114 14-Nov-2018 10:25:06 66 440.2000 XLON 11503115000051398-E0bsngaleTlr20181114 14-Nov-2018 10:26:15 792 440.1000 XLON 11503115000051733-E0bsngaleXws20181114 14-Nov-2018 10:29:28 679 440.9000 XLON 01503015000052686-E0bsngalej7y20181114 14-Nov-2018 10:29:28 114 440.9000 XLON 01503015000052686-E0bsngalej8020181114 14-Nov-2018 10:33:48 661 441.3000 XLON 11503115000053795-E0bsngaleuIM20181114 14-Nov-2018 10:35:28 990 441.3000 XLON 01503015000054435-E0bsngaleyYg20181114 14-Nov-2018 10:35:28 660 441.5000 XLON 11503115000054285-E0bsngaleyWJ20181114 14-Nov-2018 10:36:21 264 441.3000 XLON 11503115000054471-E0bsngalf0j120181114 14-Nov-2018 10:38:06 215 441.2000 XLON 01503015000054842-E0bsngalf5lp20181114 14-Nov-2018 10:38:06 555 441.2000 XLON 01503015000054842-E0bsngalf5ln20181114 14-Nov-2018 10:39:28 776 441.0000 XLON 11503115000055313-E0bsngalfAxQ20181114 14-Nov-2018 10:39:28 643 441.1000 XLON 11503115000054413-E0bsngalfAww20181114 14-Nov-2018 10:39:28 281 441.1000 XLON 11503115000054413-E0bsngalfAwy20181114 14-Nov-2018 10:43:19 70 441.0000 XLON 01503015000056546-E0bsngalfLko20181114 14-Nov-2018 10:43:32 792 440.9000 XLON 11503115000055817-E0bsngalfM9m20181114 14-Nov-2018 10:45:02 380 441.2000 XLON 11503115000056885-E0bsngalfQ7t20181114 14-Nov-2018 10:45:10 232 441.1000 XLON 01503015000057049-E0bsngalfQXA20181114 14-Nov-2018 10:46:02 15 441.2000 XLON 11503115000057228-E0bsngalfSgW20181114 14-Nov-2018 10:46:02 400 441.2000 XLON 11503115000057228-E0bsngalfSgU20181114 14-Nov-2018 10:47:50 726 441.0000 XLON 11503115000057088-E0bsngalfa4F20181114 14-Nov-2018 10:47:50 123 441.2000 XLON 11503115000057775-E0bsngalfa3o20181114 14-Nov-2018 10:47:50 571 441.2000 XLON 11503115000057775-E0bsngalfa3r20181114 14-Nov-2018 10:47:50 726 441.1000 XLON 11503115000057754-E0bsngalfa4420181114 14-Nov-2018 10:53:03 685 441.0000 XLON 01503015000058290-E0bsngalfoW520181114 14-Nov-2018 10:57:18 72 441.3000 XLON 11503115000060304-E0bsngalfyco20181114 14-Nov-2018 10:57:18 69 441.3000 XLON 11503115000060304-E0bsngalfyca20181114 14-Nov-2018 10:57:28 45 441.3000 XLON 11503115000060304-E0bsngalfzBD20181114 14-Nov-2018 10:59:41 475 441.3000 XLON 11503115000061089-E0bsngalg7Vw20181114 14-Nov-2018 10:59:41 199 441.3000 XLON 11503115000061089-E0bsngalg7Vy20181114 14-Nov-2018 11:02:45 857 441.5000 XLON 01503015000062440-E0bsngalgGs620181114 14-Nov-2018 11:04:36 406 441.6000 XLON 01503015000062911-E0bsngalgLJS20181114 14-Nov-2018 11:04:59 584 441.6000 XLON 01503015000062911-E0bsngalgMC920181114 14-Nov-2018 11:06:12 726 441.1000 XLON 11503115000063324-E0bsngalgPA020181114 14-Nov-2018 11:08:13 660 441.2000 XLON 01503015000063880-E0bsngalgTX220181114 14-Nov-2018 11:08:13 726 441.2000 XLON 01503015000063959-E0bsngalgTX820181114 14-Nov-2018 11:08:53 858 441.0000 XLON 11503115000063310-E0bsngalgUlI20181114 14-Nov-2018 11:11:31 558 441.0000 XLON 01503015000064863-E0bsngalgain20181114 14-Nov-2018 11:16:16 661 441.5000 XLON 01503015000066137-E0bsngalgo5O20181114 14-Nov-2018 11:16:16 858 441.6000 XLON 01503015000066165-E0bsngalgo4t20181114 14-Nov-2018 11:17:46 628 441.2000 XLON 01503015000066620-E0bsngalgt9R20181114 14-Nov-2018 11:17:46 95 441.2000 XLON 01503015000066620-E0bsngalgt9c20181114 14-Nov-2018 11:22:23 334 441.1000 XLON 11503115000067506-E0bsngalh4jC20181114 14-Nov-2018 11:22:23 364 441.1000 XLON 11503115000067506-E0bsngalh4jE20181114 14-Nov-2018 11:22:23 793 441.0000 XLON 01503015000067294-E0bsngalh4jd20181114 14-Nov-2018 11:25:23 591 441.2000 XLON 01503015000068672-E0bsngalhCCQ20181114 14-Nov-2018 11:25:41 614 441.1000 XLON 01503015000068529-E0bsngalhDtA20181114 14-Nov-2018 11:28:06 726 441.2000 XLON 11503115000069063-E0bsngalhJYu20181114 14-Nov-2018 11:29:02 514 441.1000 XLON 11503115000069300-E0bsngalhLWC20181114 14-Nov-2018 11:29:59 793 441.4000 XLON 01503015000069699-E0bsngalhNsd20181114 14-Nov-2018 11:31:44 726 441.0000 XLON 11503115000069899-E0bsngalhSM520181114 14-Nov-2018 11:34:41 769 441.2000 XLON 11503115000070895-E0bsngalhbqy20181114 14-Nov-2018 11:36:19 726 441.0000 XLON 01503015000071402-E0bsngalhfI320181114 14-Nov-2018 11:42:07 774 440.9000 XLON 11503115000072620-E0bsngalhuYN20181114 14-Nov-2018 11:42:07 150 440.9000 XLON 11503115000072620-E0bsngalhuYL20181114 14-Nov-2018 11:43:13 990 440.9000 XLON 01503015000073173-E0bsngalhx2E20181114 14-Nov-2018 11:43:13 526 441.0000 XLON 01503015000073255-E0bsngalhx2320181114 14-Nov-2018 11:48:13 754 440.2000 XLON 01503015000073659-E0bsngali8cr20181114 14-Nov-2018 11:48:13 696 440.0000 XLON 11503115000073408-E0bsngali8dK20181114 14-Nov-2018 11:57:32 768 440.3000 XLON 11503115000076379-E0bsngaliXzk20181114 14-Nov-2018 11:59:49 768 440.2000 XLON 01503015000077079-E0bsngalidaW20181114 14-Nov-2018 12:03:43 768 440.5000 XLON 11503115000078167-E0bsngalitxr20181114 14-Nov-2018 12:06:10 661 440.8000 XLON 01503015000079728-E0bsngalj0Gl20181114 14-Nov-2018 12:06:10 1 440.8000 XLON 01503015000079728-E0bsngalj0Gv20181114 14-Nov-2018 12:06:10 670 440.8000 XLON 11503115000079507-E0bsngalj0Gf20181114 14-Nov-2018 12:09:31 715 440.8000 XLON 11503115000080142-E0bsngalj7dD20181114 14-Nov-2018 12:11:02 162 440.6000 XLON 11503115000080512-E0bsngalj9uZ20181114 14-Nov-2018 12:13:01 104 440.9000 XLON 11503115000080980-E0bsngaljDT920181114 14-Nov-2018 12:16:31 660 440.8000 XLON 01503015000082287-E0bsngaljKHi20181114 14-Nov-2018 12:16:31 79 440.8000 XLON 01503015000082286-E0bsngaljKHg20181114 14-Nov-2018 12:16:31 660 440.9000 XLON 01503015000082293-E0bsngaljKIR20181114 14-Nov-2018 12:16:31 396 440.8000 XLON 01503015000082286-E0bsngaljKHc20181114 14-Nov-2018 12:16:31 735 440.9000 XLON 11503115000082073-E0bsngaljKIE20181114 14-Nov-2018 12:17:25 262 440.8000 XLON 01503015000082444-E0bsngaljLtp20181114 14-Nov-2018 12:17:25 530 440.8000 XLON 01503015000082444-E0bsngaljLts20181114 14-Nov-2018 12:21:05 916 440.4000 XLON 01503015000082841-E0bsngaljUQY20181114 14-Nov-2018 12:22:44 171 440.3000 XLON 01503015000082690-E0bsngaljXsM20181114 14-Nov-2018 12:22:44 995 440.3000 XLON 01503015000082690-E0bsngaljXsO20181114 14-Nov-2018 12:22:50 523 440.2000 XLON 11503115000082484-E0bsngaljY1T20181114 14-Nov-2018 12:22:50 477 440.2000 XLON 11503115000082484-E0bsngaljY1W20181114 14-Nov-2018 12:23:00 1004 440.0000 XLON 01503015000083524-E0bsngaljYGk20181114 14-Nov-2018 12:26:55 446 439.5000 XLON 01503015000083782-E0bsngaljg0S20181114 14-Nov-2018 12:26:55 226 439.5000 XLON 01503015000083782-E0bsngaljg0V20181114 14-Nov-2018 12:32:45 660 440.5000 XLON 01503015000085137-E0bsngaljsEl20181114 14-Nov-2018 12:32:45 66 440.5000 XLON 11503115000084886-E0bsngaljsEn20181114 14-Nov-2018 12:34:21 845 439.9000 XLON 11503115000085429-E0bsngaljuuY20181114 14-Nov-2018 12:34:21 374 440.0000 XLON 01503015000085679-E0bsngaljuuA20181114 14-Nov-2018 12:34:21 471 440.0000 XLON 01503015000085679-E0bsngaljuuD20181114 14-Nov-2018 12:42:08 624 440.6000 XLON 01503015000087276-E0bsngalkC1J20181114 14-Nov-2018 12:43:05 168 440.6000 XLON 01503015000087276-E0bsngalkDuN20181114 14-Nov-2018 12:45:56 587 441.0000 XLON 11503115000087810-E0bsngalkMIc20181114 14-Nov-2018 12:45:56 81 441.0000 XLON 11503115000088043-E0bsngalkMIi20181114 14-Nov-2018 12:45:56 1038 441.0000 XLON 11503115000088041-E0bsngalkMIg20181114 14-Nov-2018 12:47:32 706 441.0000 XLON 11503115000088334-E0bsngalkQED20181114 14-Nov-2018 12:50:56 661 441.1000 XLON 01503015000089470-E0bsngalkXpk20181114 14-Nov-2018 12:53:20 726 441.2000 XLON 11503115000089863-E0bsngalkcsI20181114 14-Nov-2018 12:53:50 570 441.0000 XLON 11503115000088822-E0bsngalke4b20181114 14-Nov-2018 12:53:50 289 441.0000 XLON 11503115000088822-E0bsngalke4Z20181114 14-Nov-2018 12:56:03 828 440.9000 XLON 01503015000090862-E0bsngalkkVu20181114 14-Nov-2018 12:57:55 753 440.8000 XLON 11503115000090398-E0bsngalknlx20181114 14-Nov-2018 12:59:37 811 440.9000 XLON 11503115000091479-E0bsngalkrQL20181114 14-Nov-2018 12:59:37 744 440.9000 XLON 01503015000091565-E0bsngalkrQH20181114 14-Nov-2018 12:59:37 135 440.9000 XLON 01503015000091788-E0bsngalkrQN20181114 14-Nov-2018 13:09:41 1019 441.9000 XLON 01503015000094539-E0bsngallCnk20181114 14-Nov-2018 13:09:41 9 441.9000 XLON 01503015000094539-E0bsngallCni20181114 14-Nov-2018 13:13:31 684 443.3000 XLON 01503015000095328-E0bsngallLce20181114 14-Nov-2018 13:13:31 691 443.3000 XLON 01503015000095376-E0bsngallLcx20181114 14-Nov-2018 13:14:44 311 443.0000 XLON 01503015000095693-E0bsngallO3420181114 14-Nov-2018 13:14:44 420 443.0000 XLON 01503015000095693-E0bsngallO3620181114 14-Nov-2018 13:16:46 727 442.9000 XLON 11503115000095878-E0bsngallSXT20181114 14-Nov-2018 13:17:32 727 442.9000 XLON 11503115000095957-E0bsngallUJo20181114 14-Nov-2018 13:17:32 924 442.9000 XLON 11503115000096047-E0bsngallUJw20181114 14-Nov-2018 13:20:04 386 442.2000 XLON 11503115000096562-E0bsngallYcP20181114 14-Nov-2018 13:20:04 792 442.2000 XLON 01503015000096726-E0bsngallYcF20181114 14-Nov-2018 13:20:18 274 442.2000 XLON 11503115000096562-E0bsngallZ0k20181114 14-Nov-2018 13:20:52 726 441.7000 XLON 11503115000096761-E0bsngallaDn20181114 14-Nov-2018 13:26:57 6 442.2000 XLON 11503115000098239-E0bsngallmHv20181114 14-Nov-2018 13:26:57 726 442.2000 XLON 11503115000098112-E0bsngallmHj20181114 14-Nov-2018 13:26:57 66 442.2000 XLON 01503015000098488-E0bsngallmHt20181114 14-Nov-2018 13:29:18 257 441.9000 XLON 11503115000098600-E0bsngallrM220181114 14-Nov-2018 13:30:26 660 441.9000 XLON 01503015000098931-E0bsngalluVF20181114 14-Nov-2018 13:31:56 660 442.2000 XLON 11503115000099586-E0bsngallyaZ20181114 14-Nov-2018 13:32:35 558 442.2000 XLON 01503015000099892-E0bsngalm0CI20181114 14-Nov-2018 13:32:35 536 442.1000 XLON 11503115000099320-E0bsngalm0Cd20181114 14-Nov-2018 13:32:35 168 442.2000 XLON 01503015000099892-E0bsngalm0CM20181114 14-Nov-2018 13:36:09 840 442.3000 XLON 11503115000100777-E0bsngalmCm920181114 14-Nov-2018 13:37:16 727 442.6000 XLON 11503115000101176-E0bsngalmHKf20181114 14-Nov-2018 13:41:29 337 442.8000 XLON 01503015000102506-E0bsngalmTIL20181114 14-Nov-2018 13:41:29 324 442.8000 XLON 01503015000102506-E0bsngalmTIN20181114 14-Nov-2018 13:42:09 911 442.8000 XLON 11503115000102337-E0bsngalmVHj20181114 14-Nov-2018 13:42:09 13 442.8000 XLON 11503115000102337-E0bsngalmVHh20181114 14-Nov-2018 13:44:25 215 442.6000 XLON 11503115000103108-E0bsngalmc6r20181114 14-Nov-2018 13:44:25 412 442.6000 XLON 11503115000103108-E0bsngalmc6p20181114 14-Nov-2018 13:44:37 661 442.5000 XLON 01503015000103291-E0bsngalmcV120181114 14-Nov-2018 13:45:43 711 441.9000 XLON 01503015000103765-E0bsngalmgyV20181114 14-Nov-2018 13:47:36 1067 441.7000 XLON 11503115000103480-E0bsngalmmxn20181114 14-Nov-2018 13:47:36 284 441.9000 XLON 01503015000104312-E0bsngalmmxE20181114 14-Nov-2018 13:47:36 550 441.9000 XLON 01503015000104312-E0bsngalmmxC20181114 14-Nov-2018 13:48:35 791 441.2000 XLON 01503015000104477-E0bsngalmpXE20181114 14-Nov-2018 13:52:53 660 441.9000 XLON 11503115000105325-E0bsngaln0DO20181114 14-Nov-2018 13:56:08 60 441.6000 XLON 01503015000106724-E0bsngaln9vk20181114 14-Nov-2018 13:56:08 297 441.6000 XLON 01503015000106724-E0bsngaln9vh20181114 14-Nov-2018 13:56:08 54 441.6000 XLON 01503015000106249-E0bsngaln9vY20181114 14-Nov-2018 13:56:08 310 441.6000 XLON 01503015000106724-E0bsngaln9ve20181114 14-Nov-2018 13:58:07 617 441.8000 XLON 01503015000107504-E0bsngalnFND20181114 14-Nov-2018 14:01:27 12 442.0000 XLON 11503115000108493-E0bsngalnPBA20181114 14-Nov-2018 14:01:55 247 441.8000 XLON 01503015000108628-E0bsngalnQjx20181114 14-Nov-2018 14:01:55 479 441.8000 XLON 01503015000108628-E0bsngalnQjz20181114 14-Nov-2018 14:01:55 69 441.6000 XLON 01503015000108740-E0bsngalnQkV20181114 14-Nov-2018 14:01:55 176 441.6000 XLON 01503015000108740-E0bsngalnQkS20181114 14-Nov-2018 14:02:48 300 441.6000 XLON 01503015000109046-E0bsngalnTTn20181114 14-Nov-2018 14:02:48 426 441.6000 XLON 01503015000109046-E0bsngalnTTs20181114 14-Nov-2018 14:03:50 680 441.6000 XLON 11503115000109227-E0bsngalnWFM20181114 14-Nov-2018 14:08:15 776 441.7000 XLON 01503015000110538-E0bsngalnfDO20181114 14-Nov-2018 14:08:15 315 441.7000 XLON 11503115000110299-E0bsngalnfDM20181114 14-Nov-2018 14:08:15 660 441.7000 XLON 11503115000110194-E0bsngalnfDI20181114 14-Nov-2018 14:08:15 1 441.7000 XLON 11503115000110286-E0bsngalnfDK20181114 14-Nov-2018 14:08:16 660 441.4000 XLON 01503015000110490-E0bsngalnfFM20181114 14-Nov-2018 14:11:50 1235 441.7000 XLON 11503115000111332-E0bsngalnnln20181114 14-Nov-2018 14:12:26 859 441.7000 XLON 01503015000111648-E0bsngalnq3g20181114 14-Nov-2018 14:12:39 706 441.5000 XLON 01503015000111483-E0bsngalnqjs20181114 14-Nov-2018 14:12:39 858 441.6000 XLON 01503015000111597-E0bsngalnqje20181114 14-Nov-2018 14:19:19 924 441.9000 XLON 01503015000113718-E0bsngalo7TY20181114 14-Nov-2018 14:19:19 1081 441.8000 XLON 11503115000113432-E0bsngalo7Tt20181114 14-Nov-2018 14:19:31 660 441.7000 XLON 11503115000113132-E0bsngalo7ts20181114 14-Nov-2018 14:25:47 787 441.5000 XLON 01503015000115664-E0bsngaloMDl20181114 14-Nov-2018 14:28:55 1413 441.1000 XLON 01503015000116531-E0bsngaloTw020181114 14-Nov-2018 14:28:55 743 441.1000 XLON 01503015000116583-E0bsngaloTw220181114 14-Nov-2018 14:28:55 859 441.1000 XLON 01503015000116645-E0bsngaloTw820181114 14-Nov-2018 14:28:55 183 441.1000 XLON 01503015000116637-E0bsngaloTw420181114 14-Nov-2018 14:30:38 556 440.8000 XLON 01503015000117248-E0bsngaloa9k20181114 14-Nov-2018 14:30:38 457 440.8000 XLON 01503015000117248-E0bsngaloa9i20181114 14-Nov-2018 14:32:00 247 440.7000 XLON 11503115000117254-E0bsngalofH220181114 14-Nov-2018 14:32:24 254 440.7000 XLON 11503115000117254-E0bsngalogw720181114 14-Nov-2018 14:32:51 215 440.7000 XLON 11503115000117254-E0bsngaloiNk20181114 14-Nov-2018 14:32:54 10 440.7000 XLON 11503115000117254-E0bsngaloiaw20181114 14-Nov-2018 14:35:48 792 440.4000 XLON 01503015000119050-E0bsngalotOg20181114 14-Nov-2018 14:35:52 1278 440.3000 XLON 01503015000119300-E0bsngalotqw20181114 14-Nov-2018 14:37:50 692 439.8000 XLON 11503115000119287-E0bsngalp1yK20181114 14-Nov-2018 14:37:50 576 439.8000 XLON 11503115000119287-E0bsngalp1yI20181114 14-Nov-2018 14:40:22 146 439.9000 XLON 01503015000121295-E0bsngalp9tD20181114 14-Nov-2018 14:40:22 858 440.0000 XLON 01503015000121286-E0bsngalp9rj20181114 14-Nov-2018 14:40:40 727 439.9000 XLON 01503015000121403-E0bsngalpAj720181114 14-Nov-2018 14:41:34 660 439.8000 XLON 11503115000121197-E0bsngalpDhg20181114 14-Nov-2018 14:49:05 412 440.4000 XLON 11503115000124363-E0bsngalpiME20181114 14-Nov-2018 14:49:23 294 440.4000 XLON 11503115000124444-E0bsngalpjjT20181114 14-Nov-2018 14:50:08 756 440.6000 XLON 11503115000124791-E0bsngalpmHj20181114 14-Nov-2018 14:51:25 304 440.4000 XLON 01503015000124974-E0bsngalpqpc20181114 14-Nov-2018 14:51:25 1008 440.5000 XLON 11503115000125129-E0bsngalpqpK20181114 14-Nov-2018 14:51:25 450 440.4000 XLON 11503115000124444-E0bsngalpqpQ20181114 14-Nov-2018 14:51:25 57 440.4000 XLON 11503115000124487-E0bsngalpqpa20181114 14-Nov-2018 14:51:25 818 440.4000 XLON 11503115000124478-E0bsngalpqpW20181114 14-Nov-2018 14:51:25 217 440.4000 XLON 11503115000124453-E0bsngalpqpU20181114 14-Nov-2018 14:51:25 9 440.4000 XLON 11503115000124451-E0bsngalpqpS20181114 14-Nov-2018 14:51:25 9 440.4000 XLON 11503115000124479-E0bsngalpqpY20181114 14-Nov-2018 14:52:10 660 440.3000 XLON 01503015000125456-E0bsngalpsue20181114 14-Nov-2018 14:52:18 990 440.2000 XLON 11503115000125272-E0bsngalptFu20181114 14-Nov-2018 14:55:22 679 440.1000 XLON 11503115000126499-E0bsngalq79b20181114 14-Nov-2018 14:55:22 47 440.1000 XLON 11503115000126516-E0bsngalq79h20181114 14-Nov-2018 14:55:46 233 440.1000 XLON 11503115000126639-E0bsngalq9JZ20181114 14-Nov-2018 14:58:09 726 440.2000 XLON 11503115000127401-E0bsngalqHFo20181114 14-Nov-2018 15:02:17 519 440.3000 XLON 01503015000129050-E0bsngalqVsZ20181114 14-Nov-2018 15:02:17 141 440.3000 XLON 01503015000129050-E0bsngalqVsc20181114 14-Nov-2018 15:03:54 355 440.3000 XLON 11503115000129591-E0bsngalqdGp20181114 14-Nov-2018 15:04:00 362 440.3000 XLON 11503115000129606-E0bsngalqdas20181114 14-Nov-2018 15:05:14 352 440.7000 XLON 11503115000130031-E0bsngalqhCg20181114 14-Nov-2018 15:05:14 327 440.7000 XLON 11503115000130031-E0bsngalqhCj20181114 14-Nov-2018 15:05:37 660 440.5000 XLON 01503015000130303-E0bsngalqi8x20181114 14-Nov-2018 15:06:45 662 440.8000 XLON 01503015000130678-E0bsngalqmdY20181114 14-Nov-2018 15:08:11 380 440.6000 XLON 11503115000130873-E0bsngalqrpU20181114 14-Nov-2018 15:08:11 280 440.6000 XLON 11503115000130873-E0bsngalqrpS20181114 14-Nov-2018 15:08:54 360 440.6000 XLON 01503015000131591-E0bsngalquyw20181114 14-Nov-2018 15:08:54 498 440.6000 XLON 01503015000131591-E0bsngalquyu20181114 14-Nov-2018 15:08:56 660 440.5000 XLON 01503015000131583-E0bsngalqvCf20181114 14-Nov-2018 15:10:47 364 440.3000 XLON 01503015000132302-E0bsngalr1qL20181114 14-Nov-2018 15:10:47 350 440.3000 XLON 01503015000132302-E0bsngalr1qD20181114 14-Nov-2018 15:11:29 281 440.3000 XLON 11503115000132313-E0bsngalr46d20181114 14-Nov-2018 15:11:29 514 440.3000 XLON 11503115000132313-E0bsngalr46b20181114 14-Nov-2018 15:13:24 389 440.3000 XLON 11503115000132695-E0bsngalr9hV20181114 14-Nov-2018 15:13:24 673 440.3000 XLON 11503115000132695-E0bsngalr9hT20181114 14-Nov-2018 15:13:24 716 440.3000 XLON 11503115000132969-E0bsngalr9hX20181114 14-Nov-2018 15:13:50 924 440.2000 XLON 01503015000133324-E0bsngalrBM120181114 14-Nov-2018 15:16:14 22 440.2000 XLON 01503015000134139-E0bsngalrKL320181114 14-Nov-2018 15:16:14 700 440.2000 XLON 01503015000134139-E0bsngalrKKz20181114 14-Nov-2018 15:18:38 613 440.0000 XLON 11503115000133949-E0bsngalrRVx20181114 14-Nov-2018 15:18:38 198 440.0000 XLON 11503115000133949-E0bsngalrRVv20181114 14-Nov-2018 15:18:50 575 440.0000 XLON 11503115000134735-E0bsngalrSBl20181114 14-Nov-2018 15:18:50 296 440.0000 XLON 11503115000134735-E0bsngalrSBj20181114 14-Nov-2018 15:19:40 789 439.7000 XLON 11503115000134059-E0bsngalrUZt20181114 14-Nov-2018 15:19:40 738 439.9000 XLON 01503015000134301-E0bsngalrUVK20181114 14-Nov-2018 15:24:10 280 439.9000 XLON 11503115000136443-E0bsngalrmpe20181114 14-Nov-2018 15:24:10 354 439.9000 XLON 11503115000136468-E0bsngalrmpg20181114 14-Nov-2018 15:24:10 132 439.9000 XLON 01503015000136627-E0bsngalrmpc20181114 14-Nov-2018 15:24:10 11 439.9000 XLON 01503015000136665-E0bsngalrmpk20181114 14-Nov-2018 15:24:10 11 439.9000 XLON 01503015000136676-E0bsngalrmpm20181114 14-Nov-2018 15:24:10 349 439.9000 XLON 11503115000136468-E0bsngalrmpi20181114 14-Nov-2018 15:24:10 660 439.9000 XLON 01503015000136620-E0bsngalrmpa20181114 14-Nov-2018 15:27:43 513 440.1000 XLON 01503015000138084-E0bsngalrxmn20181114 14-Nov-2018 15:27:43 999 440.1000 XLON 11503115000137864-E0bsngalrxmj20181114 14-Nov-2018 15:27:43 69 440.1000 XLON 11503115000137864-E0bsngalrxml20181114 14-Nov-2018 15:27:43 668 440.1000 XLON 11503115000137863-E0bsngalrxmh20181114 14-Nov-2018 15:27:43 876 440.1000 XLON 01503015000138084-E0bsngalrxmp20181114 14-Nov-2018 15:28:53 763 439.7000 XLON 01503015000138138-E0bsngals1tq20181114 14-Nov-2018 15:30:04 224 439.4000 XLON 01503015000138713-E0bsngals7Dn20181114 14-Nov-2018 15:30:04 135 439.3000 XLON 11503115000138489-E0bsngals7E620181114 14-Nov-2018 15:30:04 700 439.4000 XLON 01503015000138713-E0bsngals7Dk20181114 14-Nov-2018 15:30:05 499 439.3000 XLON 11503115000138489-E0bsngals7LF20181114 14-Nov-2018 15:30:05 444 439.3000 XLON 11503115000138489-E0bsngals7LD20181114 14-Nov-2018 15:31:46 160 439.1000 XLON 01503015000139416-E0bsngalsDTm20181114 14-Nov-2018 15:31:56 160 439.1000 XLON 01503015000139416-E0bsngalsDxx20181114 14-Nov-2018 15:32:15 160 439.1000 XLON 01503015000139416-E0bsngalsFEe20181114 14-Nov-2018 15:32:23 161 439.1000 XLON 01503015000139416-E0bsngalsFjz20181114 14-Nov-2018 15:32:55 842 439.2000 XLON 01503015000139791-E0bsngalsHjx20181114 14-Nov-2018 15:33:10 212 439.1000 XLON 01503015000139416-E0bsngalsJ0R20181114 14-Nov-2018 15:34:17 176 439.0000 XLON 01503015000138714-E0bsngalsMX120181114 14-Nov-2018 15:34:20 204 439.0000 XLON 01503015000138714-E0bsngalsMfc20181114 14-Nov-2018 15:34:20 775 439.0000 XLON 01503015000138714-E0bsngalsMfa20181114 14-Nov-2018 15:38:00 726 440.0000 XLON 01503015000141166-E0bsngalsYzi20181114 14-Nov-2018 15:40:21 660 440.0000 XLON 01503015000142276-E0bsngalsgmV20181114 14-Nov-2018 15:41:16 547 440.2000 XLON 01503015000142644-E0bsngalslA220181114 14-Nov-2018 15:41:16 113 440.2000 XLON 01503015000142644-E0bsngalslA420181114 14-Nov-2018 15:42:11 660 440.2000 XLON 01503015000142870-E0bsngalsoBV20181114 14-Nov-2018 15:43:05 457 440.2000 XLON 01503015000143145-E0bsngalsrkr20181114 14-Nov-2018 15:43:05 203 440.2000 XLON 01503015000143145-E0bsngalsrkp20181114 14-Nov-2018 15:44:37 36 440.3000 XLON 11503115000143180-E0bsngalsxJr20181114 14-Nov-2018 15:44:37 624 440.3000 XLON 11503115000143180-E0bsngalsxJo20181114 14-Nov-2018 15:45:03 660 440.5000 XLON 11503115000143418-E0bsngalsyg920181114 14-Nov-2018 15:45:46 921 440.2000 XLON 11503115000143702-E0bsngalt1vS20181114 14-Nov-2018 15:46:36 906 440.0000 XLON 01503015000143918-E0bsngalt4rv20181114 14-Nov-2018 15:46:36 18 440.0000 XLON 01503015000143918-E0bsngalt4rx20181114 14-Nov-2018 15:48:26 800 440.1000 XLON 01503015000144739-E0bsngaltBod20181114 14-Nov-2018 15:48:26 236 440.1000 XLON 11503115000144542-E0bsngaltBof20181114 14-Nov-2018 15:48:26 848 440.0000 XLON 01503015000144354-E0bsngaltBox20181114 14-Nov-2018 15:48:26 130 440.1000 XLON 11503115000144574-E0bsngaltBoj20181114 14-Nov-2018 15:48:26 829 440.1000 XLON 01503015000144763-E0bsngaltBoh20181114 14-Nov-2018 15:50:32 276 439.2000 XLON 01503015000145351-E0bsngaltJpu20181114 14-Nov-2018 15:50:32 255 439.2000 XLON 01503015000145351-E0bsngaltJpw20181114 14-Nov-2018 15:50:32 742 439.2000 XLON 01503015000145351-E0bsngaltJpz20181114 14-Nov-2018 15:50:33 289 439.1000 XLON 11503115000145042-E0bsngaltJsT20181114 14-Nov-2018 15:50:33 1343 439.1000 XLON 11503115000145042-E0bsngaltJsW20181114 14-Nov-2018 15:50:37 1088 439.0000 XLON 01503015000145246-E0bsngaltK7d20181114 14-Nov-2018 15:53:39 153 438.9000 XLON 01503015000146312-E0bsngaltYxY20181114 14-Nov-2018 15:53:39 217 438.9000 XLON 01503015000146312-E0bsngaltYxW20181114 14-Nov-2018 15:53:39 626 438.9000 XLON 01503015000146312-E0bsngaltYxa20181114 14-Nov-2018 15:53:42 660 438.8000 XLON 11503115000145667-E0bsngaltZAq20181114 14-Nov-2018 15:53:42 489 438.8000 XLON 01503015000145964-E0bsngaltZAs20181114 14-Nov-2018 15:54:30 792 438.4000 XLON 01503015000146490-E0bsngaltckY20181114 14-Nov-2018 15:54:30 792 438.5000 XLON 11503115000146300-E0bsngaltckH20181114 14-Nov-2018 15:55:49 202 438.3000 XLON 01503015000147100-E0bsngalthVi20181114 14-Nov-2018 15:56:10 590 438.3000 XLON 01503015000147100-E0bsngaltj9u20181114 14-Nov-2018 15:58:01 859 438.2000 XLON 01503015000147645-E0bsngaltq8o20181114 14-Nov-2018 15:58:05 208 438.1000 XLON 11503115000147447-E0bsngaltqch20181114 14-Nov-2018 15:58:05 584 438.1000 XLON 11503115000147447-E0bsngaltqcj20181114 14-Nov-2018 15:59:10 272 437.6000 XLON 01503015000148238-E0bsngaltvRP20181114 14-Nov-2018 15:59:10 247 437.6000 XLON 01503015000148238-E0bsngaltvRR20181114 14-Nov-2018 16:00:00 858 437.5000 XLON 01503015000148107-E0bsngalty5k20181114 14-Nov-2018 16:02:09 95 437.4000 XLON 11503115000149086-E0bsngalu8IB20181114 14-Nov-2018 16:02:09 417 437.4000 XLON 11503115000149086-E0bsngalu8I720181114 14-Nov-2018 16:02:10 269 437.4000 XLON 01503015000149015-E0bsngalu8Hs20181114 14-Nov-2018 16:02:10 455 437.4000 XLON 01503015000149015-E0bsngalu8Hv20181114 14-Nov-2018 16:02:10 214 437.4000 XLON 11503115000149086-E0bsngalu8I920181114 14-Nov-2018 16:03:20 660 437.3000 XLON 01503015000149884-E0bsngaluDds20181114 14-Nov-2018 16:04:47 661 437.6000 XLON 01503015000150465-E0bsngaluK3m20181114 14-Nov-2018 16:06:32 563 437.2000 XLON 01503015000150738-E0bsngaluRgj20181114 14-Nov-2018 16:06:32 361 437.2000 XLON 01503015000150738-E0bsngaluRgl20181114 14-Nov-2018 16:06:38 7 437.1000 XLON 01503015000150798-E0bsngaluS0T20181114 14-Nov-2018 16:07:29 367 436.8000 XLON 11503115000150675-E0bsngaluVHk20181114 14-Nov-2018 16:07:41 476 436.7000 XLON 01503015000151348-E0bsngaluW7g20181114 14-Nov-2018 16:07:41 399 436.7000 XLON 01503015000151348-E0bsngaluW7i20181114 14-Nov-2018 16:08:37 487 436.5000 XLON 11503115000150997-E0bsngaluZch20181114 14-Nov-2018 16:08:37 241 436.5000 XLON 11503115000150997-E0bsngaluZcj20181114 14-Nov-2018 16:10:35 854 436.5000 XLON 11503115000152147-E0bsngaluiBv20181114 14-Nov-2018 16:10:35 238 436.5000 XLON 11503115000152147-E0bsngaluiBx20181114 14-Nov-2018 16:10:36 769 436.4000 XLON 01503015000152029-E0bsngaluiGr20181114 14-Nov-2018 16:10:36 64 436.4000 XLON 01503015000152029-E0bsngaluiGv20181114 14-Nov-2018 16:10:36 350 436.4000 XLON 01503015000152029-E0bsngaluiGt20181114 14-Nov-2018 16:11:27 585 436.0000 XLON 01503015000151955-E0bsngalulVU20181114 14-Nov-2018 16:11:27 201 436.0000 XLON 01503015000151955-E0bsngalulVS20181114 14-Nov-2018 16:12:34 272 436.4000 XLON 01503015000153262-E0bsngaluqZ920181114 14-Nov-2018 16:12:34 350 436.4000 XLON 01503015000153262-E0bsngaluqZD20181114 14-Nov-2018 16:12:34 396 436.4000 XLON 01503015000153262-E0bsngaluqZB20181114 14-Nov-2018 16:12:34 56 436.4000 XLON 01503015000153262-E0bsngaluqZF20181114 14-Nov-2018 16:12:42 1038 436.3000 XLON 01503015000153235-E0bsngalur5K20181114 14-Nov-2018 16:12:42 147 436.3000 XLON 01503015000153235-E0bsngalur5G20181114 14-Nov-2018 16:14:28 555 436.0000 XLON 01503015000153966-E0bsngaluzKl20181114 14-Nov-2018 16:14:28 106 436.0000 XLON 01503015000153966-E0bsngaluzKo20181114 14-Nov-2018 16:14:36 514 435.9000 XLON 01503015000153927-E0bsngaluzkp20181114 14-Nov-2018 16:14:36 410 435.9000 XLON 01503015000153927-E0bsngaluzkr20181114 14-Nov-2018 16:15:53 362 435.9000 XLON 11503115000154535-E0bsngalv5bG20181114 14-Nov-2018 16:15:53 17 435.9000 XLON 11503115000154535-E0bsngalv5bE20181114 14-Nov-2018 16:15:53 349 435.9000 XLON 11503115000154535-E0bsngalv5bI20181114 14-Nov-2018 16:17:27 729 436.0000 XLON 11503115000155162-E0bsngalvE4v20181114 14-Nov-2018 16:17:27 383 436.0000 XLON 11503115000155162-E0bsngalvE4s20181114 14-Nov-2018 16:19:10 1413 435.9000 XLON 11503115000155720-E0bsngalvLvH20181114 14-Nov-2018 16:19:10 249 436.0000 XLON 01503015000156058-E0bsngalvLud20181114 14-Nov-2018 16:19:10 275 436.0000 XLON 01503015000156058-E0bsngalvLuk20181114 14-Nov-2018 16:19:10 700 436.0000 XLON 01503015000156058-E0bsngalvLuf20181114 14-Nov-2018 16:21:59 482 435.5000 XLON 01503015000157335-E0bsngalvZW720181114 14-Nov-2018 16:21:59 354 435.5000 XLON 01503015000157335-E0bsngalvZWE20181114 14-Nov-2018 16:22:21 206 435.4000 XLON 01503015000157218-E0bsngalvb3X20181114 14-Nov-2018 16:22:21 783 435.4000 XLON 01503015000157218-E0bsngalvb3a20181114 14-Nov-2018 16:24:12 726 435.2000 XLON 11503115000157764-E0bsngalvlD320181114 14-Nov-2018 16:26:13 700 435.6000 XLON 11503115000159238-E0bsngalvwlY20181114 14-Nov-2018 16:26:13 18 435.6000 XLON 01503015000159566-E0bsngalvwlU20181114 14-Nov-2018 16:26:13 24 435.6000 XLON 11503115000159209-E0bsngalvwlS20181114 14-Nov-2018 16:26:14 127 435.4000 XLON 01503015000159526-E0bsngalvwzW20181114 14-Nov-2018 16:26:14 714 435.4000 XLON 01503015000159526-E0bsngalvwzU20181114 14-Nov-2018 16:27:21 100 435.4000 XLON 11503115000159801-E0bsngalw4FT20181114 Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Listing of 600 000 additional GLODIV Securities CoreShares Index Tracker Managers (RF) Proprietary Limited CoreShares GlobalDivTrax Share code: GLODIV ISIN: ZAE000254249 The CoreShares S&P Global Dividend Aristocrats Exchange Traded Fund ("CoreShares GlobalDivTrax") portfolio, a portfolio in the CoreShares Index Tracker Collective Investment Scheme (formerly Grindrod Index Tracker Collective Investment Scheme)("the Scheme") registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002, managed by CoreShares Index Tracker Managers (RF) Proprietary Limited (formerly Grindrod Index Tracker Managers Proprietary Limited)("the Manager" or CITM"). Listing of 600 000 additional GLODIV Securities 600 000 additional GLODIV securities have been issued and listed at an issue price of R11.70 per security. Following the additional listing there will be 22 848 104 securities in issue with effect from today. 15 November 2018 Sponsor Grindrod Bank Limited Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Notification in terms of section 122 of the Companies Act, No 71 of 2008 Combined Motor Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1965/000270/06) Share code: CMH ISIN: ZAE000088050 ("CMH" or "the Company") Notification in terms of section 122 of the Companies Act, No 71 of 2008 In accordance with section 122(3) (b) of the Companies Act, No 71 of 2008 and section 3.83(b) of the JSE Limited`s Listings Requirements, shareholders are hereby advised that CMH has received formal notification from Protea Asset Management LLC (on behalf of client accounts) and Conduit Capital Limited ("Protea and Conduit") collectively, that they have disposed of a beneficial interest of shares of CMH such that their total interest in the Company now amounts to less than 5% of the total issued shares. As required in terms of section 122(3)(a) of the Act, the Company has filed the required notices with the Takeover Regulation Panel. Umhlanga 15 November 2018 Sponsor PricewaterhouseCoopers Corporate Finance (Proprietary) Limited Date: 15/11/2018 09:02:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Dealing in Securities by an Associate of a Director ALLIED ELECTRONICS CORPORATION LIMITED (Registration number 1947/024583/06) (Incorporated in the Republic of South Africa) Share Code: AEL ISIN: ZAE000191342 ("Altron") DEALING IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR In compliance with the JSE Limited Listings Requirements, the following information is disclosed: Director : Mr AC Ball Title : Non-Executive Director Director : Mr S Sithole Title : Non-Executive Director Company : Allied Electronics Corporation Limited Name of Associate : Value Capital Partners (Pty) Ltd* Date of transaction : 12 November 2018 Number of securities : 550 000 Nature of transaction : On-market purchase of securities Class of securities : Altron A ordinary shares Share price : R17.9727 Value of transaction : R9 884 985.00 Nature of interest : Indirect Beneficial Clearance to deal obtained : Yes Date of transaction : 13 November 2018 Number of securities : 480 000 Nature of transaction : On-market purchase of securities Class of securities : Altron A ordinary shares Share price : R17.9996 Value of transaction : R8 639 808.00 Nature of interest : Indirect Beneficial Clearance to deal obtained : Yes Date of transaction : 14 November 2018 Number of securities : 140 049 Nature of transaction : On-market purchase of securities Class of securities : Altron A ordinary shares Share price : R18.00 Value of transaction : R2 520 882.00 Nature of interest : Indirect Beneficial Clearance to deal obtained : Yes * Mr AC Ball and Mr S Sithole have an indirect beneficial interest in Value Capital Partners (Pty) Ltd ("VCP"), which is the advisor to Peregrine Fund Platform (Pty) Ltd, the registered investment manager for various funds advised by VCP. Johannesburg 15 November 2018 Sponsor Investec Bank Limited Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Fourth quarter results for the period ended September 2018 SAPPI LIMITED Registration number: 1936/008963/06 JSE code: SAP ISIN code: ZAE000006284 Issuer code: SAVVI INVESTING IN GROWTH Fourth quarter results for the period ended September 2018 4th quarter results Sappi is a global diversified woodfibre company focused on providing dissolving wood pulp, specialities and packaging papers, printing and writing papers as well as biomaterials and biochemicals to our direct and indirect customer base across more than 150 countries. Our dissolving wood pulp products are used worldwide mainly by converters to create viscose fibre for fashionable clothing and textiles, as well as other consumer products; quality specialities and packaging papers are used in the manufacture of such products as soup sachets, luxury carry bags, cosmetic and confectionery packaging, boxes for agricultural products for export, tissue wadding for household tissue products and casting release papers used by suppliers to the fashion, textiles, automobile and household industries; our market-leading range of printing and writing papers are used by printers in the production of books, brochures, magazines, catalogues, direct mail and many other print applications; biomaterials include nanocellulose, fibre composites and lignosulphonate; biochemicals include second generation sugars. The wood and pulp needed for our products are either produced within Sappi or bought from accredited suppliers. Sappi sells almost as much as it buys. Sales by source* North America 25% Southern Africa 24% Europe 51% Sales by destination* North America 23% Southern Africa 10% Europe 45% Asia and other 22% Sales by product* Coated paper 55% Uncoated paper 5% Speciality paper 14% Commodity paper 7% Dissolving wood pulp 18% Other 1% Net operating assets** North America 28% Southern Africa 34% Europe 38% * For the period ended September 2018. ** As at September 2018. Highlights for the quarter - EBITDA excluding special items US$224 million (Q4 FY17: US$221 million) - Profit for the period US$107 million (Q4 FY17: US$102 million) - EPS excluding special items 19 US cents (Q4 FY17: 19 US cents) Highlights for the year - EBITDA excluding special items US$762 million (FY17: US$785 million) - Profit for the period US$323 million (FY17: US$338 million) - EPS excluding special items 60 US cents (FY17: 64 US cents) - Net debt US$1,568 million (FY17: US$1,322 million) - Dividend of 17 US cents (FY17: 15 US cents) Quarter ended Year ended Sep 2018 Sep 2017 Jun 2018 Sep 2018 Sep 2017 Key figures: (US$ million) Sales 1,535 1,411 1,445 5,806 5,296 Operating profit excluding special items(1) 148 152 85 480 526 Special items - loss (gain)(2) 13 1 1 (9) - EBITDA excluding special items(1) 224 221 155 762 785 Profit for the period 107 102 51 323 338 Basic earnings per share (US cents) 20 19 9 60 63 EPS excluding special items (US cents)(3) 19 19 10 60 64 Net debt(3) 1,568 1,322 1,603 1,568 1,322 Key ratios: (%) Operating profit excluding special items to sales 9.6 10.8 5.9 8.3 9.9 Operating profit excluding special items to capital employed (ROCE)(3) 17.0 20.2 9.7 14.6 18.0 EBITDA excluding special items to sales 14.6 15.7 10.7 13.1 14.8 Net debt to EBITDA excluding special items 2.1 1.7 2.1 2.1 1.7 Interest cover(3) 11.0 9.1 11.0 11.0 9.1 Net asset value per share (US cents)(3) 361 327 342 361 327 (1) Refer to note 2 to the group results for the reconciliation of EBITDA excluding special items and operating profit excluding special items to segment operating profit, and profit for the period. (2) Refer to note 2 to the group results for details on special items. (3) Refer to supplemental information for the definition of the term. Year ended September 2018 compared to year ended September 2017 The overall result was in line with that of the prior year on a like-for-like basis, notwithstanding the downtime related to the completion of several large strategic growth projects during the year. Market demand for dissolving wood pulp (DWP) and speciality and packaging papers ensured our production capacity in these grades was fully utilised, further supporting our decision to invest in additional capacity in these business segments. In the graphic paper market, a series of successful selling price increases throughout the year enabled margins to be maintained notwithstanding significantly higher raw material costs, mainly from paper pulp and various process chemicals. A stronger Rand during most of the year placed the profitability of the South African business under pressure. Increased capital expenditure in strategic growth projects, including the conversions of paper machines in Europe and North America as well as debottlenecking DWP plants in South Africa, was managed around our target of two times net debt to EBITDA. This facilitated a further shift in the product mix of the group away from the traditional graphic paper business towards higher margin and growth segments. The group's EBITDA excluding special items was US$762 million, declining US$3 million on a like-for-like basis (FY2017 benefited by approximately US$20 million due to an additional accounting week). Operating profit excluding special items for the year was US$480 million compared to US$526 million in the prior year. Net finance costs for the year were US$68million, a decrease from US$80 million in the prior year, due to lower average debt levels during the year. Net profit for the year decreased by 4% to US$323 million due to an increased depreciation expense following the higher capital expenditure activity. Fourth quarter commentary The group generated EBITDA excluding special items of US$224 million, an increase of 1% over the same quarter last year. The production challenges of the prior quarter were resolved and combined with higher graphic paper prices and stable demand across most product categories led to the improved performance. DWP demand and market pricing remain healthy, albeit that net sales for the quarter were negatively impacted by translation losses related to currency hedges contracted earlier in the year at a time when the Rand was significantly stronger. The impact of lost DWP production volumes in the third quarter, following start-up issues after mill upgrade projects, was felt in this quarter as inventory levels impacted sales volumes. We launched the Sappi Verve brand as the umbrella brand for our DWP products, which emphasises Sappi's commitment to producing a natural fibre sourced from sustainably managed forests. Demand for specialities and packaging papers continued to grow in each region and across all major product categories. EBITDA margins were impacted by higher raw material prices and a delay in implementing price increases due to the longer-term contracts typical in this market. The qualification process of the paperboard grades at the Somerset and Maastricht mills is under way, with positive customer response to date. This qualification and ramp-up process also negatively impacted average pricing and costs for the quarter. The European business performed well, with coated paper price increases offsetting cost increases. Overall graphic paper markets in Europe weakened during the quarter, however, market share gains helped mitigate the impact. Higher coated paper and DWP prices in addition to the ramp-up of sales volumes from Somerset PM1 led to an improved result for the North American business. An increase in Rand selling prices offset variable costs pressures, some of which related to imported raw materials, in the South African business. Sales volumes were broadly in line with those of last year, being slightly affected by the lost DWP production volumes in the third quarter and a late citrus season which impacted containerboard sales. Net finance costs were US$14 million compared to US$15 million in the equivalent quarter last year. Earnings per share excluding special items for the quarter was 19 US cents. Cash flow and debt Net cash generated for the quarter was US$26 million, compared to US$41 million in the equivalent quarter last year. The reduction in net cash generation was as a result of a smaller decrease in working capital, offset somewhat by lower capital expenditure. Capital expenditure of US$146 million related mainly to the finalisation of debottlenecking of DWP production at the Ngodwana and Saiccor mills, the Saiccor mill woodyard upgrade as well as initial work related to the expansion at Saiccor. Agreement has yet to be reached with suppliers and contractors on the finalisation of the Somerset PM1 upgrade cost overrun, with the result that capital expenditure in the quarter was less than forecast. Net cash utilised for the financial year was US$254 million (FY2017 US$108 million generated). The cash utilisation arose from the Cham Paper acquisition cost of US$132 million, combined with increases in capital expenditure, dividends and working capital. These were partially offset by lower cash interest and tax charges. Net debt at financial year-end increased to US$1,568 million as a result of the cash utilisation. At the end of September 2018, liquidity comprised cash on hand of US$363 million and US$680 million from the unutilised committed revolving credit facilities in South Africa and Europe. Operating review for the quarter Europe Quarter ended € million Sep 2018 Jun 2018 Mar 2018 Dec 2017 Sep 2017 Sales 671 636 616 571 583 Operating profit excluding special items 38 31 37 31 35 Operating profit excluding special items to sales (%) 5.7 4.9 6.0 5.4 6.0 EBITDA excluding special items 71 60 64 59 63 EBITDA excluding special items to sales (%) 10.6 9.4 10.4 10.3 10.8 RONOA pa (%) 11.3 9.3 11.7 10.6 12.2 The European business delivered a good result in a seasonally stronger quarter, with higher graphic and speciality paper pricing, in addition to market share gains in coated paper, more than offsetting a weaker graphic paper market and higher costs. Graphic paper sales volumes were 3% below those of last year, with growth in coated mechanical sales not sufficient to offset declines in coated woodfree demand. The coated mechanical market began the quarter positively due to switching from other grades, however, demand weakened towards the end of the quarter. Coated woodfree demand was weak throughout the period. Coated woodfree and coated mechanical prices are now 9% and 8% higher respectively than they were last year following further price increases implemented during the quarter. In the speciality paper business, year-on-year sales volumes and prices grew 9% and 4% respectively on a like-for-like basis. Price increases in this segment lagged cost inflation, largely due to contract duration. The Cham integration continues to exceed expectations, with EBITDA contribution ahead of expectations after seven months. Variable costs increased 11% year-on-year, led by higher paper pulp and latex prices and exacerbated by the weakening in the Euro/US Dollar exchange rate. Fixed costs increased predominantly because of the increased headcount post the Cham acquisition. North America Quarter ended US$ million Sep 2018 Jun 2018 Mar 2018 Dec 2017 Sep 2017 Sales 388 339 363 342 357 Operating profit (loss) excluding special items 31 1 18 (1) 27 Operating profit (loss) excluding special items to sales (%) 8.0 0.3 5.0 (0.3) 7.6 EBITDA excluding special items 51 20 37 18 47 EBITDA excluding special items to sales (%) 13.1 5.9 10.2 5.3 13.2 RONOA pa (%) 10.9 0.4 6.8 (0.4) 10.7 Following the completion of the Somerset PM1 conversion, profitability in the North American business improved. Graphic paper prices increased compared to the previous quarter, however, sales volumes were affected by historically low inventory levels at the start of the quarter. The US coated paper market continued to be tightly supplied, and our average coated paper sales prices increased 13% year-on-year. Coated sales volumes were 9% lower than the equivalent quarter last year because of the lost production from Somerset PM1 in the third quarter as well as the intentional shift to packaging grades. DWP sales volumes were higher than those achieved in both the prior quarter and the equivalent quarter last year. Average DWP sales prices improved compared to the prior year. The packaging business, including the new paperboard grades from Somerset, nearly doubled sales volumes compared to the prior year. Sales prices reflect the impact of start-up and qualification of the new grades. We made good progress during the quarter with the ramp-up of first quality paperboard production. Variable costs were reduced compared to the prior quarter as lower wood and chemical prices more than offset higher purchased paper pulp prices. Southern Africa Quarter ended ZAR million Sep 2018 Jun 2018 Mar 2018 Dec 2017 Sep 2017 Sales 5,103 4,383 4,548 4,291 4,879 Operating profit excluding special items 1,081 553 950 940 1,106 Operating profit excluding special items to sales (%) 21.2 12.6 20.9 21.9 22.7 EBITDA excluding special items 1,344 742 1,168 1,144 1,344 EBITDA excluding special items to sales (%) 26.3 16.9 25.7 26.7 27.5 RONOA pa (%) 22.4 11.9 20.9 21.3 26.0 The performance of the Southern African business was very similar to that of the equivalent quarter last year, with higher Rand selling prices offsetting input cost pressure from timber, paper pulp, chemicals and energy. The weaker Rand/US Dollar exchange rate impacted both export sales prices and imported input costs, however, currency hedges on DWP sales entered into earlier in the year resulted in lower effective Rand pricing for some of our DWP sales during the quarter. DWP sales volumes were flat year-on-year as the late start-up of both Ngodwana and Saiccor mills following plant upgrades in the third quarter resulted in low initial DWP inventory levels. The paper business experienced robust demand notwithstanding a late citrus season which delayed some containerboard sales into the next quarter. Sales price increases have offset cost price pressure resulting from the weaker Rand and increased energy prices. Environmental approval for the expansion of the Saiccor Mill was granted by the relevant authorities at the end of the quarter, and construction has now commenced. Directorate Mr Bob DeKoch retired as independent non-executive director in August 2018 due to health reasons. Mr DeKoch was appointed to the board in March 2013 and also served as a member of the Social, Ethics, Transformation and Sustainability Committee. The board is pleased to announce the appointment of Ms Zola Malinga as independent non-executive director with effect from 1 October 2018. Ms Malinga will also serve as a member of the Sappi Audit and Risk Committee with effect from 1 October 2018. Dividends On 14 November 2018, the directors approved a dividend (number 88) of 17 US cents per share which will be paid to shareholders on 14 January 2019. This dividend was declared after year-end and was not included as a liability at the end of the financial year. The 2018 dividend is covered three times by basic earnings per share, excluding non-cash special items. The group aims to declare ongoing annual dividends, and over time achieve a long-term average earnings to dividend ratio of three to one. Outlook The debottlenecking of Saiccor, Ngodwana and Cloquet as well as fewer production disruptions in 2019 should lead to increased DWP sales volumes to meet growing demand. DWP spot prices are forecast to remain range-bound at current levels in the coming year as VSF prices are expected to be under pressure from excess VSF capacity, while paper pulp prices which are forecast to remain at high levels should provide support. Demand for speciality and packaging papers continues to grow, driven by increasing consumer preference for paper-based packaging and legislative changes promoting recycling and the use of recyclable materials. The completion of the conversion projects at Somerset and Maastricht in the past year will allow us to increase production of paperboard grades to serve this growing market. Industrywide conversion and closure of graphic paper machines in the US and Europe are expected to keep the markets balanced in the coming year should demand contract at similar levels to those of the past few years. Recent European data, however, indicates that a potential downturn may be realised in 2019. Cost control measures will be implemented in order to support margins as we manage the price elasticity in our paper markets. Capital expenditure in 2019 is expected to increase to US$590 million as we proceed with the Saiccor 110kt expansion project, complete the Saiccor woodyard upgrade, convert Lanaken PM8 from coated mechanical to woodfree paper production and upgrade the Gratkorn mill. Having completed significant projects in 2018 to convert paper machines to higher margin and growing packaging grades, in addition to the debottlenecking of both Saiccor and Ngodwana mills, we expect EBITDA in the first quarter of financial year 2019, given current exchange rates, to be comfortably higher than that of 2018. On behalf of the board S R Binnie Director G T Pearce Director 14 November 2018 Dividend announcement The directors have resolved to declare a gross dividend (number 88) of 17 US cents per share, payable in ZAR at an exchange rate (US$1=ZAR) of 14.43176, being ZAR245.33992 cents per share, for the year ended 30 September 2018 out of income, in respect of Sappi ordinary shares in issue on the record date as detailed below. Holders of Sappi "A" ordinary unlisted shares in issue on the record date shall be entitled to receive 8.5 US cents per share being 50% of the ordinary dividend so declared. The South African dividend tax (DT) rate is 20% and the net dividend payable to shareholders who are not exempt from DT is ZAR196.27194 cents per share. Sappi currently has 557 202 573 ordinary shares in issue. The income tax reference number is 9175203711. In compliance with the JSE Listings Requirements the salient dates in respect of the dividend are detailed below: Declaration and finalisation date: 15 November 2018 Last day to trade to qualify for the dividend: 8 January 2019 Shares commence trading ex-dividend: 9 January 2019 Record date: 11 January 2019 Payment date: 14 January 2019 Dividends payable to shareholders on the South African register will be paid in South African Rand and all dividends attributable to holders of the ADR shares on the NYSE will be dealt with in accordance with their custody agreements in place with their local custodian. Certificated shareholders who previously held their shares on the UK register, which has subsequently been discontinued, shall be paid in Pounds Sterling at the ruling exchange rate at the time. No currency elections are permitted. All shareholders need to ensure that their current bank mandates with their service providers are up to date. Furthermore, shareholders who have not yet done so, should submit their service providers with their tax numbers and other relevant information for dividend tax purposes. Where shareholders qualify for withholding tax exemptions they need to ensure that such exemption applications have been lodged with their service providers. Certificated and own name shareholders can call Computershare in South Africa on 0861 100 950 for assistance in this regard. Share certificates will not be dematerialised or rematerialised from 9 January 2019 to 11 January 2019, both days inclusive. Forward-looking statements Certain statements in this release that are neither reported financial results nor other historical information, are forward-looking statements, including but not limited to statements that are predictions of or indicate future earnings, savings, synergies, events, trends, plans or objectives. The words "believe", "anticipate", "expect", "intend", "estimate", "plan", "assume", "positioned", "will", "may", "should", "risk" and other similar expressions, which are predictions of or indicate future events and future trends and which do not relate to historical matters, identify forward-looking statements. In addition, this document includes forward-looking statements relating to our potential exposure to various types of market risks, such as interest rate risk, foreign exchange rate risk and commodity price risk. You should not rely on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are in some cases beyond our control and may cause our actual results, performance or achievements to differ materially from anticipated future results, performance or achievements expressed or implied by such forward-looking statements (and from past results, performance or achievements). Certain factors that may cause such differences include but are not limited to: - the highly cyclical nature of the pulp and paper industry (and the factors that contribute to such cyclicality, such as levels of demand, production capacity, production, input costs including raw material, energy and employee costs, and pricing); - the impact on our business of adverse changes in global economic conditions; - unanticipated production disruptions (including as a result of planned or unexpected power outages); - changes in environmental, tax and other laws and regulations; - adverse changes in the markets for our products; - the emergence of new technologies and changes in consumer trends including increased preferences for digital media; - consequences of our leverage, including as a result of adverse changes in credit markets that affect our ability to raise capital when needed; - adverse changes in the political situation and economy in the countries in which we operate or the effect of governmental efforts to address present or future economic or social problems; - the impact of restructurings, investments, acquisitions, dispositions and other strategic initiatives (including related financing), any delays, unexpected costs or other problems experienced in connection with dispositions or with integrating acquisitions or implementing restructurings or other strategic initiatives, and achieving expected savings and synergies; and - currency fluctuations. We undertake no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise. Condensed group income statement Quarter ended Year ended Reviewed Audited US$ million Notes Sep 2018 Sep 2017 Sep 2018 Sep 2017 Sales 1,535 1,411 5,806 5,296 Cost of sales 1,293 1,164 4,928 4,429 Gross profit 242 247 878 867 Selling, general and administrative expenses 103 89 396 334 Other operating expenses (income) 4 8 (4) 14 Share of profit from equity investments - (1) (3) (7) Operating profit 3 135 151 489 526 Net finance costs 14 15 68 80 Net interest expense 18 18 76 92 Interest capitalised - - (2) - Net foreign exchange gain (4) (3) (6) (12) Profit before taxation 121 136 421 446 Taxation 14 34 98 108 Profit for the period 107 102 323 338 Basic earnings per share (US cents) 4 20 19 60 63 Weighted average number of shares in issue (millions) 539.1 534.9 538.1 533.9 Diluted earnings per share (US cents) 4 19 19 59 62 Weighted average number of shares on fully diluted basis (millions) 552.1 548.9 550.0 547.4 Condensed group statement of other comprehensive income Quarter ended Year ended Reviewed Audited US$ million Sep 2018 Sep 2017 Sep 2018 Sep 2017 Profit for the period 107 102 323 338 Other comprehensive income (loss), net of tax Items that will not be reclassified subsequently to profit or loss 19 68 - 68 Actuarial gains (losses) on post-employment benefit funds 28 101 28 101 Tax effect resulting from above items and changes in tax rates (9) (33) (28) (33) Items that must be reclassified subsequently to profit or loss (26) (53) (57) 10 Exchange differences on translation of foreign operations (34) (53) (61) (1) Movements in hedging reserves 13 (1) 8 10 Movement on available for sale financial assets (1) - (1) - Tax effect of above items (4) 1 (3) 1 Total comprehensive income for the period 100 117 266 416 Condensed group balance sheet Note Reviewed Audited US$ million Sep 2018 Sept 2017 ASSETS Non-current assets 3,766 3,378 Property, plant and equipment 3,010 2,681 Plantations 5 466 458 Deferred tax assets 106 123 Goodwill and intangible assets 63 39 Equity-accounted investees 33 26 Other non-current assets 88 51 Current assets 1,904 1,869 Inventories 741 636 Trade and other receivables 767 668 Derivative financial instruments 21 3 Taxation receivable 12 12 Cash and cash equivalents 363 550 Total assets 5,670 5,247 EQUITY AND LIABILITIES Shareholders' equity Ordinary shareholders' interest 1,947 1,747 Non-current liabilities 2,550 2,457 Interest-bearing borrowings 1,818 1,739 Deferred tax liabilities 335 295 Other non-current liabilities 397 423 Current liabilities 1,173 1,043 Interest-bearing borrowings 97 133 Overdrafts 16 - Trade and other payables 1,009 858 Provisions 6 10 Derivative financial instruments 6 5 Taxation payable 39 37 Total equity and liabilities 5,670 5,247 Number of shares in issue at balance sheet date (millions) 539.3 535.0 Condensed group statement of cash flows Quarter ended Year ended Reviewed Audited US$ million Sep 2018 Sep 2017 Sep 2018 Sep 2017 Profit for the period 107 102 323 338 Adjustment for: Depreciation, fellings and amortisation 93 83 348 322 Taxation 14 34 98 108 Net finance costs 14 15 68 80 Defined post-employment benefits paid (12) (10) (45) (43) Plantation fair value adjustments (14) (20) (96) (79) Asset impairment reversal - - (3) - Net restructuring provisions 3 - 1 1 (Profit) loss on disposal of property, plant and equipment 4 2 (4) 2 Other non-cash items 3 (2) 19 19 Cash generated from operations 212 204 709 748 Movement in working capital 6 103 (79) (27) Net finance costs paid (24) (20) (66) (81) Taxation paid (23) (38) (73) (100) Dividend paid - - (81) (59) Cash generated from operating activities 171 249 410 481 Cash utilised in investing activities (145) (208) (664) (373) Capital expenditure (146) (197) (541) (357) Proceeds on disposal of assets - 1 11 4 Acquisition of subsidiary - (11) (132) (11) Other movements 1 (1) (2) (9) Net cash (utilised) generated 26 41 (254) 108 Cash effects of financing activities 21 51 68 (279) Proceeds from interest-bearing borrowings 21 50 137 186 Repayment of interest-bearing borrowings - 1 (69) (465) Net movement in cash and cash equivalents 47 92 (186) (171) Cash and cash equivalents at beginning of period 317 446 550 703 Translation effects (1) 12 (1) 18 Cash and cash equivalents at end of period 363 550 363 550 Condensed group statement of changes in equity Year ended Reviewed Audited US$ million Sep 2018 Sep 2017 Balance - beginning of period 1,747 1,378 Total comprehensive income for the period 266 416 Shareholders for dividend (81) (59) Transfers from the share purchase trust 5 5 Transfers of vested share options (1) (2) Share-based payment reserve 11 9 Balance - end of period 1,947 1,747 Notes to the condensed group results 1. Basis of preparation The condensed consolidated financial statements are prepared in accordance with the requirements of the JSE Limited Listings Requirements for preliminary reports and the requirements of the Companies Act of South Africa. The Listings Requirements require preliminary reports to be prepared in accordance with the framework concepts and the measurement and recognitions requirements of International Financial Reporting Standards (IFRS) and the SAICA Financial Reporting Guides as issued by the Accounting Practices Committee and Financial Pronouncements as issued by Financial Reporting Standards Council and to also, as a minimum, contain the information required by IAS 34 Interim Financial Reporting. The accounting policies applied in the preparation of the condensed consolidated financial statements are in terms of IFRS and are consistent with those applied in the previous consolidated annual financial statements. The preparation of these condensed consolidated financial statements was supervised by the Chief Financial Officer, G T Pearce, CA(SA). The condensed consolidated financial statements for the year ended September 2018 have been reviewed by KPMG Inc., who expressed an unmodified review conclusion. The auditor's report does not necessarily report on all of the information contained in these financial results. Shareholders are therefore advised that in order to obtain a full understanding of the nature of the auditor's engagement they should obtain a copy of the auditor's report together with the accompanying financial information from the issuer's registered office. 2. Segment information The group's reportable segments comprise the geographic regions of North America, Europe and Southern Africa and have remained unchanged from the prior year. The group has, however, changed the financial information by major product category, as reviewed by the chief operating decision maker during the quarter ended December 2017. Accordingly, the group has restated the financial information presented by major product category for the quarter and year ended September 2017. Quarter ended Year ended Metric tons (000's) Sep 2018 Sep 2017 Sep 2018 Sep 2017 Sales volume North America 363 361 1,371 1,359 Europe 864 842 3,366 3,343 Southern Africa - Pulp and paper 441 447 1,620 1,606 Forestry 352 290 1,234 1,102 Total 2,020 1,940 7,591 7,410 Which consists of: Dissolving wood pulp 332 325 1,198 1,184 Specialities and packaging papers 291 240 1,009 854 Printing and writing papers 1,045 1,085 4,150 4,270 Forestry 352 290 1,234 1,102 Quarter ended Year ended Reviewed Audited US$ million Sep 2018 Sep 2017 Sep 2018 Sep 2017 Sales North America 388 357 1,432 1,360 Europe 782 684 2,970 2,564 Southern Africa - Pulp and paper 345 352 1,328 1,307 Forestry 20 18 76 65 Total 1,535 1,411 5,806 5,296 Which consists of: Dissolving wood pulp 278 277 1,043 1,059 Specialities and packaging papers 310 231 1,087 833 Printing and writing papers 927 885 3,600 3,339 Forestry 20 18 76 65 Operating profit (loss) excluding special items North America 31 27 49 47 Europe 44 41 163 140 Southern Africa 78 84 270 337 Unallocated and eliminations(1) (5) - (2) 2 Total 148 152 480 526 Which consists of: Dissolving wood pulp 74 80 251 334 Specialities and packaging papers 19 24 78 76 Printing and writing papers 60 48 153 114 Unallocated and eliminations(1) (5) - (2) 2 Special items - (gains) losses North America (1) - 2 - Europe (2) 1 (3) 4 Southern Africa 10 (1) (25) (10) Unallocated and eliminations(1) 6 1 17 6 Total 13 1 (9) - Segment operating profit (loss) North America 32 27 47 47 Europe 46 40 166 136 Southern Africa 68 85 295 347 Unallocated and eliminations(1) (11) (1) (19) (4) Total 135 151 489 526 (1) Includes the group's treasury operations and our insurance captive. EBITDA excluding special items North America 51 47 126 126 Europe 81 73 299 262 Southern Africa 97 102 337 396 Unallocated and eliminations(1) (5) (1) - 1 Total 224 221 762 785 Which consists of: Dissolving wood pulp 88 95 306 386 Specialities and packaging papers 40 36 138 117 Printing and writing papers 101 91 318 281 Unallocated and eliminations(1) (5) (1) - 1 Reconciliation of EBITDA excluding special items and operating profit excluding special items to segment operating profit and profit for the period Special items cover those items which management believe are material by nature or amount to the operating results and require separate disclosure. EBITDA excluding special items 224 221 762 785 Depreciation and amortisation (76) (69) (282) (259) Operating profit excluding special items 148 152 480 526 Special items - gains (losses) (13) (1) 9 - Plantation price fair value adjustment (3) 7 27 21 Acquisition costs - - (2) - Net restructuring provisions (3) - (1) (1) Profit (loss) on disposal and written off assets (4) (2) 4 (2) Asset (impairment) reversal - (6) 3 (6) Black Economic Empowerment charge - - (1) (1) Fire, flood, storm and other events (3) - (21) (11) Segment operating profit 135 151 489 526 Net finance costs (14) (15) (68) (80) Profit before taxation 121 136 421 446 Taxation (14) (34) (98) (108) Profit for the period 107 102 323 338 (1) Includes the group's treasury operations and our insurance captive. Year ended Reviewed Audited US$ million Sep 2018 Sep 2017 Segment assets North America 1,137 1,026 Europe 1,574 1,373 Southern Africa 1,392 1,263 Unallocated and eliminations(1) 38 2 Total 4,141 3,664 Reconciliation of segment assets to total assets Segment assets 4,141 3,664 Deferred taxation 106 123 Cash and cash equivalents 363 550 Trade and other payables 1,009 858 Provisions 6 10 Derivative financial instruments 6 5 Taxation payable 39 37 Total assets 5,670 5,247 (1) Includes the group's treasury operations and our insurance captive. 3. Operating profit Quarter ended Year ended Reviewed Audited US$ million Sep 2018 Sep 2017 Sep 2018 Sep 2017 Included in operating profit are the following items: Depreciation and amortisation 76 69 282 259 Fair value adjustment on plantations (included in cost of sales) Changes in volume Fellings 17 14 66 63 Growth (17) (13) (69) (58) - 1 (3) 5 Plantation price fair value adjustment 3 (7) (27) (21) 3 (6) (30) (16) Net restructuring provisions 3 - 1 1 (Profit) loss on disposal and write off of assets 4 2 (4) 2 Asset impairment reversals - (2) (3) (2) Asset impairments - 6 - 6 4. Earnings per share Quarter ended Year ended Reviewed Audited US$ million Sep 2018 Sep 2017 Sep 2018 Sep 2017 Basic earnings per share (US cents) 20 19 60 63 Headline earnings per share (US cents) 20 20 59 64 EPS excluding special items (US cents) 19 19 60 64 Weighted average number of shares in issue (millions) 539.1 534.9 538.1 533.9 Diluted earnings per share (US cents) 19 19 59 62 Diluted headline earnings per share (US cents) 20 19 58 63 Weighted average number of shares on fully diluted basis (millions) 552.1 548.9 550.0 547.4 Calculation of headline earnings Profit for the period 107 102 323 338 (Profit) loss on disposal and written off assets 4 2 (4) 2 Asset impairment reversals - (2) (3) (2) Asset impairments - 6 - 6 Tax effect of above items (1) (1) 1 (1) Headline earnings 110 107 317 343 Calculation of earnings excluding special items Profit for the period 107 102 323 338 Special items after tax 13 2 (2) 2 Special items 13 1 (9) - Tax effect - 1 7 2 Tax special items (16) - 3 - Earnings excluding special items 104 104 324 340 5. Plantations Plantations are stated at fair value less estimated cost to sell at the harvesting stage. In arriving at plantation fair values, the key assumptions are estimated prices less cost of delivery, pre-tax discount rates, volume and growth estimations. Mature timber that is expected to be felled within 12 months from the end of the reporting period is valued using unadjusted current market prices. Mature timber that is to be felled in more than 12 months from the reporting date is valued using a 12 quarter rolling historical average price. Immature timber is valued using a discounted cash flow method taking into account the growth cycle of a plantation. The fair value of plantations is a Level 3 measure in terms of the fair value measurement hierarchy as established by IFRS 13 Fair Value Measurement. Reviewed Audited US$ million Sep 2018 Sep 2017 Fair value of plantations at beginning of year 458 441 Gains arising from growth 69 58 Fire, flood, storm and other events - (5) In-field inventory 1 1 Gain arising from fair value price changes 27 21 Harvesting - agriculture produce (fellings) (66) (63) Translation difference (23) 5 Fair value of plantations at end of period 466 458 6. Financial instruments The group's financial instruments that are measured at fair value on a recurring basis consist of derivative financial instruments, available-for-sale financial assets and a contingent consideration liability. These have been categorised in terms of the fair value measurement hierarchy as established by IFRS 13 Fair Value Measurement per the table below. Fair value(1) Fair value Reviewed Audited US$ million hierarchy Sep 2018 Sep 2017 Investment funds(2) Level 1 7 7 Derivative financial assets Level 2 21 3 Derivative financial liabilities Level 2 6 5 Contingent consideration liability(3) Level 3 7 13 (1) The fair value of the financial instruments is equal to their carrying value. (2) Included in other non-current assets. (3) Included in other non-current liabilities and trade and other payables. There have been no transfers of financial assets or financial liabilities between the categories of the fair value hierarchy. The fair value of all external over-the-counter derivatives is calculated based on the discount rate adjustment technique. The discount rate used is derived from observable rates of return for comparable assets or liabilities traded in the market. The credit risk of the external counterparty is incorporated into the calculation of fair values of financial assets and own credit risk is incorporated in the measurement of financial liabilities. The change in fair value is therefore impacted by the movement of the interest rate curves, by the volatility of the applied credit spreads, and by any changes to the credit profile of the involved parties. The contingent consideration is based on a multiple of targeted future earnings, of which a weighted average outcome has been considered. During the year the fair value of the liability was remeasured and a gain of US$6 million was recognised. There are no financial assets and liabilities that have been remeasured to fair value on a non-recurring basis. The carrying amounts of other financial instruments which include cash and cash equivalents, accounts receivable, certain investments, accounts payable, bank overdrafts and current interest-bearing borrowings approximate their fair values. 7. Capital commitments Reviewed Audited US$ million Sep 2018 Sept 2017 Contracted 293 253 Approved but not contracted 381 219 674 472 8. Material balance sheet movements Property, plant and equipment, cash, inventories, trade and other receivables and trade and other payables The increase in property, plant and equipment and decrease in cash is due to the major capital expansion projects undertaken by the group as well as the acquisition of a subsidiary. The increase in inventories, trade and other receivables and trade and other payables is largely attributable to seasonal working capital movements as well as the acquisition of a subsidiary. 9. Acquisition On 28 February 2018, Sappi acquired the speciality paper business of Cham Paper Group Holding AG (CPG) for CHF132 million (US$139 million). The transaction includes all brands and know-how, the Carmignano and Condino mills in Italy, as well as their digital imaging business and facility situated in Cham, Switzerland. The acquisition was financed from internal resources. The acquisition increases Sappi's relevance in specialities and packaging papers, opening up new customers and markets to Sappi's existing products and generating economies of scale and synergies. It will improve near-term profitability and serve as a platform for organic growth, further acquisitions and will add €183 million of annual sales and approximately €20 million of annual EBITDA before taking into account synergies. The fair values of assets acquired and liabilities assumed as at 28 February 2018 were as follows: EURO US$ Property, plant and equipment 81 98 Intangible assets 32 39 Inventories 25 31 Trade receivables 28 36 Prepayments and other assets 2 3 Cash and cash equivalents 6 7 Trade payables (23) (29) Pension liabilities (4) (5) Provisions (1) (2) Other payables and accruals (9) (11) Deferred tax liabilities (15) (18) Non-current interest-bearing borrowings (5) (7) Current interest-bearing borrowings (5) (6) Net asset value acquired 112 136 Goodwill 2 3 Purchase consideration 114 139 Less: Cash and cash equivalents acquired (6) (7) Net cash outflow on acquisition 108 132 CPG earned revenues of €118 million and profit after tax of €4 million since acquisition. 10. Related parties There has been no material change, by nature or amount, in transactions with related parties since the 2017 financial year-end other than purchases from The Boldt Company (Boldt) for construction-related services which amounted to US$88 million for the year ended September 2018 (September 2017: US$8 million) largely related to the rebuild at our Somerset mill. The balance outstanding as at September 2018 is US$26 million (September 2017: US$Nil). There are ongoing disputes over amounts billed, and arbitration has been requested by Boldt. 11. Accounting standards, interpretations and amendments to existing standards that are not yet effective There has been no significant change to managements estimates in respect of new accounting standards, amendments and interpretations to existing standards that have been published which are not yet effective and which have not yet been adopted by the group. No material impact is expected in respect of the adoption of IFRS 9 Financial Instruments and IFRS 15 Revenue from Contracts with Customers. Management is in the process of completing its assessment of IFRS 16 Leases. 12. Events after balance sheet date The directors have resolved to declare a gross dividend (number 88) out of income earned for the financial year ended September 2018 of 17 US cents per ordinary share in issue on the record date being 11 January 2019. The dividend is payable in ZAR at an exchange rate of ZAR14.43176, being ZAR245.33992 cents per share. Holders of Sappi "A" ordinary unlisted shares, issued in terms of the BBBEE scheme, are entitled to receive 8.5 US cents (ZAR122.66996 cents per share) per share being 50% of the ordinary dividend declared. Supplemental information (this information has not been audited or reviewed) General definitions Average - averages are calculated as the sum of the opening and closing balances for the relevant period divided by two Broad-based Black Economic Empowerment (BBBEE) charge - represents the IFRS 2 non-cash charge associated with the BBBEE transaction implemented in fiscal 2010 in terms of BBBEE legislation in South Africa Capital employed - shareholders' equity plus net debt EBITDA excluding special items - earnings before interest (net finance costs), taxation, depreciation, amortisation and special items EPS excluding special items - earnings per share excluding special items and certain once-off finance and tax items Fellings - the amount charged against the income statement representing the standing value of the plantations harvested Headline earnings - as defined in circular 4/2018, issued by the South African Institute of Chartered Accountants in April 2018, which separates from earnings all separately identifiable remeasurements. It is not necessarily a measure of sustainable earnings. It is a Listings Requirement of the JSE Limited to disclose headline earnings per share Interest cover - last 12 months EBITDA excluding special items to net interest adjusted for refinancing costs NBSK - Northern Bleached Softwood Kraft pulp. One of the main varieties of market pulp, produced from coniferous trees (ie spruce, pine) in Scandinavia, Canada and northern USA. The price of NBSK is a benchmark widely used in the pulp and paper industry for comparative purposes Net assets - total assets less total liabilities Net asset value per share - net assets divided by the number of shares in issue at balance sheet date Net debt - current and non-current interest-bearing borrowings, bank overdrafts less cash and cash equivalents Net debt to EBITDA excluding special items - net debt divided by the last 12 months EBITDA excluding special items Net operating assets - total assets (excluding deferred tax assets and cash) less current liabilities (excluding interest-bearing borrowings and overdraft). Net operating assets equate to segment assets Operating profit - a profit from business operations before deduction of net finance costs and taxes Non-GAAP measures - the group believes that it is useful to report certain non-GAAP measures for the following reasons: - these measures are used by the group for internal performance analysis; - the presentation by the group's reported business segments of these measures facilitates comparability with other companies in our industry, although the group's measures may not be comparable with similarly titled profit measurements reported by other companies; and - it is useful in connection with discussion with the investment analyst community and debt rating agencies These non-GAAP measures should not be considered in isolation or construed as a substitute for GAAP measures in accordance with IFRS ROCE - annualised return on average capital employed. Operating profit excluding special items divided by average capital employed RONOA - return on average net operating assets. Operating profit excluding special items divided by average net operating assets Special items - special items cover those items which management believe are material by nature or amount to the operating results and require separate disclosure. Such items would generally include profit or loss on disposal of property, investments and businesses, asset impairments, restructuring charges, non-recurring integration costs related to acquisitions, financial impacts of natural disasters, non-cash gains or losses on the price fair value adjustment of plantations and alternative fuel tax credits receivable in cash The above financial measures are presented to assist our shareholders and the investment community in interpreting our financial results. These financial measures are regularly used and compared between companies in our industry Summary Rand convenience translation Quarter ended Year ended Sep 2018 Sep 2017 Sep 2018 Sep 2017 Key figures: (ZAR million) Sales 21,584 18,591 75,779 70,867 Operating profit excluding special items(1) 2,081 2,003 6,265 7,039 Special items - (gains) losses(1) 183 13 (117) - EBITDA excluding special items(1) 3,150 2,912 9,945 10,504 Profit for the period 1,505 1,344 4,216 4,523 Basic earnings per share (SA cents) 279 251 783 847 Net debt(1) 22,183 17,921 22,183 17,921 Key ratios: (%) Operating profit excluding special items to sales 9.6 10.8 8.3 9.9 Operating profit excluding special items to capital employed (ROCE)(1) 17.2 20.0 13.7 17.6 EBITDA excluding special items to sales 14.6 15.7 13.1 14.8 (1) Refer to supplemental information for the definition of the term. The above financial results have been translated into Rand from US Dollar as follows: - assets and liabilities at rates of exchange ruling at period end; and - income, expenditure and cash flow items at average exchange rates. Exchange rates Sep Jun Mar Dec Sep 2018 2018 2018 2017 2017 Exchange rates: Period end rate: US$1 = ZAR 14.1473 13.7275 11.8385 12.3724 13.5561 Average rate for the quarter: US$1 = ZAR 14.0615 12.6312 11.9577 13.6220 13.1761 Average rate for the year to date: 13.0518 12.7255 12.7723 13.6220 13.3813 US$1 = ZAR Period end rate: €1 = US$ 1.1609 1.1685 1.2323 1.1998 1.1814 Average rate for the quarter: €1 = US$ 1.1626 1.1920 1.2286 1.1778 1.1756 Average rate for the year to date: €1 = US$ 1.1902 1.1995 1.2032 1.1778 1.1055 Registration number: 1936/008963/06 JSE code: SAP ISIN code: ZAE000006284 Issuer code: SAVVI Sappi has a primary listing on the JSE Limited and a Level 1 ADR programme that trades in the over-the-counter market in the United States South Africa Computershare Investor Services (Pty) Ltd Rosebank Towers, 15 Biermann Avenue Rosebank 2196, South Africa PO Box 61051, Marshalltown 2107, South Africa www.computershare.com United States ADR Depositary The Bank of New York Mellon Investor Relations PO Box 11258 Church Street Station New York, NY 10286-1258 Tel +1 610 382 7836 JSE Sponsor: UBS South Africa (Pty) Ltd This report is available on the Sappi website: www.sappi.com Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Key Surface Rights Acquired for The Makhado Project MC Mining Limited Previously Coal of Africa Limited (Incorporated and registered in Australia) Registration number ABN 008 905 388 ISIN AU000000MCM9 JSE share code: MCZ ASX/AIM code: MCM ANNOUNCEMENT 15 November 2018 KEY SURFACE RIGHTS ACQUIRED FOR THE MAKHADO PROJECT MC Mining Limited ("MC Mining" or the "Company") is pleased to announce that its subsidiary, Baobab Mining & Exploration (Pty) Ltd ("Baobab"), has reached agreement on the terms and conditions under which it will acquire the two key properties required for its Makhado hard coking and thermal coal project ("Makhado Project" or "Makhado"). The Purchase Agreement (the "Agreement") will result in Baobab owning the Lukin and Salaita properties (the "Properties") and is subject to a suspensive condition, which the parties have every expectation will be met in early January 2019. As previously stated the Company has been pursuing various avenues, including legal and negotiation on commercial terms with the owner, a privately owned company, who utilises the Properties for commercial hunting purposes. In terms of the Agreement, the Properties will be acquired for R70 million (US$4.8 million) to be settled in two equal tranches of R35 million (US$2.4 million) with the Properties pledged as security until the purchase price (including any accrued interest) is settled. The initial tranche is payable on transfer of the Properties while Baobab will have access to the Properties upon payment of this amount to the conveyancing attorneys. The second tranche will accrue interest at the South African prime interest rate (currently 10.0%) less 3.0% (from date of transfer) and is payable on the earlier of: - the third anniversary of the transfer of the Properties; or - the first anniversary of production of coal underlying the Properties; or - completion of a potential land claims and expropriation process that would, in all likelihood result in Baobab receiving market related compensation under present legislation. Should the Properties be expropriated in favour of the land claimants, MC Mining will negotiate access terms with the Minister of Land Affairs and the successful claimants who are expected to be communities who have a shareholding in Baobab. David Brown, MC Mining's Chief Executive Officer commented: "The Agreement to acquire Lukin and Salaita is a significant step for MC Mining and completes the suite of surface rights required for our permitted flagship Makhado Project. With the acquisition of the Properties, the Company can proceed with the geotechnical and related studies for the mine's infrastructure. The initial tranche of the purchase price will be funded from internal cash flows. MC Mining has made substantial progress on the Makhado Project milestones, including an off-take agreement for approximately half of the hard coking coal to be produced at the mine. Negotiations for the sale of the remaining hard coking coal as well as the thermal coal are at an advanced stage while funding initiatives are also progressing. The Company will keep shareholders appraised on these processes as well as the results of the geotechnical studies, with further updates expected in the March FY2019 quarter." AUTHORISED BY: David Brown Chief Executive Officer For more information contact: David Brown Chief Executive MC Mining Limited +27 10 003 8000 Officer Brenda Berlin Chief Financial MC Mining Limited +27 10 003 8000 Officer Tony Bevan Company Secretary Endeavour Corporate +61 08 9316 Services 9100 Company advisors: Jos Simson/ Gareth Financial PR Tavistock +44 20 7920 Tredway (United Kingdom) 3150 Ross Allister/David Nominated Adviser Peel Hunt LLP +44 20 7418 McKeown and Broker 8900 Charmane Russell/Olwen Financial PR R&A Strategic +27 11 880 3924 Auret (South Africa) Communications Investec Bank Limited is the nominated JSE Sponsor About MC Mining Limited: MC Mining is an AIM/ASX/JSE listed coal exploration, development and mining company operating in South Africa. MCM's key projects include the Uitkomst Colliery (metallurgical and thermal coal), Makhado Project (coking and thermal coal). Vele Colliery (coking and thermal coal), and the Greater Soutpansberg Projects (MbeuYashu). Forward-Looking Statements This Announcement, including information included or incorporated by reference in this Announcement, may contain "forward-looking statements" concerning MC Mining that are subject to risks and uncertainties. Generally, the words "will", "may", "should", "continue", "believes", "expects", "intends", "anticipates" or similar expressions identify forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond MCM's ability to control or estimate precisely, such as future market conditions, changes in regulatory environment and the behaviour of other market participants. MCM cannot give any assurance that such forward-looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward looking statements. MCM assumes no obligation and do not undertake any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required. Statements of intention Statements of intention are statements of current intentions only, which may change as new information becomes available or circumstances change. Regulatory This announcement is inside information for the purposes of Article 7 of Regulation 596/2014. Date: 15/11/2018 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Interim condensed consolidated financial results for the six months ended 30 September 2018 Investec Bank Limited (Registration number 1969/004763/06) Share code: INLP ISIN: ZAE000048393 Interim condensed consolidated financial results for the six months ended 30 September 2018 2018 Condensed consolidated income statement Reviewed Reviewed Audited Six months Six months Year to to 30 Sept to 30 Sept 31 March R'million 2018 2017 2018 Interest income 15 936 15 619 31 687 Interest expense (11 917) (11 956) (24 125) Net interest income 4 019 3 663 7 562 Fee and commission income 1 182 1 216 2 458 Fee and commission expense (106) (132) (213) Investment income 253 597 530 Share of post taxation profit of associates 369 382 777 Trading income/(loss) arising from - customer flow 204 196 356 - balance sheet management and other trading liabilities 227 42 (26) Other operating income 1 1 2 Total operating income before expected credit losses/impairment losses 6 149 5 965 11 446 Expected credit loss impairment charges* (376) - - Impairment losses on loans and advances* - (373) (720) Operating income 5 773 5 592 10 726 Operating costs (3 217) (3 121) (6 100) Operating profit before acquired intangibles 2 556 2 471 4 626 Amortisation of acquired intangibles (26) (26) (51) Operating profit 2 530 2 445 4 575 Additional costs on acquisition of subsidiary - - (100) Gain on acquisition of subsidiary 6 - - Profit before taxation 2 536 2 445 4 475 Taxation on operating profit before acquired intangibles (411) (143) 184 Taxation on acquired intangibles 7 7 14 Profit after taxation 2 132 2 309 4 673 * On adoption of IFRS 9, there is a move from an incurred loss model to an expected credit loss methodology. Calculation of headline earnings Reviewed Reviewed Audited Six months Six months Year to to 30 Sept to 30 Sept 31 March R'million 2018 2017 2018 Profit after taxation 2 132 2 309 4 673 Dividend paid to perpetual preference shareholders and other Additional Tier 1 security holders (88) (67) (133) Earnings attributable to ordinary shareholders 2 044 2 242 4 540 Headline adjustments, net of taxation** (6) (46) (94) Gain on realisation of available-for-sale assets recycled to the income statement - (46) (94) Gain on acquisition of subsidiary (6) - - Headline earnings attributable to ordinary shareholders 2 038 2 196 4 446 ** Net of taxation of Rnil [Six months to 30 September 2017: R18.0 million; year to 31 March 2018: R36.6 million]. Condensed consolidated statement of total comprehensive income Reviewed Reviewed Audited Six months Six months Year to to 30 Sept to 30 Sept 31 March R'million 2018 2017 2018 Profit after taxation 2 132 2 309 4 673 Other comprehensive income: Items that may be reclassified to the income statement Fair value movements on cash flow hedges taken directly to other comprehensive income*** (20) (36) (99) Fair value movements on available-for-sale assets taken directly to other comprehensive income***^ - 113 494 Gain on realisation of available-for-sale assets recycled to the income statement***^ - (46) (94) Fair value movements on debt instruments at FVOCI taken directly to other comprehensive income***^ (68) - - Gain on realisation of debt instruments at FVOCI recycled to the income statement***^ (38) - - Foreign currency adjustments on translating foreign operations 779 39 (637) Items that will never be reclassified to the income statement Fair value movements on equity instruments at FVOCI taken directly to other comprehensive income*** (452) - - Total comprehensive income 2 333 2 379 4 337 Total comprehensive income attributable to ordinary shareholders 2 245 2 312 4 204 Total comprehensive income attributable to perpetual preference shareholders and other Additional Tier 1 security holders 88 67 133 Total comprehensive income 2 333 2 379 4 337 ^ On adoption of IFRS 9 on 1 April 2018, the fair value reserve was introduced replacing the available-for-sale reserve. *** Net of taxation of (R141.3 million) [Six months to 30 September 2017: (R12.2 million); year to 31 March 2018: (R266.1 million)]. Condensed consolidated statement of changes in equity Reviewed Reviewed Audited Six months Six months Year to to 30 Sept to 30 Sept 31 March R'million 2018 2017 2018 Balance at the beginning of the period 38 415 35 165 35 165 Adoption of IFRS 9 (894) - - Total comprehensive income 2 333 2 379 4 337 Dividends paid to ordinary shareholders - (654) (1 304) Dividends paid to perpetual preference shareholders and other Additional Tier 1 security holders (88) (67) (133) Net equity movements of interest in associated undertaking (109) - - Issue of other Additional Tier 1 securities in issue - - 350 Other equity movements 2 - - Balance at the end of the period 39 659 36 823 38 415 Condensed consolidated cash flow statement Reviewed Reviewed Audited Six months to Six months to Year to 30 September 30 September 31 March R'million 2018 2017 2018 Cash inflows from operations 2 203 2 064 4 185 Increase in operating assets (3 478) (2 807) (21 277) Increase in operating liabilities 1 601 241 15 244 Net cash inflow/(outflow) from operating activities 326 (502) (1 848) Net cash outflow from investing activities (309) (86) (267) Net cash outflow from financing activities� (1 298) (429) (1 019) Effects of exchange rate changes on cash and cash equivalents 950 10 (864) Net decrease in cash and cash equivalents (331) (1 007) (3 998) Cash and cash equivalents at the beginning of the period 26 026 30 024 30 024 Cash and cash equivalents at the end of the period 25 695 29 017 26 026 Cash and cash equivalents is defined as including: cash and balances at central banks, on demand loans and advances to banks and non-sovereign and non-bank cash placements (all of which have a maturity profile of less than three months). � The net cash outflow from financing activities is detailed as below: Reviewed Reviewed Audited Six months to Six months to Year to 30 September 30 September 31 March R'million 2018 2017 2018 Net (outflow)/inflow of subordinated liabilities (1 210) 292 68 Dividends paid (88) (721) (1 437) Issue of other Additional Tier 1 securities - - 350 Net cash outflow from financing activities (1 298) (429) (1 019) Condensed consolidated balance sheet Reviewed Audited Audited Reviewed At 30 September 1 April 31 March 30 September R'million 2018 2018# 2018# 2017 Assets Cash and balances at central banks 9 586 9 180 9 187 9 200 Loans and advances to banks 18 458 17 263 17 265 18 723 Non-sovereign and non-bank cash placements 10 441 9 972 9 993 10 399 Reverse repurchase agreements and cash collateral on securities borrowed 14 033 20 480 20 480 17 933 Sovereign debt securities 58 923 62 363 62 403 50 722 Bank debt securities 10 358 8 033 8 051 8 156 Other debt securities 13 861 10 357 10 342 12 056 Derivative financial instruments 9 506 12 564 12 586 11 244 Securities arising from trading activities 1 366 875 875 1 463 Investment portfolio 7 890 9 124 7 943 8 414 Loans and advances to customers 250 806 245 162 247 474 241 093 Own originated loans and advances to customers securitised 8 341 6 826 6 830 7 231 Other loans and advances 359 265 265 291 Other securitised assets 250 241 241 274 Interest in associated undertakings 6 541 6 288 6 288 5 898 Deferred taxation assets 750 933 586 292 Other assets 8 429 6 673 6 686 6 817 Property and equipment 2 626 2 494 2 494 289 Investment properties 1 1 1 1 Goodwill 171 171 171 171 Intangible assets 461 412 412 460 Loans to group companies 15 148 13 499 13 499 16 449 448 305 443 176 444 072 427 576 Liabilities Deposits by banks 25 801 24 607 24 607 25 181 Derivative financial instruments 14 531 15 907 15 907 13 457 Other trading liabilities 2 468 2 305 2 305 1 708 Repurchase agreements and cash collateral on securities lent 6 500 8 395 8 395 9 906 Customer accounts (deposits) 331 732 321 861 321 893 309 996 Debt securities in issue 4 131 3 473 3 473 2 770 Liabilities arising on securitisation of own originated loans and advances 2 216 1 551 1 551 1 652 Current taxation liabilities - 202 202 577 Deferred taxation liabilities 92 99 99 104 Other liabilities 5 272 6 874 6 844 5 725 Loans from group companies 3 150 7 007 7 007 6 153 395 893 392 281 392 283 377 229 Subordinated liabilities 12 753 13 374 13 374 13 524 408 646 405 655 405 657 390 753 Equity Ordinary share capital 32 32 32 32 Share premium 14 885 14 885 14 885 14 885 Other reserves 1 628 1 353 1 293 1 713 Retained income 22 764 20 901 21 855 20 193 Shareholders' equity excluding non-controlling interests 39 309 37 171 38 065 36 823 Other Additional Tier 1 securities in issue 350 350 350 - Total equity 39 659 37 521 38 415 36 823 Total liabilities and equity 448 305 443 176 444 072 427 576 # The 1 April 2018 balance sheet has been presented on an IFRS 9 basis and the comparative as at 31 March 2018 on an IAS 39 basis. Liquidity coverage ratio disclosure The objective of the liquidity coverage ratio (LCR) is to promote the short-term resilience of the liquidity risk profile of banks by ensuring that they have sufficient high quality liquid assets to survive a significant stress scenario lasting 30 calendar days. In accordance with the provisions of section 6(6) of the South African Banks Act 1990 (Act No. 94 of 1990), banks are directed to comply with the relevant LCR disclosure requirements. This disclosure Template LIQ1 is in accordance with Pillar 3 of the Basel III liquidity accord, as specified by BCBS d400 (2017) and Directive 01/2018. The following table sets out the LCR for the group and bank: Investec Bank Limited Investec Bank Limited Solo - Consolidated Group - R'million Total weighted value Total weighted value High quality liquid assets (HQLA) 77 194 78 202 Net cash outflows 56 325 54 795 Actual LCR (%) 137.4 143.3 Required LCR (%) 90.0 90.0 The values in the table are calculated as the simple average of 92 calendar daily values over the period 1 July 2018 to 30 September 2018 for Investec Bank Limited (IBL) bank solo. Investec Bank Limited consolidated group use daily values for IBL bank solo, while those for other group entities use the average of July, August, September 2018 month-end values. Net stable funding ratio The objective of the net stable funding ratio (NSFR) is to promote the resilience in the banking sector by requiring banks to maintain a stable funding profile in relation to the composition of their assets and off-balance sheet activities on an ongoing structural basis. In accordance with the provisions of section 6(6) of the South African Banks Act 1990 (Act No. 94 of 1990), banks are directed to comply with the relevant NSFR disclosure requirements. This disclosure Template LIQ2 is in accordance with Pillar 3 of the Basel III liquidity accord, as specified by Directive 11/2015 and Directive 01/2018. The following table sets out the NSFR for the group and bank: Investec Bank Limited Investec Bank Limited Solo - Consolidated Group - R'million Total weighted value Total weighted value Available stable funding (ASF) 283 067 294 934 Required stable funding (RSF) 254 271 259 998 Actual NSFR (%) 111.3 113.4 Required NSFR (%) 100.0 100.0 Commentary These reviewed interim condensed consolidated financial results are published to provide information to holders of Investec Bank Limited's listed non-redeemable, non-cumulative, non-participating preference shares. Overview of results Investec Bank Limited, a subsidiary of Investec Limited, posted a decrease in headline earnings attributable to ordinary shareholders of 7.2% to R2 038 million (2017: R2 196 million). An increase in profit before tax of 3.7%, was offset by a higher tax charge off a low base in the prior period. The balance sheet remains sound with a capital adequacy ratio of 15.2% (1 April 2018: 15.4%). For full information on the Investec Group results, refer to the combined results of Investec plc and Investec Limited on the group's website https://www.investec.com. Financial review Unless the context indicates otherwise, all comparatives referred to in the financial review relate to the six months ended 30 September 2017. Salient operational features for the period under review include: Total operating income before expected credit loss impairment charges increased by 3.1% to R6 149 million (2017: R5 965 million). The components of operating income are analysed further below: - Net interest income increased by 9.7% to R4 019 million (2017: R3 663 million) supported by higher net margins and continued activity from our private client base - Net fee and commission income decreased 0.7% to R1 076 million (2017: R1 084 million) as a result of lower investment banking and corporate client activity levels - Investment income amounted to R253 million (2017: R597 million) impacted by a weaker performance from the listed and unlisted investment portfolios - Share of post taxation profit of associates of R369 million (2017: R382 million) primarily reflects earnings in relation to the group's investment in the IEP Group - Total trading income increased significantly amounting to R431 million (2017: R238 million), reflecting translation gains on foreign currency equity investments (partially offsetting the related weaker investment income performance). Expected credit loss (ECL) impairment charges amounted to R376 million (2017: R373 million under the IAS 39 incurred loss model), however, the credit loss ratio remained at the lower end of its long term average trend at 0.29% (2017: 0.31%). Stage 3 assets (net of ECL impairment charges) as a percentage of net core loans subject to ECL was 0.8% (1 April 2018: 0.7%). The ratio of total operating costs to total operating income remained at 52.3%, reflecting cost containment with operating costs up 3.1% to R3 217 million (2017: R3 121 million). As a result of the foregoing factors profit before taxation and acquired intangibles increased by 3.4% to R2 556 million (2017: R2 471 million). Profit after taxation decreased by 7.7% to R2 132 million (2017: R2 309 million) impacted by a higher tax charge off a low base in the prior period. Basis of preparation The condensed consolidated interim financial statements are prepared in accordance with International Financial Reporting Standard, (IAS) 34 Interim Financial Reporting, the SAICA Financial Reporting Guides as issued by the Accounting Practices Committee and Financial Pronouncements as issued by Financial Reporting Standards Council and the requirements of the Companies Act of South Africa. The accounting policies applied in the preparation of the results for the six months ended 30 September 2018 are consistent with those adopted in the financial statements for the year ended 31 March 2018 except as noted below. On 1 April 2018 the group adopted IFRS 9 'Financial Instruments' which replaced IAS 39 and sets out the new requirements for the recognition and measurement of financial instruments. These requirements focus primarily on the classification and measurement of financial instruments and measurement of impairment losses based on an expected credit loss (ECL) model as opposed to an incurred loss methodology under IAS 39. Disclosure related to the initial application and the impact of the transition from IAS 39 to IFRS 9 were included in the group's transition disclosures published on 15 June 2018 which can be accessed via the Investec website at www.investec.com. Additionally, on 1 April 2018 the group adopted IFRS 15 'Revenue from contracts with customers' which replaced IAS 18 'Revenue'. IFRS 15 provides a principles-based approach for revenue recognition and introduces the concept of recognising revenue for obligations as they are satisfied. It applies to all contracts with customers except leases, financial instruments and insurance contracts. The group's measurement and recognition principles were aligned to the new standard and hence there has been no material impact on measurement and recognition principles or on disclosure requirements from the adoption of IFRS 15. The financial results have been prepared under the supervision of Nishlan Samujh, the Group Chief Financial Officer. The interim financial statements for the six months ended 30 September 2018 will be posted to stakeholders on 30 November 2018. These interim financial statements will be available on the group's website at the same date. On behalf of the Board of Investec Bank Limited Khumo Shuenyane Richard Wainwright Chairman Chief Executive Officer 14 November 2018 Review conclusion The condensed consolidated interim financial statements for the period ended 30 September 2018 have been reviewed by KPMG Inc. and Ernst & Young Inc., who expressed an unmodified review conclusion. A copy of the auditors' review report is available for inspection at the company's registered office together with the financial statements identified in the auditors' report. The auditors' report does not necessarily report on all of the information contained in these financial results. Shareholders are therefore advised that in order to obtain a full understanding of the nature of the auditors' engagement, they should obtain a copy of the auditors' report together with the accompanying financial information from the issuer's registered office. Analysis of assets and liabilities by measurement basis Non- Total Financial financial financial instruments instruments or At 30 September 2018 instruments at amortised scoped out of R'million at fair value cost IFRS 9 Total Assets Cash and balances at central banks - 9 586 - 9 586 Loans and advances to banks - 18 458 - 18 458 Non-sovereign and non-bank cash placements 878 9 563 - 10 441 Reverse repurchase agreements and cash collateral on securities borrowed 9 288 4 745 - 14 033 Sovereign debt securities 53 702 5 221 - 58 923 Bank debt securities 4 046 6 312 - 10 358 Other debt securities 9 267 4 594 - 13 861 Derivative financial instruments 9 506 - - 9 506 Securities arising from trading activities 1 366 - - 1 366 Investment portfolio 7 890 - - 7 890 Loans and advances to customers 18 493 232 313 - 250 806 Own originated loans and advances to customers securitised - 8 341 - 8 341 Other loans and advances - 359 - 359 Other securitised assets - 250 - 250 Interests in associated undertakings - - 6 541 6 541 Deferred taxation assets - - 750 750 Other assets 2 163 3 369 2 897 8 429 Property and equipment - - 2 626 2 626 Investment properties - - 1 1 Goodwill - - 171 171 Intangible assets - - 461 461 Loans to group companies 87 15 061 - 15 148 116 686 318 172 13 447 448 305 Liabilities Deposits by banks - 25 801 - 25 801 Derivative financial instruments 14 531 - - 14 531 Other trading liabilities 2 468 - - 2 468 Repurchase agreements and cash collateral on securities lent 3 230 3 270 - 6 500 Customer accounts (deposits) 42 426 289 306 - 331 732 Debt securities in issue - 4 131 - 4 131 Liabilities arising on securitisation of own originated loans and advances - 2 216 - 2 216 Deferred taxation liabilities - - 92 92 Other liabilities 683 1 234 3 355 5 272 Loans from group companies - 3 150 - 3 150 Subordinated liabilities - 12 753 - 12 753 63 338 341 861 3 447 408 646 Financial instruments carried at fair value The table below analyses recurring fair value measurements for financial assets and financial liabilities. These fair value measurements are categorised into different levels in the fair value hierarchy based on the inputs to the valuation technique used. The different levels are identified as follows: Level 1 - quoted (unadjusted) prices in active markets for identical assets or liabilities Level 2 - inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices) Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs). Fair value category Financial At 30 September 2018 instruments R'million at fair value Level 1 Level 2 Level 3 Assets Non-sovereign and non-bank cash placements 878 83 795 - Reverse repurchase agreements and cash collateral on securities borrowed 9 288 - 9 288 - Sovereign debt securities 53 702 53 702 - - Bank debt securities 4 046 3 902 144 - Other debt securities 9 267 3 592 5 675 - Derivative financial instruments 9 506 - 9 494 12 Securities arising from trading activities 1 366 1 366 - - Investment portfolio 7 890 4 009 431 3 450 Loans and advances to customers 18 493 - 17 889 604 Other assets 2 163 2 163 - - Loans to group companies 87 - 87 - 116 686 68 817 43 803 4 066 Liabilities Derivative financial instruments 14 531 - 14 531 - Other trading liabilities 2 468 193 2 275 - Repurchase agreements and cash collateral on securities lent 3 230 - 3 230 - Customer accounts (deposits) 42 426 - 42 426 - Other liabilities 683 - 683 - 63 338 193 63 145 - Net financial assets/(liabilities) at fair value 53 348 68 624 (19 342) 4 066 Transfers between level 1 and level 2 There were no significant transfers between level 1 and level 2 in the current period. Level 3 instruments The following table shows a reconciliation of the opening balances to the closing balances for financial instruments in level 3 at fair value category. All instruments are at fair value through profit and loss. R'million Balance at 31 March 2018 1 983 Adoption of IFRS 9 1 690 Balance at 1 April 2018 3 673 Total losses included in the income statement (170) Purchases 135 Sales (89) Issues 247 Transfers into level 3 215 Foreign exchange adjustments 55 Balance at 30 September 2018 4 066 For the period ended 30 September 2018, R214.9 million has been transferred from level 2 into level 3 as a result of the inputs to the valuation methods becoming unobservable in the market. The following table quantifies the losses included in the income statement recognised on level 3 financial instruments: For the six months to 30 September 2018 R'million Total Realised Unrealised Total (losses)/gains included in the income statement for the period Investment income (170) (208) 38 Sensitivity of fair values to reasonably possible alternative assumptions by level 3 instrument type The fair value of financial instruments in level 3 are measured using valuation techniques that incorporate assumptions that are not evidenced by prices from observable market data. The following table shows the sensitivity of these fair values to reasonably possible alternative assumptions, determined at a transactional level: Potential impact Level 3 on the income statement balance Range which sheet Significant unobservable Favourable Unfavourable value Valuation unobservable input has been changes changes At 30 September 2018 R'million method input changed stressed R'million R'million Assets Derivative financial instruments 12 Price earnings EBITDA (5%) - 20% 2 (1) Investment portfolio 3 450 534 (566) Price earnings EBITDA * 407 (326) Discounted Precious and cash flow industrial metals prices (10%) - 6% 21 (35) Discounted cash flow Cash flow (15%) - 5% 10 (29) Other Various ** 96 (176) Loans and advances to customers 604 Discounted cash flow Cash flow (15%) - 5% 30 (91) Total 4 066 566 (658) * The EBITDA has been stressed on an investment-by-investment basis in order to obtain favourable and unfavourable valuations. ** The valuation sensitivity for certain equity investments and fair value loans have been assessed by adjusting various inputs such as expected cash flows, discount rates, earnings multiples rather than a single input. It is deemed appropriate to reflect the outcome on a portfolio basis for the purpose of this analysis as the sensitivity of the investment cannot be determined through the adjustment of a single input. In determining the value of level 3 financial instruments, the following are principal inputs that can require judgement: Price earnings multiple The price earnings ratio is an equity valuation multiple. It is a key driver in the valuation of unlisted investments. EBITDA The company's earnings before interest, taxes, depreciation and amortisation. This is the main input into a price earnings multiple valuation method. Precious and industrial metals The price of property and precious and industrial metals is a key driver of future cash flows on these investments. Cash flows Cash flows relate to the future cash flows which can be expected from the instrument and requires judgement. Measurement of financial assets and liabilities at level 2 The table below sets out information about the valuation techniques used at the end of the reporting period in measuring financial instruments categorised as level 2 in the fair value hierarchy: Valuation basis/techniques Main inputs Assets Non-sovereign and non-bank cash placements Discounted cash flow model Yield curve Reverse repurchase agreements and cash collateral on securities borrowed Discounted cash flow model Yield curve Bank debt securities Discounted cash flow model Yield curve Other debt securities Discounted cash flow model Yield curve Derivative financial instruments Discounted cash flow model Yield curve Black-Scholes Volatilities Investment portfolio Adjusted quoted price Liquidity adjustment Loans and advances to customers Discounted cash flow model Yield curve Loans to group companies Discounted cash flow model Yield curve Liabilities Derivative financial instruments Discounted cash flow model Yield curve Black-Scholes Volatilities Other trading liabilities Discounted cash flow model Yield curve Repurchase agreements and cash collateral on securities lent Discounted cash flow model Yield curve Customer accounts (deposits) Discounted cash flow model Yield curve Other liabilities Discounted cash flow model Yield curve Fair value of financial assets and liabilities at amortised cost The following table sets out the fair value of financial instruments held at amortised cost where the carrying value is not a reasonable approximation of fair value: At 30 September 2018 Carrying Fair R'million value value Assets Loans and advances to banks 18 458 18 467 Reverse repurchase agreements and cash collateral on securities borrowed 4 745 4 743 Sovereign debt securities 5 221 5 055 Bank debt securities 6 312 6 288 Other debt securities 4 594 4 502 Loans and advances to customers 232 313 232 376 Liabilities Deposits by banks 25 801 26 260 Repurchase agreements and cash collateral on securities lent 3 270 3 205 Customer accounts (deposits) 289 306 289 634 Subordinated liabilities 12 753 14 135 Investec Bank Limited Incorporated in the Republic of South Africa Registration number: 1969/004763/06 Share code: INLP ISIN: ZAE000048393 Preference share dividend announcement Non-redeemable non-cumulative non-participating preference shares ("preference shares") Declaration of dividend number 31 Notice is hereby given that preference dividend number 31 has been declared by the Board from income reserves for the period 1 April 2018 to 30 September 2018 amounting to a gross preference dividend of 417.79151 cents per preference share payable to holders of the non-redeemable non-cumulative non-participating preference shares as recorded in the books of the company at the close of business on Friday, 14 December 2018. The relevant dates for the payment of dividend number 31 are as follows: Last day to trade cum-dividend Tuesday, 11 December 2018 Shares commence trading ex-dividend Wednesday, 12 December 2018 Record date Friday, 14 December 2018 Payment date Tuesday, 18 December 2018 Share certificates may not be dematerialised or rematerialised between Wednesday, 12 December 2018 and Friday, 14 December 2018, both dates inclusive. Additional information to take note of: - Investec Bank Limited tax reference number: 9675/053/71/5 - The issued preference share capital of Investec Bank Limited is 15 447 630 preference shares - The dividend paid by Investec Bank Limited is subject to South African Dividend Tax (Dividend Tax) of 20% (subject to any available exemptions as legislated) - The net dividend amounts to 334.23321 cents per preference share for shareholders liable to pay the Dividend Tax and 417.79151 cents per preference share for preference shareholders exempt from paying the Dividend Tax. By order of the board N van Wyk Company Secretary 14 November 2018 Investec Bank Limited (Registration number 1969/004763/06) Share code: INLP ISIN: ZAE000048393 Registered office 100 Grayston Drive Sandown Sandton 2196 Transfer secretaries Computershare Investor Services (Pty) Ltd Rosebank Towers 15 Biermann Avenue Rosebank 2196 Company Secretary N van Wyk Sponsor: Investec Bank Limited Directors KL Shuenyane (Chairman) DM Lawrence (Deputy Chairman) RJ Wainwright^ (Chief Executive Officer) ZBM Bassa, GR Burger^ D Friedland, B Kantor^ S Koseff^, NA Samujh^ PRS Thomas, F Titi^ ^ Executive SE Abrahams retired effective 8 August 2018 Date: 15/11/2018 08:59:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Release of a Trading Statement by the Guarantor TransCapital Investments Limited (Incorporated in the Republic of South Africa) (Registration No. 2016/130129/06) Bond Company code: TCII ("TransCapital" or "the Issuer") RELEASE OF A TRADING STATEMENT BY THE GUARANTOR Prospective bondholders are advised that Transaction Capital Limited ("the Guarantor") has released a trading statement in respect of the year ended 30 September 2018, on the JSE Limited's Stock Exchange News Service on Wednesday, 14 November 2018. A copy of this announcement has been made available on the Guarantor's website at http://www.transactioncapital.co.za/investor.php. Dunkeld West 15 November 2018 Enquiries: Investor Relations Telephone: +27 (0) 11 049 6700 Debt Sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 15/11/2018 08:40:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Shareholder Approval Of Resolution In Terms Of Section 60 Of The Companies Act, 71 Of 2008 ("Companies Act") Sea Harvest Group Limited (Incorporated in the Republic of South Africa) (Registration number: 2008/001066/06) Share code: SHG ISIN: ZAE000240198 ("Sea Harvest" or "the Company") SHAREHOLDER APPROVAL OF RESOLUTION IN TERMS OF SECTION 60 OF THE COMPANIES ACT, 71 OF 2008 ("Companies Act") Sea Harvest shareholders ("Shareholders") are referred to the announcement released on the Stock Exchange News Service of the JSE Limited on Wednesday, 17 October 2018 relating to the notice of submission of a proposed special resolution ("the Resolution") to be adopted in terms of section 60 of the Companies Act. The Resolution was distributed to Shareholders on Wednesday, 17 October 2018. Shareholders are hereby advised that, as at the date of this announcement, the Resolution has been approved and adopted by Shareholders entitled to exercise sufficient voting rights, for the Resolution to have been adopted, in terms of section 60(2) of the Companies Act. In accordance with section 60(4) of the Companies Act, Sea Harvest will deliver a statement describing the results of the vote to Shareholders recorded in the Company's share register as at the record date for voting, being, Friday 12 October 2018. Cape Town 15 November 2018 Investment Bank and Sponsor The Standard Bank of South Africa Limited Legal Advisor Cliffe Dekker Hofmeyr 1 Date: 15/11/2018 08:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Daily Share Buy-Back Notice South32 Limited (Incorporated in Australia under the Corporations Act 2001) (ACN 093 732 597) ASX / LSE / JSE Share Code: S32 ISIN: AU000000S320 south32.net South32 Limited Daily Share Buy-Back Notice The Daily share buy-back notice (Appendix 3E) lodged on the Australian Securities Exchange and voluntarily disclosed on the Johannesburg Stock Exchange and London Stock Exchange has today been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/nsm: South32 Limited - Daily share buy-back notice - Appendix 3E Further information on South32 can be found at: www.south32.net. INVESTOR RELATIONS Alex Volante Tom Gallop T +61 8 9324 9029 T +61 8 9324 9030 M +61 403 328 408 M +61 439 353 948 E Alex.Volante@south32.net E Tom.Gallop@south32.net MEDIA RELATIONS James Clothier Jenny White T +61 8 9324 9697 T +44 20 7798 1773 M +61 413 391 031 M +44 7900 046 758 E James.Clothier@south32.net E Jenny.White@south32.net JSE Sponsor: UBS South Africa (Pty) Ltd 15 November 2018 Date: 15/11/2018 08:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Listing of Additional Satrixwdm Securities - STXWDM SATRIX COLLECTIVE INVESTMENT SCHEME Satrix MSCI World Feeder Portfolio JSE code: STXWDM ISIN code: ZAE000246104 ("SATRIXWDM" or "STXWDM") A portfolio in the Satrix Collective Investment Scheme, registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002 LISTING OF ADDITIONAL SATRIXWDM SECURITIES SATRIXWDM has issued and listed an additional 100 000 securities with effect from the commencement of business today, at an issue price of approximately R38.35 per security. Following the listing of the 100 000 securities, there will be 16 370 139 SATRIXWDM in issue. 15 November 2018 Sponsor Vunani Corporate Finance Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Listing of Additional Satrixndq Securities - STXNDQ SATRIX COLLECTIVE INVESTMENT SCHEME Satrix NASDAQ 100 Feeder Portfolio JSE code: STXNDQ ISIN code: ZAE000256301 ("SATRIXNDQ" or "STXNDQ") A portfolio in the Satrix Collective Investment Scheme, registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002 LISTING OF ADDITIONAL SATRIXNDQ SECURITIES SATRIXNDQ has issued and listed an additional 100 000 securities with effect from the commencement of business today, at an issue price of approximately R54.80 per security. Following the listing of the 100 000 securities, there will be 4 720 908 SATRIXNDQ securities in issue. 15 November 2018 Vunani Corporate Finance Sponsor Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Listing of Additional Satrixemg Securities - STXEMG SATRIX COLLECTIVE INVESTMENT SCHEME Satrix MSCI Emerging Markets Feeder Portfolio JSE code: STXEMG ISIN code: ZAE000246633 ("SATRIXEMG" or "STXEMG") A portfolio in the Satrix Collective Investment Scheme, registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002 LISTING OF ADDITIONAL SATRIXEMG SECURITIES SATRIXEMG has issued and listed an additional 100 000 securities with effect from the commencement of business today, at an issue price of approximately R36.43 per security. Following the listing of the 100 000 securities, there will be 9 972 719 SATRIXEMG securities in issue. 15 November 2018 Sponsor Vunani Corporate Finance Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Listing of Additional Satrix500 Securities - STX500 SATRIX COLLECTIVE INVESTMENT SCHEME Satrix S&P 500 Feeder Portfolio JSE code: STX500 ISIN code: ZAE000246641 ("SATRIX500" or "STX500") A portfolio in the Satrix Collective Investment Scheme, registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002 LISTING OF ADDITIONAL SATRIX500 SECURITIES SATRIX500 has issued and listed an additional 100 000 securities with effect from the commencement of business today, at an issue price of approximately R38.52 per security. Following the listing of the 100 000 securities, there will be 10 774 051 SATRIX500 securities in issue. 15 November 2018 Vunani Corporate Finance Sponsor Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

NFTRCI - Listing of additional NewFunds TRACI 3 month ETF participatory interests NEWFUNDS TRACI 3 MONTH EXCHANGE TRADED FUND PORTFOLIO Abbreviated Name: NEWFTRACI Share Code: NFTRCI ISIN: ZAE000162251 ("TRACI") A portfolio in the NewFunds Collective Investment Scheme in Securities ("NewFunds") (established on 21 December 2011 in the Republic of South Africa in terms of the Collective Investment Schemes Control Act, 45 of 2002), managed by NewFunds (RF) Proprietary Limited. LISTING OF ADDITIONAL NEWFUNDS TRACI 3 MONTH ETF PARTICIPATORY INTERESTS Following the creation of 800,000 NewFunds TRACI 3 Month Exchange Traded Fund participatory interests at a price of R24.34 per unit, an additional 800,000 units will list on the JSE Limited from commencement of business today. There will be 7,516,726 units in issue after the listing. 15 November 2018 Sponsor Absa Corporate and Investment Bank, a division of Absa Bank Limited Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

NFTRCI - Interest distribution and re-investment for the month ended 31 October 2018 NEWFUNDS TRACI 3 MONTH EXCHANGE TRADED FUND PORTFOLIO Share code: NFTRCI ISIN: ZAE000162251 Portfolios in the NewFunds Collective Investment Scheme in Securities registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002 and managed by NewFunds (RF) Proprietary Limited (Registration Number 2005/034899/07) ("NewFunds") INTEREST DISTRIBUTION AND RE-INVESTMENT ANNOUNCEMENT FOR THE MONTH ENDED 31 OCTOBER 2018 Holders of NewFunds TRACI 3 Month ETF securities are advised that no distribution has been declared for the month ended 31 October 2018. Additional information: Number of securities in issue Tax reference number NFTRCI 6,716,726 9397128175 15 November 2018 Sponsor Absa Corporate and Investment Bank, a division of Absa Bank Limited Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

NFILBI - Interest distribution and reinvestment for the month ended 31 October 2018 NEWFUNDS ILBI EXCHANGE TRADED FUND PORTFOLIO Share code: NFILBI ISIN: ZAE000162244 Portfolios in the NewFunds Collective Investment Scheme in Securities registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002 and managed by NewFunds (RF) Proprietary Limited (Registration Number 2005/034899/07) ("NewFunds") INTEREST DISTRIBUTION AND RE-INVESTMENT ANNOUNCEMENT FOR THE MONTH ENDED 31 OCTOBER 2018 NewFunds has today finalised a distribution to holders of NewFunds ILBI ETF securities recorded as such in the register on Friday, 23 November 2018, for the month ended 31 October 2018 as follows: NFILBI Cents per ETF security, comprising of Interest 17.13600 Investors are advised that the distribution amount will not comprise of any dividends, therefore no dividend tax will be applicable to the distribution amount. Holders of the ETF securities should note the following dates in relation to the distribution: Declaration and finalisation Thursday, 15 November 2018 Last day to trade Tuesday, 20 November 2018 Securities trading ‘ex' distribution Wednesday, 21 November 2018 Record date Friday, 23 November 2018 Payment date Monday, 26 November 2018 In accordance with the investment policy of the ETFs, the distribution will be re-invested on behalf of investors via the purchase by the ETF of additional Constituent Securities, or Index Constituents, (as defined in the relevant Portfolio Supplement) in the appropriate weightings, thereby increasing the net asset value of the ETF and, proportionately increasing the value of each ETF security. Withholding Tax on Interest (WTI) came into effect on 1 March 2015 Interest accruing from a South African source to a non-resident, excluding a controlled foreign company, will be subject to withholding tax at a rate of 15% on payment, except interest, - arising on any Government debt instrument - arising on any listed debt instrument - arising on any debt owed by a bank or the South African Reserve Bank - arising from a bill of exchange or letter of credit where goods are imported into South Africa and where an authorised dealer has certified such on the instrument - payable by a headquarter company - accruing to a non-resident natural person who was physically present in South Africa for a period exceeding 183 days in aggregate, during that year, or carried on a business through a permanent establishment in South Africa Investors are advised that to the extent that the distribution amount comprise of any interest, it will not be subject to WTI by virtue of the fact that it is Government debt, listed debt instruments and/or bank debt. Additional information: Number of securities in issue Tax reference number NFILBI 900,000 9398125170 15 November 2018 Sponsor Absa Corporate and Investment Bank, a division of Absa Bank Limited Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

NFGOVI - Interest distribution and re-investment for the month ended 31 October 2018 NEWFUNDS GOVI EXCHANGE TRADED FUND PORTFOLIO Share code: NFGOVI ISIN: ZAE000161949 Portfolios in the NewFunds Collective Investment Scheme in Securities registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002 and managed by NewFunds (RF) Proprietary Limited (Registration Number 2005/034899/07) ("NewFunds") INTEREST DISTRIBUTION AND RE-INVESTMENT ANNOUNCEMENT FOR THE MONTH ENDED 31 OCTOBER 2018 NewFunds has today finalised a distribution to holders of NewFunds GOVI ETF securities recorded as such in the register on Friday, 23 November 2018, for the month ended 31 October 2018 as follows: NFGOVI Cents per ETF security, comprising of Interest 47.28900 Investors are advised that the distribution amount will not comprise of any dividends, therefore no dividend tax will be applicable to the distribution amount. Holders of the ETF securities should note the following dates in relation to the distribution: Declaration and finalisation Thursday, 15 November 2018 Last day to trade Tuesday, 20 November 2018 Securities trading ‘ex' distribution Wednesday, 21 November 2018 Record date Friday, 23 November 2018 Payment date Monday, 26 November 2018 In accordance with the investment policy of the ETFs, the distribution will be re-invested on behalf of investors via the purchase by the ETF of additional Constituent Securities, or Index Constituents, (as defined in the relevant Portfolio Supplement) in the appropriate weightings, thereby increasing the net asset value of the ETF and, proportionately increasing the value of each ETF security. Withholding Tax on Interest (WTI) came into effect on 1 March 2015 Interest accruing from a South African source to a non-resident, excluding a controlled foreign company, will be subject to withholding tax at a rate of 15% on payment, except interest, - arising on any Government debt instrument - arising on any listed debt instrument - arising on any debt owed by a bank or the South African Reserve Bank - arising from a bill of exchange or letter of credit where goods are imported into South Africa and where an authorised dealer has certified such on the instrument - payable by a headquarter company - accruing to a non-resident natural person who was physically present in South Africa for a period exceeding 183 days in aggregate, during that year, or carried on a business through a permanent establishment in South Africa. Investors are advised that to the extent that the distribution amount comprise of any interest, it will not be subject to WTI by virtue of the fact that it is Government debt, listed debt instruments and/or bank debt. Additional information: Number of securities in issue Tax reference number NFGOVI 11,225,000 9019670224 15 November 2018 Sponsor Absa Corporate and Investment Bank, a division of Absa Bank Limited Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Change to the board of directors Metrofile Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1983/012697/06) Share code: MFL ISIN: ZAE000061727 ("Metrofile Holdings") CHANGE TO THE BOARD OF DIRECTORS In compliance with paragraph 3.59 of the JSE Limited Listings Requirements, the board of directors of Metrofile Holdings is pleased to advise shareholders of the appointment of Ms Kelebogile Dludla (H.BAcc, CA(SA)) as an executive director and Group Chief Financial Officer with effect from 15 November 2018. Ms Dludla was previously CFO of iX Engineers, and prior to that held senior positions at De Beers Group Services, De Beers Consolidated Mines, Anglo American and Anglo Platinum. Prior to that she held a corporate finance role at Deloitte & Touche. The Metrofile Holdings board welcomes Ms Dludla to her new role. Johannesburg 15 November 2018 Sponsor The Standard Bank of South Africa Limited Date: 15/11/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Updated Corporate Action Timetables GEN - General - JSE Limited Updated Corporate Action Timetables The JSE has updated the Corporate Action Timetables relating to the JSE Listings Requirements (Schedule 2 Form H1). The marked-up updates are available on the JSE's website (Route: Companies & Issuer Regulation/Useful Links/ Equity Schedule 2). The updated Corporate Action Timetables will take effect from Tuesday, 18 December 2018. 15 November 2018 Date: 15/11/2018 07:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Trading update and trading statement Woolworths Holdings Limited (Incorporated in the Republic of South Africa) Registration number 1929/001986/06 Share code: WHL Share ISIN: ZAE000063863 Bond company code: WHLI Bond ISIN: ZAG000147133 (‘the Group') TRADING UPDATE: 20 WEEKS ENDED 11 NOVEMBER 2018 AND TRADING STATEMENT: 26 WEEKS ENDED 23 DECEMBER 2018 AND 53 WEEKS ENDED 30 JUNE 2019 TRADING UPDATE Group sales for the first 20 weeks ended 11 November 2018 (‘current period') increased by 2.7% compared to the 20 weeks ended 12 November 2017 (‘prior period') prior period (and by 3.6% in constant currency). In South Africa, Woolworths Fashion, Beauty and Home sales declined by 3.3%, with price movement of 4.0%. Comparable store sales were 3.9% lower, with net retail space growth of 0.5%. While sales for the first quarter ended 23 September 2018 were affected by a significantly smaller winter sale, regular sales in October, particularly in womenswear, have shown a positive trend. Woolworths Food sales increased by 7.2%, with volume growth driven by low inflation (price movement was 1.0%) and higher levels of promotion. Comparable store sales increased by 5.0%, with net retail space growth of 1.5%. The Woolworths Financial Services debtors book reflected positive year-on-year growth of 4.0% as at the end of October 2018. The annualised impairment rate for the four months ended 31 October 2018 was 3.9% (4 months ended 31 October 2017: 5.7%). The Group implemented IFRS 9 with effect from 1 July 2018. David Jones sales momentum has continued into the new financial year, with sales increasing by 2.9% (and by 2.4% in comparable stores). Online sales have grown by 48.4%, and now contribute 5.2%, up from 3.6% of sales in the prior period. Net retail space grew by 2.7%, with 3.4% new space offset by 0.7% of space reductions and closures. Country Road Group (CRG) sales increased by 3.4%, and by 0.5% in comparable stores. Online sales in CRG represent 20% of sales, with growth of 25% over the period. Net retail space grew by 4.3%. TRADING STATEMENT Shareholders are advised that earnings per share (EPS) is expected to be more than 100% (more than 505.9 cents) higher than the reported EPS for the 26-week period ended 24 December 2017 (2017 EPS: -505.9 cents), and more than 150% (more than 554.3 cents) higher than the reported EPS for the 52- week period ended 24 June 2018 (2018 EPS: -369.5 cents), due to the impairment of the carrying value of the David Jones assets in the prior period ended 24 December 2017. Shareholders are advised that once the Group obtains reasonable certainty regarding the HEPS growth ranges for the 26 weeks ended 23 December 2018 and 53 weeks ended 30 June 2019, it will issue a further trading statement in order to provide guidance. CONSTANT CURRENCY INFORMATION The constant currency information contained in this announcement has been presented to illustrate the impact of changes in the Group's major foreign currency, the Australian dollar. In determining the constant currency turnover and concession sales' growth rate, turnover and concession sales denominated in Australian dollars for the current financial reporting period have been adjusted by application of the aggregated monthly average Australian dollar exchange rate for the prior comparable period. The foreign currency fluctuations of our rest of Africa operations are not considered material, and have therefore not been applied in determining the constant currency turnover and concession sales growth rate. The aggregated monthly average Australian dollar exchange rate is R10.30 for the current financial reporting period and R10.52 for the prior comparable period. The constant currency information, which is the responsibility of the Group's directors, has been prepared for illustrative purposes only, and may not fairly present the Group's financial position, changes in equity, cash flows or results of operations. The information contained in this announcement, including forecast financial information, has not been reviewed or reported on by the Group's external auditors. Contact: Reeza Isaacs (Group Finance Director) on 021 407 2464 Ralph Buddle (Director: Strategy and Business Development) on 021 407 3250 InvestorRelations@woolworths.co.za Cape Town 15 November 2018 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) 2 Date: 15/11/2018 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Sibanye-Stillwater signs three-year gold wage agreement with three unions Sibanye Gold Limited Trading as Sibanye-Stillwater Incorporated in the Republic of South Africa Registration number 2002/031431/06 Share code: SGL ISIN - ZAE000173951 Issuer code: SGL ("Sibanye-Stillwater" or "the Group" or "the Company") Sibanye-Stillwater signs three-year gold wage agreement with three unions Johannesburg, 15 November 2018. Sibanye-Stillwater (Tickers JSE: SGL and NYSE: SBGL) is pleased to advise that it has concluded a three-year wage agreement with the National Union of Mineworkers (the NUM), Solidarity and UASA in respect of wages and conditions of service for the period 1 July 2018 to 30 June 2021. The agreement allows for increases to the basic wage of Category 4-8 surface and underground employees of R700 per month in the first year, R700 per month in the second year and R825 per month in the third year. Miners, artisans and officials will receive increases of 5.5% in year one and 5.5% or CPI (whichever is the greater) in years two and three of the agreement. Sibanye-Stillwater CEO, Neal Froneman commented: "We are pleased to have reached a wage agreement with the NUM, UASA and Solidarity, which we believe is fair, but takes into consideration the longer term sustainability of the gold operations. It is only through ensuring sustainable and economically viable operations, that the mining industry can continue to support and create value for all of its stakeholders." In addition to the basic wage, the parties agreed to an increase in the current living- out allowance by R50 to a maximum of R2 150 per month from 1 September 2018. The company will increase the living-out allowance by R75 to a maximum of R2 225 per month on 1 September 2019 and by R100 to a maximum of R2 325 per month in the year that follows. Sibanye-Stillwater has also agreed to increase incrementally the current minimum medical incapacity benefit of R55 000 to R60 000 over the three-year period by increasing the benefit by R1 500 on 1 July 2018; R 1 500 on 1 July 2019; and R 2 000 on 1 July 2020. Sibanye-Stillwater currently employs 32 231 employees at its SA gold operations in the bargaining unit. Other non-wage items agreed In addition to the wage increase, the following additional non-wage issues have been agreed by the parties: • Increase of the guaranteed minimum severance payment to R50,000 over the three- year period. • Female employees will be entitled to four months of paid leave with an option of spreading the four months paid maternity leave over a period of six months. Medical Aid The parties agreed that the company needs to introduce a cost-effective uniform approach to healthcare across all its gold operations. This requires a review of the company's current approach of providing healthcare to category 4-8 employees and the subsidised benefits offered to miners, artisans and officials. The company will establish a task team to look at the various medical aid schemes with a view to shifting employees to a new medical aid dispensation. The task team will complete its work within six months of signing of the wage agreement and the new system will be implemented no later than January 2020.Sibanye-Stillwater, which has been contributing 60% of category 4-8 employees' medical aid payments since 2011, has agreed to make this concession a condition of employment in respect of category 4-8 employees who will join the medical aid option(s) that will be agreed to by the medical aid task team. This will then inform the freedom of choice dispensation. Contacts: Email: ir@sibanyestillwater.com James Wellsted Head of Investor Relations +27 (0) 83 453 4014 Sponsor: J.P. Morgan Equities South Africa Proprietary Limited FORWARD LOOKING STATEMENTS This announcement contains forward-looking statements within the meaning of the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this announcement may be forward-looking statements. Forward-looking statements may be identified by the use of words such as "will", "would", "expect", "may", "could" "believe", "anticipate", "target", "estimate" and words of similar meaning. These forward-looking statements, including among others, those relating to our future business prospects, financial positions, ability to reduce debt leverage, business strategies, plans and objectives of management for future operations and the anticipated benefits and synergies of transactions, are necessarily estimates reflecting the best judgement of our senior management. Readers are cautioned not to place undue reliance on such statements. Forward looking statements involve a number of known and unknown risks, uncertainties and other factors, many of which are difficult to predict and generally beyond the control of Sibanye-Stillwater that could cause Sibanye-Stillwater's actual results and outcomes to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. As a consequence, these forward-looking statements should be considered in light of various important factors, including those set forth in the Group's Annual Integrated Report and Annual Financial Report, published on 30 March 2018, and the Group's Annual Report on Form 20-F filed by Sibanye-Stillwater with the Securities and Exchange Commission on 2 April 2018 (SEC File no. 001-35785). These forward-looking statements speak only as of the date of this announcement. Sibanye-Stillwater expressly disclaims any obligation or undertaking to update or revise these forward-looking statements, save as required by applicable law. Date: 15/11/2018 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Notification of directors' dealings in Net1 securities Net 1 UEPS Technologies, Inc. Registered in the state of Florida, USA (IRS Employer Identification No. 98-0171860) Nasdaq share code: UEPS JSE share code: NT1 ISIN: US64107N2062 ("Net1" or the "Company") Notification of directors' dealings in Net1 securities Shareholders are advised that the following dealings in the securities of Net1 have taken place by directors ("reporting person") of the Company: Director: Paul Edwards Name of company: Net1 Class of security: Common stock Nature of interest: Direct, beneficial Nature of transaction: On market purchase of securities Number of securities: 10,000 Date of transaction: November 13, 2018 Price per security (VWAP): USD 4.5287 (1) Total transaction value: USD 45,287 (1) (1) Purchase prices for the transactions reported here range from $4.45 to $4.63. Director: Alasdair J.K. Pein Name of company: Net1 Class of security: Common stock Nature of interest: Indirect, beneficial Nature of transaction: On market purchase of securities Number of securities: 6,000 Date of transaction: November 13, 2018 Price per security (VWAP): USD 4.5344 (1) Total transaction value: USD 27,206.40 (1) (1) Purchase prices for the transactions reported here range from $4.49 to $4.63. Clearance to deal in respect of the above transactions was given. November 15, 2018 Johannesburg Sponsor Rand Merchant Bank, a division of FirstRand Bank Limited Date: 15/11/2018 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

GLN - Transactions in own shares - 14 November 2018 Glencore plc (Incorporated in Jersey under the Companies (Jersey) Law 1991) (Registration number 107710) JSE Share Code: GLN LSE Share Code: GLEN HKSE Share Code: 805HK ISIN: JE00B4T3BW64 Baar, Switzerland 15 November 2018 Transactions in own shares - 14 November 2018 Glencore plc (the Company) announces today it has purchased the following number of its ordinary shares of USD 0.01 each on the London Stock Exchange from Citigroup Global Markets Limited. Date of purchase: 14 November 2018 Aggregate number of ordinary shares of USD 0.01 each purchased: 3,250,000 Lowest price paid per share (GBp): 287.2000 Highest price paid per share (GBp): 296.7000 Volume weighted average price paid per share (GBp): 291.6349 The Company will hold the repurchased shares in treasury. Following the above transaction, the Company holds 480,902,802 of its ordinary shares in treasury and has 14,586,200,066 ordinary shares in issue (including treasury shares). Therefore the total voting rights in Glencore plc will be 14,105,297,264. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. These share purchases form part of the second part of the Company's existing buy-back programme which is expected to be completed over the period from 8 August 2018 to 20 February 2019, details of which were announced by the Company on 5 July 2018 and 25 September 2018. Aggregated information Trading venue Volume weighted Aggregated volume average price London Stock Exchange 291.5614 1,949,728 BATS 292.8013 8,965 Chi-X 291.7379 1,291,307 Transaction details In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Citigroup Global Markets Limited as part of the buyback programme. Schedule of Purchases Shares purchased: Glencore plc (ISIN: JE00B4T3BW64) Date of purchases: 14 November 2018 Investment firm: Citigroup Global Markets Limited Individual transactions: Transaction date and time Volume Price (GBp) Trading Transaction Venue Reference Number Wed 14 Nov 16:27:55 BST 2018 111 291.35 CHIX 18318XJcvle Wed 14 Nov 16:27:50 BST 2018 1463 291.35 CHIX 18318XJcvkv Wed 14 Nov 16:27:50 BST 2018 537 291.30 CHIX 18318XJcvku Wed 14 Nov 16:27:38 BST 2018 284 291.35 CHIX 18318XJcvjd Wed 14 Nov 16:27:38 BST 2018 403 291.35 XLON 18318XJcvjc Wed 14 Nov 16:27:38 BST 2018 253 291.35 CHIX 18318XJcvjb Wed 14 Nov 16:27:38 BST 2018 515 291.40 CHIX 18318XJcvja Wed 14 Nov 16:27:38 BST 2018 217 291.45 CHIX 18318XJcvj9 Wed 14 Nov 16:27:28 BST 2018 475 291.55 CHIX 18318XJcvi7 Wed 14 Nov 16:27:28 BST 2018 526 291.55 CHIX 18318XJcvi6 Wed 14 Nov 16:27:28 BST 2018 681 291.60 CHIX 18318XJcvi4 Wed 14 Nov 16:27:28 BST 2018 537 291.60 CHIX 18318XJcvi3 Wed 14 Nov 16:27:28 BST 2018 905 291.60 XLON 18318XJcvi5 Wed 14 Nov 16:27:19 BST 2018 125 291.65 CHIX 18318XJcvgi Wed 14 Nov 16:27:19 BST 2018 1250 291.65 CHIX 18318XJcvgh Wed 14 Nov 16:27:03 BST 2018 601 291.80 BATE 18318XJcvee Wed 14 Nov 16:27:03 BST 2018 1252 291.80 CHIX 18318XJcved Wed 14 Nov 16:27:03 BST 2018 782 291.80 XLON 18318XJcvec Wed 14 Nov 16:27:03 BST 2018 1174 291.80 CHIX 18318XJcveb Wed 14 Nov 16:27:02 BST 2018 234 291.85 CHIX 18318XJcve8 Wed 14 Nov 16:26:36 BST 2018 1646 291.40 XLON 18318XJcv8u Wed 14 Nov 16:26:35 BST 2018 622 291.45 CHIX 18318XJcv8h Wed 14 Nov 16:26:35 BST 2018 1358 291.45 XLON 18318XJcv8f Wed 14 Nov 16:26:25 BST 2018 364 291.35 XLON 18318XJcv5i Wed 14 Nov 16:26:14 BST 2018 434 291.40 XLON 18318XJcv2h Wed 14 Nov 16:26:14 BST 2018 537 291.40 CHIX 18318XJcv2g Wed 14 Nov 16:26:08 BST 2018 537 291.40 CHIX 18318XJcv0n Wed 14 Nov 16:26:08 BST 2018 537 291.40 CHIX 18318XJcv0m Wed 14 Nov 16:26:08 BST 2018 561 291.40 XLON 18318XJcv0k Wed 14 Nov 16:26:08 BST 2018 435 291.40 XLON 18318XJcv0l Wed 14 Nov 16:25:54 BST 2018 2203 291.30 CHIX 18318XJcuyw Wed 14 Nov 16:25:54 BST 2018 275 291.30 XLON 18318XJcuyv Wed 14 Nov 16:25:54 BST 2018 169 291.30 XLON 18318XJcuyu Wed 14 Nov 16:25:39 BST 2018 302 291.30 BATE 18318XJcuwn Wed 14 Nov 16:24:59 BST 2018 649 291.45 CHIX 18318XJcupr Wed 14 Nov 16:24:59 BST 2018 1508 291.45 CHIX 18318XJcupq Wed 14 Nov 16:24:56 BST 2018 789 291.45 CHIX 18318XJcupf Wed 14 Nov 16:24:55 BST 2018 17 291.45 BATE 18318XJcupc Wed 14 Nov 16:24:55 BST 2018 750 291.45 BATE 18318XJcupa Wed 14 Nov 16:24:55 BST 2018 1250 291.45 CHIX 18318XJcup8 Wed 14 Nov 16:24:55 BST 2018 2000 291.45 CHIX 18318XJcup9 Wed 14 Nov 16:24:55 BST 2018 1305 291.45 CHIX 18318XJcupd Wed 14 Nov 16:24:55 BST 2018 1390 291.45 CHIX 18318XJcupb Wed 14 Nov 16:24:55 BST 2018 1500 291.45 XLON 18318XJcup7 Wed 14 Nov 16:24:40 BST 2018 4270 291.45 XLON 18318XJcum7 Wed 14 Nov 16:24:40 BST 2018 1900 291.45 XLON 18318XJcum6 Wed 14 Nov 16:24:40 BST 2018 6162 291.45 CHIX 18318XJcum5 Wed 14 Nov 16:24:40 BST 2018 4436 291.45 XLON 18318XJcum4 Wed 14 Nov 16:24:40 BST 2018 3067 291.45 XLON 18318XJcum3 Wed 14 Nov 16:24:34 BST 2018 1266 291.55 CHIX 18318XJcujy Wed 14 Nov 16:24:34 BST 2018 2808 291.55 XLON 18318XJcujj Wed 14 Nov 16:24:34 BST 2018 8 291.55 XLON 18318XJcujt Wed 14 Nov 16:23:58 BST 2018 517 291.35 CHIX 18318XJcucu Wed 14 Nov 16:23:42 BST 2018 521 291.45 CHIX 18318XJcu9u Wed 14 Nov 16:23:36 BST 2018 302 291.45 CHIX 18318XJcu8o Wed 14 Nov 16:23:22 BST 2018 2742 291.55 XLON 18318XJcu6w Wed 14 Nov 16:23:22 BST 2018 3439 291.55 XLON 18318XJcu6v Wed 14 Nov 16:23:22 BST 2018 2787 291.55 CHIX 18318XJcu6x Wed 14 Nov 16:23:05 BST 2018 590 291.50 XLON 18318XJcu2u Wed 14 Nov 16:23:05 BST 2018 2068 291.55 CHIX 18318XJcu2r Wed 14 Nov 16:23:05 BST 2018 4588 291.55 XLON 18318XJcu2p Wed 14 Nov 16:22:53 BST 2018 32 291.65 XLON 18318XJctzb Wed 14 Nov 16:22:53 BST 2018 1456 291.65 XLON 18318XJctza Wed 14 Nov 16:22:53 BST 2018 308 291.65 CHIX 18318XJctz9 Wed 14 Nov 16:22:53 BST 2018 671 291.65 CHIX 18318XJctz8 Wed 14 Nov 16:22:11 BST 2018 604 291.75 XLON 18318XJctt3 Wed 14 Nov 16:22:11 BST 2018 536 291.75 CHIX 18318XJctt2 Wed 14 Nov 16:22:02 BST 2018 1 291.80 CHIX 18318XJctrz Wed 14 Nov 16:22:02 BST 2018 458 291.80 XLON 18318XJctrw Wed 14 Nov 16:22:02 BST 2018 4 291.80 XLON 18318XJctru Wed 14 Nov 16:22:02 BST 2018 2004 291.80 XLON 18318XJctrs Wed 14 Nov 16:22:02 BST 2018 535 291.80 CHIX 18318XJctrv Wed 14 Nov 16:22:02 BST 2018 218 291.80 CHIX 18318XJctrt Wed 14 Nov 16:22:02 BST 2018 1073 291.80 CHIX 18318XJctrr Wed 14 Nov 16:22:02 BST 2018 375 291.80 XLON 18318XJctrq Wed 14 Nov 16:21:57 BST 2018 12 291.85 XLON 18318XJctr7 Wed 14 Nov 16:21:57 BST 2018 672 291.85 CHIX 18318XJctqy Wed 14 Nov 16:21:57 BST 2018 459 291.85 CHIX 18318XJctqx Wed 14 Nov 16:21:57 BST 2018 779 291.85 CHIX 18318XJctqw Wed 14 Nov 16:21:57 BST 2018 2692 291.85 XLON 18318XJctr4 Wed 14 Nov 16:21:57 BST 2018 39 291.85 XLON 18318XJctr0 Wed 14 Nov 16:21:55 BST 2018 273 291.90 CHIX 18318XJctq5 Wed 14 Nov 16:21:55 BST 2018 297 291.90 CHIX 18318XJctq3 Wed 14 Nov 16:21:55 BST 2018 951 291.90 CHIX 18318XJctq0 Wed 14 Nov 16:21:55 BST 2018 530 291.90 XLON 18318XJctpy Wed 14 Nov 16:21:55 BST 2018 1347 291.90 XLON 18318XJctpw Wed 14 Nov 16:21:55 BST 2018 232 291.90 XLON 18318XJctpu Wed 14 Nov 16:21:47 BST 2018 512 291.95 XLON 18318XJctov Wed 14 Nov 16:21:47 BST 2018 536 291.95 CHIX 18318XJctou Wed 14 Nov 16:21:46 BST 2018 1 292.00 CHIX 18318XJctop Wed 14 Nov 16:21:46 BST 2018 1274 292.00 CHIX 18318XJctoo Wed 14 Nov 16:21:46 BST 2018 35 292.00 XLON 18318XJcton Wed 14 Nov 16:21:46 BST 2018 2826 292.00 XLON 18318XJctom Wed 14 Nov 16:20:51 BST 2018 542 291.65 CHIX 18318XJcthp Wed 14 Nov 16:20:51 BST 2018 335 291.65 XLON 18318XJctho Wed 14 Nov 16:20:51 BST 2018 2154 291.65 XLON 18318XJcthm Wed 14 Nov 16:20:51 BST 2018 2439 291.65 XLON 18318XJcthk Wed 14 Nov 16:20:51 BST 2018 2071 291.65 CHIX 18318XJcthh Wed 14 Nov 16:20:19 BST 2018 4014 291.60 XLON 18318XJctcs Wed 14 Nov 16:20:19 BST 2018 219 291.60 CHIX 18318XJctct Wed 14 Nov 16:20:19 BST 2018 1810 291.60 CHIX 18318XJctcq Wed 14 Nov 16:19:56 BST 2018 536 291.75 CHIX 18318XJct98 Wed 14 Nov 16:19:56 BST 2018 747 291.75 XLON 18318XJct97 Wed 14 Nov 16:19:32 BST 2018 1370 291.75 CHIX 18318XJct67 Wed 14 Nov 16:19:32 BST 2018 1830 291.75 XLON 18318XJct66 Wed 14 Nov 16:19:32 BST 2018 1207 291.75 XLON 18318XJct65 Wed 14 Nov 16:19:20 BST 2018 653 291.80 CHIX 18318XJct4k Wed 14 Nov 16:19:20 BST 2018 49 291.80 CHIX 18318XJct4j Wed 14 Nov 16:19:20 BST 2018 102 291.80 XLON 18318XJct4i Wed 14 Nov 16:19:20 BST 2018 38 291.80 XLON 18318XJct4h Wed 14 Nov 16:19:20 BST 2018 1408 291.80 XLON 18318XJct4g Wed 14 Nov 16:19:20 BST 2018 27 291.80 XLON 18318XJct4f Wed 14 Nov 16:19:20 BST 2018 3800 291.80 XLON 18318XJct4e Wed 14 Nov 16:19:09 BST 2018 610 291.80 CHIX 18318XJct2t Wed 14 Nov 16:19:09 BST 2018 686 291.80 CHIX 18318XJct2s Wed 14 Nov 16:19:09 BST 2018 288 291.80 CHIX 18318XJct2r Wed 14 Nov 16:19:09 BST 2018 1438 291.80 CHIX 18318XJct2q Wed 14 Nov 16:19:01 BST 2018 3892 291.90 XLON 18318XJct21 Wed 14 Nov 16:19:01 BST 2018 1755 291.90 CHIX 18318XJct22 Wed 14 Nov 16:19:01 BST 2018 533 291.95 CHIX 18318XJct18 Wed 14 Nov 16:19:01 BST 2018 1211 292.00 CHIX 18318XJct14 Wed 14 Nov 16:19:01 BST 2018 2686 292.00 XLON 18318XJct10 Wed 14 Nov 16:18:56 BST 2018 536 292.05 CHIX 18318XJct0l Wed 14 Nov 16:18:56 BST 2018 536 292.05 CHIX 18318XJct0k Wed 14 Nov 16:18:56 BST 2018 473 292.05 CHIX 18318XJct0j Wed 14 Nov 16:18:56 BST 2018 568 292.05 CHIX 18318XJct0e Wed 14 Nov 16:18:56 BST 2018 767 292.05 CHIX 18318XJct0h Wed 14 Nov 16:18:56 BST 2018 463 292.05 XLON 18318XJct0i Wed 14 Nov 16:18:56 BST 2018 15 292.05 XLON 18318XJct0g Wed 14 Nov 16:18:56 BST 2018 1165 292.05 XLON 18318XJct0d Wed 14 Nov 16:18:56 BST 2018 727 292.05 XLON 18318XJct0f Wed 14 Nov 16:17:45 BST 2018 652 291.75 CHIX 18318XJcsrb Wed 14 Nov 16:17:45 BST 2018 57 291.75 CHIX 18318XJcsra Wed 14 Nov 16:17:45 BST 2018 366 291.75 XLON 18318XJcsr9 Wed 14 Nov 16:17:45 BST 2018 479 291.75 CHIX 18318XJcsr8 Wed 14 Nov 16:17:40 BST 2018 1126 291.80 CHIX 18318XJcsqp Wed 14 Nov 16:17:40 BST 2018 2497 291.80 XLON 18318XJcsqn Wed 14 Nov 16:17:34 BST 2018 546 291.80 CHIX 18318XJcspq Wed 14 Nov 16:17:34 BST 2018 1117 291.80 XLON 18318XJcspn Wed 14 Nov 16:15:20 BST 2018 1893 291.25 CHIX 18318XJcs7w Wed 14 Nov 16:15:20 BST 2018 5796 291.25 XLON 18318XJcs7y Wed 14 Nov 16:15:20 BST 2018 721 291.25 CHIX 18318XJcs7u Wed 14 Nov 16:15:20 BST 2018 1259 291.30 CHIX 18318XJcs7k Wed 14 Nov 16:15:20 BST 2018 26 291.30 XLON 18318XJcs7c Wed 14 Nov 16:15:20 BST 2018 2791 291.30 XLON 18318XJcs7b Wed 14 Nov 16:15:20 BST 2018 89 291.35 XLON 18318XJcs79 Wed 14 Nov 16:15:20 BST 2018 1559 291.35 XLON 18318XJcs78 Wed 14 Nov 16:15:20 BST 2018 1076 291.35 XLON 18318XJcs77 Wed 14 Nov 16:15:20 BST 2018 705 291.35 CHIX 18318XJcs75 Wed 14 Nov 16:15:20 BST 2018 537 291.35 CHIX 18318XJcs70 Wed 14 Nov 16:15:20 BST 2018 589 291.35 CHIX 18318XJcs6u Wed 14 Nov 16:15:11 BST 2018 831 291.50 CHIX 18318XJcs45 Wed 14 Nov 16:14:47 BST 2018 664 291.40 XLON 18318XJcs1c Wed 14 Nov 16:14:47 BST 2018 1080 291.40 XLON 18318XJcs1b Wed 14 Nov 16:14:47 BST 2018 2691 291.40 XLON 18318XJcs17 Wed 14 Nov 16:14:47 BST 2018 945 291.40 CHIX 18318XJcs1a Wed 14 Nov 16:14:47 BST 2018 1054 291.40 CHIX 18318XJcs19 Wed 14 Nov 16:14:35 BST 2018 1263 291.50 CHIX 18318XJcrzw Wed 14 Nov 16:14:35 BST 2018 2801 291.50 XLON 18318XJcrzu Wed 14 Nov 16:14:35 BST 2018 530 291.55 CHIX 18318XJcrzq Wed 14 Nov 16:14:35 BST 2018 2597 291.55 CHIX 18318XJcrzn Wed 14 Nov 16:14:35 BST 2018 5762 291.55 XLON 18318XJcrzm Wed 14 Nov 16:14:13 BST 2018 522 291.60 XLON 18318XJcrve Wed 14 Nov 16:14:13 BST 2018 537 291.60 CHIX 18318XJcrvd Wed 14 Nov 16:14:01 BST 2018 1162 291.65 CHIX 18318XJcrto Wed 14 Nov 16:14:01 BST 2018 2577 291.65 XLON 18318XJcrtn Wed 14 Nov 16:14:00 BST 2018 3210 291.65 XLON 18318XJcrt8 Wed 14 Nov 16:14:00 BST 2018 1447 291.65 CHIX 18318XJcrt5 Wed 14 Nov 16:13:28 BST 2018 41 291.50 XLON 18318XJcrnj Wed 14 Nov 16:13:28 BST 2018 2 291.50 XLON 18318XJcrni Wed 14 Nov 16:13:28 BST 2018 2551 291.50 XLON 18318XJcrng Wed 14 Nov 16:13:28 BST 2018 1151 291.50 CHIX 18318XJcrn9 Wed 14 Nov 16:13:28 BST 2018 323 291.50 CHIX 18318XJcrnc Wed 14 Nov 16:13:04 BST 2018 1448 291.40 XLON 18318XJcrl3 Wed 14 Nov 16:13:04 BST 2018 1193 291.40 XLON 18318XJcrl4 Wed 14 Nov 16:13:04 BST 2018 654 291.40 CHIX 18318XJcrl2 Wed 14 Nov 16:13:04 BST 2018 254 291.40 CHIX 18318XJcrl1 Wed 14 Nov 16:13:00 BST 2018 329 291.40 CHIX 18318XJcrkd Wed 14 Nov 16:12:39 BST 2018 587 291.35 CHIX 18318XJcrhu Wed 14 Nov 16:12:39 BST 2018 843 291.35 XLON 18318XJcrhs Wed 14 Nov 16:12:39 BST 2018 2578 291.35 XLON 18318XJcrht Wed 14 Nov 16:12:39 BST 2018 576 291.35 CHIX 18318XJcrhr Wed 14 Nov 16:12:39 BST 2018 537 291.35 CHIX 18318XJcrhq Wed 14 Nov 16:12:34 BST 2018 749 291.40 CHIX 18318XJcrha Wed 14 Nov 16:12:26 BST 2018 566 291.40 CHIX 18318XJcrcx Wed 14 Nov 16:12:20 BST 2018 753 291.45 CHIX 18318XJcrc1 Wed 14 Nov 16:12:19 BST 2018 537 291.50 CHIX 18318XJcrbz Wed 14 Nov 16:12:19 BST 2018 373 291.50 CHIX 18318XJcrc0 Wed 14 Nov 16:12:19 BST 2018 869 291.50 XLON 18318XJcrby Wed 14 Nov 16:12:19 BST 2018 1214 291.55 XLON 18318XJcrbx Wed 14 Nov 16:12:19 BST 2018 96 291.55 XLON 18318XJcrbw Wed 14 Nov 16:12:19 BST 2018 1416 291.55 XLON 18318XJcrbv Wed 14 Nov 16:12:18 BST 2018 593 291.55 CHIX 18318XJcrbu Wed 14 Nov 16:12:18 BST 2018 566 291.55 CHIX 18318XJcrbt Wed 14 Nov 16:12:18 BST 2018 257 291.55 CHIX 18318XJcrbs Wed 14 Nov 16:12:18 BST 2018 398 291.55 CHIX 18318XJcrbq Wed 14 Nov 16:12:18 BST 2018 639 291.55 CHIX 18318XJcrbp Wed 14 Nov 16:12:18 BST 2018 302 291.55 CHIX 18318XJcrbo Wed 14 Nov 16:12:18 BST 2018 319 291.55 CHIX 18318XJcrbr Wed 14 Nov 16:12:18 BST 2018 986 291.60 XLON 18318XJcrbn Wed 14 Nov 16:12:18 BST 2018 1923 291.60 XLON 18318XJcrbm Wed 14 Nov 16:12:18 BST 2018 1312 291.60 CHIX 18318XJcrbl Wed 14 Nov 16:12:16 BST 2018 546 291.65 CHIX 18318XJcrbd Wed 14 Nov 16:12:16 BST 2018 441 291.65 CHIX 18318XJcrbc Wed 14 Nov 16:12:16 BST 2018 1007 291.65 CHIX 18318XJcrb9 Wed 14 Nov 16:12:16 BST 2018 326 291.65 CHIX 18318XJcrba Wed 14 Nov 16:12:16 BST 2018 96 291.65 CHIX 18318XJcrbb Wed 14 Nov 16:12:16 BST 2018 491 291.65 XLON 18318XJcrb8 Wed 14 Nov 16:12:16 BST 2018 2231 291.65 XLON 18318XJcrb7 Wed 14 Nov 16:12:14 BST 2018 196 291.70 CHIX 18318XJcrb2 Wed 14 Nov 16:12:13 BST 2018 519 291.70 CHIX 18318XJcraz Wed 14 Nov 16:12:10 BST 2018 13 291.70 XLON 18318XJcra3 Wed 14 Nov 16:12:10 BST 2018 175 291.70 XLON 18318XJcr9g Wed 14 Nov 16:12:09 BST 2018 303 291.70 CHIX 18318XJcr99 Wed 14 Nov 16:12:08 BST 2018 915 291.70 CHIX 18318XJcr92 Wed 14 Nov 16:12:04 BST 2018 2028 291.70 XLON 18318XJcr8n Wed 14 Nov 16:12:03 BST 2018 1915 291.70 XLON 18318XJcr8m Wed 14 Nov 16:12:03 BST 2018 27 291.70 XLON 18318XJcr8l Wed 14 Nov 16:12:03 BST 2018 877 291.70 CHIX 18318XJcr8k Wed 14 Nov 16:12:03 BST 2018 412 291.70 CHIX 18318XJcr8j Wed 14 Nov 16:12:02 BST 2018 399 291.75 CHIX 18318XJcr8e Wed 14 Nov 16:11:54 BST 2018 337 291.70 CHIX 18318XJcr6m Wed 14 Nov 16:11:38 BST 2018 374 291.70 CHIX 18318XJcr4t Wed 14 Nov 16:10:57 BST 2018 412 291.35 CHIX 18318XJcqyk Wed 14 Nov 16:10:57 BST 2018 813 291.35 CHIX 18318XJcqyj Wed 14 Nov 16:10:54 BST 2018 119 291.35 CHIX 18318XJcqy8 Wed 14 Nov 16:10:46 BST 2018 64 291.40 XLON 18318XJcqwi Wed 14 Nov 16:10:39 BST 2018 190 291.35 CHIX 18318XJcqvy Wed 14 Nov 16:10:33 BST 2018 1027 291.30 CHIX 18318XJcqub Wed 14 Nov 16:10:22 BST 2018 7 291.30 XLON 18318XJcqqy Wed 14 Nov 16:10:22 BST 2018 822 291.30 XLON 18318XJcqqx Wed 14 Nov 16:10:22 BST 2018 877 291.30 XLON 18318XJcqqv Wed 14 Nov 16:10:22 BST 2018 769 291.30 CHIX 18318XJcqqw Wed 14 Nov 16:10:22 BST 2018 768 291.30 CHIX 18318XJcqqu Wed 14 Nov 16:10:06 BST 2018 263 291.35 CHIX 18318XJcqp7 Wed 14 Nov 16:10:06 BST 2018 392 291.35 CHIX 18318XJcqp5 Wed 14 Nov 16:10:06 BST 2018 169 291.35 XLON 18318XJcqp0 Wed 14 Nov 16:10:06 BST 2018 169 291.35 XLON 18318XJcqp4 Wed 14 Nov 16:10:06 BST 2018 1449 291.35 XLON 18318XJcqow Wed 14 Nov 16:09:58 BST 2018 2147 291.40 XLON 18318XJcqnr Wed 14 Nov 16:09:58 BST 2018 329 291.40 CHIX 18318XJcqnq Wed 14 Nov 16:09:58 BST 2018 640 291.40 CHIX 18318XJcqnp Wed 14 Nov 16:08:45 BST 2018 2372 290.95 XLON 18318XJcqco Wed 14 Nov 16:08:45 BST 2018 1830 290.95 XLON 18318XJcqcn Wed 14 Nov 16:08:45 BST 2018 195 290.95 XLON 18318XJcqcm Wed 14 Nov 16:08:45 BST 2018 98 290.95 XLON 18318XJcqcl Wed 14 Nov 16:08:45 BST 2018 95 290.95 XLON 18318XJcqcq Wed 14 Nov 16:08:45 BST 2018 414 290.95 XLON 18318XJcqcp Wed 14 Nov 16:08:45 BST 2018 455 290.95 CHIX 18318XJcqck Wed 14 Nov 16:08:45 BST 2018 538 290.95 CHIX 18318XJcqcj Wed 14 Nov 16:08:45 BST 2018 1070 290.95 CHIX 18318XJcqci Wed 14 Nov 16:08:45 BST 2018 509 290.95 CHIX 18318XJcqch Wed 14 Nov 16:08:45 BST 2018 37 290.95 XLON 18318XJcqcg Wed 14 Nov 16:08:45 BST 2018 14 290.95 CHIX 18318XJcqcf Wed 14 Nov 16:08:45 BST 2018 303 290.95 CHIX 18318XJcqce Wed 14 Nov 16:08:18 BST 2018 252 291.00 XLON 18318XJcq89 Wed 14 Nov 16:08:18 BST 2018 3668 291.00 XLON 18318XJcq87 Wed 14 Nov 16:08:18 BST 2018 1768 291.00 CHIX 18318XJcq88 Wed 14 Nov 16:08:05 BST 2018 123 291.05 CHIX 18318XJcq4r Wed 14 Nov 16:08:05 BST 2018 112 291.05 XLON 18318XJcq4t Wed 14 Nov 16:08:05 BST 2018 494 291.05 CHIX 18318XJcq4p Wed 14 Nov 16:08:05 BST 2018 1152 291.05 XLON 18318XJcq4s Wed 14 Nov 16:08:05 BST 2018 1 291.05 CHIX 18318XJcq4d Wed 14 Nov 16:08:05 BST 2018 1540 291.05 CHIX 18318XJcq46 Wed 14 Nov 16:08:05 BST 2018 3419 291.05 XLON 18318XJcq4o Wed 14 Nov 16:08:05 BST 2018 836 291.10 CHIX 18318XJcq3z Wed 14 Nov 16:08:05 BST 2018 538 291.10 CHIX 18318XJcq3w Wed 14 Nov 16:08:05 BST 2018 538 291.10 CHIX 18318XJcq41 Wed 14 Nov 16:08:05 BST 2018 1067 291.10 XLON 18318XJcq4m Wed 14 Nov 16:08:05 BST 2018 759 291.10 XLON 18318XJcq4g Wed 14 Nov 16:04:41 BST 2018 3775 291.00 CHIX 18318XJcp9m Wed 14 Nov 16:04:41 BST 2018 6075 291.00 XLON 18318XJcp9l Wed 14 Nov 16:04:41 BST 2018 2302 291.00 XLON 18318XJcp9k Wed 14 Nov 16:04:33 BST 2018 2748 291.05 CHIX 18318XJcp8j Wed 14 Nov 16:04:33 BST 2018 5787 291.05 XLON 18318XJcp8i Wed 14 Nov 16:04:33 BST 2018 309 291.05 XLON 18318XJcp8h Wed 14 Nov 16:03:53 BST 2018 427 291.10 CHIX 18318XJcp2t Wed 14 Nov 16:03:34 BST 2018 1509 291.25 XLON 18318XJcoys Wed 14 Nov 16:03:34 BST 2018 1127 291.25 XLON 18318XJcoyr Wed 14 Nov 16:03:34 BST 2018 1189 291.25 CHIX 18318XJcoyq Wed 14 Nov 16:03:29 BST 2018 970 291.30 CHIX 18318XJcoxr Wed 14 Nov 16:03:29 BST 2018 520 291.30 XLON 18318XJcoxq Wed 14 Nov 16:03:29 BST 2018 859 291.30 XLON 18318XJcoxp Wed 14 Nov 16:03:29 BST 2018 771 291.30 XLON 18318XJcoxn Wed 14 Nov 16:03:29 BST 2018 2744 291.35 XLON 18318XJcoxj Wed 14 Nov 16:03:29 BST 2018 1239 291.35 CHIX 18318XJcoxh Wed 14 Nov 16:03:27 BST 2018 1782 291.40 XLON 18318XJcoxc Wed 14 Nov 16:03:27 BST 2018 3058 291.40 CHIX 18318XJcox9 Wed 14 Nov 16:03:27 BST 2018 4116 291.40 XLON 18318XJcoxb Wed 14 Nov 16:03:27 BST 2018 889 291.40 XLON 18318XJcoxa Wed 14 Nov 16:02:10 BST 2018 1929 291.40 CHIX 18318XJcon7 Wed 14 Nov 16:02:10 BST 2018 1366 291.40 XLON 18318XJcon8 Wed 14 Nov 16:02:10 BST 2018 2910 291.40 XLON 18318XJcon6 Wed 14 Nov 16:02:07 BST 2018 3015 291.55 XLON 18318XJcomz Wed 14 Nov 16:02:07 BST 2018 901 291.55 XLON 18318XJcon2 Wed 14 Nov 16:02:07 BST 2018 590 291.55 XLON 18318XJcomq Wed 14 Nov 16:02:07 BST 2018 1626 291.55 CHIX 18318XJcomx Wed 14 Nov 16:02:07 BST 2018 537 291.55 CHIX 18318XJcon1 Wed 14 Nov 16:02:00 BST 2018 2648 291.70 CHIX 18318XJcolc Wed 14 Nov 16:02:00 BST 2018 2436 291.70 XLON 18318XJcol6 Wed 14 Nov 16:02:00 BST 2018 2013 291.70 XLON 18318XJcokz Wed 14 Nov 16:02:00 BST 2018 1426 291.70 XLON 18318XJcokq Wed 14 Nov 16:01:58 BST 2018 415 291.80 XLON 18318XJcokc Wed 14 Nov 16:01:58 BST 2018 536 291.80 CHIX 18318XJcoke Wed 14 Nov 16:01:58 BST 2018 454 291.80 CHIX 18318XJcokd Wed 14 Nov 16:01:13 BST 2018 369 291.70 CHIX 18318XJcoed Wed 14 Nov 16:01:13 BST 2018 2321 291.70 XLON 18318XJcoec Wed 14 Nov 16:01:13 BST 2018 678 291.70 CHIX 18318XJcoe8 Wed 14 Nov 16:00:39 BST 2018 151 291.50 CHIX 18318XJco5d Wed 14 Nov 16:00:39 BST 2018 82 291.50 CHIX 18318XJco5b Wed 14 Nov 16:00:39 BST 2018 3832 291.50 XLON 18318XJco58 Wed 14 Nov 16:00:39 BST 2018 1494 291.50 CHIX 18318XJco59 Wed 14 Nov 16:00:29 BST 2018 1377 291.70 CHIX 18318XJco36 Wed 14 Nov 16:00:29 BST 2018 3053 291.70 XLON 18318XJco35 Wed 14 Nov 16:00:14 BST 2018 1493 291.75 CHIX 18318XJco1k Wed 14 Nov 16:00:14 BST 2018 3308 291.75 XLON 18318XJco15 Wed 14 Nov 16:00:14 BST 2018 696 291.80 CHIX 18318XJco13 Wed 14 Nov 16:00:14 BST 2018 560 291.80 CHIX 18318XJco11 Wed 14 Nov 16:00:14 BST 2018 94 291.80 CHIX 18318XJco0y Wed 14 Nov 16:00:14 BST 2018 990 291.80 XLON 18318XJco0q Wed 14 Nov 16:00:14 BST 2018 1542 291.80 XLON 18318XJco0u Wed 14 Nov 16:00:14 BST 2018 458 291.80 XLON 18318XJco0o Wed 14 Nov 16:00:12 BST 2018 217 291.85 CHIX 18318XJcnze Wed 14 Nov 16:00:11 BST 2018 925 291.85 XLON 18318XJcnz2 Wed 14 Nov 16:00:11 BST 2018 130 291.90 CHIX 18318XJcnz0 Wed 14 Nov 16:00:10 BST 2018 193 291.90 CHIX 18318XJcnyn Wed 14 Nov 15:59:59 BST 2018 536 291.90 CHIX 18318XJcnu9 Wed 14 Nov 15:59:59 BST 2018 112 291.90 XLON 18318XJcnu8 Wed 14 Nov 15:59:59 BST 2018 533 291.90 XLON 18318XJcnu7 Wed 14 Nov 15:58:51 BST 2018 854 291.55 CHIX 18318XJcnma Wed 14 Nov 15:58:51 BST 2018 965 291.55 XLON 18318XJcnm9 Wed 14 Nov 15:58:51 BST 2018 927 291.55 XLON 18318XJcnm7 Wed 14 Nov 15:58:15 BST 2018 1434 291.35 XLON 18318XJcngk Wed 14 Nov 15:58:15 BST 2018 648 291.35 CHIX 18318XJcngj Wed 14 Nov 15:57:49 BST 2018 2790 291.40 XLON 18318XJcndx Wed 14 Nov 15:57:49 BST 2018 1259 291.40 CHIX 18318XJcndt Wed 14 Nov 15:57:46 BST 2018 495 291.45 XLON 18318XJcnd9 Wed 14 Nov 15:57:46 BST 2018 2884 291.45 XLON 18318XJcnd8 Wed 14 Nov 15:57:46 BST 2018 1524 291.45 CHIX 18318XJcnd6 Wed 14 Nov 15:57:13 BST 2018 1 291.50 CHIX 18318XJcn7y Wed 14 Nov 15:57:13 BST 2018 1889 291.50 CHIX 18318XJcn7u Wed 14 Nov 15:57:13 BST 2018 2446 291.50 XLON 18318XJcn7r Wed 14 Nov 15:57:13 BST 2018 1747 291.50 XLON 18318XJcn7n Wed 14 Nov 15:56:47 BST 2018 75 291.55 XLON 18318XJcn2p Wed 14 Nov 15:56:47 BST 2018 1095 291.55 XLON 18318XJcn2l Wed 14 Nov 15:56:45 BST 2018 536 291.60 CHIX 18318XJcn25 Wed 14 Nov 15:56:45 BST 2018 1399 291.60 CHIX 18318XJcn22 Wed 14 Nov 15:56:45 BST 2018 2058 291.60 XLON 18318XJcn20 Wed 14 Nov 15:56:45 BST 2018 742 291.60 XLON 18318XJcn1u Wed 14 Nov 15:56:33 BST 2018 318 291.70 XLON 18318XJcmzv Wed 14 Nov 15:56:33 BST 2018 151 291.70 XLON 18318XJcmzu Wed 14 Nov 15:56:33 BST 2018 2417 291.70 XLON 18318XJcmzt Wed 14 Nov 15:56:33 BST 2018 1302 291.70 CHIX 18318XJcmzs Wed 14 Nov 15:56:20 BST 2018 1485 291.65 XLON 18318XJcmxq Wed 14 Nov 15:56:17 BST 2018 596 291.65 XLON 18318XJcmx5 Wed 14 Nov 15:56:17 BST 2018 1041 291.65 CHIX 18318XJcmx6 Wed 14 Nov 15:56:14 BST 2018 367 291.65 CHIX 18318XJcmwl Wed 14 Nov 15:56:12 BST 2018 1041 291.65 XLON 18318XJcmvq Wed 14 Nov 15:56:04 BST 2018 71 291.85 XLON 18318XJcmu6 Wed 14 Nov 15:56:04 BST 2018 343 291.85 XLON 18318XJcmu5 Wed 14 Nov 15:56:04 BST 2018 870 291.85 XLON 18318XJcmu4 Wed 14 Nov 15:56:04 BST 2018 130 291.85 XLON 18318XJcmu3 Wed 14 Nov 15:56:04 BST 2018 22 291.85 XLON 18318XJcmu1 Wed 14 Nov 15:56:04 BST 2018 178 291.85 XLON 18318XJcmu0 Wed 14 Nov 15:56:04 BST 2018 536 291.85 CHIX 18318XJcmu2 Wed 14 Nov 15:56:04 BST 2018 536 291.85 CHIX 18318XJcmtz Wed 14 Nov 15:55:56 BST 2018 31 291.90 XLON 18318XJcms8 Wed 14 Nov 15:53:13 BST 2018 5629 291.60 XLON 18318XJclyf Wed 14 Nov 15:53:13 BST 2018 1135 291.60 CHIX 18318XJclye Wed 14 Nov 15:53:13 BST 2018 1402 291.60 CHIX 18318XJclyd Wed 14 Nov 15:52:56 BST 2018 7 291.75 XLON 18318XJclw9 Wed 14 Nov 15:52:51 BST 2018 3298 291.80 XLON 18318XJclw5 Wed 14 Nov 15:52:51 BST 2018 3598 291.80 XLON 18318XJclw3 Wed 14 Nov 15:52:51 BST 2018 1590 291.80 CHIX 18318XJclw2 Wed 14 Nov 15:52:51 BST 2018 1518 291.80 CHIX 18318XJclw1 Wed 14 Nov 15:52:35 BST 2018 1312 291.85 CHIX 18318XJcluw Wed 14 Nov 15:52:35 BST 2018 2907 291.85 XLON 18318XJcluv Wed 14 Nov 15:52:26 BST 2018 1463 291.95 CHIX 18318XJclu9 Wed 14 Nov 15:52:26 BST 2018 3244 291.95 XLON 18318XJclu8 Wed 14 Nov 15:52:17 BST 2018 497 291.80 XLON 18318XJclrw Wed 14 Nov 15:52:17 BST 2018 536 291.80 CHIX 18318XJclrv Wed 14 Nov 15:52:14 BST 2018 133 291.90 XLON 18318XJclq2 Wed 14 Nov 15:52:13 BST 2018 3793 291.90 XLON 18318XJclpr Wed 14 Nov 15:52:13 BST 2018 1710 291.90 CHIX 18318XJclpq Wed 14 Nov 15:51:44 BST 2018 536 292.00 CHIX 18318XJclnd Wed 14 Nov 15:51:44 BST 2018 871 292.00 XLON 18318XJclnb Wed 14 Nov 15:51:11 BST 2018 554 291.85 CHIX 18318XJclfr Wed 14 Nov 15:50:17 BST 2018 3398 292.10 CHIX 18318XJcl6j Wed 14 Nov 15:50:17 BST 2018 4940 292.10 XLON 18318XJcl6i Wed 14 Nov 15:50:17 BST 2018 2600 292.10 XLON 18318XJcl6h Wed 14 Nov 15:50:11 BST 2018 541 292.15 CHIX 18318XJcl5o Wed 14 Nov 15:49:18 BST 2018 1128 292.25 CHIX 18318XJckyq Wed 14 Nov 15:49:18 BST 2018 2632 292.25 XLON 18318XJckyp Wed 14 Nov 15:49:18 BST 2018 60 292.25 CHIX 18318XJckyo Wed 14 Nov 15:49:09 BST 2018 4706 292.35 XLON 18318XJcky0 Wed 14 Nov 15:49:09 BST 2018 2121 292.35 CHIX 18318XJcky3 Wed 14 Nov 15:48:33 BST 2018 849 292.25 CHIX 18318XJckum Wed 14 Nov 15:48:33 BST 2018 1880 292.25 XLON 18318XJckul Wed 14 Nov 15:48:25 BST 2018 1013 292.35 CHIX 18318XJckty Wed 14 Nov 15:48:25 BST 2018 564 292.35 CHIX 18318XJcktx Wed 14 Nov 15:48:22 BST 2018 195 292.35 XLON 18318XJcktj Wed 14 Nov 15:48:22 BST 2018 7317 292.35 XLON 18318XJckti Wed 14 Nov 15:48:22 BST 2018 1808 292.35 CHIX 18318XJckth Wed 14 Nov 15:46:02 BST 2018 1317 292.35 CHIX 18318XJckdf Wed 14 Nov 15:46:02 BST 2018 5029 292.35 XLON 18318XJckde Wed 14 Nov 15:46:02 BST 2018 558 292.35 XLON 18318XJckdd Wed 14 Nov 15:46:02 BST 2018 1202 292.35 CHIX 18318XJckdc Wed 14 Nov 15:46:02 BST 2018 1 292.40 CHIX 18318XJckdb Wed 14 Nov 15:46:02 BST 2018 3618 292.40 CHIX 18318XJckda Wed 14 Nov 15:46:02 BST 2018 7159 292.40 XLON 18318XJckd9 Wed 14 Nov 15:46:02 BST 2018 872 292.40 XLON 18318XJckd8 Wed 14 Nov 15:45:21 BST 2018 1073 292.50 XLON 18318XJck2u Wed 14 Nov 15:45:21 BST 2018 535 292.50 CHIX 18318XJck2t Wed 14 Nov 15:44:25 BST 2018 342 292.60 XLON 18318XJcjv9 Wed 14 Nov 15:44:25 BST 2018 1561 292.65 XLON 18318XJcjv8 Wed 14 Nov 15:44:25 BST 2018 704 292.65 CHIX 18318XJcjv7 Wed 14 Nov 15:44:22 BST 2018 1002 292.75 XLON 18318XJcjur Wed 14 Nov 15:44:22 BST 2018 535 292.75 CHIX 18318XJcjuq Wed 14 Nov 15:44:22 BST 2018 1750 292.85 CHIX 18318XJcjup Wed 14 Nov 15:44:22 BST 2018 2999 292.85 XLON 18318XJcjuo Wed 14 Nov 15:44:22 BST 2018 884 292.85 XLON 18318XJcjun Wed 14 Nov 15:43:14 BST 2018 1920 292.90 XLON 18318XJcjpd Wed 14 Nov 15:43:14 BST 2018 8240 292.90 XLON 18318XJcjpb Wed 14 Nov 15:43:14 BST 2018 1019 292.90 CHIX 18318XJcjpc Wed 14 Nov 15:43:14 BST 2018 3560 292.90 CHIX 18318XJcjpa Wed 14 Nov 15:41:31 BST 2018 3129 292.80 XLON 18318XJcjcj Wed 14 Nov 15:41:31 BST 2018 1255 292.80 CHIX 18318XJcjci Wed 14 Nov 15:41:31 BST 2018 157 292.80 CHIX 18318XJcjch Wed 14 Nov 15:41:25 BST 2018 16457 292.85 XLON 18318XJcjbt Wed 14 Nov 15:41:25 BST 2018 3800 292.85 CHIX 18318XJcjbs Wed 14 Nov 15:41:25 BST 2018 62 292.85 CHIX 18318XJcjbr Wed 14 Nov 15:41:05 BST 2018 2355 292.90 XLON 18318XJcja5 Wed 14 Nov 15:40:49 BST 2018 1063 292.90 CHIX 18318XJcj77 Wed 14 Nov 15:40:43 BST 2018 825 292.95 CHIX 18318XJcj6l Wed 14 Nov 15:40:43 BST 2018 685 292.95 CHIX 18318XJcj6k Wed 14 Nov 15:40:43 BST 2018 149 292.95 XLON 18318XJcj6f Wed 14 Nov 15:40:43 BST 2018 3200 292.95 XLON 18318XJcj6e Wed 14 Nov 15:40:24 BST 2018 1 293.20 CHIX 18318XJcj4t Wed 14 Nov 15:40:24 BST 2018 533 293.20 CHIX 18318XJcj4s Wed 14 Nov 15:40:24 BST 2018 621 293.20 CHIX 18318XJcj4r Wed 14 Nov 15:40:24 BST 2018 845 293.20 CHIX 18318XJcj4q Wed 14 Nov 15:40:24 BST 2018 656 293.20 XLON 18318XJcj4p Wed 14 Nov 15:40:24 BST 2018 1870 293.20 XLON 18318XJcj4o Wed 14 Nov 15:39:38 BST 2018 698 293.25 CHIX 18318XJciz4 Wed 14 Nov 15:39:38 BST 2018 1045 293.25 CHIX 18318XJciz3 Wed 14 Nov 15:39:38 BST 2018 197 293.25 XLON 18318XJciyy Wed 14 Nov 15:39:38 BST 2018 2314 293.25 XLON 18318XJciyx Wed 14 Nov 15:39:38 BST 2018 17 293.25 XLON 18318XJciyz Wed 14 Nov 15:39:38 BST 2018 1546 293.25 XLON 18318XJciz1 Wed 14 Nov 15:39:33 BST 2018 260 293.40 XLON 18318XJcixi Wed 14 Nov 15:39:33 BST 2018 333 293.40 XLON 18318XJcixg Wed 14 Nov 15:39:33 BST 2018 1390 293.40 XLON 18318XJcixe Wed 14 Nov 15:39:33 BST 2018 895 293.40 CHIX 18318XJcixd Wed 14 Nov 15:39:30 BST 2018 811 293.45 CHIX 18318XJciws Wed 14 Nov 15:39:30 BST 2018 1798 293.45 XLON 18318XJciwr Wed 14 Nov 15:39:30 BST 2018 73 293.50 XLON 18318XJciwq Wed 14 Nov 15:39:30 BST 2018 2087 293.50 XLON 18318XJciwo Wed 14 Nov 15:39:30 BST 2018 124 293.50 XLON 18318XJciwp Wed 14 Nov 15:39:30 BST 2018 942 293.50 CHIX 18318XJciwm Wed 14 Nov 15:39:15 BST 2018 2101 293.35 XLON 18318XJcivj Wed 14 Nov 15:39:14 BST 2018 380 293.40 CHIX 18318XJcivi Wed 14 Nov 15:38:56 BST 2018 534 293.30 CHIX 18318XJcitq Wed 14 Nov 15:38:56 BST 2018 734 293.30 XLON 18318XJcitp Wed 14 Nov 15:38:42 BST 2018 793 293.25 CHIX 18318XJcirr Wed 14 Nov 15:38:42 BST 2018 653 293.25 CHIX 18318XJcirv Wed 14 Nov 15:38:42 BST 2018 221 293.25 CHIX 18318XJcirt Wed 14 Nov 15:38:42 BST 2018 1757 293.25 XLON 18318XJcirp Wed 14 Nov 15:38:16 BST 2018 250 293.20 CHIX 18318XJcinz Wed 14 Nov 15:37:42 BST 2018 932 293.25 CHIX 18318XJciiy Wed 14 Nov 15:37:42 BST 2018 1639 293.25 XLON 18318XJciix Wed 14 Nov 15:37:42 BST 2018 426 293.25 XLON 18318XJciiw Wed 14 Nov 15:37:41 BST 2018 534 293.35 CHIX 18318XJciik Wed 14 Nov 15:37:41 BST 2018 534 293.35 CHIX 18318XJciij Wed 14 Nov 15:37:41 BST 2018 978 293.35 XLON 18318XJciii Wed 14 Nov 15:37:41 BST 2018 33 293.35 XLON 18318XJciih Wed 14 Nov 15:37:41 BST 2018 552 293.35 XLON 18318XJciig Wed 14 Nov 15:37:32 BST 2018 191 293.40 XLON 18318XJcihk Wed 14 Nov 15:37:29 BST 2018 4772 293.45 XLON 18318XJcih7 Wed 14 Nov 15:37:29 BST 2018 989 293.45 CHIX 18318XJcih3 Wed 14 Nov 15:37:29 BST 2018 1162 293.45 CHIX 18318XJcih0 Wed 14 Nov 15:36:32 BST 2018 1941 293.30 CHIX 18318XJci8l Wed 14 Nov 15:36:32 BST 2018 4306 293.30 XLON 18318XJci8k Wed 14 Nov 15:36:18 BST 2018 93 293.35 XLON 18318XJci6r Wed 14 Nov 15:36:18 BST 2018 44 293.35 XLON 18318XJci6q Wed 14 Nov 15:36:17 BST 2018 717 293.40 CHIX 18318XJci6f Wed 14 Nov 15:36:17 BST 2018 533 293.40 CHIX 18318XJci6g Wed 14 Nov 15:36:17 BST 2018 444 293.40 XLON 18318XJci6e Wed 14 Nov 15:36:17 BST 2018 1588 293.40 XLON 18318XJci6d Wed 14 Nov 15:35:17 BST 2018 1060 293.45 XLON 18318XJchzu Wed 14 Nov 15:35:17 BST 2018 1144 293.45 XLON 18318XJchzt Wed 14 Nov 15:35:17 BST 2018 460 293.45 CHIX 18318XJchzy Wed 14 Nov 15:35:17 BST 2018 73 293.45 CHIX 18318XJchzx Wed 14 Nov 15:35:17 BST 2018 828 293.45 CHIX 18318XJchzs Wed 14 Nov 15:35:17 BST 2018 559 293.45 CHIX 18318XJchzw Wed 14 Nov 15:35:17 BST 2018 418 293.45 CHIX 18318XJchzv Wed 14 Nov 15:35:13 BST 2018 1062 293.50 CHIX 18318XJchz3 Wed 14 Nov 15:35:13 BST 2018 2353 293.50 XLON 18318XJchz2 Wed 14 Nov 15:35:13 BST 2018 49 293.50 XLON 18318XJchz4 Wed 14 Nov 15:35:01 BST 2018 1286 293.55 CHIX 18318XJchxf Wed 14 Nov 15:35:01 BST 2018 2849 293.55 XLON 18318XJchxe Wed 14 Nov 15:34:48 BST 2018 2366 293.55 XLON 18318XJchvx Wed 14 Nov 15:34:48 BST 2018 562 293.55 CHIX 18318XJchvw Wed 14 Nov 15:34:48 BST 2018 553 293.55 CHIX 18318XJchvv Wed 14 Nov 15:34:48 BST 2018 515 293.55 CHIX 18318XJchvr Wed 14 Nov 15:34:48 BST 2018 2114 293.60 XLON 18318XJchvi Wed 14 Nov 15:34:48 BST 2018 159 293.60 XLON 18318XJchvo Wed 14 Nov 15:34:48 BST 2018 858 293.60 XLON 18318XJchvl Wed 14 Nov 15:34:48 BST 2018 53 293.60 XLON 18318XJchvp Wed 14 Nov 15:34:48 BST 2018 1 293.65 CHIX 18318XJchve Wed 14 Nov 15:34:48 BST 2018 1003 293.65 CHIX 18318XJchvc Wed 14 Nov 15:34:48 BST 2018 533 293.65 CHIX 18318XJchvb Wed 14 Nov 15:34:48 BST 2018 502 293.65 XLON 18318XJchv9 Wed 14 Nov 15:34:48 BST 2018 2224 293.65 XLON 18318XJchva Wed 14 Nov 15:34:36 BST 2018 652 293.70 CHIX 18318XJchu1 Wed 14 Nov 15:34:31 BST 2018 149 293.75 XLON 18318XJchth Wed 14 Nov 15:34:31 BST 2018 533 293.75 CHIX 18318XJchtg Wed 14 Nov 15:34:31 BST 2018 590 293.75 CHIX 18318XJchtf Wed 14 Nov 15:34:31 BST 2018 1070 293.75 XLON 18318XJchte Wed 14 Nov 15:34:31 BST 2018 1210 293.75 XLON 18318XJchtd Wed 14 Nov 15:34:15 BST 2018 427 293.85 CHIX 18318XJchrf Wed 14 Nov 15:34:15 BST 2018 271 293.85 XLON 18318XJchrd Wed 14 Nov 15:34:15 BST 2018 1546 293.85 XLON 18318XJchr6 Wed 14 Nov 15:33:40 BST 2018 422 293.65 XLON 18318XJchlz Wed 14 Nov 15:33:40 BST 2018 302 293.65 CHIX 18318XJchly Wed 14 Nov 15:33:40 BST 2018 533 293.65 CHIX 18318XJchlx Wed 14 Nov 15:33:40 BST 2018 981 293.65 CHIX 18318XJchlw Wed 14 Nov 15:33:40 BST 2018 9 293.65 XLON 18318XJchlu Wed 14 Nov 15:33:40 BST 2018 696 293.65 XLON 18318XJchlv Wed 14 Nov 15:33:40 BST 2018 2058 293.65 XLON 18318XJchlt Wed 14 Nov 15:33:40 BST 2018 105 293.65 XLON 18318XJchls Wed 14 Nov 15:32:32 BST 2018 783 293.50 XLON 18318XJchbk Wed 14 Nov 15:32:32 BST 2018 2712 293.50 XLON 18318XJchbi Wed 14 Nov 15:32:32 BST 2018 1577 293.50 CHIX 18318XJchbl Wed 14 Nov 15:32:28 BST 2018 533 293.55 CHIX 18318XJchag Wed 14 Nov 15:32:28 BST 2018 267 293.55 CHIX 18318XJchaf Wed 14 Nov 15:32:28 BST 2018 552 293.55 CHIX 18318XJchae Wed 14 Nov 15:32:28 BST 2018 364 293.55 XLON 18318XJchad Wed 14 Nov 15:32:28 BST 2018 1131 293.55 XLON 18318XJchac Wed 14 Nov 15:31:58 BST 2018 643 293.50 CHIX 18318XJch8c Wed 14 Nov 15:31:58 BST 2018 647 293.55 CHIX 18318XJch8b Wed 14 Nov 15:31:58 BST 2018 1433 293.55 XLON 18318XJch89 Wed 14 Nov 15:31:58 BST 2018 1425 293.50 XLON 18318XJch8a Wed 14 Nov 15:31:36 BST 2018 1173 293.50 XLON 18318XJch59 Wed 14 Nov 15:31:36 BST 2018 28 293.50 XLON 18318XJch5a Wed 14 Nov 15:31:36 BST 2018 673 293.55 CHIX 18318XJch58 Wed 14 Nov 15:31:32 BST 2018 57 293.55 XLON 18318XJch4p Wed 14 Nov 15:31:25 BST 2018 580 293.55 CHIX 18318XJch4e Wed 14 Nov 15:31:25 BST 2018 533 293.55 CHIX 18318XJch4h Wed 14 Nov 15:31:25 BST 2018 585 293.55 CHIX 18318XJch4g Wed 14 Nov 15:31:25 BST 2018 3 293.55 XLON 18318XJch4d Wed 14 Nov 15:31:25 BST 2018 20 293.55 XLON 18318XJch4c Wed 14 Nov 15:31:25 BST 2018 417 293.55 XLON 18318XJch4f Wed 14 Nov 15:31:16 BST 2018 641 293.65 CHIX 18318XJch3v Wed 14 Nov 15:31:10 BST 2018 533 293.70 CHIX 18318XJch3d Wed 14 Nov 15:31:10 BST 2018 776 293.70 XLON 18318XJch3c Wed 14 Nov 15:31:03 BST 2018 914 293.70 CHIX 18318XJch2l Wed 14 Nov 15:31:03 BST 2018 2024 293.70 XLON 18318XJch2k Wed 14 Nov 15:31:00 BST 2018 885 293.75 CHIX 18318XJch26 Wed 14 Nov 15:31:00 BST 2018 985 293.75 CHIX 18318XJch21 Wed 14 Nov 15:31:00 BST 2018 598 293.75 CHIX 18318XJch20 Wed 14 Nov 15:31:00 BST 2018 526 293.75 XLON 18318XJch25 Wed 14 Nov 15:31:00 BST 2018 1658 293.75 XLON 18318XJch23 Wed 14 Nov 15:30:21 BST 2018 334 293.65 CHIX 18318XJcgxs Wed 14 Nov 15:30:17 BST 2018 533 293.75 CHIX 18318XJcgxk Wed 14 Nov 15:30:17 BST 2018 147 293.75 XLON 18318XJcgxj Wed 14 Nov 15:30:17 BST 2018 806 293.75 XLON 18318XJcgxi Wed 14 Nov 15:30:08 BST 2018 599 293.75 CHIX 18318XJcgx2 Wed 14 Nov 15:30:08 BST 2018 678 293.75 CHIX 18318XJcgx1 Wed 14 Nov 15:30:08 BST 2018 533 293.75 CHIX 18318XJcgx0 Wed 14 Nov 15:30:03 BST 2018 1227 293.75 XLON 18318XJcgw0 Wed 14 Nov 15:30:03 BST 2018 1002 293.75 XLON 18318XJcgvz Wed 14 Nov 15:29:54 BST 2018 751 293.80 XLON 18318XJcgun Wed 14 Nov 15:29:33 BST 2018 1196 293.55 XLON 18318XJcgr3 Wed 14 Nov 15:29:33 BST 2018 584 293.55 CHIX 18318XJcgr5 Wed 14 Nov 15:29:20 BST 2018 547 293.65 CHIX 18318XJcgp9 Wed 14 Nov 15:29:20 BST 2018 514 293.65 CHIX 18318XJcgp8 Wed 14 Nov 15:29:20 BST 2018 377 293.65 CHIX 18318XJcgp7 Wed 14 Nov 15:29:20 BST 2018 188 293.65 CHIX 18318XJcgp6 Wed 14 Nov 15:29:20 BST 2018 1531 293.65 XLON 18318XJcgp5 Wed 14 Nov 15:29:20 BST 2018 859 293.65 XLON 18318XJcgp4 Wed 14 Nov 15:28:27 BST 2018 1289 293.65 XLON 18318XJcgii Wed 14 Nov 15:28:27 BST 2018 216 293.65 CHIX 18318XJcgik Wed 14 Nov 15:28:27 BST 2018 617 293.65 CHIX 18318XJcgij Wed 14 Nov 15:28:27 BST 2018 480 293.65 CHIX 18318XJcgil Wed 14 Nov 15:28:27 BST 2018 967 293.70 CHIX 18318XJcgih Wed 14 Nov 15:28:27 BST 2018 2143 293.70 XLON 18318XJcgig Wed 14 Nov 15:28:26 BST 2018 533 293.75 CHIX 18318XJcgic Wed 14 Nov 15:28:26 BST 2018 832 293.75 XLON 18318XJcgia Wed 14 Nov 15:28:17 BST 2018 260 293.75 XLON 18318XJcghe Wed 14 Nov 15:28:10 BST 2018 537 293.80 CHIX 18318XJcgh5 Wed 14 Nov 15:28:10 BST 2018 1100 293.80 XLON 18318XJcgh2 Wed 14 Nov 15:28:10 BST 2018 533 293.85 CHIX 18318XJcgh0 Wed 14 Nov 15:28:10 BST 2018 779 293.85 CHIX 18318XJcggy Wed 14 Nov 15:28:10 BST 2018 808 293.85 XLON 18318XJcggw Wed 14 Nov 15:27:37 BST 2018 757 293.55 CHIX 18318XJcgcj Wed 14 Nov 15:27:37 BST 2018 1678 293.55 XLON 18318XJcgci Wed 14 Nov 15:27:31 BST 2018 533 293.50 CHIX 18318XJcgc9 Wed 14 Nov 15:27:31 BST 2018 572 293.50 XLON 18318XJcgc8 Wed 14 Nov 15:27:29 BST 2018 820 293.50 CHIX 18318XJcgc4 Wed 14 Nov 15:27:29 BST 2018 1815 293.50 XLON 18318XJcgc3 Wed 14 Nov 15:26:46 BST 2018 82 293.05 XLON 18318XJcg76 Wed 14 Nov 15:26:46 BST 2018 754 293.05 CHIX 18318XJcg75 Wed 14 Nov 15:26:46 BST 2018 745 293.05 CHIX 18318XJcg74 Wed 14 Nov 15:26:46 BST 2018 214 293.05 CHIX 18318XJcg73 Wed 14 Nov 15:26:46 BST 2018 626 293.05 XLON 18318XJcg71 Wed 14 Nov 15:26:46 BST 2018 944 293.05 XLON 18318XJcg6z Wed 14 Nov 15:26:32 BST 2018 516 293.15 CHIX 18318XJcg5t Wed 14 Nov 15:26:32 BST 2018 534 293.15 CHIX 18318XJcg5s Wed 14 Nov 15:26:32 BST 2018 40 293.15 CHIX 18318XJcg5r Wed 14 Nov 15:26:32 BST 2018 577 293.15 CHIX 18318XJcg5q Wed 14 Nov 15:26:32 BST 2018 1265 293.15 XLON 18318XJcg5o Wed 14 Nov 15:26:32 BST 2018 745 293.15 XLON 18318XJcg5p Wed 14 Nov 15:26:02 BST 2018 1507 293.15 XLON 18318XJcg2k Wed 14 Nov 15:26:02 BST 2018 680 293.15 CHIX 18318XJcg2l Wed 14 Nov 15:25:56 BST 2018 669 293.20 CHIX 18318XJcg1m Wed 14 Nov 15:25:56 BST 2018 952 293.20 CHIX 18318XJcg1l Wed 14 Nov 15:25:56 BST 2018 107 293.20 XLON 18318XJcg1k Wed 14 Nov 15:25:56 BST 2018 2109 293.20 XLON 18318XJcg1j Wed 14 Nov 15:25:12 BST 2018 965 293.05 CHIX 18318XJcfwo Wed 14 Nov 15:25:12 BST 2018 2139 293.05 XLON 18318XJcfwl Wed 14 Nov 15:25:04 BST 2018 1372 293.30 XLON 18318XJcfvc Wed 14 Nov 15:25:04 BST 2018 620 293.30 CHIX 18318XJcfvb Wed 14 Nov 15:24:53 BST 2018 1024 293.25 XLON 18318XJcfu9 Wed 14 Nov 15:24:53 BST 2018 215 293.25 XLON 18318XJcfu5 Wed 14 Nov 15:24:53 BST 2018 3169 293.25 XLON 18318XJcfu3 Wed 14 Nov 15:24:53 BST 2018 625 293.25 CHIX 18318XJcfu8 Wed 14 Nov 15:24:53 BST 2018 702 293.25 CHIX 18318XJcfu7 Wed 14 Nov 15:24:53 BST 2018 889 293.25 CHIX 18318XJcfu4 Wed 14 Nov 15:24:53 BST 2018 540 293.25 CHIX 18318XJcfu1 Wed 14 Nov 15:24:35 BST 2018 666 293.30 CHIX 18318XJcfrh Wed 14 Nov 15:24:35 BST 2018 518 293.30 CHIX 18318XJcfrg Wed 14 Nov 15:24:34 BST 2018 451 293.35 CHIX 18318XJcfr5 Wed 14 Nov 15:24:34 BST 2018 534 293.35 CHIX 18318XJcfr4 Wed 14 Nov 15:24:34 BST 2018 701 293.35 CHIX 18318XJcfr3 Wed 14 Nov 15:24:34 BST 2018 641 293.35 XLON 18318XJcfr2 Wed 14 Nov 15:24:34 BST 2018 104 293.35 XLON 18318XJcfr1 Wed 14 Nov 15:24:22 BST 2018 430 293.40 CHIX 18318XJcfqi Wed 14 Nov 15:24:06 BST 2018 565 293.40 CHIX 18318XJcfoj Wed 14 Nov 15:24:06 BST 2018 1158 293.40 XLON 18318XJcfoi Wed 14 Nov 15:24:05 BST 2018 510 293.45 CHIX 18318XJcfo5 Wed 14 Nov 15:24:01 BST 2018 214 293.45 CHIX 18318XJcfny Wed 14 Nov 15:24:01 BST 2018 533 293.45 CHIX 18318XJcfnw Wed 14 Nov 15:24:01 BST 2018 431 293.45 CHIX 18318XJcfnz Wed 14 Nov 15:24:01 BST 2018 109 293.45 XLON 18318XJcfnx Wed 14 Nov 15:24:01 BST 2018 25 293.45 XLON 18318XJcfnv Wed 14 Nov 15:24:01 BST 2018 564 293.45 XLON 18318XJcfnu Wed 14 Nov 15:24:01 BST 2018 543 293.50 CHIX 18318XJcfnt Wed 14 Nov 15:24:01 BST 2018 1111 293.50 XLON 18318XJcfnr Wed 14 Nov 15:23:04 BST 2018 587 293.10 CHIX 18318XJcfib Wed 14 Nov 15:23:04 BST 2018 1201 293.10 XLON 18318XJcfi1 Wed 14 Nov 15:23:04 BST 2018 94 293.10 XLON 18318XJcfi6 Wed 14 Nov 15:23:02 BST 2018 699 293.15 CHIX 18318XJcfhb Wed 14 Nov 15:23:02 BST 2018 1549 293.15 XLON 18318XJcfha Wed 14 Nov 15:22:50 BST 2018 172 293.05 XLON 18318XJcfgn Wed 14 Nov 15:22:46 BST 2018 309 293.25 XLON 18318XJcffz Wed 14 Nov 15:22:46 BST 2018 442 293.25 CHIX 18318XJcfg2 Wed 14 Nov 15:22:46 BST 2018 571 293.25 CHIX 18318XJcfg3 Wed 14 Nov 15:22:46 BST 2018 92 293.25 CHIX 18318XJcfg1 Wed 14 Nov 15:22:46 BST 2018 843 293.25 CHIX 18318XJcffy Wed 14 Nov 15:22:46 BST 2018 1868 293.25 XLON 18318XJcffx Wed 14 Nov 15:22:46 BST 2018 190 293.25 XLON 18318XJcffv Wed 14 Nov 15:22:43 BST 2018 565 293.30 CHIX 18318XJcffe Wed 14 Nov 15:22:43 BST 2018 618 293.30 CHIX 18318XJcffd Wed 14 Nov 15:22:43 BST 2018 270 293.30 CHIX 18318XJcffc Wed 14 Nov 15:22:43 BST 2018 1309 293.30 XLON 18318XJcffb Wed 14 Nov 15:22:43 BST 2018 41 293.30 XLON 18318XJcffa Wed 14 Nov 15:21:34 BST 2018 534 293.00 CHIX 18318XJcf8i Wed 14 Nov 15:21:34 BST 2018 742 293.00 CHIX 18318XJcf8h Wed 14 Nov 15:21:34 BST 2018 854 293.00 XLON 18318XJcf8g Wed 14 Nov 15:21:34 BST 2018 1644 293.00 XLON 18318XJcf8f Wed 14 Nov 15:21:33 BST 2018 224 293.05 XLON 18318XJcf8a Wed 14 Nov 15:21:33 BST 2018 619 293.05 CHIX 18318XJcf89 Wed 14 Nov 15:21:15 BST 2018 308 293.00 CHIX 18318XJcf66 Wed 14 Nov 15:21:15 BST 2018 517 293.00 CHIX 18318XJcf65 Wed 14 Nov 15:21:15 BST 2018 534 293.00 CHIX 18318XJcf64 Wed 14 Nov 15:21:15 BST 2018 1069 293.00 XLON 18318XJcf63 Wed 14 Nov 15:21:08 BST 2018 1153 293.00 CHIX 18318XJcf43 Wed 14 Nov 15:21:08 BST 2018 2557 293.00 XLON 18318XJcf42 Wed 14 Nov 15:21:08 BST 2018 344 293.05 CHIX 18318XJcf3z Wed 14 Nov 15:21:08 BST 2018 534 293.05 CHIX 18318XJcf41 Wed 14 Nov 15:21:08 BST 2018 812 293.05 XLON 18318XJcf3x Wed 14 Nov 15:21:01 BST 2018 243 293.05 CHIX 18318XJcf3d Wed 14 Nov 15:21:01 BST 2018 694 293.05 CHIX 18318XJcf2y Wed 14 Nov 15:21:01 BST 2018 534 293.10 CHIX 18318XJcf2s Wed 14 Nov 15:21:01 BST 2018 597 293.10 CHIX 18318XJcf2r Wed 14 Nov 15:21:01 BST 2018 626 293.10 XLON 18318XJcf2q Wed 14 Nov 15:21:01 BST 2018 1222 293.10 XLON 18318XJcf2p Wed 14 Nov 15:19:47 BST 2018 518 293.00 CHIX 18318XJcew9 Wed 14 Nov 15:19:47 BST 2018 622 293.00 CHIX 18318XJcew8 Wed 14 Nov 15:19:47 BST 2018 534 293.00 CHIX 18318XJcewa Wed 14 Nov 15:19:47 BST 2018 574 293.00 XLON 18318XJcew7 Wed 14 Nov 15:19:47 BST 2018 36 293.00 XLON 18318XJcew6 Wed 14 Nov 15:19:47 BST 2018 1339 293.00 XLON 18318XJcew5 Wed 14 Nov 15:19:41 BST 2018 2002 293.15 XLON 18318XJcev9 Wed 14 Nov 15:19:41 BST 2018 904 293.15 CHIX 18318XJcev8 Wed 14 Nov 15:19:41 BST 2018 534 293.25 CHIX 18318XJceuk Wed 14 Nov 15:19:41 BST 2018 696 293.25 XLON 18318XJceu7 Wed 14 Nov 15:19:41 BST 2018 142 293.25 XLON 18318XJcets Wed 14 Nov 15:19:39 BST 2018 534 293.30 CHIX 18318XJcet7 Wed 14 Nov 15:19:39 BST 2018 382 293.30 CHIX 18318XJcet9 Wed 14 Nov 15:19:39 BST 2018 657 293.30 XLON 18318XJcesv Wed 14 Nov 15:19:39 BST 2018 165 293.30 XLON 18318XJcesy Wed 14 Nov 15:18:46 BST 2018 55 292.85 XLON 18318XJcenn Wed 14 Nov 15:17:10 BST 2018 815 293.00 CHIX 18318XJceea Wed 14 Nov 15:17:10 BST 2018 9 293.00 XLON 18318XJcee9 Wed 14 Nov 15:17:10 BST 2018 1700 293.00 CHIX 18318XJcee8 Wed 14 Nov 15:17:10 BST 2018 3409 293.00 CHIX 18318XJcee7 Wed 14 Nov 15:17:10 BST 2018 3299 293.00 XLON 18318XJcee5 Wed 14 Nov 15:17:10 BST 2018 2000 293.00 XLON 18318XJcee4 Wed 14 Nov 15:17:10 BST 2018 415 293.00 XLON 18318XJcee3 Wed 14 Nov 15:17:10 BST 2018 7422 293.00 XLON 18318XJcee2 Wed 14 Nov 15:16:56 BST 2018 1078 293.25 CHIX 18318XJcedk Wed 14 Nov 15:16:56 BST 2018 2388 293.25 XLON 18318XJcedj Wed 14 Nov 15:15:25 BST 2018 686 293.30 CHIX 18318XJce1z Wed 14 Nov 15:15:25 BST 2018 1519 293.30 XLON 18318XJce1y Wed 14 Nov 15:15:18 BST 2018 1 293.35 CHIX 18318XJce0u Wed 14 Nov 15:15:18 BST 2018 1068 293.35 CHIX 18318XJce0s Wed 14 Nov 15:15:18 BST 2018 1284 293.35 XLON 18318XJce0q Wed 14 Nov 15:15:18 BST 2018 1086 293.35 XLON 18318XJce0l Wed 14 Nov 15:15:02 BST 2018 440 293.45 CHIX 18318XJcdz2 Wed 14 Nov 15:15:02 BST 2018 5145 293.50 XLON 18318XJcdz0 Wed 14 Nov 15:15:02 BST 2018 2319 293.50 CHIX 18318XJcdyz Wed 14 Nov 15:14:59 BST 2018 452 293.55 XLON 18318XJcdyh Wed 14 Nov 15:14:59 BST 2018 533 293.55 CHIX 18318XJcdyf Wed 14 Nov 15:14:59 BST 2018 608 293.55 CHIX 18318XJcdye Wed 14 Nov 15:14:59 BST 2018 397 293.55 CHIX 18318XJcdyd Wed 14 Nov 15:14:59 BST 2018 342 293.55 CHIX 18318XJcdyg Wed 14 Nov 15:14:52 BST 2018 736 293.60 CHIX 18318XJcdxl Wed 14 Nov 15:14:52 BST 2018 1630 293.60 XLON 18318XJcdxk Wed 14 Nov 15:14:37 BST 2018 667 293.60 CHIX 18318XJcdw4 Wed 14 Nov 15:14:37 BST 2018 748 293.60 CHIX 18318XJcdw3 Wed 14 Nov 15:14:37 BST 2018 566 293.60 CHIX 18318XJcdw2 Wed 14 Nov 15:14:37 BST 2018 48 293.60 CHIX 18318XJcdw1 Wed 14 Nov 15:14:37 BST 2018 647 293.60 CHIX 18318XJcdw0 Wed 14 Nov 15:14:37 BST 2018 107 293.60 XLON 18318XJcdvz Wed 14 Nov 15:14:37 BST 2018 295 293.60 XLON 18318XJcdvy Wed 14 Nov 15:14:36 BST 2018 3 293.65 XLON 18318XJcdvo Wed 14 Nov 15:14:36 BST 2018 14 293.65 XLON 18318XJcdvr Wed 14 Nov 15:14:36 BST 2018 241 293.65 CHIX 18318XJcdvm Wed 14 Nov 15:14:36 BST 2018 533 293.65 CHIX 18318XJcdvl Wed 14 Nov 15:14:36 BST 2018 889 293.65 XLON 18318XJcdvk Wed 14 Nov 15:14:28 BST 2018 221 293.70 XLON 18318XJcdun Wed 14 Nov 15:14:28 BST 2018 533 293.70 CHIX 18318XJcduo Wed 14 Nov 15:14:28 BST 2018 443 293.70 XLON 18318XJcdum Wed 14 Nov 15:14:28 BST 2018 49 293.65 XLON 18318XJcduj Wed 14 Nov 15:14:28 BST 2018 945 293.65 XLON 18318XJcduh Wed 14 Nov 15:14:28 BST 2018 1187 293.65 XLON 18318XJcduk Wed 14 Nov 15:14:28 BST 2018 579 293.65 CHIX 18318XJcdug Wed 14 Nov 15:14:28 BST 2018 533 293.65 CHIX 18318XJcdud Wed 14 Nov 15:14:07 BST 2018 395 293.70 CHIX 18318XJcdt1 Wed 14 Nov 15:14:05 BST 2018 729 293.75 XLON 18318XJcdsx Wed 14 Nov 15:14:05 BST 2018 533 293.75 CHIX 18318XJcdsv Wed 14 Nov 15:14:00 BST 2018 914 293.65 XLON 18318XJcdrz Wed 14 Nov 15:14:00 BST 2018 1841 293.65 XLON 18318XJcdrx Wed 14 Nov 15:14:00 BST 2018 1243 293.65 CHIX 18318XJcdry Wed 14 Nov 15:13:42 BST 2018 567 293.65 CHIX 18318XJcdqh Wed 14 Nov 15:13:26 BST 2018 626 293.60 CHIX 18318XJcdnx Wed 14 Nov 15:11:30 BST 2018 4420 293.75 XLON 18318XJcdag Wed 14 Nov 15:11:30 BST 2018 2058 293.75 XLON 18318XJcdaf Wed 14 Nov 15:11:30 BST 2018 1465 293.75 XLON 18318XJcdae Wed 14 Nov 15:11:30 BST 2018 2018 293.75 CHIX 18318XJcdac Wed 14 Nov 15:11:30 BST 2018 1562 293.75 CHIX 18318XJcdab Wed 14 Nov 15:09:58 BST 2018 5706 293.65 XLON 18318XJcd28 Wed 14 Nov 15:09:58 BST 2018 2074 293.65 XLON 18318XJcd26 Wed 14 Nov 15:09:58 BST 2018 1400 293.65 XLON 18318XJcd25 Wed 14 Nov 15:09:58 BST 2018 1199 293.65 XLON 18318XJcd23 Wed 14 Nov 15:09:58 BST 2018 853 293.65 XLON 18318XJcd1y Wed 14 Nov 15:09:58 BST 2018 1230 293.65 CHIX 18318XJcd21 Wed 14 Nov 15:09:58 BST 2018 1400 293.65 CHIX 18318XJcd1w Wed 14 Nov 15:09:58 BST 2018 2432 293.65 CHIX 18318XJcd1u Wed 14 Nov 15:09:58 BST 2018 524 293.70 CHIX 18318XJcd19 Wed 14 Nov 15:09:58 BST 2018 42 293.70 CHIX 18318XJcd18 Wed 14 Nov 15:09:58 BST 2018 234 293.70 CHIX 18318XJcd16 Wed 14 Nov 15:09:47 BST 2018 533 293.80 CHIX 18318XJcczg Wed 14 Nov 15:09:47 BST 2018 466 293.80 XLON 18318XJcczf Wed 14 Nov 15:09:43 BST 2018 385 293.90 XLON 18318XJccys Wed 14 Nov 15:09:43 BST 2018 533 293.90 CHIX 18318XJccyt Wed 14 Nov 15:09:43 BST 2018 635 293.90 XLON 18318XJccyr Wed 14 Nov 15:09:21 BST 2018 22 293.95 XLON 18318XJccxq Wed 14 Nov 15:09:21 BST 2018 4210 293.95 XLON 18318XJccxs Wed 14 Nov 15:09:21 BST 2018 1898 293.95 CHIX 18318XJccxp Wed 14 Nov 15:08:56 BST 2018 1084 293.95 XLON 18318XJccuo Wed 14 Nov 15:08:56 BST 2018 532 293.95 CHIX 18318XJccup Wed 14 Nov 15:08:41 BST 2018 179 294.00 XLON 18318XJcctm Wed 14 Nov 15:08:31 BST 2018 1250 294.10 CHIX 18318XJccsn Wed 14 Nov 15:08:31 BST 2018 71 294.15 CHIX 18318XJccsm Wed 14 Nov 15:08:31 BST 2018 1000 294.15 CHIX 18318XJccsl Wed 14 Nov 15:08:31 BST 2018 182 294.15 XLON 18318XJccsi Wed 14 Nov 15:08:31 BST 2018 602 294.15 XLON 18318XJccsk Wed 14 Nov 15:08:30 BST 2018 1773 294.15 XLON 18318XJccs6 Wed 14 Nov 15:08:30 BST 2018 809 294.20 CHIX 18318XJccs5 Wed 14 Nov 15:08:30 BST 2018 1792 294.20 XLON 18318XJccs4 Wed 14 Nov 15:08:30 BST 2018 55 294.25 XLON 18318XJccs3 Wed 14 Nov 15:08:24 BST 2018 532 294.35 CHIX 18318XJccqq Wed 14 Nov 15:08:24 BST 2018 639 294.35 CHIX 18318XJccqp Wed 14 Nov 15:08:24 BST 2018 633 294.35 XLON 18318XJccqo Wed 14 Nov 15:08:24 BST 2018 186 294.35 XLON 18318XJccqn Wed 14 Nov 15:08:24 BST 2018 1413 294.35 XLON 18318XJccqm Wed 14 Nov 15:08:20 BST 2018 147 294.40 XLON 18318XJccps Wed 14 Nov 15:08:20 BST 2018 1463 294.40 XLON 18318XJccpq Wed 14 Nov 15:08:20 BST 2018 661 294.40 CHIX 18318XJccpp Wed 14 Nov 15:08:18 BST 2018 1523 294.45 XLON 18318XJccpk Wed 14 Nov 15:08:18 BST 2018 411 294.45 XLON 18318XJccpi Wed 14 Nov 15:08:18 BST 2018 872 294.45 CHIX 18318XJccpj Wed 14 Nov 15:08:17 BST 2018 196 294.50 XLON 18318XJccph Wed 14 Nov 15:08:17 BST 2018 725 294.50 CHIX 18318XJccpg Wed 14 Nov 15:08:16 BST 2018 499 294.50 XLON 18318XJccp6 Wed 14 Nov 15:08:16 BST 2018 581 294.50 CHIX 18318XJccp5 Wed 14 Nov 15:08:16 BST 2018 718 294.50 CHIX 18318XJccp7 Wed 14 Nov 15:08:16 BST 2018 213 294.50 CHIX 18318XJccp4 Wed 14 Nov 15:08:16 BST 2018 531 294.50 CHIX 18318XJccp3 Wed 14 Nov 15:08:16 BST 2018 725 294.60 CHIX 18318XJccp1 Wed 14 Nov 15:08:16 BST 2018 336 294.60 CHIX 18318XJccp0 Wed 14 Nov 15:08:16 BST 2018 281 294.60 CHIX 18318XJccoy Wed 14 Nov 15:08:16 BST 2018 232 294.60 CHIX 18318XJccot Wed 14 Nov 15:08:16 BST 2018 671 294.60 CHIX 18318XJccox Wed 14 Nov 15:08:16 BST 2018 316 294.60 CHIX 18318XJccoq Wed 14 Nov 15:08:16 BST 2018 215 294.60 CHIX 18318XJccoo Wed 14 Nov 15:08:16 BST 2018 17 294.60 XLON 18318XJccos Wed 14 Nov 15:08:16 BST 2018 1487 294.60 XLON 18318XJccor Wed 14 Nov 15:08:16 BST 2018 170 294.60 XLON 18318XJccow Wed 14 Nov 15:08:16 BST 2018 904 294.60 XLON 18318XJccop Wed 14 Nov 15:08:07 BST 2018 631 294.65 XLON 18318XJccny Wed 14 Nov 15:08:07 BST 2018 745 294.65 XLON 18318XJccnx Wed 14 Nov 15:08:07 BST 2018 1894 294.65 XLON 18318XJccnv Wed 14 Nov 15:08:07 BST 2018 656 294.65 XLON 18318XJccnt Wed 14 Nov 15:08:07 BST 2018 345 294.65 CHIX 18318XJccnz Wed 14 Nov 15:08:07 BST 2018 276 294.65 CHIX 18318XJccnw Wed 14 Nov 15:08:07 BST 2018 1151 294.65 CHIX 18318XJccnu Wed 14 Nov 15:08:07 BST 2018 718 294.70 XLON 18318XJccnp Wed 14 Nov 15:08:07 BST 2018 531 294.70 CHIX 18318XJccns Wed 14 Nov 15:08:07 BST 2018 608 294.70 CHIX 18318XJccnr Wed 14 Nov 15:08:07 BST 2018 596 294.70 CHIX 18318XJccnq Wed 14 Nov 15:08:07 BST 2018 233 294.70 XLON 18318XJccno Wed 14 Nov 15:07:00 BST 2018 320 294.20 CHIX 18318XJcci2 Wed 14 Nov 15:05:34 BST 2018 1672 293.30 CHIX 18318XJcc6j Wed 14 Nov 15:05:34 BST 2018 1044 293.30 XLON 18318XJcc6g Wed 14 Nov 15:05:34 BST 2018 2663 293.30 XLON 18318XJcc6f Wed 14 Nov 15:04:01 BST 2018 809 293.15 CHIX 18318XJcbv0 Wed 14 Nov 15:04:01 BST 2018 1791 293.15 XLON 18318XJcbuz Wed 14 Nov 15:03:31 BST 2018 209 293.25 CHIX 18318XJcbru Wed 14 Nov 15:03:31 BST 2018 1403 293.25 XLON 18318XJcbrt Wed 14 Nov 15:03:31 BST 2018 604 293.25 XLON 18318XJcbrs Wed 14 Nov 15:03:31 BST 2018 1570 293.30 XLON 18318XJcbrr Wed 14 Nov 15:03:31 BST 2018 708 293.30 CHIX 18318XJcbrq Wed 14 Nov 15:03:04 BST 2018 1113 293.35 CHIX 18318XJcbp4 Wed 14 Nov 15:03:04 BST 2018 1578 293.35 CHIX 18318XJcbp1 Wed 14 Nov 15:03:04 BST 2018 217 293.35 CHIX 18318XJcboz Wed 14 Nov 15:03:04 BST 2018 8830 293.35 XLON 18318XJcboy Wed 14 Nov 15:02:53 BST 2018 551 293.35 CHIX 18318XJcbks Wed 14 Nov 15:02:53 BST 2018 1130 293.35 XLON 18318XJcbkt Wed 14 Nov 15:02:42 BST 2018 504 293.35 CHIX 18318XJcbjx Wed 14 Nov 15:02:42 BST 2018 884 293.40 CHIX 18318XJcbjw Wed 14 Nov 15:02:42 BST 2018 1956 293.40 XLON 18318XJcbjv Wed 14 Nov 15:02:37 BST 2018 3049 293.50 XLON 18318XJcbj0 Wed 14 Nov 15:02:37 BST 2018 138 293.50 CHIX 18318XJcbiz Wed 14 Nov 15:02:37 BST 2018 1237 293.50 CHIX 18318XJcbiy Wed 14 Nov 15:02:34 BST 2018 1 293.55 CHIX 18318XJcbib Wed 14 Nov 15:02:34 BST 2018 532 293.55 CHIX 18318XJcbia Wed 14 Nov 15:02:34 BST 2018 429 293.55 XLON 18318XJcbi9 Wed 14 Nov 15:02:33 BST 2018 465 293.65 XLON 18318XJcbhh Wed 14 Nov 15:02:33 BST 2018 614 293.65 CHIX 18318XJcbhg Wed 14 Nov 15:02:33 BST 2018 533 293.65 CHIX 18318XJcbhi Wed 14 Nov 15:02:33 BST 2018 521 293.65 XLON 18318XJcbhf Wed 14 Nov 15:02:22 BST 2018 87 293.80 XLON 18318XJcbeo Wed 14 Nov 15:01:42 BST 2018 692 293.65 CHIX 18318XJcbar Wed 14 Nov 15:01:42 BST 2018 1531 293.65 XLON 18318XJcbaq Wed 14 Nov 15:01:13 BST 2018 1812 293.55 XLON 18318XJcb8a Wed 14 Nov 15:01:13 BST 2018 801 293.55 XLON 18318XJcb85 Wed 14 Nov 15:01:13 BST 2018 1179 293.55 CHIX 18318XJcb87 Wed 14 Nov 15:01:12 BST 2018 482 293.65 XLON 18318XJcb7x Wed 14 Nov 15:01:12 BST 2018 3102 293.65 XLON 18318XJcb7w Wed 14 Nov 15:01:12 BST 2018 1616 293.65 CHIX 18318XJcb7t Wed 14 Nov 15:00:21 BST 2018 2038 293.40 XLON 18318XJcb1r Wed 14 Nov 15:00:01 BST 2018 1585 293.50 CHIX 18318XJcaed Wed 14 Nov 15:00:01 BST 2018 3515 293.50 XLON 18318XJcaeb Wed 14 Nov 14:59:40 BST 2018 300 293.30 CHIX 18318XJcaaw Wed 14 Nov 14:59:40 BST 2018 759 293.35 CHIX 18318XJcaat Wed 14 Nov 14:59:34 BST 2018 1232 293.35 XLON 18318XJcaae Wed 14 Nov 14:59:34 BST 2018 601 293.35 CHIX 18318XJcaad Wed 14 Nov 14:59:33 BST 2018 338 293.40 CHIX 18318XJca9z Wed 14 Nov 14:59:33 BST 2018 195 293.40 CHIX 18318XJca9y Wed 14 Nov 14:59:33 BST 2018 635 293.40 XLON 18318XJca9x Wed 14 Nov 14:59:23 BST 2018 1221 293.55 CHIX 18318XJca7b Wed 14 Nov 14:59:23 BST 2018 2706 293.55 XLON 18318XJca7a Wed 14 Nov 14:58:47 BST 2018 1414 293.35 XLON 18318XJc9zz Wed 14 Nov 14:58:47 BST 2018 163 293.35 XLON 18318XJc9zn Wed 14 Nov 14:58:47 BST 2018 713 293.35 CHIX 18318XJc9zt Wed 14 Nov 14:58:47 BST 2018 140 293.40 XLON 18318XJc9zk Wed 14 Nov 14:58:23 BST 2018 99 293.55 XLON 18318XJc9w1 Wed 14 Nov 14:58:15 BST 2018 1191 293.55 CHIX 18318XJc9v9 Wed 14 Nov 14:58:15 BST 2018 650 293.60 CHIX 18318XJc9v8 Wed 14 Nov 14:58:15 BST 2018 1439 293.60 XLON 18318XJc9v6 Wed 14 Nov 14:58:15 BST 2018 2641 293.55 XLON 18318XJc9v7 Wed 14 Nov 14:58:09 BST 2018 391 293.65 CHIX 18318XJc9un Wed 14 Nov 14:57:53 BST 2018 1801 293.70 CHIX 18318XJc9t4 Wed 14 Nov 14:57:53 BST 2018 3995 293.70 XLON 18318XJc9t3 Wed 14 Nov 14:57:19 BST 2018 1259 293.95 CHIX 18318XJc9qv Wed 14 Nov 14:57:19 BST 2018 1843 293.95 XLON 18318XJc9qu Wed 14 Nov 14:57:19 BST 2018 948 293.95 XLON 18318XJc9qt Wed 14 Nov 14:55:25 BST 2018 409 293.75 CHIX 18318XJc9em Wed 14 Nov 14:55:25 BST 2018 533 293.85 CHIX 18318XJc9ec Wed 14 Nov 14:55:25 BST 2018 937 293.85 XLON 18318XJc9eb Wed 14 Nov 14:55:24 BST 2018 985 293.95 XLON 18318XJc9ea Wed 14 Nov 14:55:24 BST 2018 5761 293.95 XLON 18318XJc9e8 Wed 14 Nov 14:55:24 BST 2018 2521 293.95 CHIX 18318XJc9e9 Wed 14 Nov 14:55:24 BST 2018 519 293.95 CHIX 18318XJc9e7 Wed 14 Nov 14:54:06 BST 2018 1190 294.10 XLON 18318XJc95u Wed 14 Nov 14:54:06 BST 2018 1500 294.10 XLON 18318XJc95s Wed 14 Nov 14:54:06 BST 2018 2071 294.15 CHIX 18318XJc95p Wed 14 Nov 14:54:06 BST 2018 2010 294.15 XLON 18318XJc95m Wed 14 Nov 14:54:06 BST 2018 403 294.15 XLON 18318XJc95l Wed 14 Nov 14:54:06 BST 2018 806 294.15 XLON 18318XJc95k Wed 14 Nov 14:54:06 BST 2018 1373 294.15 XLON 18318XJc95j Wed 14 Nov 14:53:48 BST 2018 743 294.25 XLON 18318XJc91j Wed 14 Nov 14:53:48 BST 2018 2599 294.25 XLON 18318XJc91i Wed 14 Nov 14:53:48 BST 2018 1508 294.25 CHIX 18318XJc91h Wed 14 Nov 14:53:48 BST 2018 16 294.30 XLON 18318XJc90u Wed 14 Nov 14:53:48 BST 2018 38 294.30 XLON 18318XJc913 Wed 14 Nov 14:53:39 BST 2018 532 294.45 CHIX 18318XJc904 Wed 14 Nov 14:53:39 BST 2018 992 294.45 XLON 18318XJc903 Wed 14 Nov 14:53:13 BST 2018 1379 294.60 XLON 18318XJc8xj Wed 14 Nov 14:53:13 BST 2018 622 294.60 CHIX 18318XJc8xl Wed 14 Nov 14:53:12 BST 2018 584 294.65 CHIX 18318XJc8x1 Wed 14 Nov 14:52:42 BST 2018 671 294.85 XLON 18318XJc8u0 Wed 14 Nov 14:52:31 BST 2018 1114 295.00 CHIX 18318XJc8sg Wed 14 Nov 14:52:31 BST 2018 2468 295.00 XLON 18318XJc8sf Wed 14 Nov 14:52:24 BST 2018 33 295.05 CHIX 18318XJc8rh Wed 14 Nov 14:52:24 BST 2018 530 295.05 CHIX 18318XJc8ri Wed 14 Nov 14:52:24 BST 2018 530 295.05 CHIX 18318XJc8rl Wed 14 Nov 14:52:24 BST 2018 320 295.05 CHIX 18318XJc8rg Wed 14 Nov 14:52:24 BST 2018 525 295.05 XLON 18318XJc8rf Wed 14 Nov 14:52:24 BST 2018 536 295.05 XLON 18318XJc8re Wed 14 Nov 14:52:24 BST 2018 43 295.05 XLON 18318XJc8rd Wed 14 Nov 14:52:22 BST 2018 417 295.05 CHIX 18318XJc8r1 Wed 14 Nov 14:52:21 BST 2018 733 295.10 XLON 18318XJc8qm Wed 14 Nov 14:52:21 BST 2018 1735 295.10 XLON 18318XJc8ql Wed 14 Nov 14:52:21 BST 2018 1114 295.10 CHIX 18318XJc8qk Wed 14 Nov 14:52:21 BST 2018 791 295.15 XLON 18318XJc8qi Wed 14 Nov 14:52:21 BST 2018 454 295.15 XLON 18318XJc8qj Wed 14 Nov 14:52:21 BST 2018 469 295.15 CHIX 18318XJc8qh Wed 14 Nov 14:52:21 BST 2018 1024 295.15 XLON 18318XJc8qg Wed 14 Nov 14:52:21 BST 2018 819 295.15 CHIX 18318XJc8qe Wed 14 Nov 14:52:21 BST 2018 61 295.15 CHIX 18318XJc8qf Wed 14 Nov 14:51:47 BST 2018 1905 295.25 XLON 18318XJc8mw Wed 14 Nov 14:51:47 BST 2018 50 295.25 CHIX 18318XJc8my Wed 14 Nov 14:51:47 BST 2018 860 295.25 CHIX 18318XJc8mu Wed 14 Nov 14:51:47 BST 2018 703 295.25 CHIX 18318XJc8mv Wed 14 Nov 14:51:44 BST 2018 534 295.30 CHIX 18318XJc8mc Wed 14 Nov 14:51:43 BST 2018 7353 295.35 XLON 18318XJc8mb Wed 14 Nov 14:51:43 BST 2018 2102 295.35 CHIX 18318XJc8ma Wed 14 Nov 14:51:43 BST 2018 1211 295.35 CHIX 18318XJc8m9 Wed 14 Nov 14:51:43 BST 2018 1635 295.40 XLON 18318XJc8m8 Wed 14 Nov 14:51:43 BST 2018 923 295.40 XLON 18318XJc8m5 Wed 14 Nov 14:51:43 BST 2018 1463 295.40 CHIX 18318XJc8m7 Wed 14 Nov 14:51:43 BST 2018 688 295.40 XLON 18318XJc8m3 Wed 14 Nov 14:51:39 BST 2018 1499 295.45 XLON 18318XJc8lg Wed 14 Nov 14:51:39 BST 2018 678 295.45 CHIX 18318XJc8lf Wed 14 Nov 14:51:36 BST 2018 538 295.45 CHIX 18318XJc8l7 Wed 14 Nov 14:51:34 BST 2018 365 295.45 CHIX 18318XJc8kx Wed 14 Nov 14:51:00 BST 2018 557 295.20 CHIX 18318XJc8hm Wed 14 Nov 14:51:00 BST 2018 494 295.20 XLON 18318XJc8hl Wed 14 Nov 14:51:00 BST 2018 530 295.20 CHIX 18318XJc8hk Wed 14 Nov 14:51:00 BST 2018 799 295.25 XLON 18318XJc8hi Wed 14 Nov 14:51:00 BST 2018 10 295.25 XLON 18318XJc8hj Wed 14 Nov 14:51:00 BST 2018 1711 295.25 XLON 18318XJc8hg Wed 14 Nov 14:51:00 BST 2018 1132 295.25 CHIX 18318XJc8hh Wed 14 Nov 14:50:11 BST 2018 530 295.40 CHIX 18318XJc89l Wed 14 Nov 14:50:11 BST 2018 415 295.40 XLON 18318XJc89k Wed 14 Nov 14:49:43 BST 2018 804 295.20 XLON 18318XJc82y Wed 14 Nov 14:49:43 BST 2018 1425 295.20 XLON 18318XJc82x Wed 14 Nov 14:49:43 BST 2018 515 295.20 XLON 18318XJc82w Wed 14 Nov 14:49:43 BST 2018 1238 295.20 CHIX 18318XJc82v Wed 14 Nov 14:49:30 BST 2018 500 295.05 CHIX 18318XJc812 Wed 14 Nov 14:49:10 BST 2018 551 295.00 CHIX 18318XJc7xj Wed 14 Nov 14:49:09 BST 2018 806 295.05 CHIX 18318XJc7xg Wed 14 Nov 14:48:16 BST 2018 1 295.10 CHIX 18318XJc7l6 Wed 14 Nov 14:48:16 BST 2018 529 295.10 CHIX 18318XJc7l5 Wed 14 Nov 14:48:16 BST 2018 489 295.10 XLON 18318XJc7l4 Wed 14 Nov 14:48:05 BST 2018 1426 295.20 CHIX 18318XJc7hi Wed 14 Nov 14:48:05 BST 2018 1215 295.20 CHIX 18318XJc7hh Wed 14 Nov 14:48:04 BST 2018 380 295.20 CHIX 18318XJc7h0 Wed 14 Nov 14:48:03 BST 2018 248 295.25 CHIX 18318XJc7gl Wed 14 Nov 14:48:03 BST 2018 517 295.25 CHIX 18318XJc7g5 Wed 14 Nov 14:47:59 BST 2018 2329 295.35 CHIX 18318XJc7er Wed 14 Nov 14:47:59 BST 2018 3641 295.35 XLON 18318XJc7eq Wed 14 Nov 14:47:59 BST 2018 440 295.35 XLON 18318XJc7ep Wed 14 Nov 14:47:59 BST 2018 537 295.35 XLON 18318XJc7eo Wed 14 Nov 14:47:59 BST 2018 549 295.35 XLON 18318XJc7em Wed 14 Nov 14:47:58 BST 2018 585 295.40 CHIX 18318XJc7ei Wed 14 Nov 14:47:50 BST 2018 261 295.45 CHIX 18318XJc7ce Wed 14 Nov 14:47:50 BST 2018 644 295.45 CHIX 18318XJc7cb Wed 14 Nov 14:47:50 BST 2018 907 295.45 XLON 18318XJc7ca Wed 14 Nov 14:47:50 BST 2018 1098 295.45 XLON 18318XJc7c9 Wed 14 Nov 14:47:40 BST 2018 1554 295.55 CHIX 18318XJc7ap Wed 14 Nov 14:47:40 BST 2018 1389 295.55 XLON 18318XJc7ao Wed 14 Nov 14:47:40 BST 2018 2057 295.55 XLON 18318XJc7an Wed 14 Nov 14:47:35 BST 2018 403 295.65 XLON 18318XJc79c Wed 14 Nov 14:47:35 BST 2018 120 295.65 XLON 18318XJc799 Wed 14 Nov 14:47:35 BST 2018 529 295.65 CHIX 18318XJc798 Wed 14 Nov 14:47:35 BST 2018 512 295.65 CHIX 18318XJc797 Wed 14 Nov 14:47:27 BST 2018 575 295.70 CHIX 18318XJc78f Wed 14 Nov 14:47:23 BST 2018 144 295.70 XLON 18318XJc77p Wed 14 Nov 14:47:23 BST 2018 1965 295.70 XLON 18318XJc77n Wed 14 Nov 14:47:23 BST 2018 640 295.70 CHIX 18318XJc77q Wed 14 Nov 14:47:23 BST 2018 41 295.70 CHIX 18318XJc77o Wed 14 Nov 14:47:23 BST 2018 297 295.70 CHIX 18318XJc77r Wed 14 Nov 14:47:22 BST 2018 253 295.75 CHIX 18318XJc77l Wed 14 Nov 14:47:22 BST 2018 180 295.75 XLON 18318XJc77g Wed 14 Nov 14:47:22 BST 2018 624 295.75 XLON 18318XJc77k Wed 14 Nov 14:47:22 BST 2018 529 295.75 CHIX 18318XJc77h Wed 14 Nov 14:47:22 BST 2018 26 295.75 CHIX 18318XJc77f Wed 14 Nov 14:47:22 BST 2018 503 295.75 CHIX 18318XJc77c Wed 14 Nov 14:47:22 BST 2018 503 295.75 XLON 18318XJc779 Wed 14 Nov 14:47:03 BST 2018 846 295.70 CHIX 18318XJc73z Wed 14 Nov 14:46:49 BST 2018 290 295.85 CHIX 18318XJc719 Wed 14 Nov 14:46:49 BST 2018 239 295.85 CHIX 18318XJc715 Wed 14 Nov 14:46:49 BST 2018 493 295.85 XLON 18318XJc711 Wed 14 Nov 14:46:47 BST 2018 455 295.90 XLON 18318XJc705 Wed 14 Nov 14:46:47 BST 2018 194 295.90 CHIX 18318XJc704 Wed 14 Nov 14:46:47 BST 2018 335 295.90 CHIX 18318XJc703 Wed 14 Nov 14:46:46 BST 2018 1836 295.95 XLON 18318XJc6zu Wed 14 Nov 14:46:46 BST 2018 828 295.95 CHIX 18318XJc6zt Wed 14 Nov 14:46:45 BST 2018 1365 296.05 XLON 18318XJc6zn Wed 14 Nov 14:46:45 BST 2018 358 296.05 XLON 18318XJc6zo Wed 14 Nov 14:46:45 BST 2018 617 296.05 CHIX 18318XJc6zl Wed 14 Nov 14:46:45 BST 2018 529 296.05 CHIX 18318XJc6zm Wed 14 Nov 14:46:45 BST 2018 610 296.05 CHIX 18318XJc6zk Wed 14 Nov 14:46:29 BST 2018 528 296.20 CHIX 18318XJc6xs Wed 14 Nov 14:46:29 BST 2018 528 296.20 CHIX 18318XJc6xt Wed 14 Nov 14:46:29 BST 2018 711 296.20 XLON 18318XJc6xr Wed 14 Nov 14:46:29 BST 2018 345 296.20 XLON 18318XJc6xq Wed 14 Nov 14:46:06 BST 2018 484 296.20 CHIX 18318XJc6vm Wed 14 Nov 14:45:50 BST 2018 8 296.05 XLON 18318XJc6rv Wed 14 Nov 14:45:50 BST 2018 11 296.05 XLON 18318XJc6rw Wed 14 Nov 14:45:50 BST 2018 221 296.05 CHIX 18318XJc6ru Wed 14 Nov 14:45:41 BST 2018 170 296.10 XLON 18318XJc6px Wed 14 Nov 14:45:41 BST 2018 1929 296.10 XLON 18318XJc6py Wed 14 Nov 14:45:41 BST 2018 97 296.10 XLON 18318XJc6q1 Wed 14 Nov 14:45:41 BST 2018 149 296.10 XLON 18318XJc6q2 Wed 14 Nov 14:45:41 BST 2018 299 296.10 CHIX 18318XJc6pz Wed 14 Nov 14:45:41 BST 2018 466 296.10 CHIX 18318XJc6q0 Wed 14 Nov 14:45:41 BST 2018 871 296.10 CHIX 18318XJc6pw Wed 14 Nov 14:45:40 BST 2018 397 296.15 XLON 18318XJc6pr Wed 14 Nov 14:45:40 BST 2018 544 296.15 XLON 18318XJc6pp Wed 14 Nov 14:45:40 BST 2018 528 296.15 CHIX 18318XJc6po Wed 14 Nov 14:45:39 BST 2018 3293 296.20 XLON 18318XJc6pd Wed 14 Nov 14:45:39 BST 2018 1486 296.20 CHIX 18318XJc6pc Wed 14 Nov 14:45:38 BST 2018 696 296.30 CHIX 18318XJc6p1 Wed 14 Nov 14:45:38 BST 2018 717 296.30 CHIX 18318XJc6ox Wed 14 Nov 14:45:38 BST 2018 1590 296.30 XLON 18318XJc6ov Wed 14 Nov 14:45:36 BST 2018 715 296.35 CHIX 18318XJc6oj Wed 14 Nov 14:45:35 BST 2018 3 296.35 XLON 18318XJc6oe Wed 14 Nov 14:45:35 BST 2018 90 296.35 XLON 18318XJc6od Wed 14 Nov 14:45:35 BST 2018 710 296.35 XLON 18318XJc6oc Wed 14 Nov 14:45:35 BST 2018 1297 296.35 XLON 18318XJc6ob Wed 14 Nov 14:45:35 BST 2018 907 296.35 CHIX 18318XJc6oa Wed 14 Nov 14:45:33 BST 2018 429 296.40 CHIX 18318XJc6o1 Wed 14 Nov 14:45:33 BST 2018 528 296.40 CHIX 18318XJc6o0 Wed 14 Nov 14:45:33 BST 2018 591 296.40 CHIX 18318XJc6ny Wed 14 Nov 14:45:33 BST 2018 749 296.40 XLON 18318XJc6nx Wed 14 Nov 14:45:33 BST 2018 509 296.40 XLON 18318XJc6nw Wed 14 Nov 14:45:33 BST 2018 702 296.40 XLON 18318XJc6nt Wed 14 Nov 14:45:21 BST 2018 23 296.45 XLON 18318XJc6mf Wed 14 Nov 14:45:17 BST 2018 1075 296.35 BATE 18318XJc6li Wed 14 Nov 14:45:17 BST 2018 268 296.35 CHIX 18318XJc6lh Wed 14 Nov 14:45:17 BST 2018 12 296.35 XLON 18318XJc6lf Wed 14 Nov 14:45:17 BST 2018 279 296.35 XLON 18318XJc6lg Wed 14 Nov 14:45:08 BST 2018 489 296.25 CHIX 18318XJc6ib Wed 14 Nov 14:45:08 BST 2018 649 296.25 CHIX 18318XJc6hx Wed 14 Nov 14:45:08 BST 2018 2532 296.25 CHIX 18318XJc6hw Wed 14 Nov 14:45:08 BST 2018 1068 296.25 XLON 18318XJc6hu Wed 14 Nov 14:45:07 BST 2018 120 296.20 XLON 18318XJc6hf Wed 14 Nov 14:45:03 BST 2018 804 296.25 XLON 18318XJc6gz Wed 14 Nov 14:45:03 BST 2018 528 296.25 CHIX 18318XJc6h0 Wed 14 Nov 14:42:41 BST 2018 716 295.10 CHIX 18318XJc5s4 Wed 14 Nov 14:42:41 BST 2018 589 295.10 CHIX 18318XJc5s5 Wed 14 Nov 14:42:41 BST 2018 289 295.10 CHIX 18318XJc5s3 Wed 14 Nov 14:42:41 BST 2018 241 295.10 CHIX 18318XJc5s1 Wed 14 Nov 14:42:41 BST 2018 7 295.10 XLON 18318XJc5s2 Wed 14 Nov 14:42:41 BST 2018 522 295.10 XLON 18318XJc5s0 Wed 14 Nov 14:42:41 BST 2018 140 295.10 XLON 18318XJc5rz Wed 14 Nov 14:42:33 BST 2018 530 295.15 CHIX 18318XJc5r5 Wed 14 Nov 14:42:33 BST 2018 422 295.15 XLON 18318XJc5r4 Wed 14 Nov 14:42:33 BST 2018 1322 295.20 XLON 18318XJc5r2 Wed 14 Nov 14:42:33 BST 2018 427 295.20 XLON 18318XJc5r0 Wed 14 Nov 14:42:33 BST 2018 265 295.20 CHIX 18318XJc5r3 Wed 14 Nov 14:42:33 BST 2018 790 295.20 CHIX 18318XJc5r1 Wed 14 Nov 14:42:33 BST 2018 309 295.20 CHIX 18318XJc5qz Wed 14 Nov 14:42:15 BST 2018 423 295.25 XLON 18318XJc5nh Wed 14 Nov 14:42:15 BST 2018 20 295.25 CHIX 18318XJc5ne Wed 14 Nov 14:42:15 BST 2018 321 295.25 CHIX 18318XJc5nd Wed 14 Nov 14:42:15 BST 2018 221 295.25 CHIX 18318XJc5nb Wed 14 Nov 14:42:15 BST 2018 100 295.25 CHIX 18318XJc5nc Wed 14 Nov 14:42:15 BST 2018 100 295.25 CHIX 18318XJc5na Wed 14 Nov 14:42:15 BST 2018 100 295.25 CHIX 18318XJc5n9 Wed 14 Nov 14:42:15 BST 2018 100 295.25 CHIX 18318XJc5n8 Wed 14 Nov 14:42:15 BST 2018 811 295.25 XLON 18318XJc5n7 Wed 14 Nov 14:42:15 BST 2018 530 295.25 CHIX 18318XJc5n5 Wed 14 Nov 14:42:15 BST 2018 530 295.25 CHIX 18318XJc5n6 Wed 14 Nov 14:42:15 BST 2018 530 295.25 CHIX 18318XJc5n4 Wed 14 Nov 14:42:05 BST 2018 302 295.20 CHIX 18318XJc5kj Wed 14 Nov 14:41:56 BST 2018 387 295.20 CHIX 18318XJc5hb Wed 14 Nov 14:41:42 BST 2018 750 295.10 BATE 18318XJc5e5 Wed 14 Nov 14:41:42 BST 2018 530 295.05 CHIX 18318XJc5e4 Wed 14 Nov 14:41:42 BST 2018 544 295.05 CHIX 18318XJc5e2 Wed 14 Nov 14:41:42 BST 2018 648 295.05 CHIX 18318XJc5e3 Wed 14 Nov 14:41:42 BST 2018 1114 295.05 XLON 18318XJc5e0 Wed 14 Nov 14:41:42 BST 2018 567 295.05 XLON 18318XJc5e1 Wed 14 Nov 14:41:42 BST 2018 461 295.05 XLON 18318XJc5dz Wed 14 Nov 14:41:42 BST 2018 332 295.10 CHIX 18318XJc5dy Wed 14 Nov 14:41:36 BST 2018 588 295.10 CHIX 18318XJc5cl Wed 14 Nov 14:41:36 BST 2018 108 295.10 XLON 18318XJc5ck Wed 14 Nov 14:41:36 BST 2018 1963 295.10 XLON 18318XJc5ci Wed 14 Nov 14:41:36 BST 2018 262 295.10 CHIX 18318XJc5cj Wed 14 Nov 14:41:36 BST 2018 886 295.10 CHIX 18318XJc5ch Wed 14 Nov 14:41:33 BST 2018 915 295.15 CHIX 18318XJc5bd Wed 14 Nov 14:41:33 BST 2018 603 295.15 CHIX 18318XJc5ba Wed 14 Nov 14:41:33 BST 2018 308 295.15 CHIX 18318XJc5bb Wed 14 Nov 14:41:33 BST 2018 1234 295.15 XLON 18318XJc5b9 Wed 14 Nov 14:41:14 BST 2018 289 295.15 CHIX 18318XJc572 Wed 14 Nov 14:41:14 BST 2018 41 295.15 CHIX 18318XJc571 Wed 14 Nov 14:41:02 BST 2018 133 295.15 CHIX 18318XJc55x Wed 14 Nov 14:41:02 BST 2018 175 295.15 CHIX 18318XJc55w Wed 14 Nov 14:40:54 BST 2018 146 295.15 XLON 18318XJc556 Wed 14 Nov 14:40:40 BST 2018 279 295.20 CHIX 18318XJc52a Wed 14 Nov 14:40:40 BST 2018 530 295.20 CHIX 18318XJc52b Wed 14 Nov 14:40:40 BST 2018 189 295.20 XLON 18318XJc529 Wed 14 Nov 14:40:40 BST 2018 482 295.20 XLON 18318XJc528 Wed 14 Nov 14:40:40 BST 2018 530 295.25 CHIX 18318XJc525 Wed 14 Nov 14:40:40 BST 2018 800 295.25 XLON 18318XJc526 Wed 14 Nov 14:40:40 BST 2018 9 295.25 XLON 18318XJc527 Wed 14 Nov 14:40:26 BST 2018 337 295.35 CHIX 18318XJc502 Wed 14 Nov 14:40:24 BST 2018 530 295.35 CHIX 18318XJc500 Wed 14 Nov 14:40:24 BST 2018 727 295.35 XLON 18318XJc4zz Wed 14 Nov 14:40:11 BST 2018 530 295.35 CHIX 18318XJc4yu Wed 14 Nov 14:40:11 BST 2018 514 295.35 XLON 18318XJc4yt Wed 14 Nov 14:39:54 BST 2018 1242 295.25 XLON 18318XJc4wd Wed 14 Nov 14:39:54 BST 2018 606 295.25 CHIX 18318XJc4we Wed 14 Nov 14:39:20 BST 2018 334 295.05 CHIX 18318XJc4rl Wed 14 Nov 14:39:20 BST 2018 530 295.05 CHIX 18318XJc4rk Wed 14 Nov 14:39:20 BST 2018 336 295.15 CHIX 18318XJc4rg Wed 14 Nov 14:39:20 BST 2018 681 295.15 CHIX 18318XJc4rh Wed 14 Nov 14:39:20 BST 2018 516 295.15 CHIX 18318XJc4ri Wed 14 Nov 14:39:20 BST 2018 1509 295.15 XLON 18318XJc4rf Wed 14 Nov 14:39:12 BST 2018 991 295.20 XLON 18318XJc4q2 Wed 14 Nov 14:39:02 BST 2018 530 295.20 CHIX 18318XJc4ov Wed 14 Nov 14:39:02 BST 2018 1003 295.20 XLON 18318XJc4ou Wed 14 Nov 14:38:48 BST 2018 497 295.35 CHIX 18318XJc4lw Wed 14 Nov 14:38:48 BST 2018 1498 295.35 XLON 18318XJc4lu Wed 14 Nov 14:38:48 BST 2018 180 295.35 CHIX 18318XJc4lt Wed 14 Nov 14:38:45 BST 2018 210 295.40 XLON 18318XJc4l7 Wed 14 Nov 14:38:45 BST 2018 623 295.40 CHIX 18318XJc4l6 Wed 14 Nov 14:38:38 BST 2018 763 295.50 CHIX 18318XJc4js Wed 14 Nov 14:38:33 BST 2018 736 295.60 CHIX 18318XJc4j0 Wed 14 Nov 14:38:33 BST 2018 1369 295.60 XLON 18318XJc4iz Wed 14 Nov 14:38:33 BST 2018 261 295.60 XLON 18318XJc4iy Wed 14 Nov 14:38:29 BST 2018 1950 295.70 XLON 18318XJc4hc Wed 14 Nov 14:38:28 BST 2018 637 295.80 CHIX 18318XJc4h4 Wed 14 Nov 14:38:27 BST 2018 637 295.80 CHIX 18318XJc4h2 Wed 14 Nov 14:38:27 BST 2018 529 295.80 CHIX 18318XJc4h1 Wed 14 Nov 14:38:27 BST 2018 76 295.80 XLON 18318XJc4h0 Wed 14 Nov 14:38:27 BST 2018 428 295.80 XLON 18318XJc4gz Wed 14 Nov 14:38:15 BST 2018 129 295.90 CHIX 18318XJc4em Wed 14 Nov 14:38:15 BST 2018 1 295.90 CHIX 18318XJc4en Wed 14 Nov 14:38:15 BST 2018 1475 295.90 XLON 18318XJc4ek Wed 14 Nov 14:38:15 BST 2018 923 295.90 CHIX 18318XJc4el Wed 14 Nov 14:38:13 BST 2018 663 295.75 CHIX 18318XJc4ea Wed 14 Nov 14:38:13 BST 2018 252 295.75 CHIX 18318XJc4e9 Wed 14 Nov 14:38:13 BST 2018 203 295.85 CHIX 18318XJc4e8 Wed 14 Nov 14:38:13 BST 2018 84 295.80 XLON 18318XJc4e7 Wed 14 Nov 14:38:00 BST 2018 457 295.85 CHIX 18318XJc4co Wed 14 Nov 14:38:00 BST 2018 444 295.85 CHIX 18318XJc4cn Wed 14 Nov 14:38:00 BST 2018 454 295.85 CHIX 18318XJc4cl Wed 14 Nov 14:38:00 BST 2018 720 295.85 XLON 18318XJc4ci Wed 14 Nov 14:38:00 BST 2018 768 295.85 XLON 18318XJc4cj Wed 14 Nov 14:37:59 BST 2018 75 295.85 CHIX 18318XJc4c7 Wed 14 Nov 14:37:59 BST 2018 529 295.85 CHIX 18318XJc4c6 Wed 14 Nov 14:37:55 BST 2018 498 295.90 XLON 18318XJc4bo Wed 14 Nov 14:37:55 BST 2018 529 295.90 CHIX 18318XJc4bm Wed 14 Nov 14:37:55 BST 2018 438 295.90 XLON 18318XJc4bl Wed 14 Nov 14:37:46 BST 2018 416 295.95 CHIX 18318XJc498 Wed 14 Nov 14:37:46 BST 2018 278 296.00 CHIX 18318XJc496 Wed 14 Nov 14:37:46 BST 2018 146 296.00 CHIX 18318XJc493 Wed 14 Nov 14:37:46 BST 2018 383 296.00 CHIX 18318XJc490 Wed 14 Nov 14:37:46 BST 2018 770 296.00 XLON 18318XJc48y Wed 14 Nov 14:37:44 BST 2018 88 296.05 XLON 18318XJc48r Wed 14 Nov 14:37:44 BST 2018 721 296.05 XLON 18318XJc48p Wed 14 Nov 14:37:44 BST 2018 529 296.05 CHIX 18318XJc48q Wed 14 Nov 14:37:43 BST 2018 809 296.10 XLON 18318XJc48f Wed 14 Nov 14:37:43 BST 2018 314 296.10 CHIX 18318XJc48e Wed 14 Nov 14:37:43 BST 2018 529 296.10 CHIX 18318XJc48g Wed 14 Nov 14:37:29 BST 2018 91 296.10 CHIX 18318XJc471 Wed 14 Nov 14:37:29 BST 2018 320 296.10 CHIX 18318XJc46y Wed 14 Nov 14:37:25 BST 2018 300 296.10 CHIX 18318XJc46t Wed 14 Nov 14:37:20 BST 2018 1107 296.15 XLON 18318XJc467 Wed 14 Nov 14:37:20 BST 2018 541 296.15 CHIX 18318XJc466 Wed 14 Nov 14:37:18 BST 2018 540 296.25 CHIX 18318XJc45z Wed 14 Nov 14:37:18 BST 2018 1106 296.25 XLON 18318XJc45y Wed 14 Nov 14:37:08 BST 2018 355 296.10 CHIX 18318XJc43s Wed 14 Nov 14:37:07 BST 2018 166 296.15 XLON 18318XJc43p Wed 14 Nov 14:37:05 BST 2018 447 296.15 CHIX 18318XJc431 Wed 14 Nov 14:37:05 BST 2018 558 296.15 CHIX 18318XJc432 Wed 14 Nov 14:37:05 BST 2018 496 296.20 CHIX 18318XJc430 Wed 14 Nov 14:37:05 BST 2018 1144 296.15 XLON 18318XJc42z Wed 14 Nov 14:37:05 BST 2018 9 296.20 XLON 18318XJc42y Wed 14 Nov 14:37:05 BST 2018 328 296.20 CHIX 18318XJc42x Wed 14 Nov 14:37:03 BST 2018 680 296.25 CHIX 18318XJc42q Wed 14 Nov 14:37:00 BST 2018 20 296.30 CHIX 18318XJc42i Wed 14 Nov 14:37:00 BST 2018 1077 296.30 XLON 18318XJc42h Wed 14 Nov 14:37:00 BST 2018 715 296.30 XLON 18318XJc42g Wed 14 Nov 14:37:00 BST 2018 790 296.30 CHIX 18318XJc42f Wed 14 Nov 14:36:53 BST 2018 612 296.40 CHIX 18318XJc40r Wed 14 Nov 14:36:53 BST 2018 463 296.40 XLON 18318XJc415 Wed 14 Nov 14:36:53 BST 2018 796 296.40 XLON 18318XJc414 Wed 14 Nov 14:36:52 BST 2018 686 296.50 BATE 18318XJc40p Wed 14 Nov 14:36:52 BST 2018 551 296.50 XLON 18318XJc40l Wed 14 Nov 14:36:52 BST 2018 15 296.50 XLON 18318XJc40n Wed 14 Nov 14:36:52 BST 2018 13 296.50 XLON 18318XJc40o Wed 14 Nov 14:36:52 BST 2018 528 296.50 CHIX 18318XJc40m Wed 14 Nov 14:36:44 BST 2018 7 296.55 XLON 18318XJc3zx Wed 14 Nov 14:36:43 BST 2018 1046 296.55 CHIX 18318XJc3zw Wed 14 Nov 14:36:43 BST 2018 2319 296.55 XLON 18318XJc3zv Wed 14 Nov 14:36:34 BST 2018 793 296.70 XLON 18318XJc3yx Wed 14 Nov 14:36:34 BST 2018 674 296.70 XLON 18318XJc3yw Wed 14 Nov 14:36:34 BST 2018 662 296.70 CHIX 18318XJc3yv Wed 14 Nov 14:36:23 BST 2018 335 296.60 CHIX 18318XJc3xf Wed 14 Nov 14:36:03 BST 2018 539 296.55 CHIX 18318XJc3rw Wed 14 Nov 14:36:03 BST 2018 1105 296.55 XLON 18318XJc3rv Wed 14 Nov 14:34:55 BST 2018 579 295.60 CHIX 18318XJc3bc Wed 14 Nov 14:34:55 BST 2018 949 295.60 CHIX 18318XJc3bb Wed 14 Nov 14:34:55 BST 2018 2004 295.60 XLON 18318XJc3b9 Wed 14 Nov 14:34:55 BST 2018 1187 295.60 XLON 18318XJc3ba Wed 14 Nov 14:34:55 BST 2018 100 295.60 XLON 18318XJc3b8 Wed 14 Nov 14:34:47 BST 2018 628 295.70 CHIX 18318XJc39s Wed 14 Nov 14:34:47 BST 2018 195 295.70 CHIX 18318XJc39q Wed 14 Nov 14:34:47 BST 2018 557 295.70 CHIX 18318XJc39p Wed 14 Nov 14:34:10 BST 2018 693 295.60 CHIX 18318XJc346 Wed 14 Nov 14:34:10 BST 2018 1147 295.60 XLON 18318XJc342 Wed 14 Nov 14:34:10 BST 2018 600 295.60 CHIX 18318XJc344 Wed 14 Nov 14:34:10 BST 2018 1720 295.60 XLON 18318XJc341 Wed 14 Nov 14:34:03 BST 2018 839 295.70 XLON 18318XJc32u Wed 14 Nov 14:34:03 BST 2018 213 295.70 XLON 18318XJc32s Wed 14 Nov 14:34:03 BST 2018 1116 295.70 XLON 18318XJc32r Wed 14 Nov 14:34:03 BST 2018 580 295.70 CHIX 18318XJc32o Wed 14 Nov 14:34:03 BST 2018 529 295.70 CHIX 18318XJc32p Wed 14 Nov 14:34:03 BST 2018 588 295.70 CHIX 18318XJc32t Wed 14 Nov 14:34:03 BST 2018 104 295.70 CHIX 18318XJc32q Wed 14 Nov 14:33:50 BST 2018 137 295.85 XLON 18318XJc30p Wed 14 Nov 14:33:50 BST 2018 19 295.85 CHIX 18318XJc30o Wed 14 Nov 14:33:50 BST 2018 529 295.85 CHIX 18318XJc30m Wed 14 Nov 14:33:50 BST 2018 671 295.85 CHIX 18318XJc30n Wed 14 Nov 14:33:50 BST 2018 436 295.85 XLON 18318XJc30k Wed 14 Nov 14:33:50 BST 2018 1530 295.85 XLON 18318XJc30l Wed 14 Nov 14:33:43 BST 2018 51 295.95 CHIX 18318XJc2zq Wed 14 Nov 14:33:43 BST 2018 586 295.95 CHIX 18318XJc2zp Wed 14 Nov 14:33:43 BST 2018 594 295.95 CHIX 18318XJc2zo Wed 14 Nov 14:33:43 BST 2018 362 295.95 XLON 18318XJc2zm Wed 14 Nov 14:33:43 BST 2018 673 295.95 XLON 18318XJc2zl Wed 14 Nov 14:33:43 BST 2018 183 295.95 XLON 18318XJc2zk Wed 14 Nov 14:33:30 BST 2018 340 295.70 CHIX 18318XJc2wv Wed 14 Nov 14:33:30 BST 2018 107 295.70 CHIX 18318XJc2wx Wed 14 Nov 14:33:30 BST 2018 406 295.70 XLON 18318XJc2wt Wed 14 Nov 14:33:20 BST 2018 95 295.75 XLON 18318XJc2tr Wed 14 Nov 14:33:20 BST 2018 21 295.75 XLON 18318XJc2ts Wed 14 Nov 14:33:20 BST 2018 376 295.75 XLON 18318XJc2tq Wed 14 Nov 14:33:20 BST 2018 166 295.75 XLON 18318XJc2tt Wed 14 Nov 14:33:20 BST 2018 440 295.75 CHIX 18318XJc2tp Wed 14 Nov 14:33:20 BST 2018 304 295.75 CHIX 18318XJc2tn Wed 14 Nov 14:33:20 BST 2018 529 295.75 CHIX 18318XJc2to Wed 14 Nov 14:33:20 BST 2018 243 295.75 CHIX 18318XJc2tm Wed 14 Nov 14:33:19 BST 2018 329 295.80 CHIX 18318XJc2tb Wed 14 Nov 14:33:13 BST 2018 553 295.80 CHIX 18318XJc2s3 Wed 14 Nov 14:33:05 BST 2018 211 295.80 CHIX 18318XJc2q8 Wed 14 Nov 14:33:05 BST 2018 96 295.80 CHIX 18318XJc2q9 Wed 14 Nov 14:33:05 BST 2018 1007 295.80 XLON 18318XJc2q5 Wed 14 Nov 14:33:05 BST 2018 477 295.80 XLON 18318XJc2q3 Wed 14 Nov 14:33:05 BST 2018 384 295.80 CHIX 18318XJc2q7 Wed 14 Nov 14:33:05 BST 2018 218 295.80 CHIX 18318XJc2q6 Wed 14 Nov 14:33:05 BST 2018 358 295.80 CHIX 18318XJc2q4 Wed 14 Nov 14:33:05 BST 2018 529 295.80 CHIX 18318XJc2q1 Wed 14 Nov 14:33:05 BST 2018 171 295.80 CHIX 18318XJc2q2 Wed 14 Nov 14:32:57 BST 2018 356 295.95 BATE 18318XJc2ns Wed 14 Nov 14:32:57 BST 2018 285 295.95 CHIX 18318XJc2nq Wed 14 Nov 14:32:56 BST 2018 529 295.95 CHIX 18318XJc2ni Wed 14 Nov 14:32:56 BST 2018 683 295.95 XLON 18318XJc2nh Wed 14 Nov 14:32:53 BST 2018 529 296.00 CHIX 18318XJc2nd Wed 14 Nov 14:32:53 BST 2018 529 296.00 CHIX 18318XJc2nb Wed 14 Nov 14:32:53 BST 2018 417 296.00 XLON 18318XJc2nc Wed 14 Nov 14:32:53 BST 2018 290 296.00 XLON 18318XJc2na Wed 14 Nov 14:32:53 BST 2018 501 296.00 XLON 18318XJc2n9 Wed 14 Nov 14:32:52 BST 2018 327 296.05 CHIX 18318XJc2mv Wed 14 Nov 14:32:46 BST 2018 529 296.05 CHIX 18318XJc2mq Wed 14 Nov 14:32:46 BST 2018 385 296.05 CHIX 18318XJc2mp Wed 14 Nov 14:32:46 BST 2018 503 296.05 XLON 18318XJc2mo Wed 14 Nov 14:32:04 BST 2018 744 295.90 CHIX 18318XJc2cl Wed 14 Nov 14:32:04 BST 2018 529 295.95 CHIX 18318XJc2ch Wed 14 Nov 14:32:04 BST 2018 352 295.85 XLON 18318XJc2ce Wed 14 Nov 14:32:04 BST 2018 1648 295.90 XLON 18318XJc2cf Wed 14 Nov 14:32:04 BST 2018 925 295.95 XLON 18318XJc2cc Wed 14 Nov 14:32:04 BST 2018 20 295.90 XLON 18318XJc2cd Wed 14 Nov 14:31:51 BST 2018 529 295.85 CHIX 18318XJc29w Wed 14 Nov 14:31:51 BST 2018 396 295.85 XLON 18318XJc29v Wed 14 Nov 14:31:51 BST 2018 1098 295.85 CHIX 18318XJc29t Wed 14 Nov 14:31:51 BST 2018 2432 295.85 XLON 18318XJc29s Wed 14 Nov 14:31:51 BST 2018 273 295.90 CHIX 18318XJc29r Wed 14 Nov 14:31:50 BST 2018 69 295.90 XLON 18318XJc29q Wed 14 Nov 14:31:50 BST 2018 580 295.90 CHIX 18318XJc29o Wed 14 Nov 14:31:42 BST 2018 549 295.95 CHIX 18318XJc272 Wed 14 Nov 14:31:35 BST 2018 273 296.05 CHIX 18318XJc25l Wed 14 Nov 14:31:35 BST 2018 483 296.05 XLON 18318XJc25k Wed 14 Nov 14:31:35 BST 2018 311 296.05 XLON 18318XJc25j Wed 14 Nov 14:31:35 BST 2018 107 296.05 CHIX 18318XJc25i Wed 14 Nov 14:31:35 BST 2018 229 296.05 CHIX 18318XJc25h Wed 14 Nov 14:31:35 BST 2018 300 296.05 CHIX 18318XJc25g Wed 14 Nov 14:31:27 BST 2018 618 296.15 XLON 18318XJc23f Wed 14 Nov 14:31:27 BST 2018 613 296.15 CHIX 18318XJc23e Wed 14 Nov 14:31:27 BST 2018 632 296.15 CHIX 18318XJc23d Wed 14 Nov 14:31:27 BST 2018 1398 296.15 XLON 18318XJc23c Wed 14 Nov 14:30:53 BST 2018 155 295.80 XLON 18318XJc1ug Wed 14 Nov 14:30:53 BST 2018 346 295.80 CHIX 18318XJc1uf Wed 14 Nov 14:30:49 BST 2018 848 295.85 CHIX 18318XJc1ts Wed 14 Nov 14:30:49 BST 2018 1878 295.85 XLON 18318XJc1tr Wed 14 Nov 14:29:00 BST 2018 192 295.30 CHIX 18318XJc16q Wed 14 Nov 14:29:00 BST 2018 547 295.30 CHIX 18318XJc16p Wed 14 Nov 14:29:00 BST 2018 34 295.30 XLON 18318XJc16o Wed 14 Nov 14:29:00 BST 2018 1600 295.30 XLON 18318XJc16n Wed 14 Nov 14:28:53 BST 2018 382 295.40 CHIX 18318XJc158 Wed 14 Nov 14:28:53 BST 2018 669 295.40 CHIX 18318XJc155 Wed 14 Nov 14:28:53 BST 2018 530 295.40 CHIX 18318XJc156 Wed 14 Nov 14:28:53 BST 2018 530 295.40 CHIX 18318XJc157 Wed 14 Nov 14:28:53 BST 2018 705 295.40 XLON 18318XJc153 Wed 14 Nov 14:28:53 BST 2018 491 295.40 XLON 18318XJc152 Wed 14 Nov 14:28:53 BST 2018 871 295.40 XLON 18318XJc151 Wed 14 Nov 14:28:53 BST 2018 609 295.40 XLON 18318XJc150 Wed 14 Nov 14:28:40 BST 2018 400 295.45 CHIX 18318XJc13o Wed 14 Nov 14:28:25 BST 2018 598 295.50 CHIX 18318XJc11f Wed 14 Nov 14:28:25 BST 2018 244 295.50 XLON 18318XJc11c Wed 14 Nov 14:28:24 BST 2018 1192 295.55 BATE 18318XJc11b Wed 14 Nov 14:28:24 BST 2018 732 295.55 XLON 18318XJc11a Wed 14 Nov 14:28:24 BST 2018 1 295.50 CHIX 18318XJc119 Wed 14 Nov 14:28:24 BST 2018 529 295.50 CHIX 18318XJc118 Wed 14 Nov 14:28:24 BST 2018 420 295.50 XLON 18318XJc116 Wed 14 Nov 14:28:24 BST 2018 42 295.50 XLON 18318XJc117 Wed 14 Nov 14:28:24 BST 2018 10 295.50 XLON 18318XJc114 Wed 14 Nov 14:28:20 BST 2018 500 295.60 CHIX 18318XJc10m Wed 14 Nov 14:28:19 BST 2018 746 295.60 CHIX 18318XJc10l Wed 14 Nov 14:28:19 BST 2018 10 295.60 XLON 18318XJc10k Wed 14 Nov 14:28:19 BST 2018 620 295.60 XLON 18318XJc10i Wed 14 Nov 14:28:19 BST 2018 667 295.60 XLON 18318XJc10f Wed 14 Nov 14:28:19 BST 2018 363 295.60 XLON 18318XJc10e Wed 14 Nov 14:28:10 BST 2018 400 295.65 CHIX 18318XJc0y9 Wed 14 Nov 14:27:51 BST 2018 530 295.50 CHIX 18318XJc0vj Wed 14 Nov 14:27:51 BST 2018 619 295.50 CHIX 18318XJc0vh Wed 14 Nov 14:27:51 BST 2018 530 295.50 CHIX 18318XJc0vi Wed 14 Nov 14:27:51 BST 2018 736 295.50 XLON 18318XJc0vf Wed 14 Nov 14:27:51 BST 2018 986 295.50 XLON 18318XJc0vg Wed 14 Nov 14:27:51 BST 2018 215 295.50 XLON 18318XJc0vd Wed 14 Nov 14:27:51 BST 2018 174 295.50 XLON 18318XJc0ve Wed 14 Nov 14:27:41 BST 2018 257 295.55 CHIX 18318XJc0th Wed 14 Nov 14:27:41 BST 2018 381 295.55 CHIX 18318XJc0tf Wed 14 Nov 14:27:41 BST 2018 76 295.55 XLON 18318XJc0ti Wed 14 Nov 14:27:21 BST 2018 514 295.60 CHIX 18318XJc0ra Wed 14 Nov 14:27:21 BST 2018 29 295.60 XLON 18318XJc0r9 Wed 14 Nov 14:27:21 BST 2018 43 295.65 CHIX 18318XJc0r8 Wed 14 Nov 14:27:10 BST 2018 300 295.65 CHIX 18318XJc0pi Wed 14 Nov 14:26:55 BST 2018 523 295.60 CHIX 18318XJc0o7 Wed 14 Nov 14:26:48 BST 2018 747 295.65 CHIX 18318XJc0n7 Wed 14 Nov 14:26:43 BST 2018 80 295.70 XLON 18318XJc0m7 Wed 14 Nov 14:26:43 BST 2018 46 295.70 XLON 18318XJc0m6 Wed 14 Nov 14:26:43 BST 2018 538 295.70 XLON 18318XJc0m4 Wed 14 Nov 14:26:43 BST 2018 283 295.70 CHIX 18318XJc0m5 Wed 14 Nov 14:26:43 BST 2018 529 295.70 CHIX 18318XJc0m9 Wed 14 Nov 14:26:43 BST 2018 226 295.70 CHIX 18318XJc0m8 Wed 14 Nov 14:26:43 BST 2018 349 295.70 CHIX 18318XJc0m3 Wed 14 Nov 14:26:01 BST 2018 333 295.60 CHIX 18318XJc0g5 Wed 14 Nov 14:25:57 BST 2018 512 295.60 CHIX 18318XJc0f4 Wed 14 Nov 14:25:57 BST 2018 529 295.60 CHIX 18318XJc0f2 Wed 14 Nov 14:25:57 BST 2018 584 295.60 CHIX 18318XJc0f3 Wed 14 Nov 14:25:57 BST 2018 1048 295.60 XLON 18318XJc0ez Wed 14 Nov 14:25:57 BST 2018 47 295.60 XLON 18318XJc0f0 Wed 14 Nov 14:25:57 BST 2018 114 295.60 XLON 18318XJc0f1 Wed 14 Nov 14:25:57 BST 2018 1 295.65 CHIX 18318XJc0ey Wed 14 Nov 14:25:57 BST 2018 706 295.65 CHIX 18318XJc0eu Wed 14 Nov 14:25:57 BST 2018 318 295.65 CHIX 18318XJc0es Wed 14 Nov 14:25:57 BST 2018 529 295.65 CHIX 18318XJc0ew Wed 14 Nov 14:25:57 BST 2018 554 295.65 CHIX 18318XJc0ex Wed 14 Nov 14:25:57 BST 2018 1138 295.65 XLON 18318XJc0ev Wed 14 Nov 14:25:57 BST 2018 504 295.65 XLON 18318XJc0et Wed 14 Nov 14:25:57 BST 2018 45 295.65 XLON 18318XJc0en Wed 14 Nov 14:25:57 BST 2018 136 295.65 XLON 18318XJc0eq Wed 14 Nov 14:25:57 BST 2018 372 295.65 XLON 18318XJc0er Wed 14 Nov 14:25:57 BST 2018 26 295.65 XLON 18318XJc0eo Wed 14 Nov 14:25:55 BST 2018 380 295.70 CHIX 18318XJc0ei Wed 14 Nov 14:25:52 BST 2018 307 295.70 CHIX 18318XJc0ed Wed 14 Nov 14:25:52 BST 2018 326 295.70 CHIX 18318XJc0ec Wed 14 Nov 14:25:52 BST 2018 1 295.75 CHIX 18318XJc0eb Wed 14 Nov 14:25:52 BST 2018 528 295.75 CHIX 18318XJc0ea Wed 14 Nov 14:25:52 BST 2018 264 295.75 XLON 18318XJc0e7 Wed 14 Nov 14:25:52 BST 2018 582 295.75 XLON 18318XJc0e6 Wed 14 Nov 14:25:50 BST 2018 36 295.75 CHIX 18318XJc0dz Wed 14 Nov 14:25:50 BST 2018 109 295.75 CHIX 18318XJc0e0 Wed 14 Nov 14:25:50 BST 2018 416 295.75 XLON 18318XJc0dy Wed 14 Nov 14:25:50 BST 2018 1250 295.75 CHIX 18318XJc0dx Wed 14 Nov 14:25:36 BST 2018 29 295.75 XLON 18318XJc0cr Wed 14 Nov 14:25:33 BST 2018 1900 295.80 XLON 18318XJc0cl Wed 14 Nov 14:25:33 BST 2018 616 295.70 XLON 18318XJc0ck Wed 14 Nov 14:25:33 BST 2018 198 295.75 CHIX 18318XJc0cj Wed 14 Nov 14:24:52 BST 2018 22 295.70 XLON 18318XJc06r Wed 14 Nov 14:24:52 BST 2018 529 295.75 CHIX 18318XJc06s Wed 14 Nov 14:24:51 BST 2018 47 295.75 XLON 18318XJc06q Wed 14 Nov 14:24:51 BST 2018 613 295.75 XLON 18318XJc06p Wed 14 Nov 14:24:35 BST 2018 337 295.70 CHIX 18318XJc04p Wed 14 Nov 14:24:29 BST 2018 1250 295.75 CHIX 18318XJc03o Wed 14 Nov 14:24:28 BST 2018 632 295.70 CHIX 18318XJc03m Wed 14 Nov 14:24:07 BST 2018 134 295.70 CHIX 18318XJc01j Wed 14 Nov 14:24:07 BST 2018 219 295.70 CHIX 18318XJc01i Wed 14 Nov 14:24:07 BST 2018 649 295.70 CHIX 18318XJc01h Wed 14 Nov 14:24:07 BST 2018 62 295.70 XLON 18318XJc01g Wed 14 Nov 14:24:07 BST 2018 1436 295.70 XLON 18318XJc01d Wed 14 Nov 14:24:00 BST 2018 133 295.75 XLON 18318XJc00x Wed 14 Nov 14:23:30 BST 2018 200 295.55 CHIX 18318XJbzx7 Wed 14 Nov 14:22:14 BST 2018 61 295.40 XLON 18318XJbzoy Wed 14 Nov 14:22:00 BST 2018 278 295.40 CHIX 18318XJbzns Wed 14 Nov 14:22:00 BST 2018 137 295.40 CHIX 18318XJbznr Wed 14 Nov 14:22:00 BST 2018 407 295.40 CHIX 18318XJbznq Wed 14 Nov 14:22:00 BST 2018 791 295.40 XLON 18318XJbznp Wed 14 Nov 14:22:00 BST 2018 322 295.40 XLON 18318XJbzno Wed 14 Nov 14:22:00 BST 2018 3 295.40 XLON 18318XJbznn Wed 14 Nov 14:22:00 BST 2018 100 295.45 XLON 18318XJbznl Wed 14 Nov 14:21:59 BST 2018 151 295.45 XLON 18318XJbznj Wed 14 Nov 14:21:40 BST 2018 100 295.45 CHIX 18318XJbzly Wed 14 Nov 14:21:35 BST 2018 373 295.40 CHIX 18318XJbzlq Wed 14 Nov 14:21:24 BST 2018 236 295.40 CHIX 18318XJbzl9 Wed 14 Nov 14:21:24 BST 2018 530 295.40 CHIX 18318XJbzlb Wed 14 Nov 14:21:24 BST 2018 674 295.40 CHIX 18318XJbzla Wed 14 Nov 14:21:24 BST 2018 63 295.40 XLON 18318XJbzl8 Wed 14 Nov 14:21:24 BST 2018 22 295.40 XLON 18318XJbzl7 Wed 14 Nov 14:21:24 BST 2018 331 295.40 XLON 18318XJbzl6 Wed 14 Nov 14:21:24 BST 2018 178 295.40 XLON 18318XJbzl2 Wed 14 Nov 14:21:24 BST 2018 510 295.40 XLON 18318XJbzl5 Wed 14 Nov 14:21:24 BST 2018 56 295.40 XLON 18318XJbzl4 Wed 14 Nov 14:21:24 BST 2018 51 295.40 XLON 18318XJbzl3 Wed 14 Nov 14:21:24 BST 2018 734 295.50 CHIX 18318XJbzl1 Wed 14 Nov 14:20:49 BST 2018 140 295.40 XLON 18318XJbzh1 Wed 14 Nov 14:20:40 BST 2018 180 295.45 XLON 18318XJbzgd Wed 14 Nov 14:20:40 BST 2018 143 295.45 XLON 18318XJbzgc Wed 14 Nov 14:20:26 BST 2018 266 295.50 CHIX 18318XJbzff Wed 14 Nov 14:20:26 BST 2018 255 295.50 CHIX 18318XJbzfe Wed 14 Nov 14:20:10 BST 2018 715 295.45 XLON 18318XJbze7 Wed 14 Nov 14:20:10 BST 2018 530 295.45 CHIX 18318XJbze8 Wed 14 Nov 14:20:04 BST 2018 637 295.50 CHIX 18318XJbzd0 Wed 14 Nov 14:19:49 BST 2018 606 295.40 CHIX 18318XJbz9d Wed 14 Nov 14:19:49 BST 2018 305 295.50 CHIX 18318XJbz9c Wed 14 Nov 14:19:49 BST 2018 1240 295.40 XLON 18318XJbz9b Wed 14 Nov 14:19:14 BST 2018 331 295.30 CHIX 18318XJbz5p Wed 14 Nov 14:19:02 BST 2018 45 295.20 CHIX 18318XJbz4w Wed 14 Nov 14:19:02 BST 2018 485 295.20 CHIX 18318XJbz4u Wed 14 Nov 14:19:02 BST 2018 73 295.20 XLON 18318XJbz4v Wed 14 Nov 14:19:02 BST 2018 90 295.20 XLON 18318XJbz4t Wed 14 Nov 14:19:02 BST 2018 19 295.20 XLON 18318XJbz4s Wed 14 Nov 14:19:02 BST 2018 18 295.20 XLON 18318XJbz4x Wed 14 Nov 14:19:02 BST 2018 485 295.20 XLON 18318XJbz4r Wed 14 Nov 14:18:56 BST 2018 1524 295.25 XLON 18318XJbz4l Wed 14 Nov 14:18:56 BST 2018 443 295.25 XLON 18318XJbz4k Wed 14 Nov 14:18:56 BST 2018 2221 295.25 XLON 18318XJbz4j Wed 14 Nov 14:18:56 BST 2018 1202 295.25 CHIX 18318XJbz4f Wed 14 Nov 14:18:49 BST 2018 530 295.35 CHIX 18318XJbz2t Wed 14 Nov 14:18:49 BST 2018 530 295.35 CHIX 18318XJbz2s Wed 14 Nov 14:18:49 BST 2018 708 295.35 XLON 18318XJbz2p Wed 14 Nov 14:18:49 BST 2018 914 295.35 XLON 18318XJbz2r Wed 14 Nov 14:18:49 BST 2018 174 295.35 XLON 18318XJbz2q Wed 14 Nov 14:18:46 BST 2018 679 295.40 CHIX 18318XJbz2k Wed 14 Nov 14:18:46 BST 2018 331 295.45 CHIX 18318XJbz2f Wed 14 Nov 14:18:46 BST 2018 530 295.40 CHIX 18318XJbz2e Wed 14 Nov 14:18:46 BST 2018 709 295.40 CHIX 18318XJbz2c Wed 14 Nov 14:18:46 BST 2018 549 295.40 XLON 18318XJbz28 Wed 14 Nov 14:18:46 BST 2018 111 295.40 XLON 18318XJbz2a Wed 14 Nov 14:18:43 BST 2018 803 295.45 CHIX 18318XJbz1k Wed 14 Nov 14:18:40 BST 2018 1823 295.50 CHIX 18318XJbz1i Wed 14 Nov 14:18:40 BST 2018 182 295.50 XLON 18318XJbz1h Wed 14 Nov 14:18:21 BST 2018 530 295.40 CHIX 18318XJbz0a Wed 14 Nov 14:18:21 BST 2018 860 295.40 XLON 18318XJbz09 Wed 14 Nov 14:17:32 BST 2018 676 295.05 CHIX 18318XJbyuw Wed 14 Nov 14:17:32 BST 2018 440 295.05 CHIX 18318XJbyuu Wed 14 Nov 14:17:29 BST 2018 530 295.10 CHIX 18318XJbyty Wed 14 Nov 14:17:29 BST 2018 530 295.10 CHIX 18318XJbytx Wed 14 Nov 14:17:29 BST 2018 469 295.10 XLON 18318XJbytw Wed 14 Nov 14:17:29 BST 2018 17 295.10 XLON 18318XJbytv Wed 14 Nov 14:17:29 BST 2018 427 295.10 XLON 18318XJbytu Wed 14 Nov 14:17:00 BST 2018 642 295.05 CHIX 18318XJbyqg Wed 14 Nov 14:15:31 BST 2018 835 294.70 CHIX 18318XJbyi4 Wed 14 Nov 14:15:31 BST 2018 206 294.70 CHIX 18318XJbyi3 Wed 14 Nov 14:15:31 BST 2018 747 294.70 CHIX 18318XJbyi2 Wed 14 Nov 14:15:31 BST 2018 1654 294.70 XLON 18318XJbyi0 Wed 14 Nov 14:15:31 BST 2018 5 294.70 XLON 18318XJbyi1 Wed 14 Nov 14:15:13 BST 2018 477 294.80 CHIX 18318XJbygo Wed 14 Nov 14:14:50 BST 2018 336 294.70 CHIX 18318XJbydx Wed 14 Nov 14:14:50 BST 2018 531 294.70 CHIX 18318XJbydw Wed 14 Nov 14:14:50 BST 2018 682 294.70 XLON 18318XJbydv Wed 14 Nov 14:14:46 BST 2018 540 294.70 CHIX 18318XJbydf Wed 14 Nov 14:14:39 BST 2018 1105 294.70 XLON 18318XJbycs Wed 14 Nov 14:14:31 BST 2018 244 294.60 CHIX 18318XJbyaz Wed 14 Nov 14:14:31 BST 2018 618 294.60 CHIX 18318XJbyay Wed 14 Nov 14:14:07 BST 2018 8 294.60 XLON 18318XJby90 Wed 14 Nov 14:14:07 BST 2018 341 294.60 XLON 18318XJby8z Wed 14 Nov 14:14:07 BST 2018 888 294.60 XLON 18318XJby8y Wed 14 Nov 14:14:07 BST 2018 600 294.60 CHIX 18318XJby8x Wed 14 Nov 14:14:07 BST 2018 225 294.65 CHIX 18318XJby8w Wed 14 Nov 14:14:07 BST 2018 370 294.65 CHIX 18318XJby8v Wed 14 Nov 14:14:06 BST 2018 156 294.70 XLON 18318XJby8u Wed 14 Nov 14:13:53 BST 2018 471 294.65 CHIX 18318XJby6p Wed 14 Nov 14:13:53 BST 2018 1746 294.70 XLON 18318XJby6o Wed 14 Nov 14:13:53 BST 2018 787 294.70 CHIX 18318XJby6n Wed 14 Nov 14:12:43 BST 2018 435 293.55 CHIX 18318XJbxz2 Wed 14 Nov 14:12:43 BST 2018 1250 293.55 CHIX 18318XJbxz0 Wed 14 Nov 14:12:43 BST 2018 1270 293.55 XLON 18318XJbxyt Wed 14 Nov 14:12:43 BST 2018 2464 293.55 XLON 18318XJbxyq Wed 14 Nov 14:12:27 BST 2018 533 293.60 CHIX 18318XJbxw4 Wed 14 Nov 14:12:27 BST 2018 447 293.60 XLON 18318XJbxw1 Wed 14 Nov 14:12:26 BST 2018 640 293.60 XLON 18318XJbxvt Wed 14 Nov 14:12:02 BST 2018 533 293.45 CHIX 18318XJbxrx Wed 14 Nov 14:12:02 BST 2018 417 293.45 XLON 18318XJbxrw Wed 14 Nov 14:12:02 BST 2018 533 293.55 CHIX 18318XJbxrv Wed 14 Nov 14:12:02 BST 2018 713 293.55 XLON 18318XJbxru Wed 14 Nov 14:12:02 BST 2018 533 293.60 CHIX 18318XJbxrq Wed 14 Nov 14:12:02 BST 2018 533 293.60 CHIX 18318XJbxrt Wed 14 Nov 14:12:02 BST 2018 311 293.60 CHIX 18318XJbxrs Wed 14 Nov 14:12:02 BST 2018 386 293.60 XLON 18318XJbxrr Wed 14 Nov 14:12:02 BST 2018 798 293.60 XLON 18318XJbxrp Wed 14 Nov 14:11:34 BST 2018 295 293.45 CHIX 18318XJbxps Wed 14 Nov 14:11:34 BST 2018 338 293.45 CHIX 18318XJbxpr Wed 14 Nov 14:11:32 BST 2018 706 293.50 CHIX 18318XJbxpq Wed 14 Nov 14:11:32 BST 2018 1564 293.50 XLON 18318XJbxpp Wed 14 Nov 14:11:23 BST 2018 825 293.55 CHIX 18318XJbxoq Wed 14 Nov 14:11:22 BST 2018 953 293.55 CHIX 18318XJbxom Wed 14 Nov 14:11:22 BST 2018 599 293.55 CHIX 18318XJbxop Wed 14 Nov 14:11:22 BST 2018 2113 293.55 XLON 18318XJbxon Wed 14 Nov 14:11:22 BST 2018 548 293.60 CHIX 18318XJbxoj Wed 14 Nov 14:11:22 BST 2018 1122 293.60 XLON 18318XJbxoi Wed 14 Nov 14:11:16 BST 2018 533 293.60 CHIX 18318XJbxnw Wed 14 Nov 14:11:16 BST 2018 497 293.60 XLON 18318XJbxnv Wed 14 Nov 14:09:09 BST 2018 534 292.95 CHIX 18318XJbx7o Wed 14 Nov 14:09:09 BST 2018 543 292.95 XLON 18318XJbx7n Wed 14 Nov 14:09:09 BST 2018 693 292.95 CHIX 18318XJbx7l Wed 14 Nov 14:09:01 BST 2018 500 293.00 CHIX 18318XJbx4k Wed 14 Nov 14:08:55 BST 2018 278 293.05 CHIX 18318XJbx2v Wed 14 Nov 14:08:55 BST 2018 776 293.05 CHIX 18318XJbx2w Wed 14 Nov 14:08:44 BST 2018 112 293.05 XLON 18318XJbx16 Wed 14 Nov 14:08:41 BST 2018 1814 293.05 XLON 18318XJbx0c Wed 14 Nov 14:08:41 BST 2018 289 293.05 CHIX 18318XJbx0e Wed 14 Nov 14:08:41 BST 2018 818 293.05 CHIX 18318XJbx0d Wed 14 Nov 14:08:40 BST 2018 534 293.10 CHIX 18318XJbx0b Wed 14 Nov 14:08:40 BST 2018 904 293.10 CHIX 18318XJbx0a Wed 14 Nov 14:08:40 BST 2018 185 293.10 XLON 18318XJbx08 Wed 14 Nov 14:08:40 BST 2018 616 293.10 XLON 18318XJbx07 Wed 14 Nov 14:08:40 BST 2018 26 293.10 XLON 18318XJbx09 Wed 14 Nov 14:08:25 BST 2018 708 293.15 CHIX 18318XJbwz0 Wed 14 Nov 14:08:25 BST 2018 317 293.15 CHIX 18318XJbwyz Wed 14 Nov 14:08:25 BST 2018 332 293.15 CHIX 18318XJbwyx Wed 14 Nov 14:08:25 BST 2018 1568 293.15 XLON 18318XJbwyt Wed 14 Nov 14:08:10 BST 2018 134 293.20 XLON 18318XJbwwp Wed 14 Nov 14:08:10 BST 2018 1083 293.20 XLON 18318XJbwwo Wed 14 Nov 14:08:10 BST 2018 156 293.20 XLON 18318XJbwwr Wed 14 Nov 14:08:10 BST 2018 125 293.20 XLON 18318XJbwwq Wed 14 Nov 14:08:10 BST 2018 534 293.20 CHIX 18318XJbwwn Wed 14 Nov 14:08:10 BST 2018 342 293.20 CHIX 18318XJbwwm Wed 14 Nov 14:08:10 BST 2018 284 293.25 CHIX 18318XJbwwl Wed 14 Nov 14:08:10 BST 2018 658 293.25 CHIX 18318XJbwwf Wed 14 Nov 14:08:10 BST 2018 534 293.25 CHIX 18318XJbwwi Wed 14 Nov 14:08:10 BST 2018 336 293.25 CHIX 18318XJbwwd Wed 14 Nov 14:08:05 BST 2018 73 293.25 XLON 18318XJbww0 Wed 14 Nov 14:08:05 BST 2018 1005 293.25 XLON 18318XJbwvz Wed 14 Nov 14:08:01 BST 2018 515 293.30 XLON 18318XJbwvg Wed 14 Nov 14:08:01 BST 2018 556 293.30 XLON 18318XJbwvf Wed 14 Nov 14:08:01 BST 2018 534 293.30 CHIX 18318XJbwve Wed 14 Nov 14:08:01 BST 2018 534 293.30 CHIX 18318XJbwvd Wed 14 Nov 14:08:01 BST 2018 315 293.30 CHIX 18318XJbwvc Wed 14 Nov 14:08:01 BST 2018 635 293.30 XLON 18318XJbwvb Wed 14 Nov 14:07:41 BST 2018 1240 293.35 XLON 18318XJbwtk Wed 14 Nov 14:07:40 BST 2018 500 293.30 CHIX 18318XJbwth Wed 14 Nov 14:07:01 BST 2018 534 293.35 CHIX 18318XJbwp3 Wed 14 Nov 14:07:01 BST 2018 430 293.35 XLON 18318XJbwp2 Wed 14 Nov 14:07:00 BST 2018 344 293.35 CHIX 18318XJbwow Wed 14 Nov 14:06:32 BST 2018 634 293.30 CHIX 18318XJbwke Wed 14 Nov 14:06:12 BST 2018 533 293.45 CHIX 18318XJbwis Wed 14 Nov 14:06:12 BST 2018 172 293.45 XLON 18318XJbwir Wed 14 Nov 14:06:09 BST 2018 458 293.45 XLON 18318XJbwip Wed 14 Nov 14:05:25 BST 2018 1581 293.30 XLON 18318XJbwdu Wed 14 Nov 14:05:25 BST 2018 206 293.30 CHIX 18318XJbwdw Wed 14 Nov 14:05:25 BST 2018 400 293.30 CHIX 18318XJbwdv Wed 14 Nov 14:05:25 BST 2018 713 293.30 CHIX 18318XJbwdt Wed 14 Nov 14:05:25 BST 2018 329 293.35 CHIX 18318XJbwdm Wed 14 Nov 14:05:18 BST 2018 165 293.35 XLON 18318XJbwcz Wed 14 Nov 14:05:03 BST 2018 745 293.40 CHIX 18318XJbwba Wed 14 Nov 14:05:03 BST 2018 103 293.40 XLON 18318XJbwb9 Wed 14 Nov 14:05:03 BST 2018 385 293.40 XLON 18318XJbwb8 Wed 14 Nov 14:05:03 BST 2018 533 293.40 CHIX 18318XJbwb7 Wed 14 Nov 14:04:01 BST 2018 130 293.15 CHIX 18318XJbw6f Wed 14 Nov 14:04:01 BST 2018 167 293.10 XLON 18318XJbw6e Wed 14 Nov 14:04:01 BST 2018 2004 293.10 XLON 18318XJbw6b Wed 14 Nov 14:04:01 BST 2018 1134 293.15 XLON 18318XJbw6a Wed 14 Nov 14:03:55 BST 2018 270 293.25 CHIX 18318XJbw5m Wed 14 Nov 14:03:46 BST 2018 347 293.25 CHIX 18318XJbw4t Wed 14 Nov 14:03:18 BST 2018 251 293.30 BATE 18318XJbw2f Wed 14 Nov 14:03:18 BST 2018 534 293.30 CHIX 18318XJbw2b Wed 14 Nov 14:03:18 BST 2018 819 293.30 XLON 18318XJbw2a Wed 14 Nov 14:02:10 BST 2018 785 293.05 CHIX 18318XJbvup Wed 14 Nov 14:02:07 BST 2018 1739 293.05 XLON 18318XJbvu5 Wed 14 Nov 14:01:30 BST 2018 828 293.00 CHIX 18318XJbvng Wed 14 Nov 14:01:30 BST 2018 273 293.00 CHIX 18318XJbvnf Wed 14 Nov 14:01:30 BST 2018 618 293.00 CHIX 18318XJbvne Wed 14 Nov 14:01:30 BST 2018 1661 293.00 XLON 18318XJbvnd Wed 14 Nov 14:01:30 BST 2018 173 293.00 XLON 18318XJbvnc Wed 14 Nov 14:01:30 BST 2018 1345 293.00 XLON 18318XJbvnb Wed 14 Nov 14:01:23 BST 2018 1 293.10 CHIX 18318XJbvm9 Wed 14 Nov 14:01:23 BST 2018 684 293.10 CHIX 18318XJbvm8 Wed 14 Nov 14:01:09 BST 2018 331 293.05 XLON 18318XJbvkk Wed 14 Nov 14:01:09 BST 2018 334 293.05 XLON 18318XJbvkj Wed 14 Nov 14:01:09 BST 2018 129 293.05 XLON 18318XJbvki Wed 14 Nov 14:01:09 BST 2018 534 293.05 XLON 18318XJbvkf Wed 14 Nov 14:01:09 BST 2018 534 293.05 CHIX 18318XJbvkh Wed 14 Nov 14:01:09 BST 2018 534 293.05 CHIX 18318XJbvkd Wed 14 Nov 14:01:09 BST 2018 343 293.10 CHIX 18318XJbvjw Wed 14 Nov 14:01:04 BST 2018 608 293.10 CHIX 18318XJbvj8 Wed 14 Nov 14:01:04 BST 2018 633 293.10 CHIX 18318XJbvj7 Wed 14 Nov 14:01:04 BST 2018 334 293.10 XLON 18318XJbvj6 Wed 14 Nov 14:01:04 BST 2018 912 293.10 XLON 18318XJbvj5 Wed 14 Nov 13:59:56 BST 2018 801 292.35 XLON 18318XJbv6s Wed 14 Nov 13:59:56 BST 2018 535 292.35 CHIX 18318XJbv6t Wed 14 Nov 13:59:53 BST 2018 4 292.45 XLON 18318XJbv6p Wed 14 Nov 13:59:53 BST 2018 379 292.45 XLON 18318XJbv6o Wed 14 Nov 13:59:53 BST 2018 1110 292.45 XLON 18318XJbv6q Wed 14 Nov 13:59:53 BST 2018 425 292.45 XLON 18318XJbv6n Wed 14 Nov 13:59:53 BST 2018 542 292.45 CHIX 18318XJbv6m Wed 14 Nov 13:59:53 BST 2018 535 292.45 CHIX 18318XJbv6l Wed 14 Nov 13:59:45 BST 2018 429 292.50 CHIX 18318XJbv67 Wed 14 Nov 13:59:39 BST 2018 2 292.50 XLON 18318XJbv5q Wed 14 Nov 13:59:39 BST 2018 16 292.50 XLON 18318XJbv5p Wed 14 Nov 13:59:39 BST 2018 414 292.50 CHIX 18318XJbv5o Wed 14 Nov 13:59:39 BST 2018 12 292.50 XLON 18318XJbv5n Wed 14 Nov 13:59:23 BST 2018 193 292.55 CHIX 18318XJbv42 Wed 14 Nov 13:59:23 BST 2018 190 292.60 XLON 18318XJbv3z Wed 14 Nov 13:59:23 BST 2018 71 292.60 XLON 18318XJbv40 Wed 14 Nov 13:59:23 BST 2018 586 292.60 CHIX 18318XJbv3x Wed 14 Nov 13:59:23 BST 2018 179 292.60 XLON 18318XJbv3y Wed 14 Nov 13:59:23 BST 2018 92 292.60 XLON 18318XJbv3w Wed 14 Nov 13:57:04 BST 2018 1033 292.80 CHIX 18318XJbund Wed 14 Nov 13:57:04 BST 2018 2291 292.80 XLON 18318XJbunc Wed 14 Nov 13:56:54 BST 2018 792 292.90 CHIX 18318XJbump Wed 14 Nov 13:56:54 BST 2018 1756 292.90 XLON 18318XJbumo Wed 14 Nov 13:56:11 BST 2018 362 292.95 XLON 18318XJbuk5 Wed 14 Nov 13:56:11 BST 2018 348 292.95 XLON 18318XJbuk3 Wed 14 Nov 13:56:11 BST 2018 534 292.95 CHIX 18318XJbuk2 Wed 14 Nov 13:56:11 BST 2018 382 292.95 CHIX 18318XJbuk6 Wed 14 Nov 13:56:11 BST 2018 534 292.95 CHIX 18318XJbuk4 Wed 14 Nov 13:56:04 BST 2018 609 293.25 CHIX 18318XJbuig Wed 14 Nov 13:56:04 BST 2018 240 293.25 CHIX 18318XJbuid Wed 14 Nov 13:56:04 BST 2018 292 293.15 CHIX 18318XJbuhx Wed 14 Nov 13:56:04 BST 2018 627 293.15 CHIX 18318XJbuhw Wed 14 Nov 13:56:04 BST 2018 534 293.15 CHIX 18318XJbuht Wed 14 Nov 13:56:04 BST 2018 117 293.20 XLON 18318XJbui8 Wed 14 Nov 13:56:04 BST 2018 1699 293.20 XLON 18318XJbuib Wed 14 Nov 13:56:04 BST 2018 742 293.20 XLON 18318XJbui4 Wed 14 Nov 13:56:04 BST 2018 789 293.20 XLON 18318XJbui1 Wed 14 Nov 13:56:04 BST 2018 638 293.20 CHIX 18318XJbuhl Wed 14 Nov 13:56:04 BST 2018 745 293.20 CHIX 18318XJbuhf Wed 14 Nov 13:56:04 BST 2018 768 293.20 CHIX 18318XJbuhr Wed 14 Nov 13:56:04 BST 2018 210 293.25 CHIX 18318XJbugx Wed 14 Nov 13:56:04 BST 2018 344 293.25 CHIX 18318XJbugn Wed 14 Nov 13:56:04 BST 2018 491 293.25 CHIX 18318XJbuh8 Wed 14 Nov 13:56:04 BST 2018 534 293.25 CHIX 18318XJbuh1 Wed 14 Nov 13:56:04 BST 2018 360 293.25 XLON 18318XJbug8 Wed 14 Nov 13:55:50 BST 2018 79 293.30 XLON 18318XJbufj Wed 14 Nov 13:55:37 BST 2018 669 293.30 CHIX 18318XJbue4 Wed 14 Nov 13:55:33 BST 2018 750 293.30 CHIX 18318XJbue0 Wed 14 Nov 13:55:23 BST 2018 138 293.30 CHIX 18318XJbudn Wed 14 Nov 13:55:23 BST 2018 181 293.30 CHIX 18318XJbudm Wed 14 Nov 13:54:03 BST 2018 712 293.15 XLON 18318XJbu6b Wed 14 Nov 13:53:40 BST 2018 534 293.25 CHIX 18318XJbu31 Wed 14 Nov 13:53:40 BST 2018 474 293.25 XLON 18318XJbu30 Wed 14 Nov 13:53:24 BST 2018 534 293.35 CHIX 18318XJbu1b Wed 14 Nov 13:53:24 BST 2018 688 293.35 XLON 18318XJbu1a Wed 14 Nov 13:53:21 BST 2018 618 293.40 CHIX 18318XJbu0o Wed 14 Nov 13:53:21 BST 2018 517 293.40 XLON 18318XJbu0n Wed 14 Nov 13:53:21 BST 2018 818 293.40 XLON 18318XJbu0m Wed 14 Nov 13:53:19 BST 2018 363 293.50 CHIX 18318XJbu0i Wed 14 Nov 13:53:19 BST 2018 1388 293.50 CHIX 18318XJbu0h Wed 14 Nov 13:53:19 BST 2018 83 293.50 XLON 18318XJbu0g Wed 14 Nov 13:53:19 BST 2018 648 293.50 XLON 18318XJbu0f Wed 14 Nov 13:53:09 BST 2018 535 293.55 XLON 18318XJbtyp Wed 14 Nov 13:53:09 BST 2018 533 293.55 CHIX 18318XJbtyo Wed 14 Nov 13:53:09 BST 2018 418 293.55 XLON 18318XJbtyn Wed 14 Nov 13:53:07 BST 2018 2428 293.50 XLON 18318XJbty3 Wed 14 Nov 13:53:04 BST 2018 4 293.55 CHIX 18318XJbtxj Wed 14 Nov 13:53:04 BST 2018 632 293.60 XLON 18318XJbtxg Wed 14 Nov 13:53:04 BST 2018 620 293.60 CHIX 18318XJbtxi Wed 14 Nov 13:53:04 BST 2018 533 293.60 CHIX 18318XJbtxh Wed 14 Nov 13:50:03 BST 2018 4017 293.00 XLON 18318XJbt1e Wed 14 Nov 13:50:03 BST 2018 1811 293.00 CHIX 18318XJbt1d Wed 14 Nov 13:50:02 BST 2018 1514 293.05 CHIX 18318XJbt0e Wed 14 Nov 13:50:02 BST 2018 41 293.05 CHIX 18318XJbt0a Wed 14 Nov 13:50:02 BST 2018 479 293.05 XLON 18318XJbt0h Wed 14 Nov 13:50:02 BST 2018 792 293.05 XLON 18318XJbt06 Wed 14 Nov 13:50:02 BST 2018 2177 293.05 XLON 18318XJbt04 Wed 14 Nov 13:48:22 BST 2018 264 293.00 CHIX 18318XJbsqc Wed 14 Nov 13:48:22 BST 2018 2046 293.00 XLON 18318XJbsqd Wed 14 Nov 13:48:22 BST 2018 1590 293.00 XLON 18318XJbsqa Wed 14 Nov 13:48:09 BST 2018 1470 293.20 XLON 18318XJbson Wed 14 Nov 13:48:09 BST 2018 665 293.20 CHIX 18318XJbsol Wed 14 Nov 13:47:46 BST 2018 1501 293.30 XLON 18318XJbsme Wed 14 Nov 13:47:46 BST 2018 678 293.30 CHIX 18318XJbsmf Wed 14 Nov 13:47:46 BST 2018 663 293.35 CHIX 18318XJbsmd Wed 14 Nov 13:47:46 BST 2018 1191 293.35 XLON 18318XJbsmc Wed 14 Nov 13:47:46 BST 2018 276 293.35 XLON 18318XJbsmb Wed 14 Nov 13:47:15 BST 2018 1336 293.40 XLON 18318XJbsjj Wed 14 Nov 13:47:15 BST 2018 618 293.40 CHIX 18318XJbsji Wed 14 Nov 13:46:17 BST 2018 659 293.00 CHIX 18318XJbscx Wed 14 Nov 13:46:17 BST 2018 717 293.00 CHIX 18318XJbscw Wed 14 Nov 13:45:53 BST 2018 258 293.20 CHIX 18318XJbsah Wed 14 Nov 13:45:53 BST 2018 59 293.20 CHIX 18318XJbsag Wed 14 Nov 13:45:53 BST 2018 1070 293.20 XLON 18318XJbsaf Wed 14 Nov 13:45:53 BST 2018 388 293.20 XLON 18318XJbsac Wed 14 Nov 13:45:53 BST 2018 342 293.20 CHIX 18318XJbsab Wed 14 Nov 13:45:50 BST 2018 1121 293.25 XLON 18318XJbs9h Wed 14 Nov 13:45:50 BST 2018 220 293.25 CHIX 18318XJbs9l Wed 14 Nov 13:45:50 BST 2018 448 293.25 CHIX 18318XJbs9k Wed 14 Nov 13:45:50 BST 2018 547 293.25 CHIX 18318XJbs9f Wed 14 Nov 13:45:43 BST 2018 534 293.30 CHIX 18318XJbs7q Wed 14 Nov 13:45:43 BST 2018 773 293.30 CHIX 18318XJbs7p Wed 14 Nov 13:45:43 BST 2018 128 293.30 XLON 18318XJbs7o Wed 14 Nov 13:45:43 BST 2018 797 293.30 XLON 18318XJbs7n Wed 14 Nov 13:45:43 BST 2018 1711 293.30 XLON 18318XJbs7m Wed 14 Nov 13:45:36 BST 2018 748 293.40 CHIX 18318XJbs6o Wed 14 Nov 13:45:34 BST 2018 289 293.45 CHIX 18318XJbs6i Wed 14 Nov 13:45:34 BST 2018 545 293.50 CHIX 18318XJbs6h Wed 14 Nov 13:45:34 BST 2018 307 293.50 CHIX 18318XJbs6f Wed 14 Nov 13:45:34 BST 2018 949 293.50 XLON 18318XJbs6g Wed 14 Nov 13:45:34 BST 2018 46 293.50 XLON 18318XJbs6e Wed 14 Nov 13:45:34 BST 2018 166 293.50 XLON 18318XJbs6d Wed 14 Nov 13:45:26 BST 2018 152 293.65 XLON 18318XJbs4z Wed 14 Nov 13:44:23 BST 2018 684 293.00 CHIX 18318XJbrtx Wed 14 Nov 13:44:23 BST 2018 161 293.00 XLON 18318XJbrtv Wed 14 Nov 13:44:23 BST 2018 2 293.00 XLON 18318XJbrts Wed 14 Nov 13:44:04 BST 2018 541 293.05 CHIX 18318XJbrr1 Wed 14 Nov 13:44:04 BST 2018 444 293.05 XLON 18318XJbrr0 Wed 14 Nov 13:44:04 BST 2018 718 293.05 CHIX 18318XJbrqw Wed 14 Nov 13:44:04 BST 2018 534 293.05 CHIX 18318XJbrqx Wed 14 Nov 13:43:57 BST 2018 621 293.15 CHIX 18318XJbrpl Wed 14 Nov 13:43:57 BST 2018 1375 293.15 XLON 18318XJbrpj Wed 14 Nov 13:43:20 BST 2018 483 292.95 CHIX 18318XJbrkq Wed 14 Nov 13:43:20 BST 2018 51 292.95 CHIX 18318XJbrkp Wed 14 Nov 13:43:20 BST 2018 187 292.95 XLON 18318XJbrko Wed 14 Nov 13:43:20 BST 2018 438 292.95 XLON 18318XJbrkn Wed 14 Nov 13:39:58 BST 2018 2716 292.90 XLON 18318XJbqs7 Wed 14 Nov 13:39:58 BST 2018 3008 292.90 CHIX 18318XJbqs3 Wed 14 Nov 13:39:58 BST 2018 157 292.90 XLON 18318XJbqs2 Wed 14 Nov 13:39:58 BST 2018 3800 292.90 XLON 18318XJbqs1 Wed 14 Nov 13:39:32 BST 2018 1240 292.50 XLON 18318XJbqmz Wed 14 Nov 13:39:32 BST 2018 2446 292.50 XLON 18318XJbqmy Wed 14 Nov 13:39:32 BST 2018 768 292.50 CHIX 18318XJbqmx Wed 14 Nov 13:39:19 BST 2018 897 292.55 CHIX 18318XJbqku Wed 14 Nov 13:39:19 BST 2018 1986 292.55 XLON 18318XJbqkt Wed 14 Nov 13:39:17 BST 2018 1204 292.65 XLON 18318XJbqkm Wed 14 Nov 13:39:17 BST 2018 588 292.65 CHIX 18318XJbqkn Wed 14 Nov 13:35:54 BST 2018 688 291.15 XLON 18318XJbpk8 Wed 14 Nov 13:35:52 BST 2018 1073 291.20 CHIX 18318XJbpk2 Wed 14 Nov 13:35:52 BST 2018 2378 291.20 XLON 18318XJbpk1 Wed 14 Nov 13:35:40 BST 2018 2495 291.30 XLON 18318XJbpib Wed 14 Nov 13:35:40 BST 2018 863 291.30 CHIX 18318XJbpia Wed 14 Nov 13:35:40 BST 2018 262 291.30 CHIX 18318XJbpi9 Wed 14 Nov 13:35:37 BST 2018 2440 291.35 CHIX 18318XJbpi7 Wed 14 Nov 13:35:37 BST 2018 4353 291.35 XLON 18318XJbpi6 Wed 14 Nov 13:35:37 BST 2018 832 291.35 XLON 18318XJbpi5 Wed 14 Nov 13:35:30 BST 2018 616 291.45 CHIX 18318XJbpht Wed 14 Nov 13:35:30 BST 2018 2870 291.45 XLON 18318XJbphs Wed 14 Nov 13:35:30 BST 2018 678 291.45 CHIX 18318XJbphr Wed 14 Nov 13:35:01 BST 2018 226 291.35 XLON 18318XJbpcx Wed 14 Nov 13:34:40 BST 2018 233 291.35 CHIX 18318XJbp9l Wed 14 Nov 13:34:40 BST 2018 726 291.35 CHIX 18318XJbp9k Wed 14 Nov 13:34:40 BST 2018 622 291.35 CHIX 18318XJbp9j Wed 14 Nov 13:34:40 BST 2018 1317 291.35 XLON 18318XJbp9i Wed 14 Nov 13:34:20 BST 2018 666 291.35 CHIX 18318XJbp7p Wed 14 Nov 13:34:20 BST 2018 1477 291.35 XLON 18318XJbp7o Wed 14 Nov 13:34:15 BST 2018 493 291.25 CHIX 18318XJbp75 Wed 14 Nov 13:34:12 BST 2018 143 291.25 XLON 18318XJbp65 Wed 14 Nov 13:34:12 BST 2018 1497 291.25 XLON 18318XJbp68 Wed 14 Nov 13:34:12 BST 2018 675 291.25 CHIX 18318XJbp62 Wed 14 Nov 13:33:46 BST 2018 303 291.25 CHIX 18318XJbp4b Wed 14 Nov 13:33:44 BST 2018 537 291.30 CHIX 18318XJbp3w Wed 14 Nov 13:33:44 BST 2018 1056 291.30 XLON 18318XJbp3x Wed 14 Nov 13:33:41 BST 2018 537 291.40 CHIX 18318XJbp3i Wed 14 Nov 13:33:41 BST 2018 478 291.40 XLON 18318XJbp3g Wed 14 Nov 13:33:31 BST 2018 21 291.45 XLON 18318XJbp2v Wed 14 Nov 13:33:31 BST 2018 34 291.45 XLON 18318XJbp2u Wed 14 Nov 13:33:31 BST 2018 1083 291.45 XLON 18318XJbp2t Wed 14 Nov 13:33:31 BST 2018 537 291.45 CHIX 18318XJbp2s Wed 14 Nov 13:33:03 BST 2018 538 291.15 CHIX 18318XJbovh Wed 14 Nov 13:33:03 BST 2018 315 291.20 CHIX 18318XJbovg Wed 14 Nov 13:33:03 BST 2018 645 291.20 CHIX 18318XJbovf Wed 14 Nov 13:32:47 BST 2018 157 291.10 XLON 18318XJboue Wed 14 Nov 13:32:46 BST 2018 722 291.10 CHIX 18318XJboud Wed 14 Nov 13:32:46 BST 2018 597 291.10 CHIX 18318XJbouc Wed 14 Nov 13:32:46 BST 2018 1223 291.10 XLON 18318XJboub Wed 14 Nov 13:32:18 BST 2018 384 291.15 CHIX 18318XJbopw Wed 14 Nov 13:32:00 BST 2018 100 291.15 XLON 18318XJbonb Wed 14 Nov 13:32:00 BST 2018 431 291.15 CHIX 18318XJbonc Wed 14 Nov 13:32:00 BST 2018 613 291.15 CHIX 18318XJbona Wed 14 Nov 13:32:00 BST 2018 188 291.15 XLON 18318XJbon9 Wed 14 Nov 13:32:00 BST 2018 1068 291.15 XLON 18318XJbon8 Wed 14 Nov 13:31:50 BST 2018 549 291.20 XLON 18318XJbomh Wed 14 Nov 13:31:03 BST 2018 627 291.05 CHIX 18318XJbojv Wed 14 Nov 13:31:01 BST 2018 806 291.10 XLON 18318XJboj7 Wed 14 Nov 13:31:01 BST 2018 272 291.10 XLON 18318XJboj6 Wed 14 Nov 13:31:01 BST 2018 538 291.10 CHIX 18318XJboj8 Wed 14 Nov 13:30:45 BST 2018 538 290.90 CHIX 18318XJboh5 Wed 14 Nov 13:30:45 BST 2018 204 290.90 XLON 18318XJboh4 Wed 14 Nov 13:30:45 BST 2018 719 290.90 XLON 18318XJboh3 Wed 14 Nov 13:30:45 BST 2018 538 290.95 CHIX 18318XJboh2 Wed 14 Nov 13:30:45 BST 2018 16 290.95 XLON 18318XJboh1 Wed 14 Nov 13:30:45 BST 2018 1010 290.95 XLON 18318XJboh0 Wed 14 Nov 13:30:28 BST 2018 284 290.90 CHIX 18318XJboef Wed 14 Nov 13:30:28 BST 2018 538 290.90 CHIX 18318XJboee Wed 14 Nov 13:30:28 BST 2018 200 290.90 CHIX 18318XJboed Wed 14 Nov 13:30:28 BST 2018 90 290.90 XLON 18318XJboec Wed 14 Nov 13:30:28 BST 2018 80 290.90 XLON 18318XJboeb Wed 14 Nov 13:30:28 BST 2018 929 290.90 XLON 18318XJboea Wed 14 Nov 13:30:13 BST 2018 1263 290.95 XLON 18318XJbob2 Wed 14 Nov 13:30:13 BST 2018 617 290.95 CHIX 18318XJbob6 Wed 14 Nov 13:30:06 BST 2018 6 291.00 BATE 18318XJboaa Wed 14 Nov 13:30:06 BST 2018 613 290.90 CHIX 18318XJboa7 Wed 14 Nov 13:30:01 BST 2018 538 291.00 CHIX 18318XJbo99 Wed 14 Nov 13:30:01 BST 2018 21 291.00 XLON 18318XJbo98 Wed 14 Nov 13:30:01 BST 2018 49 291.00 XLON 18318XJbo97 Wed 14 Nov 13:30:01 BST 2018 898 291.00 XLON 18318XJbo95 Wed 14 Nov 13:27:05 BST 2018 539 290.35 CHIX 18318XJbnsa Wed 14 Nov 13:27:05 BST 2018 539 290.35 CHIX 18318XJbns9 Wed 14 Nov 13:27:05 BST 2018 1357 290.35 CHIX 18318XJbns8 Wed 14 Nov 13:26:45 BST 2018 657 290.35 XLON 18318XJbnrc Wed 14 Nov 13:26:45 BST 2018 57 290.35 XLON 18318XJbnrb Wed 14 Nov 13:26:45 BST 2018 2887 290.35 XLON 18318XJbnra Wed 14 Nov 13:26:45 BST 2018 479 290.35 XLON 18318XJbnr9 Wed 14 Nov 13:26:30 BST 2018 624 290.40 CHIX 18318XJbnq9 Wed 14 Nov 13:26:30 BST 2018 1048 290.40 XLON 18318XJbnq8 Wed 14 Nov 13:26:30 BST 2018 334 290.40 XLON 18318XJbnq7 Wed 14 Nov 13:25:35 BST 2018 123 290.35 XLON 18318XJbnk3 Wed 14 Nov 13:24:02 BST 2018 2078 290.40 XLON 18318XJbn88 Wed 14 Nov 13:24:02 BST 2018 987 290.40 XLON 18318XJbn86 Wed 14 Nov 13:24:02 BST 2018 937 290.40 CHIX 18318XJbn87 Wed 14 Nov 13:24:02 BST 2018 539 290.40 CHIX 18318XJbn85 Wed 14 Nov 13:24:02 BST 2018 544 290.40 CHIX 18318XJbn84 Wed 14 Nov 13:23:43 BST 2018 594 290.45 CHIX 18318XJbn6g Wed 14 Nov 13:23:43 BST 2018 346 290.45 CHIX 18318XJbn6f Wed 14 Nov 13:23:41 BST 2018 583 290.50 CHIX 18318XJbn64 Wed 14 Nov 13:23:41 BST 2018 624 290.50 CHIX 18318XJbn63 Wed 14 Nov 13:23:41 BST 2018 841 290.50 CHIX 18318XJbn62 Wed 14 Nov 13:23:41 BST 2018 1195 290.50 XLON 18318XJbn61 Wed 14 Nov 13:23:30 BST 2018 966 290.50 CHIX 18318XJbn5e Wed 14 Nov 13:23:30 BST 2018 4009 290.50 XLON 18318XJbn5c Wed 14 Nov 13:23:30 BST 2018 1344 290.50 XLON 18318XJbn5d Wed 14 Nov 13:21:09 BST 2018 2950 290.30 XLON 18318XJbmpp Wed 14 Nov 13:21:09 BST 2018 1464 290.30 CHIX 18318XJbmps Wed 14 Nov 13:21:09 BST 2018 690 290.30 XLON 18318XJbmpm Wed 14 Nov 13:21:09 BST 2018 297 290.30 XLON 18318XJbmph Wed 14 Nov 13:21:05 BST 2018 311 290.30 CHIX 18318XJbmp7 Wed 14 Nov 13:18:00 BST 2018 539 290.35 CHIX 18318XJbm80 Wed 14 Nov 13:18:00 BST 2018 1734 290.35 CHIX 18318XJbm7z Wed 14 Nov 13:18:00 BST 2018 955 290.35 XLON 18318XJbm7y Wed 14 Nov 13:18:00 BST 2018 46 290.35 XLON 18318XJbm7x Wed 14 Nov 13:18:00 BST 2018 3800 290.35 XLON 18318XJbm7w Wed 14 Nov 13:18:00 BST 2018 261 290.40 CHIX 18318XJbm7v Wed 14 Nov 13:18:00 BST 2018 539 290.40 CHIX 18318XJbm7u Wed 14 Nov 13:18:00 BST 2018 547 290.40 CHIX 18318XJbm7t Wed 14 Nov 13:18:00 BST 2018 538 290.40 CHIX 18318XJbm7s Wed 14 Nov 13:18:00 BST 2018 858 290.40 XLON 18318XJbm7r Wed 14 Nov 13:18:00 BST 2018 153 290.40 XLON 18318XJbm7q Wed 14 Nov 13:18:00 BST 2018 186 290.40 XLON 18318XJbm7p Wed 14 Nov 13:17:26 BST 2018 1420 290.50 XLON 18318XJbm4s Wed 14 Nov 13:17:26 BST 2018 640 290.50 CHIX 18318XJbm4r Wed 14 Nov 13:17:26 BST 2018 1319 290.55 XLON 18318XJbm4q Wed 14 Nov 13:17:26 BST 2018 2235 290.55 XLON 18318XJbm4p Wed 14 Nov 13:17:26 BST 2018 624 290.55 CHIX 18318XJbm4o Wed 14 Nov 13:17:26 BST 2018 1009 290.55 CHIX 18318XJbm4n Wed 14 Nov 13:16:56 BST 2018 524 290.45 XLON 18318XJbm0n Wed 14 Nov 13:16:56 BST 2018 793 290.45 XLON 18318XJbm0l Wed 14 Nov 13:16:56 BST 2018 624 290.45 CHIX 18318XJbm0k Wed 14 Nov 13:13:57 BST 2018 1903 290.60 CHIX 18318XJblmx Wed 14 Nov 13:13:57 BST 2018 4220 290.60 XLON 18318XJblmw Wed 14 Nov 13:13:47 BST 2018 700 290.80 CHIX 18318XJblmh Wed 14 Nov 13:13:47 BST 2018 1551 290.80 XLON 18318XJblmg Wed 14 Nov 13:13:47 BST 2018 7 290.80 CHIX 18318XJblmf Wed 14 Nov 13:13:47 BST 2018 634 290.80 CHIX 18318XJblme Wed 14 Nov 13:13:47 BST 2018 2171 290.80 XLON 18318XJblmd Wed 14 Nov 13:13:47 BST 2018 339 290.80 CHIX 18318XJblmc Wed 14 Nov 13:13:05 BST 2018 2161 290.55 XLON 18318XJbljv Wed 14 Nov 13:13:05 BST 2018 1909 290.55 XLON 18318XJbljy Wed 14 Nov 13:13:05 BST 2018 794 290.55 XLON 18318XJblju Wed 14 Nov 13:11:29 BST 2018 1560 290.60 CHIX 18318XJblar Wed 14 Nov 13:11:29 BST 2018 3459 290.60 XLON 18318XJblaq Wed 14 Nov 13:09:21 BST 2018 758 290.30 XLON 18318XJbkx5 Wed 14 Nov 13:09:21 BST 2018 6 290.30 XLON 18318XJbkx6 Wed 14 Nov 13:09:21 BST 2018 714 290.30 XLON 18318XJbkx4 Wed 14 Nov 13:09:21 BST 2018 665 290.30 CHIX 18318XJbkx3 Wed 14 Nov 13:09:16 BST 2018 819 290.35 CHIX 18318XJbkwd Wed 14 Nov 13:09:16 BST 2018 117 290.35 CHIX 18318XJbkwc Wed 14 Nov 13:09:16 BST 2018 1813 290.35 XLON 18318XJbkw9 Wed 14 Nov 13:09:16 BST 2018 429 290.35 CHIX 18318XJbkw3 Wed 14 Nov 13:08:48 BST 2018 1588 290.40 XLON 18318XJbktc Wed 14 Nov 13:08:48 BST 2018 926 290.40 XLON 18318XJbktb Wed 14 Nov 13:08:48 BST 2018 539 290.40 CHIX 18318XJbkt9 Wed 14 Nov 13:08:48 BST 2018 307 290.40 CHIX 18318XJbkt8 Wed 14 Nov 13:08:48 BST 2018 717 290.40 CHIX 18318XJbkta Wed 14 Nov 13:08:48 BST 2018 2661 290.45 XLON 18318XJbkt6 Wed 14 Nov 13:08:48 BST 2018 1200 290.45 CHIX 18318XJbkt7 Wed 14 Nov 13:08:48 BST 2018 706 290.45 CHIX 18318XJbkt5 Wed 14 Nov 13:08:32 BST 2018 449 290.50 CHIX 18318XJbks5 Wed 14 Nov 13:08:32 BST 2018 632 290.50 CHIX 18318XJbks4 Wed 14 Nov 13:08:32 BST 2018 1398 290.50 XLON 18318XJbks3 Wed 14 Nov 13:08:06 BST 2018 540 290.40 CHIX 18318XJbkpz Wed 14 Nov 13:08:06 BST 2018 646 290.40 CHIX 18318XJbkpy Wed 14 Nov 13:08:06 BST 2018 1432 290.40 XLON 18318XJbkpx Wed 14 Nov 13:07:59 BST 2018 745 290.45 XLON 18318XJbkoz Wed 14 Nov 13:07:59 BST 2018 468 290.45 XLON 18318XJbkoy Wed 14 Nov 13:07:59 BST 2018 592 290.45 CHIX 18318XJbkox Wed 14 Nov 13:06:08 BST 2018 615 290.40 CHIX 18318XJbkdu Wed 14 Nov 13:06:08 BST 2018 1261 290.40 XLON 18318XJbkdt Wed 14 Nov 13:06:08 BST 2018 539 290.35 CHIX 18318XJbkds Wed 14 Nov 13:06:04 BST 2018 742 290.45 CHIX 18318XJbkdi Wed 14 Nov 13:06:00 BST 2018 275 290.45 CHIX 18318XJbkd4 Wed 14 Nov 13:06:00 BST 2018 384 290.45 CHIX 18318XJbkd3 Wed 14 Nov 13:06:00 BST 2018 168 290.45 CHIX 18318XJbkd2 Wed 14 Nov 13:04:33 BST 2018 730 289.75 CHIX 18318XJbk3c Wed 14 Nov 13:04:33 BST 2018 540 289.75 CHIX 18318XJbk3b Wed 14 Nov 13:04:33 BST 2018 990 289.75 XLON 18318XJbk3a Wed 14 Nov 13:04:33 BST 2018 375 289.80 CHIX 18318XJbk39 Wed 14 Nov 13:04:33 BST 2018 231 289.80 XLON 18318XJbk2z Wed 14 Nov 13:04:33 BST 2018 346 289.80 XLON 18318XJbk38 Wed 14 Nov 13:04:33 BST 2018 108 289.80 XLON 18318XJbk37 Wed 14 Nov 13:04:33 BST 2018 387 289.80 XLON 18318XJbk36 Wed 14 Nov 13:04:33 BST 2018 6 289.80 XLON 18318XJbk34 Wed 14 Nov 13:04:33 BST 2018 166 289.80 XLON 18318XJbk31 Wed 14 Nov 13:04:33 BST 2018 165 289.80 CHIX 18318XJbk35 Wed 14 Nov 13:04:33 BST 2018 413 289.80 CHIX 18318XJbk32 Wed 14 Nov 13:04:33 BST 2018 442 289.80 CHIX 18318XJbk2y Wed 14 Nov 13:04:33 BST 2018 914 289.80 CHIX 18318XJbk2x Wed 14 Nov 13:04:33 BST 2018 127 289.80 CHIX 18318XJbk30 Wed 14 Nov 13:03:52 BST 2018 819 289.80 XLON 18318XJbjz5 Wed 14 Nov 13:03:52 BST 2018 715 289.80 XLON 18318XJbjz4 Wed 14 Nov 13:03:52 BST 2018 261 289.80 XLON 18318XJbjz3 Wed 14 Nov 13:03:12 BST 2018 1743 289.85 XLON 18318XJbjvs Wed 14 Nov 13:03:12 BST 2018 788 289.85 CHIX 18318XJbjvt Wed 14 Nov 13:03:12 BST 2018 304 289.85 CHIX 18318XJbjvu Wed 14 Nov 13:01:10 BST 2018 542 289.00 CHIX 18318XJbjls Wed 14 Nov 13:01:10 BST 2018 944 289.00 XLON 18318XJbjlp Wed 14 Nov 13:00:29 BST 2018 1423 289.25 CHIX 18318XJbjeh Wed 14 Nov 13:00:29 BST 2018 1541 289.25 XLON 18318XJbjeg Wed 14 Nov 13:00:29 BST 2018 1615 289.25 XLON 18318XJbjef Wed 14 Nov 13:00:00 BST 2018 1548 289.35 CHIX 18318XJbjap Wed 14 Nov 13:00:00 BST 2018 3434 289.35 XLON 18318XJbjao Wed 14 Nov 12:59:10 BST 2018 801 289.25 CHIX 18318XJbj4k Wed 14 Nov 12:59:10 BST 2018 1776 289.25 XLON 18318XJbj4h Wed 14 Nov 12:57:27 BST 2018 350 289.10 CHIX 18318XJbitz Wed 14 Nov 12:57:27 BST 2018 2277 289.10 XLON 18318XJbity Wed 14 Nov 12:57:27 BST 2018 678 289.10 CHIX 18318XJbitx Wed 14 Nov 12:55:57 BST 2018 542 289.00 CHIX 18318XJbimq Wed 14 Nov 12:55:57 BST 2018 582 289.00 XLON 18318XJbimp Wed 14 Nov 12:55:17 BST 2018 541 289.30 CHIX 18318XJbiiy Wed 14 Nov 12:55:15 BST 2018 662 289.30 XLON 18318XJbiiu Wed 14 Nov 12:54:55 BST 2018 44 289.65 XLON 18318XJbigj Wed 14 Nov 12:54:55 BST 2018 374 289.65 XLON 18318XJbigi Wed 14 Nov 12:54:53 BST 2018 261 289.65 XLON 18318XJbigh Wed 14 Nov 12:54:49 BST 2018 707 289.75 CHIX 18318XJbige Wed 14 Nov 12:54:49 BST 2018 1565 289.75 XLON 18318XJbigd Wed 14 Nov 12:54:45 BST 2018 43 289.85 XLON 18318XJbig6 Wed 14 Nov 12:54:45 BST 2018 18 289.85 XLON 18318XJbig9 Wed 14 Nov 12:54:45 BST 2018 199 289.85 XLON 18318XJbig8 Wed 14 Nov 12:54:45 BST 2018 144 289.85 XLON 18318XJbig7 Wed 14 Nov 12:54:45 BST 2018 317 289.85 XLON 18318XJbiga Wed 14 Nov 12:54:45 BST 2018 2111 289.85 XLON 18318XJbig4 Wed 14 Nov 12:54:45 BST 2018 560 289.85 CHIX 18318XJbig5 Wed 14 Nov 12:54:45 BST 2018 266 289.85 CHIX 18318XJbig3 Wed 14 Nov 12:54:45 BST 2018 972 289.85 CHIX 18318XJbig2 Wed 14 Nov 12:54:43 BST 2018 931 289.90 CHIX 18318XJbifs Wed 14 Nov 12:54:43 BST 2018 2063 289.90 XLON 18318XJbift Wed 14 Nov 12:54:11 BST 2018 686 289.95 CHIX 18318XJbicc Wed 14 Nov 12:54:11 BST 2018 1519 289.95 XLON 18318XJbicb Wed 14 Nov 12:53:10 BST 2018 368 290.00 CHIX 18318XJbi8b Wed 14 Nov 12:53:10 BST 2018 927 290.00 CHIX 18318XJbi8a Wed 14 Nov 12:53:10 BST 2018 130 290.00 XLON 18318XJbi87 Wed 14 Nov 12:53:10 BST 2018 190 290.00 XLON 18318XJbi88 Wed 14 Nov 12:53:10 BST 2018 40 290.00 XLON 18318XJbi89 Wed 14 Nov 12:53:10 BST 2018 1926 290.00 XLON 18318XJbi85 Wed 14 Nov 12:53:09 BST 2018 385 290.05 CHIX 18318XJbi81 Wed 14 Nov 12:53:09 BST 2018 540 290.05 CHIX 18318XJbi80 Wed 14 Nov 12:53:09 BST 2018 317 290.05 CHIX 18318XJbi7z Wed 14 Nov 12:53:09 BST 2018 415 290.05 CHIX 18318XJbi7y Wed 14 Nov 12:53:09 BST 2018 1622 290.05 XLON 18318XJbi7w Wed 14 Nov 12:53:09 BST 2018 726 290.05 XLON 18318XJbi7x Wed 14 Nov 12:52:18 BST 2018 1566 290.05 XLON 18318XJbi3k Wed 14 Nov 12:52:18 BST 2018 706 290.05 CHIX 18318XJbi3l Wed 14 Nov 12:52:13 BST 2018 902 290.05 CHIX 18318XJbi37 Wed 14 Nov 12:52:13 BST 2018 220 290.05 XLON 18318XJbi36 Wed 14 Nov 12:52:13 BST 2018 1776 290.05 XLON 18318XJbi35 Wed 14 Nov 12:51:50 BST 2018 559 289.90 CHIX 18318XJbi1s Wed 14 Nov 12:51:50 BST 2018 100 289.90 CHIX 18318XJbi1r Wed 14 Nov 12:51:30 BST 2018 629 289.90 CHIX 18318XJbi05 Wed 14 Nov 12:51:25 BST 2018 24 289.90 XLON 18318XJbhz8 Wed 14 Nov 12:51:22 BST 2018 484 289.90 XLON 18318XJbhyx Wed 14 Nov 12:51:22 BST 2018 540 289.90 CHIX 18318XJbhyw Wed 14 Nov 12:49:55 BST 2018 639 289.85 CHIX 18318XJbhsd Wed 14 Nov 12:49:55 BST 2018 1413 289.85 XLON 18318XJbhsc Wed 14 Nov 12:49:52 BST 2018 584 289.85 CHIX 18318XJbhs9 Wed 14 Nov 12:49:52 BST 2018 1086 289.85 CHIX 18318XJbhs8 Wed 14 Nov 12:49:52 BST 2018 406 289.85 CHIX 18318XJbhs7 Wed 14 Nov 12:49:52 BST 2018 2155 289.85 XLON 18318XJbhs6 Wed 14 Nov 12:49:52 BST 2018 252 289.85 XLON 18318XJbhs5 Wed 14 Nov 12:49:06 BST 2018 815 289.85 CHIX 18318XJbhnx Wed 14 Nov 12:48:35 BST 2018 320 289.80 CHIX 18318XJbhir Wed 14 Nov 12:48:26 BST 2018 1002 289.80 CHIX 18318XJbhi6 Wed 14 Nov 12:48:26 BST 2018 794 289.80 XLON 18318XJbhi5 Wed 14 Nov 12:48:26 BST 2018 1428 289.80 XLON 18318XJbhi4 Wed 14 Nov 12:47:35 BST 2018 1 289.80 CHIX 18318XJbhd3 Wed 14 Nov 12:47:35 BST 2018 727 289.80 CHIX 18318XJbhd2 Wed 14 Nov 12:47:35 BST 2018 4 289.80 XLON 18318XJbhd1 Wed 14 Nov 12:47:35 BST 2018 62 289.80 XLON 18318XJbhd0 Wed 14 Nov 12:47:35 BST 2018 1551 289.80 XLON 18318XJbhcz Wed 14 Nov 12:46:40 BST 2018 992 289.80 CHIX 18318XJbh91 Wed 14 Nov 12:46:40 BST 2018 2151 289.80 XLON 18318XJbh90 Wed 14 Nov 12:45:25 BST 2018 1 289.85 CHIX 18318XJbh2z Wed 14 Nov 12:45:25 BST 2018 264 289.85 CHIX 18318XJbh2y Wed 14 Nov 12:45:25 BST 2018 1166 289.85 CHIX 18318XJbh2v Wed 14 Nov 12:45:25 BST 2018 2586 289.85 XLON 18318XJbh2u Wed 14 Nov 12:44:42 BST 2018 1 289.80 CHIX 18318XJbh05 Wed 14 Nov 12:44:42 BST 2018 1244 289.80 CHIX 18318XJbh04 Wed 14 Nov 12:44:42 BST 2018 100 289.80 XLON 18318XJbh03 Wed 14 Nov 12:44:42 BST 2018 960 289.80 XLON 18318XJbh01 Wed 14 Nov 12:44:42 BST 2018 1799 289.80 XLON 18318XJbh00 Wed 14 Nov 12:41:15 BST 2018 5385 289.90 XLON 18318XJbgmj Wed 14 Nov 12:41:15 BST 2018 3310 289.90 XLON 18318XJbgmi Wed 14 Nov 12:41:15 BST 2018 3918 289.90 CHIX 18318XJbgmh Wed 14 Nov 12:41:03 BST 2018 1957 290.00 XLON 18318XJbglk Wed 14 Nov 12:40:41 BST 2018 1260 289.70 XLON 18318XJbgl0 Wed 14 Nov 12:40:41 BST 2018 53 289.70 XLON 18318XJbgkz Wed 14 Nov 12:40:41 BST 2018 626 289.70 CHIX 18318XJbgky Wed 14 Nov 12:40:20 BST 2018 208 289.65 CHIX 18318XJbgi9 Wed 14 Nov 12:40:20 BST 2018 145 289.65 CHIX 18318XJbgi8 Wed 14 Nov 12:40:20 BST 2018 331 289.65 CHIX 18318XJbgi7 Wed 14 Nov 12:40:20 BST 2018 517 289.65 CHIX 18318XJbgi5 Wed 14 Nov 12:40:20 BST 2018 102 289.65 CHIX 18318XJbgi3 Wed 14 Nov 12:40:20 BST 2018 36 289.65 XLON 18318XJbgi6 Wed 14 Nov 12:40:20 BST 2018 1268 289.65 XLON 18318XJbgi4 Wed 14 Nov 12:40:20 BST 2018 653 289.70 XLON 18318XJbgi1 Wed 14 Nov 12:40:20 BST 2018 2305 289.70 XLON 18318XJbgi0 Wed 14 Nov 12:40:20 BST 2018 1334 289.70 CHIX 18318XJbghz Wed 14 Nov 12:40:20 BST 2018 482 289.70 CHIX 18318XJbgi2 Wed 14 Nov 12:39:20 BST 2018 888 289.80 XLON 18318XJbgb3 Wed 14 Nov 12:39:20 BST 2018 197 289.80 XLON 18318XJbgb4 Wed 14 Nov 12:39:20 BST 2018 178 289.80 XLON 18318XJbgb1 Wed 14 Nov 12:39:20 BST 2018 540 289.80 CHIX 18318XJbgb2 Wed 14 Nov 12:38:33 BST 2018 219 289.85 CHIX 18318XJbg6r Wed 14 Nov 12:38:33 BST 2018 321 289.85 CHIX 18318XJbg6q Wed 14 Nov 12:38:33 BST 2018 12 289.85 XLON 18318XJbg6p Wed 14 Nov 12:38:33 BST 2018 468 289.85 XLON 18318XJbg6o Wed 14 Nov 12:38:10 BST 2018 590 289.85 CHIX 18318XJbg4z Wed 14 Nov 12:38:10 BST 2018 11 289.85 CHIX 18318XJbg4y Wed 14 Nov 12:38:10 BST 2018 704 289.85 XLON 18318XJbg4v Wed 14 Nov 12:38:10 BST 2018 697 289.85 CHIX 18318XJbg4x Wed 14 Nov 12:38:10 BST 2018 540 289.85 CHIX 18318XJbg4w Wed 14 Nov 12:37:51 BST 2018 5 289.85 XLON 18318XJbg49 Wed 14 Nov 12:37:51 BST 2018 697 289.85 CHIX 18318XJbg47 Wed 14 Nov 12:37:28 BST 2018 299 289.90 CHIX 18318XJbg3m Wed 14 Nov 12:37:15 BST 2018 98 290.00 CHIX 18318XJbg2t Wed 14 Nov 12:37:15 BST 2018 216 290.00 CHIX 18318XJbg2s Wed 14 Nov 12:36:56 BST 2018 454 289.95 CHIX 18318XJbfzn Wed 14 Nov 12:36:45 BST 2018 179 290.00 CHIX 18318XJbfxo Wed 14 Nov 12:35:53 BST 2018 1619 289.55 XLON 18318XJbfr9 Wed 14 Nov 12:35:53 BST 2018 1251 289.55 XLON 18318XJbfr7 Wed 14 Nov 12:35:53 BST 2018 191 289.55 XLON 18318XJbfrb Wed 14 Nov 12:35:53 BST 2018 611 289.55 CHIX 18318XJbfr8 Wed 14 Nov 12:35:53 BST 2018 731 289.55 CHIX 18318XJbfra Wed 14 Nov 12:35:14 BST 2018 305 289.70 CHIX 18318XJbfod Wed 14 Nov 12:35:12 BST 2018 865 289.75 XLON 18318XJbfo1 Wed 14 Nov 12:35:12 BST 2018 1663 289.75 XLON 18318XJbfo0 Wed 14 Nov 12:35:12 BST 2018 510 289.75 CHIX 18318XJbfo4 Wed 14 Nov 12:35:12 BST 2018 446 289.75 CHIX 18318XJbfo3 Wed 14 Nov 12:35:12 BST 2018 170 289.75 CHIX 18318XJbfo2 Wed 14 Nov 12:35:12 BST 2018 525 289.75 CHIX 18318XJbfnz Wed 14 Nov 12:34:50 BST 2018 315 289.80 CHIX 18318XJbfmr Wed 14 Nov 12:34:16 BST 2018 617 289.75 XLON 18318XJbfl7 Wed 14 Nov 12:34:16 BST 2018 162 289.75 XLON 18318XJbfl8 Wed 14 Nov 12:34:16 BST 2018 291 289.75 XLON 18318XJbfl5 Wed 14 Nov 12:34:16 BST 2018 540 289.75 CHIX 18318XJbfl6 Wed 14 Nov 12:34:14 BST 2018 297 289.80 CHIX 18318XJbfku Wed 14 Nov 12:34:04 BST 2018 429 289.85 CHIX 18318XJbfkk Wed 14 Nov 12:33:52 BST 2018 500 289.85 CHIX 18318XJbfju Wed 14 Nov 12:33:44 BST 2018 395 289.80 CHIX 18318XJbfjb Wed 14 Nov 12:32:14 BST 2018 671 289.65 CHIX 18318XJbfd3 Wed 14 Nov 12:32:14 BST 2018 1488 289.65 XLON 18318XJbfd0 Wed 14 Nov 12:30:19 BST 2018 175 289.95 XLON 18318XJbf47 Wed 14 Nov 12:30:19 BST 2018 549 289.95 CHIX 18318XJbf45 Wed 14 Nov 12:30:19 BST 2018 832 289.95 CHIX 18318XJbf46 Wed 14 Nov 12:30:19 BST 2018 251 289.95 CHIX 18318XJbf48 Wed 14 Nov 12:30:19 BST 2018 949 289.95 XLON 18318XJbf44 Wed 14 Nov 12:30:19 BST 2018 739 290.00 CHIX 18318XJbf43 Wed 14 Nov 12:30:19 BST 2018 928 290.00 CHIX 18318XJbf41 Wed 14 Nov 12:30:19 BST 2018 586 290.00 CHIX 18318XJbf42 Wed 14 Nov 12:30:19 BST 2018 1635 290.00 XLON 18318XJbf40 Wed 14 Nov 12:30:19 BST 2018 1909 290.00 XLON 18318XJbf3z Wed 14 Nov 12:30:19 BST 2018 147 290.00 XLON 18318XJbf3y Wed 14 Nov 12:29:39 BST 2018 2468 290.05 XLON 18318XJbf29 Wed 14 Nov 12:29:39 BST 2018 794 290.05 XLON 18318XJbf28 Wed 14 Nov 12:29:39 BST 2018 134 290.05 XLON 18318XJbf26 Wed 14 Nov 12:29:39 BST 2018 242 290.05 CHIX 18318XJbf27 Wed 14 Nov 12:29:39 BST 2018 1229 290.05 CHIX 18318XJbf25 Wed 14 Nov 12:29:19 BST 2018 394 290.15 XLON 18318XJbf15 Wed 14 Nov 12:29:19 BST 2018 539 290.15 CHIX 18318XJbf16 Wed 14 Nov 12:29:19 BST 2018 584 290.15 CHIX 18318XJbf17 Wed 14 Nov 12:29:13 BST 2018 778 290.20 CHIX 18318XJbf0x Wed 14 Nov 12:29:13 BST 2018 1725 290.20 XLON 18318XJbf0v Wed 14 Nov 12:29:13 BST 2018 570 290.25 CHIX 18318XJbf0r Wed 14 Nov 12:29:13 BST 2018 719 290.25 CHIX 18318XJbf0u Wed 14 Nov 12:29:13 BST 2018 338 290.25 CHIX 18318XJbf0t Wed 14 Nov 12:29:13 BST 2018 462 290.25 XLON 18318XJbf0q Wed 14 Nov 12:29:13 BST 2018 707 290.25 XLON 18318XJbf0p Wed 14 Nov 12:28:58 BST 2018 145 290.35 XLON 18318XJbez9 Wed 14 Nov 12:28:27 BST 2018 1588 290.50 XLON 18318XJbewa Wed 14 Nov 12:28:27 BST 2018 1116 290.50 XLON 18318XJbewb Wed 14 Nov 12:28:27 BST 2018 717 290.55 CHIX 18318XJbew9 Wed 14 Nov 12:28:08 BST 2018 721 290.55 CHIX 18318XJbert Wed 14 Nov 12:27:41 BST 2018 446 290.50 XLON 18318XJbepi Wed 14 Nov 12:27:41 BST 2018 396 290.50 CHIX 18318XJbeph Wed 14 Nov 12:27:41 BST 2018 539 290.50 CHIX 18318XJbepg Wed 14 Nov 12:27:19 BST 2018 750 290.50 CHIX 18318XJbenp Wed 14 Nov 12:27:19 BST 2018 45 290.50 CHIX 18318XJbenq Wed 14 Nov 12:27:19 BST 2018 1585 290.55 XLON 18318XJbeni Wed 14 Nov 12:27:19 BST 2018 590 290.55 CHIX 18318XJbenn Wed 14 Nov 12:27:19 BST 2018 716 290.55 CHIX 18318XJbenk Wed 14 Nov 12:27:09 BST 2018 1210 290.60 XLON 18318XJbemd Wed 14 Nov 12:27:09 BST 2018 590 290.60 CHIX 18318XJbemc Wed 14 Nov 12:26:54 BST 2018 539 290.55 CHIX 18318XJbelo Wed 14 Nov 12:26:54 BST 2018 984 290.55 XLON 18318XJbeln Wed 14 Nov 12:25:35 BST 2018 138 290.05 XLON 18318XJbegk Wed 14 Nov 12:25:20 BST 2018 407 290.05 CHIX 18318XJbeep Wed 14 Nov 12:25:20 BST 2018 510 290.10 CHIX 18318XJbeeo Wed 14 Nov 12:25:20 BST 2018 1262 290.10 CHIX 18318XJbeen Wed 14 Nov 12:25:20 BST 2018 1980 290.10 XLON 18318XJbeem Wed 14 Nov 12:25:20 BST 2018 820 290.10 XLON 18318XJbeel Wed 14 Nov 12:25:16 BST 2018 725 290.20 XLON 18318XJbeeb Wed 14 Nov 12:25:16 BST 2018 142 290.20 XLON 18318XJbeea Wed 14 Nov 12:25:16 BST 2018 539 290.20 CHIX 18318XJbee9 Wed 14 Nov 12:25:01 BST 2018 1544 290.10 XLON 18318XJbed6 Wed 14 Nov 12:25:01 BST 2018 698 290.10 CHIX 18318XJbed7 Wed 14 Nov 12:24:15 BST 2018 193 290.00 CHIX 18318XJbe92 Wed 14 Nov 12:23:37 BST 2018 1 290.00 CHIX 18318XJbe74 Wed 14 Nov 12:23:37 BST 2018 681 290.00 CHIX 18318XJbe6x Wed 14 Nov 12:23:37 BST 2018 314 290.00 CHIX 18318XJbe6z Wed 14 Nov 12:23:37 BST 2018 504 290.00 CHIX 18318XJbe70 Wed 14 Nov 12:23:37 BST 2018 654 290.00 XLON 18318XJbe6v Wed 14 Nov 12:23:37 BST 2018 854 290.00 XLON 18318XJbe6u Wed 14 Nov 12:23:05 BST 2018 1397 290.05 XLON 18318XJbe5k Wed 14 Nov 12:23:05 BST 2018 369 290.10 CHIX 18318XJbe5i Wed 14 Nov 12:23:05 BST 2018 374 290.10 CHIX 18318XJbe5j Wed 14 Nov 12:22:54 BST 2018 343 290.10 CHIX 18318XJbe4g Wed 14 Nov 12:22:54 BST 2018 797 290.10 CHIX 18318XJbe4h Wed 14 Nov 12:22:23 BST 2018 447 290.15 CHIX 18318XJbe0u Wed 14 Nov 12:22:23 BST 2018 801 290.20 CHIX 18318XJbe0s Wed 14 Nov 12:22:05 BST 2018 631 290.25 XLON 18318XJbdzk Wed 14 Nov 12:22:05 BST 2018 539 290.25 CHIX 18318XJbdzj Wed 14 Nov 12:21:36 BST 2018 12 290.10 XLON 18318XJbdx5 Wed 14 Nov 12:21:36 BST 2018 1066 290.10 XLON 18318XJbdx6 Wed 14 Nov 12:21:36 BST 2018 682 290.10 XLON 18318XJbdx4 Wed 14 Nov 12:21:36 BST 2018 790 290.10 CHIX 18318XJbdx7 Wed 14 Nov 12:21:36 BST 2018 431 290.10 CHIX 18318XJbdx8 Wed 14 Nov 12:21:31 BST 2018 528 290.15 CHIX 18318XJbdwz Wed 14 Nov 12:21:05 BST 2018 198 290.15 XLON 18318XJbdum Wed 14 Nov 12:21:05 BST 2018 609 290.15 CHIX 18318XJbduk Wed 14 Nov 12:21:05 BST 2018 1249 290.15 XLON 18318XJbduh Wed 14 Nov 12:19:37 BST 2018 737 289.40 XLON 18318XJbdig Wed 14 Nov 12:19:37 BST 2018 1627 289.40 XLON 18318XJbdif Wed 14 Nov 12:19:37 BST 2018 1067 289.40 CHIX 18318XJbdie Wed 14 Nov 12:19:37 BST 2018 487 289.40 CHIX 18318XJbdih Wed 14 Nov 12:18:44 BST 2018 85 289.40 XLON 18318XJbdbw Wed 14 Nov 12:17:43 BST 2018 704 289.15 CHIX 18318XJbd61 Wed 14 Nov 12:17:43 BST 2018 1561 289.15 XLON 18318XJbd60 Wed 14 Nov 12:16:58 BST 2018 920 289.00 CHIX 18318XJbd3r Wed 14 Nov 12:16:58 BST 2018 2038 289.00 XLON 18318XJbd3q Wed 14 Nov 12:14:54 BST 2018 2711 289.15 XLON 18318XJbcui Wed 14 Nov 12:14:54 BST 2018 121 289.15 XLON 18318XJbcug Wed 14 Nov 12:14:54 BST 2018 1278 289.15 CHIX 18318XJbcuh Wed 14 Nov 12:14:44 BST 2018 630 289.25 XLON 18318XJbcrv Wed 14 Nov 12:14:44 BST 2018 501 289.25 XLON 18318XJbcru Wed 14 Nov 12:14:44 BST 2018 310 289.25 XLON 18318XJbcrs Wed 14 Nov 12:14:44 BST 2018 661 289.25 XLON 18318XJbcrq Wed 14 Nov 12:14:44 BST 2018 541 289.25 CHIX 18318XJbcrt Wed 14 Nov 12:14:44 BST 2018 541 289.25 CHIX 18318XJbcrr Wed 14 Nov 12:14:44 BST 2018 541 289.25 CHIX 18318XJbcrp Wed 14 Nov 12:14:14 BST 2018 1257 289.35 CHIX 18318XJbcqu Wed 14 Nov 12:14:14 BST 2018 31 289.35 XLON 18318XJbcqt Wed 14 Nov 12:14:14 BST 2018 2756 289.35 XLON 18318XJbcqs Wed 14 Nov 12:13:55 BST 2018 989 289.35 CHIX 18318XJbcnr Wed 14 Nov 12:13:55 BST 2018 260 289.35 CHIX 18318XJbcnq Wed 14 Nov 12:13:55 BST 2018 2193 289.35 XLON 18318XJbcnp Wed 14 Nov 12:13:55 BST 2018 580 289.35 CHIX 18318XJbcno Wed 14 Nov 12:13:10 BST 2018 1 289.35 XLON 18318XJbchf Wed 14 Nov 12:13:10 BST 2018 2191 289.35 XLON 18318XJbchd Wed 14 Nov 12:13:10 BST 2018 626 289.35 CHIX 18318XJbche Wed 14 Nov 12:13:10 BST 2018 989 289.35 CHIX 18318XJbchc Wed 14 Nov 12:11:05 BST 2018 1692 289.00 XLON 18318XJbc2o Wed 14 Nov 12:11:05 BST 2018 763 289.00 CHIX 18318XJbc2h Wed 14 Nov 12:11:05 BST 2018 443 289.05 XLON 18318XJbc2n Wed 14 Nov 12:11:05 BST 2018 122 289.05 XLON 18318XJbc2l Wed 14 Nov 12:11:05 BST 2018 99 289.05 XLON 18318XJbc2m Wed 14 Nov 12:11:05 BST 2018 190 289.05 XLON 18318XJbc2j Wed 14 Nov 12:11:05 BST 2018 363 289.05 XLON 18318XJbc2k Wed 14 Nov 12:11:05 BST 2018 530 289.05 XLON 18318XJbc2i Wed 14 Nov 12:11:05 BST 2018 170 289.05 CHIX 18318XJbc2g Wed 14 Nov 12:11:05 BST 2018 371 289.05 CHIX 18318XJbc2f Wed 14 Nov 12:11:05 BST 2018 129 289.05 CHIX 18318XJbc2d Wed 14 Nov 12:11:05 BST 2018 541 289.05 CHIX 18318XJbc2b Wed 14 Nov 12:11:05 BST 2018 412 289.05 CHIX 18318XJbc2c Wed 14 Nov 12:09:35 BST 2018 23 289.10 XLON 18318XJbbub Wed 14 Nov 12:09:35 BST 2018 153 289.10 XLON 18318XJbbuc Wed 14 Nov 12:09:35 BST 2018 1419 289.10 XLON 18318XJbbua Wed 14 Nov 12:09:34 BST 2018 706 289.10 CHIX 18318XJbbu3 Wed 14 Nov 12:09:34 BST 2018 651 289.10 CHIX 18318XJbbu1 Wed 14 Nov 12:09:17 BST 2018 1153 289.20 XLON 18318XJbbrl Wed 14 Nov 12:09:17 BST 2018 563 289.20 CHIX 18318XJbbrm Wed 14 Nov 12:09:13 BST 2018 66 289.25 CHIX 18318XJbbr2 Wed 14 Nov 12:09:13 BST 2018 475 289.25 CHIX 18318XJbbr1 Wed 14 Nov 12:09:13 BST 2018 664 289.25 CHIX 18318XJbbr0 Wed 14 Nov 12:09:13 BST 2018 695 289.25 XLON 18318XJbbqz Wed 14 Nov 12:09:13 BST 2018 1471 289.25 XLON 18318XJbbqy Wed 14 Nov 12:09:10 BST 2018 383 289.30 XLON 18318XJbbqp Wed 14 Nov 12:09:10 BST 2018 541 289.30 CHIX 18318XJbbqn Wed 14 Nov 12:09:10 BST 2018 627 289.30 CHIX 18318XJbbqo Wed 14 Nov 12:09:10 BST 2018 449 289.30 XLON 18318XJbbql Wed 14 Nov 12:09:10 BST 2018 1345 289.30 XLON 18318XJbbqm Wed 14 Nov 12:09:10 BST 2018 300 289.30 XLON 18318XJbbqk Wed 14 Nov 12:07:32 BST 2018 528 289.30 XLON 18318XJbbcb Wed 14 Nov 12:07:32 BST 2018 983 289.30 XLON 18318XJbbca Wed 14 Nov 12:07:32 BST 2018 682 289.30 CHIX 18318XJbbcc Wed 14 Nov 12:07:06 BST 2018 1109 289.45 XLON 18318XJbb8a Wed 14 Nov 12:07:06 BST 2018 206 289.45 CHIX 18318XJbb8c Wed 14 Nov 12:07:06 BST 2018 510 289.45 CHIX 18318XJbb8b Wed 14 Nov 12:07:06 BST 2018 32 289.45 CHIX 18318XJbb89 Wed 14 Nov 12:06:52 BST 2018 809 289.50 CHIX 18318XJbb6q Wed 14 Nov 12:06:52 BST 2018 1382 289.50 XLON 18318XJbb6p Wed 14 Nov 12:06:52 BST 2018 408 289.50 XLON 18318XJbb6o Wed 14 Nov 12:05:36 BST 2018 1250 289.40 CHIX 18318XJbb13 Wed 14 Nov 12:05:36 BST 2018 1183 289.45 CHIX 18318XJbb12 Wed 14 Nov 12:05:36 BST 2018 2621 289.45 XLON 18318XJbb11 Wed 14 Nov 12:05:25 BST 2018 248 289.60 BATE 18318XJbaz1 Wed 14 Nov 12:05:25 BST 2018 599 289.55 CHIX 18318XJbaz0 Wed 14 Nov 12:05:25 BST 2018 637 289.55 XLON 18318XJbayz Wed 14 Nov 12:05:25 BST 2018 589 289.55 XLON 18318XJbayy Wed 14 Nov 12:05:25 BST 2018 637 289.60 CHIX 18318XJbayw Wed 14 Nov 12:05:25 BST 2018 1411 289.60 XLON 18318XJbayx Wed 14 Nov 12:05:04 BST 2018 87 289.70 BATE 18318XJbaw6 Wed 14 Nov 12:05:04 BST 2018 561 289.70 CHIX 18318XJbaw5 Wed 14 Nov 12:05:04 BST 2018 316 289.70 XLON 18318XJbaw4 Wed 14 Nov 12:03:59 BST 2018 680 289.35 XLON 18318XJbary Wed 14 Nov 12:03:55 BST 2018 465 289.55 XLON 18318XJbarb Wed 14 Nov 12:03:55 BST 2018 1006 289.55 CHIX 18318XJbara Wed 14 Nov 12:03:55 BST 2018 1350 289.55 XLON 18318XJbar8 Wed 14 Nov 12:03:55 BST 2018 66 289.55 XLON 18318XJbar9 Wed 14 Nov 12:03:55 BST 2018 880 289.55 XLON 18318XJbar7 Wed 14 Nov 12:03:55 BST 2018 540 289.60 CHIX 18318XJbar6 Wed 14 Nov 12:03:55 BST 2018 540 289.60 CHIX 18318XJbar5 Wed 14 Nov 12:03:55 BST 2018 347 289.60 CHIX 18318XJbar4 Wed 14 Nov 12:03:55 BST 2018 355 289.60 XLON 18318XJbar2 Wed 14 Nov 12:03:55 BST 2018 368 289.60 XLON 18318XJbar3 Wed 14 Nov 12:03:54 BST 2018 1929 289.70 XLON 18318XJbar1 Wed 14 Nov 12:03:54 BST 2018 1588 289.70 XLON 18318XJbar0 Wed 14 Nov 12:03:54 BST 2018 58 289.70 XLON 18318XJbaqz Wed 14 Nov 12:03:38 BST 2018 624 289.60 CHIX 18318XJbapk Wed 14 Nov 12:03:17 BST 2018 750 289.60 BATE 18318XJbanf Wed 14 Nov 12:03:17 BST 2018 1375 289.60 XLON 18318XJbane Wed 14 Nov 12:03:06 BST 2018 84 289.50 CHIX 18318XJbamq Wed 14 Nov 12:03:06 BST 2018 664 289.50 CHIX 18318XJbamp Wed 14 Nov 11:59:59 BST 2018 597 288.70 XLON 18318XJba6n Wed 14 Nov 11:59:33 BST 2018 1311 288.65 XLON 18318XJba4t Wed 14 Nov 11:59:33 BST 2018 56 288.65 XLON 18318XJba4u Wed 14 Nov 11:59:33 BST 2018 874 288.65 CHIX 18318XJba4s Wed 14 Nov 11:59:33 BST 2018 629 288.65 XLON 18318XJba4r Wed 14 Nov 11:57:42 BST 2018 30 288.10 XLON 18318XJb9xb Wed 14 Nov 11:57:42 BST 2018 992 288.10 CHIX 18318XJb9xa Wed 14 Nov 11:57:40 BST 2018 543 288.15 CHIX 18318XJb9wt Wed 14 Nov 11:57:40 BST 2018 1006 288.15 XLON 18318XJb9ws Wed 14 Nov 11:56:15 BST 2018 3605 288.35 XLON 18318XJb9k5 Wed 14 Nov 11:56:15 BST 2018 1625 288.35 CHIX 18318XJb9k6 Wed 14 Nov 11:56:15 BST 2018 1273 288.40 XLON 18318XJb9k0 Wed 14 Nov 11:56:15 BST 2018 621 288.40 CHIX 18318XJb9jz Wed 14 Nov 11:55:31 BST 2018 2610 288.40 XLON 18318XJb9d9 Wed 14 Nov 11:55:31 BST 2018 1177 288.40 CHIX 18318XJb9d8 Wed 14 Nov 11:54:00 BST 2018 1489 288.50 XLON 18318XJb97z Wed 14 Nov 11:54:00 BST 2018 673 288.50 CHIX 18318XJb97y Wed 14 Nov 11:53:51 BST 2018 2468 288.60 XLON 18318XJb96r Wed 14 Nov 11:53:51 BST 2018 1113 288.60 CHIX 18318XJb96q Wed 14 Nov 11:53:20 BST 2018 1083 288.65 XLON 18318XJb95p Wed 14 Nov 11:53:20 BST 2018 542 288.65 CHIX 18318XJb95o Wed 14 Nov 11:52:43 BST 2018 1274 288.65 XLON 18318XJb91s Wed 14 Nov 11:52:37 BST 2018 625 288.70 CHIX 18318XJb8zu Wed 14 Nov 11:52:37 BST 2018 232 288.70 XLON 18318XJb8zy Wed 14 Nov 11:52:06 BST 2018 633 288.75 CHIX 18318XJb8ud Wed 14 Nov 11:50:42 BST 2018 1194 288.90 XLON 18318XJb8n9 Wed 14 Nov 11:50:42 BST 2018 583 288.90 CHIX 18318XJb8na Wed 14 Nov 11:50:23 BST 2018 788 289.20 XLON 18318XJb8jz Wed 14 Nov 11:50:23 BST 2018 541 289.20 CHIX 18318XJb8jy Wed 14 Nov 11:50:18 BST 2018 1119 289.25 CHIX 18318XJb8jd Wed 14 Nov 11:50:18 BST 2018 1129 289.25 XLON 18318XJb8jc Wed 14 Nov 11:50:18 BST 2018 1351 289.25 XLON 18318XJb8jb Wed 14 Nov 11:50:08 BST 2018 765 289.30 XLON 18318XJb8hq Wed 14 Nov 11:50:08 BST 2018 408 289.30 XLON 18318XJb8hp Wed 14 Nov 11:50:08 BST 2018 572 289.30 CHIX 18318XJb8ho Wed 14 Nov 11:49:47 BST 2018 380 289.35 XLON 18318XJb8h3 Wed 14 Nov 11:49:47 BST 2018 541 289.35 CHIX 18318XJb8h2 Wed 14 Nov 11:48:47 BST 2018 1023 289.50 XLON 18318XJb8eo Wed 14 Nov 11:48:47 BST 2018 598 289.50 XLON 18318XJb8en Wed 14 Nov 11:48:47 BST 2018 733 289.50 CHIX 18318XJb8em Wed 14 Nov 11:48:45 BST 2018 1 289.55 CHIX 18318XJb8e8 Wed 14 Nov 11:48:45 BST 2018 1192 289.55 CHIX 18318XJb8e7 Wed 14 Nov 11:48:45 BST 2018 2645 289.55 XLON 18318XJb8e6 Wed 14 Nov 11:48:21 BST 2018 755 289.60 CHIX 18318XJb8be Wed 14 Nov 11:48:21 BST 2018 1670 289.60 XLON 18318XJb8bd Wed 14 Nov 11:48:12 BST 2018 218 289.60 CHIX 18318XJb8ae Wed 14 Nov 11:47:28 BST 2018 541 289.40 CHIX 18318XJb87q Wed 14 Nov 11:47:28 BST 2018 958 289.40 XLON 18318XJb87p Wed 14 Nov 11:47:28 BST 2018 947 289.45 CHIX 18318XJb87n Wed 14 Nov 11:47:28 BST 2018 553 289.45 XLON 18318XJb87l Wed 14 Nov 11:47:28 BST 2018 1545 289.45 XLON 18318XJb87k Wed 14 Nov 11:41:35 BST 2018 1081 290.05 XLON 18318XJb7ix Wed 14 Nov 11:41:35 BST 2018 3188 290.05 CHIX 18318XJb7iw Wed 14 Nov 11:41:35 BST 2018 3188 290.05 XLON 18318XJb7iv Wed 14 Nov 11:41:35 BST 2018 2805 290.05 XLON 18318XJb7iu Wed 14 Nov 11:41:35 BST 2018 3188 290.10 CHIX 18318XJb7ir Wed 14 Nov 11:41:35 BST 2018 7074 290.10 XLON 18318XJb7io Wed 14 Nov 11:40:28 BST 2018 860 289.90 CHIX 18318XJb7eg Wed 14 Nov 11:40:28 BST 2018 597 289.90 CHIX 18318XJb7eh Wed 14 Nov 11:40:28 BST 2018 1907 289.90 XLON 18318XJb7ee Wed 14 Nov 11:40:28 BST 2018 4 289.90 XLON 18318XJb7ef Wed 14 Nov 11:40:12 BST 2018 847 290.00 CHIX 18318XJb7d8 Wed 14 Nov 11:40:12 BST 2018 540 290.00 CHIX 18318XJb7d9 Wed 14 Nov 11:40:12 BST 2018 1877 290.00 XLON 18318XJb7d6 Wed 14 Nov 11:40:12 BST 2018 801 290.00 XLON 18318XJb7d7 Wed 14 Nov 11:40:11 BST 2018 718 290.05 CHIX 18318XJb7d4 Wed 14 Nov 11:40:11 BST 2018 1592 290.05 XLON 18318XJb7d3 Wed 14 Nov 11:40:11 BST 2018 762 290.10 CHIX 18318XJb7d2 Wed 14 Nov 11:39:56 BST 2018 341 290.15 CHIX 18318XJb7co Wed 14 Nov 11:39:39 BST 2018 373 290.00 CHIX 18318XJb7c5 Wed 14 Nov 11:39:39 BST 2018 535 290.00 XLON 18318XJb7c4 Wed 14 Nov 11:39:39 BST 2018 540 290.00 CHIX 18318XJb7c3 Wed 14 Nov 11:39:14 BST 2018 540 289.90 CHIX 18318XJb7ai Wed 14 Nov 11:39:14 BST 2018 1035 289.90 XLON 18318XJb7ah Wed 14 Nov 11:38:58 BST 2018 765 289.85 CHIX 18318XJb78e Wed 14 Nov 11:38:58 BST 2018 1694 289.85 XLON 18318XJb78d Wed 14 Nov 11:36:50 BST 2018 1364 289.45 CHIX 18318XJb719 Wed 14 Nov 11:36:50 BST 2018 1125 289.45 XLON 18318XJb718 Wed 14 Nov 11:36:50 BST 2018 1899 289.45 XLON 18318XJb717 Wed 14 Nov 11:35:58 BST 2018 903 289.50 CHIX 18318XJb6wr Wed 14 Nov 11:35:58 BST 2018 541 289.50 CHIX 18318XJb6ws Wed 14 Nov 11:35:58 BST 2018 334 289.50 XLON 18318XJb6wp Wed 14 Nov 11:35:58 BST 2018 954 289.50 XLON 18318XJb6wq Wed 14 Nov 11:35:58 BST 2018 1668 289.50 XLON 18318XJb6wo Wed 14 Nov 11:35:17 BST 2018 561 289.55 CHIX 18318XJb6uv Wed 14 Nov 11:34:35 BST 2018 222 289.55 XLON 18318XJb6rk Wed 14 Nov 11:34:35 BST 2018 630 289.55 CHIX 18318XJb6rj Wed 14 Nov 11:34:01 BST 2018 1234 289.60 CHIX 18318XJb6p2 Wed 14 Nov 11:34:01 BST 2018 723 289.60 XLON 18318XJb6p0 Wed 14 Nov 11:34:01 BST 2018 2013 289.60 XLON 18318XJb6oy Wed 14 Nov 11:30:20 BST 2018 1885 289.50 XLON 18318XJb67e Wed 14 Nov 11:30:20 BST 2018 910 289.50 CHIX 18318XJb675 Wed 14 Nov 11:30:20 BST 2018 134 289.50 XLON 18318XJb679 Wed 14 Nov 11:30:14 BST 2018 1 289.55 CHIX 18318XJb669 Wed 14 Nov 11:30:14 BST 2018 540 289.55 CHIX 18318XJb668 Wed 14 Nov 11:30:14 BST 2018 651 289.55 XLON 18318XJb667 Wed 14 Nov 11:30:13 BST 2018 2665 289.60 CHIX 18318XJb665 Wed 14 Nov 11:30:13 BST 2018 2730 289.60 XLON 18318XJb664 Wed 14 Nov 11:30:13 BST 2018 3180 289.60 XLON 18318XJb663 Wed 14 Nov 11:30:13 BST 2018 626 289.65 CHIX 18318XJb65q Wed 14 Nov 11:30:13 BST 2018 1372 289.65 XLON 18318XJb65l Wed 14 Nov 11:30:09 BST 2018 540 289.70 CHIX 18318XJb65h Wed 14 Nov 11:30:09 BST 2018 303 289.70 XLON 18318XJb65g Wed 14 Nov 11:30:09 BST 2018 696 289.70 XLON 18318XJb65f Wed 14 Nov 11:29:53 BST 2018 540 289.65 CHIX 18318XJb64a Wed 14 Nov 11:29:53 BST 2018 778 289.65 XLON 18318XJb649 Wed 14 Nov 11:28:38 BST 2018 631 289.80 CHIX 18318XJb60h Wed 14 Nov 11:28:38 BST 2018 1398 289.80 XLON 18318XJb60g Wed 14 Nov 11:26:01 BST 2018 1360 289.90 CHIX 18318XJb5ql Wed 14 Nov 11:26:01 BST 2018 3015 289.90 XLON 18318XJb5qk Wed 14 Nov 11:25:58 BST 2018 534 290.00 CHIX 18318XJb5qg Wed 14 Nov 11:25:58 BST 2018 575 290.10 CHIX 18318XJb5qf Wed 14 Nov 11:25:58 BST 2018 1178 290.10 XLON 18318XJb5qh Wed 14 Nov 11:24:58 BST 2018 1 290.05 CHIX 18318XJb5kr Wed 14 Nov 11:24:58 BST 2018 569 290.05 CHIX 18318XJb5kq Wed 14 Nov 11:24:58 BST 2018 1169 290.05 XLON 18318XJb5kp Wed 14 Nov 11:24:54 BST 2018 663 290.15 CHIX 18318XJb5ke Wed 14 Nov 11:24:54 BST 2018 600 290.15 CHIX 18318XJb5kc Wed 14 Nov 11:24:54 BST 2018 539 290.15 CHIX 18318XJb5kd Wed 14 Nov 11:24:54 BST 2018 23 290.15 XLON 18318XJb5kb Wed 14 Nov 11:24:54 BST 2018 984 290.15 XLON 18318XJb5k9 Wed 14 Nov 11:24:54 BST 2018 110 290.15 XLON 18318XJb5k8 Wed 14 Nov 11:24:54 BST 2018 1444 290.15 XLON 18318XJb5ka Wed 14 Nov 11:24:52 BST 2018 1 290.20 CHIX 18318XJb5k6 Wed 14 Nov 11:24:52 BST 2018 1237 290.20 CHIX 18318XJb5k5 Wed 14 Nov 11:24:52 BST 2018 2745 290.20 XLON 18318XJb5k4 Wed 14 Nov 11:24:40 BST 2018 982 290.25 CHIX 18318XJb5iw Wed 14 Nov 11:24:40 BST 2018 120 290.25 CHIX 18318XJb5iv Wed 14 Nov 11:24:40 BST 2018 2444 290.25 XLON 18318XJb5iu Wed 14 Nov 11:23:58 BST 2018 2539 290.20 XLON 18318XJb5gb Wed 14 Nov 11:23:58 BST 2018 1145 290.20 CHIX 18318XJb5gc Wed 14 Nov 11:23:58 BST 2018 539 290.25 CHIX 18318XJb5g9 Wed 14 Nov 11:23:58 BST 2018 270 290.25 CHIX 18318XJb5g8 Wed 14 Nov 11:23:58 BST 2018 539 290.25 CHIX 18318XJb5ga Wed 14 Nov 11:23:58 BST 2018 373 290.25 XLON 18318XJb5g7 Wed 14 Nov 11:23:58 BST 2018 517 290.25 XLON 18318XJb5g5 Wed 14 Nov 11:23:58 BST 2018 618 290.25 XLON 18318XJb5g6 Wed 14 Nov 11:23:58 BST 2018 15 290.25 XLON 18318XJb5g4 Wed 14 Nov 11:23:56 BST 2018 868 290.30 CHIX 18318XJb5fp Wed 14 Nov 11:23:56 BST 2018 539 290.30 CHIX 18318XJb5fr Wed 14 Nov 11:23:56 BST 2018 547 290.30 XLON 18318XJb5fq Wed 14 Nov 11:23:56 BST 2018 337 290.30 XLON 18318XJb5fo Wed 14 Nov 11:23:56 BST 2018 117 290.30 XLON 18318XJb5fs Wed 14 Nov 11:23:56 BST 2018 1586 290.30 XLON 18318XJb5fn Wed 14 Nov 11:23:31 BST 2018 787 290.35 CHIX 18318XJb5dn Wed 14 Nov 11:22:50 BST 2018 450 290.30 CHIX 18318XJb5b8 Wed 14 Nov 11:22:21 BST 2018 607 290.30 CHIX 18318XJb58x Wed 14 Nov 11:21:46 BST 2018 389 290.15 CHIX 18318XJb55n Wed 14 Nov 11:21:46 BST 2018 642 290.20 CHIX 18318XJb55m Wed 14 Nov 11:21:46 BST 2018 277 290.20 CHIX 18318XJb55l Wed 14 Nov 11:21:46 BST 2018 539 290.20 CHIX 18318XJb55j Wed 14 Nov 11:21:46 BST 2018 203 290.20 XLON 18318XJb55h Wed 14 Nov 11:21:46 BST 2018 100 290.20 XLON 18318XJb55k Wed 14 Nov 11:21:46 BST 2018 1004 290.20 XLON 18318XJb55i Wed 14 Nov 11:21:46 BST 2018 343 290.25 CHIX 18318XJb55g Wed 14 Nov 11:21:15 BST 2018 310 290.30 CHIX 18318XJb53g Wed 14 Nov 11:20:14 BST 2018 392 290.00 CHIX 18318XJb4z1 Wed 14 Nov 11:20:14 BST 2018 148 290.00 CHIX 18318XJb4z0 Wed 14 Nov 11:20:14 BST 2018 880 290.00 XLON 18318XJb4yz Wed 14 Nov 11:18:47 BST 2018 181 290.00 XLON 18318XJb4li Wed 14 Nov 11:18:47 BST 2018 262 290.00 CHIX 18318XJb4lk Wed 14 Nov 11:18:47 BST 2018 1084 290.00 CHIX 18318XJb4lj Wed 14 Nov 11:18:47 BST 2018 2220 290.00 XLON 18318XJb4lh Wed 14 Nov 11:17:15 BST 2018 869 290.25 CHIX 18318XJb4ap Wed 14 Nov 11:17:15 BST 2018 539 290.25 CHIX 18318XJb4ao Wed 14 Nov 11:17:15 BST 2018 2000 290.25 XLON 18318XJb4an Wed 14 Nov 11:17:15 BST 2018 326 290.30 CHIX 18318XJb4ah Wed 14 Nov 11:17:15 BST 2018 539 290.30 CHIX 18318XJb4ai Wed 14 Nov 11:17:15 BST 2018 784 290.30 CHIX 18318XJb4al Wed 14 Nov 11:17:15 BST 2018 624 290.30 CHIX 18318XJb4am Wed 14 Nov 11:17:15 BST 2018 287 290.30 CHIX 18318XJb4aj Wed 14 Nov 11:17:15 BST 2018 226 290.30 CHIX 18318XJb4ak Wed 14 Nov 11:17:15 BST 2018 585 290.30 XLON 18318XJb4ad Wed 14 Nov 11:17:15 BST 2018 12 290.30 XLON 18318XJb4ae Wed 14 Nov 11:17:15 BST 2018 1308 290.30 XLON 18318XJb4af Wed 14 Nov 11:17:15 BST 2018 539 290.35 CHIX 18318XJb4a7 Wed 14 Nov 11:17:15 BST 2018 539 290.35 CHIX 18318XJb4ac Wed 14 Nov 11:17:15 BST 2018 539 290.35 CHIX 18318XJb4aa Wed 14 Nov 11:17:15 BST 2018 663 290.35 XLON 18318XJb4a2 Wed 14 Nov 11:17:15 BST 2018 491 290.35 XLON 18318XJb4a9 Wed 14 Nov 11:17:15 BST 2018 511 290.35 XLON 18318XJb4ab Wed 14 Nov 11:16:48 BST 2018 663 290.40 CHIX 18318XJb48k Wed 14 Nov 11:16:48 BST 2018 539 290.40 CHIX 18318XJb48l Wed 14 Nov 11:16:48 BST 2018 1096 290.40 XLON 18318XJb48j Wed 14 Nov 11:16:36 BST 2018 316 290.50 CHIX 18318XJb45i Wed 14 Nov 11:16:33 BST 2018 190 290.55 CHIX 18318XJb44h Wed 14 Nov 11:16:33 BST 2018 539 290.55 CHIX 18318XJb44g Wed 14 Nov 11:16:33 BST 2018 607 290.55 CHIX 18318XJb44f Wed 14 Nov 11:16:33 BST 2018 828 290.55 XLON 18318XJb44e Wed 14 Nov 11:16:33 BST 2018 1242 290.55 XLON 18318XJb44d Wed 14 Nov 11:16:28 BST 2018 979 290.65 CHIX 18318XJb43r Wed 14 Nov 11:16:28 BST 2018 2170 290.65 XLON 18318XJb43q Wed 14 Nov 11:16:21 BST 2018 3285 290.65 XLON 18318XJb43b Wed 14 Nov 11:16:21 BST 2018 343 290.65 XLON 18318XJb43a Wed 14 Nov 11:16:18 BST 2018 1250 290.60 CHIX 18318XJb437 Wed 14 Nov 11:16:14 BST 2018 1250 290.60 CHIX 18318XJb42i Wed 14 Nov 11:16:14 BST 2018 563 290.60 CHIX 18318XJb42f Wed 14 Nov 11:16:14 BST 2018 1153 290.60 XLON 18318XJb42e Wed 14 Nov 11:16:14 BST 2018 9 290.60 XLON 18318XJb42g Wed 14 Nov 11:16:14 BST 2018 132 290.60 XLON 18318XJb42h Wed 14 Nov 11:15:03 BST 2018 395 290.40 CHIX 18318XJb3ul Wed 14 Nov 11:14:27 BST 2018 329 290.35 CHIX 18318XJb3rg Wed 14 Nov 11:13:42 BST 2018 116 290.35 XLON 18318XJb3n4 Wed 14 Nov 11:13:04 BST 2018 600 290.25 XLON 18318XJb3k7 Wed 14 Nov 11:13:04 BST 2018 175 290.25 XLON 18318XJb3k8 Wed 14 Nov 11:13:02 BST 2018 340 290.30 CHIX 18318XJb3k5 Wed 14 Nov 11:11:49 BST 2018 3147 290.10 XLON 18318XJb3eg Wed 14 Nov 11:10:35 BST 2018 208 290.00 CHIX 18318XJb39s Wed 14 Nov 11:10:35 BST 2018 610 290.00 CHIX 18318XJb39t Wed 14 Nov 11:10:35 BST 2018 540 290.00 CHIX 18318XJb39r Wed 14 Nov 11:10:35 BST 2018 941 290.00 CHIX 18318XJb39p Wed 14 Nov 11:10:35 BST 2018 867 290.00 XLON 18318XJb39m Wed 14 Nov 11:10:35 BST 2018 2085 290.00 XLON 18318XJb39n Wed 14 Nov 11:10:35 BST 2018 201 290.00 XLON 18318XJb39q Wed 14 Nov 11:10:35 BST 2018 35 290.00 XLON 18318XJb39o Wed 14 Nov 11:10:10 BST 2018 1388 290.05 CHIX 18318XJb37q Wed 14 Nov 11:10:10 BST 2018 3077 290.05 XLON 18318XJb37p Wed 14 Nov 11:10:07 BST 2018 229 290.10 CHIX 18318XJb36s Wed 14 Nov 11:10:00 BST 2018 1 290.10 CHIX 18318XJb36h Wed 14 Nov 11:10:00 BST 2018 538 290.10 CHIX 18318XJb36f Wed 14 Nov 11:10:00 BST 2018 799 290.10 CHIX 18318XJb36d Wed 14 Nov 11:10:00 BST 2018 1020 290.05 XLON 18318XJb36i Wed 14 Nov 11:10:00 BST 2018 192 290.05 XLON 18318XJb36e Wed 14 Nov 11:10:00 BST 2018 1770 290.10 XLON 18318XJb36b Wed 14 Nov 11:10:00 BST 2018 417 290.10 XLON 18318XJb36c Wed 14 Nov 11:09:25 BST 2018 299 290.20 CHIX 18318XJb351 Wed 14 Nov 11:09:25 BST 2018 1 290.20 XLON 18318XJb350 Wed 14 Nov 11:07:35 BST 2018 1024 290.05 CHIX 18318XJb2y8 Wed 14 Nov 11:07:35 BST 2018 2269 290.05 XLON 18318XJb2y7 Wed 14 Nov 11:07:21 BST 2018 1294 290.15 CHIX 18318XJb2xb Wed 14 Nov 11:07:21 BST 2018 2870 290.15 XLON 18318XJb2x9 Wed 14 Nov 11:07:21 BST 2018 29 290.15 XLON 18318XJb2xa Wed 14 Nov 11:06:56 BST 2018 291 290.25 CHIX 18318XJb2vv Wed 14 Nov 11:06:55 BST 2018 43 290.25 XLON 18318XJb2vo Wed 14 Nov 11:06:55 BST 2018 2843 290.25 XLON 18318XJb2vn Wed 14 Nov 11:06:55 BST 2018 992 290.25 CHIX 18318XJb2vm Wed 14 Nov 11:05:06 BST 2018 410 290.25 CHIX 18318XJb2oh Wed 14 Nov 11:05:06 BST 2018 391 290.25 XLON 18318XJb2oc Wed 14 Nov 11:05:06 BST 2018 776 290.25 XLON 18318XJb2of Wed 14 Nov 11:05:06 BST 2018 539 290.25 CHIX 18318XJb2od Wed 14 Nov 11:05:06 BST 2018 129 290.25 CHIX 18318XJb2og Wed 14 Nov 11:05:06 BST 2018 786 290.30 CHIX 18318XJb2o8 Wed 14 Nov 11:05:06 BST 2018 892 290.30 CHIX 18318XJb2oa Wed 14 Nov 11:05:06 BST 2018 345 290.30 XLON 18318XJb2o4 Wed 14 Nov 11:05:06 BST 2018 1975 290.30 XLON 18318XJb2o6 Wed 14 Nov 11:05:06 BST 2018 1394 290.30 XLON 18318XJb2o2 Wed 14 Nov 11:05:01 BST 2018 1 290.35 CHIX 18318XJb2mw Wed 14 Nov 11:05:01 BST 2018 893 290.35 CHIX 18318XJb2mv Wed 14 Nov 11:05:01 BST 2018 539 290.35 CHIX 18318XJb2mu Wed 14 Nov 11:05:01 BST 2018 935 290.35 XLON 18318XJb2ms Wed 14 Nov 11:05:01 BST 2018 1981 290.35 XLON 18318XJb2mt Wed 14 Nov 11:03:45 BST 2018 624 290.30 CHIX 18318XJb2ic Wed 14 Nov 11:03:45 BST 2018 1088 290.30 XLON 18318XJb2ia Wed 14 Nov 11:03:45 BST 2018 231 290.30 XLON 18318XJb2i9 Wed 14 Nov 11:03:38 BST 2018 2065 290.35 XLON 18318XJb2hz Wed 14 Nov 11:03:38 BST 2018 779 290.35 XLON 18318XJb2hx Wed 14 Nov 11:03:38 BST 2018 933 290.35 CHIX 18318XJb2hy Wed 14 Nov 11:03:38 BST 2018 539 290.35 CHIX 18318XJb2hw Wed 14 Nov 11:03:35 BST 2018 378 290.40 CHIX 18318XJb2hb Wed 14 Nov 11:00:41 BST 2018 329 290.10 CHIX 18318XJb274 Wed 14 Nov 11:00:41 BST 2018 505 290.10 CHIX 18318XJb275 Wed 14 Nov 11:00:41 BST 2018 741 290.15 CHIX 18318XJb272 Wed 14 Nov 11:00:41 BST 2018 832 290.15 CHIX 18318XJb273 Wed 14 Nov 11:00:41 BST 2018 1643 290.15 XLON 18318XJb271 Wed 14 Nov 11:00:37 BST 2018 342 290.20 CHIX 18318XJb26v Wed 14 Nov 11:00:37 BST 2018 927 290.20 CHIX 18318XJb26u Wed 14 Nov 11:00:37 BST 2018 100 290.20 XLON 18318XJb26t Wed 14 Nov 11:00:37 BST 2018 1344 290.20 XLON 18318XJb26s Wed 14 Nov 11:00:37 BST 2018 1369 290.20 XLON 18318XJb26r Wed 14 Nov 11:00:13 BST 2018 1124 290.35 CHIX 18318XJb25e Wed 14 Nov 11:00:13 BST 2018 993 290.35 XLON 18318XJb25c Wed 14 Nov 11:00:13 BST 2018 181 290.35 XLON 18318XJb25d Wed 14 Nov 11:00:13 BST 2018 1498 290.35 XLON 18318XJb25b Wed 14 Nov 10:59:39 BST 2018 1324 290.30 CHIX 18318XJb20x Wed 14 Nov 10:59:39 BST 2018 77 290.30 XLON 18318XJb214 Wed 14 Nov 10:59:39 BST 2018 59 290.30 XLON 18318XJb212 Wed 14 Nov 10:59:39 BST 2018 1035 290.30 XLON 18318XJb211 Wed 14 Nov 10:59:39 BST 2018 1900 290.30 XLON 18318XJb20z Wed 14 Nov 10:58:51 BST 2018 254 290.30 CHIX 18318XJb1yk Wed 14 Nov 10:58:51 BST 2018 260 290.30 CHIX 18318XJb1yi Wed 14 Nov 10:58:51 BST 2018 323 290.30 CHIX 18318XJb1yj Wed 14 Nov 10:58:51 BST 2018 458 290.30 XLON 18318XJb1yh Wed 14 Nov 10:58:51 BST 2018 408 290.30 XLON 18318XJb1yg Wed 14 Nov 10:58:51 BST 2018 1367 290.30 XLON 18318XJb1yf Wed 14 Nov 10:58:51 BST 2018 747 290.30 CHIX 18318XJb1ye Wed 14 Nov 10:58:16 BST 2018 618 290.25 CHIX 18318XJb1uw Wed 14 Nov 10:58:16 BST 2018 298 290.25 CHIX 18318XJb1ux Wed 14 Nov 10:58:16 BST 2018 103 290.25 CHIX 18318XJb1uv Wed 14 Nov 10:58:16 BST 2018 539 290.30 CHIX 18318XJb1uu Wed 14 Nov 10:58:16 BST 2018 1596 290.25 XLON 18318XJb1ut Wed 14 Nov 10:58:16 BST 2018 435 290.30 XLON 18318XJb1us Wed 14 Nov 10:57:03 BST 2018 663 290.25 CHIX 18318XJb1qh Wed 14 Nov 10:57:03 BST 2018 1470 290.25 XLON 18318XJb1qf Wed 14 Nov 10:56:47 BST 2018 748 290.35 XLON 18318XJb1pg Wed 14 Nov 10:56:47 BST 2018 405 290.35 XLON 18318XJb1pf Wed 14 Nov 10:56:23 BST 2018 702 290.50 CHIX 18318XJb1nj Wed 14 Nov 10:56:23 BST 2018 539 290.55 CHIX 18318XJb1ni Wed 14 Nov 10:56:23 BST 2018 539 290.55 CHIX 18318XJb1ng Wed 14 Nov 10:56:23 BST 2018 1554 290.50 XLON 18318XJb1nh Wed 14 Nov 10:56:23 BST 2018 890 290.55 XLON 18318XJb1nd Wed 14 Nov 10:56:23 BST 2018 88 290.55 XLON 18318XJb1ne Wed 14 Nov 10:56:23 BST 2018 37 290.55 XLON 18318XJb1nc Wed 14 Nov 10:56:23 BST 2018 824 290.55 XLON 18318XJb1nf Wed 14 Nov 10:56:22 BST 2018 627 290.65 CHIX 18318XJb1mk Wed 14 Nov 10:56:22 BST 2018 538 290.65 CHIX 18318XJb1mj Wed 14 Nov 10:56:22 BST 2018 839 290.65 XLON 18318XJb1mi Wed 14 Nov 10:56:22 BST 2018 15 290.65 XLON 18318XJb1mh Wed 14 Nov 10:55:31 BST 2018 599 290.55 CHIX 18318XJb1jg Wed 14 Nov 10:55:31 BST 2018 434 290.55 XLON 18318XJb1jj Wed 14 Nov 10:55:31 BST 2018 621 290.55 XLON 18318XJb1ji Wed 14 Nov 10:55:31 BST 2018 171 290.55 XLON 18318XJb1jh Wed 14 Nov 10:53:36 BST 2018 563 290.35 CHIX 18318XJb1ci Wed 14 Nov 10:53:36 BST 2018 822 290.40 CHIX 18318XJb1ch Wed 14 Nov 10:53:36 BST 2018 1822 290.40 XLON 18318XJb1cg Wed 14 Nov 10:53:32 BST 2018 538 290.65 CHIX 18318XJb1bz Wed 14 Nov 10:53:32 BST 2018 801 290.65 XLON 18318XJb1by Wed 14 Nov 10:53:19 BST 2018 1139 290.70 CHIX 18318XJb1bf Wed 14 Nov 10:53:19 BST 2018 2418 290.70 XLON 18318XJb1bd Wed 14 Nov 10:53:19 BST 2018 106 290.70 XLON 18318XJb1bc Wed 14 Nov 10:53:03 BST 2018 538 290.80 CHIX 18318XJb19i Wed 14 Nov 10:53:03 BST 2018 699 290.80 XLON 18318XJb19h Wed 14 Nov 10:52:54 BST 2018 713 290.90 CHIX 18318XJb18p Wed 14 Nov 10:52:54 BST 2018 1579 290.90 XLON 18318XJb18n Wed 14 Nov 10:52:54 BST 2018 1044 290.95 CHIX 18318XJb18o Wed 14 Nov 10:52:54 BST 2018 2315 290.95 XLON 18318XJb18m Wed 14 Nov 10:52:48 BST 2018 690 291.00 CHIX 18318XJb18h Wed 14 Nov 10:52:48 BST 2018 46 291.00 XLON 18318XJb18f Wed 14 Nov 10:52:48 BST 2018 708 291.00 CHIX 18318XJb18g Wed 14 Nov 10:52:48 BST 2018 1520 291.00 XLON 18318XJb18e Wed 14 Nov 10:52:27 BST 2018 780 290.85 CHIX 18318XJb175 Wed 14 Nov 10:52:27 BST 2018 73 290.90 XLON 18318XJb171 Wed 14 Nov 10:52:27 BST 2018 482 290.90 XLON 18318XJb16z Wed 14 Nov 10:52:27 BST 2018 240 290.90 CHIX 18318XJb174 Wed 14 Nov 10:52:27 BST 2018 244 290.90 CHIX 18318XJb173 Wed 14 Nov 10:52:27 BST 2018 364 290.90 CHIX 18318XJb172 Wed 14 Nov 10:52:27 BST 2018 749 290.90 CHIX 18318XJb170 Wed 14 Nov 10:52:27 BST 2018 538 290.90 CHIX 18318XJb16y Wed 14 Nov 10:51:18 BST 2018 776 290.70 CHIX 18318XJb12y Wed 14 Nov 10:51:18 BST 2018 709 290.70 CHIX 18318XJb12w Wed 14 Nov 10:51:18 BST 2018 1571 290.70 XLON 18318XJb12u Wed 14 Nov 10:51:10 BST 2018 538 290.70 CHIX 18318XJb11h Wed 14 Nov 10:51:10 BST 2018 375 290.70 XLON 18318XJb11g Wed 14 Nov 10:48:52 BST 2018 821 290.10 CHIX 18318XJb0ta Wed 14 Nov 10:48:52 BST 2018 1818 290.10 XLON 18318XJb0t9 Wed 14 Nov 10:48:18 BST 2018 1194 290.15 CHIX 18318XJb0rg Wed 14 Nov 10:48:18 BST 2018 2648 290.15 XLON 18318XJb0rf Wed 14 Nov 10:48:15 BST 2018 1694 290.15 XLON 18318XJb0rb Wed 14 Nov 10:48:15 BST 2018 21 290.15 XLON 18318XJb0rc Wed 14 Nov 10:48:15 BST 2018 2000 290.15 XLON 18318XJb0ra Wed 14 Nov 10:48:15 BST 2018 728 290.15 CHIX 18318XJb0r9 Wed 14 Nov 10:48:15 BST 2018 1099 290.15 CHIX 18318XJb0r7 Wed 14 Nov 10:48:15 BST 2018 203 290.15 CHIX 18318XJb0r8 Wed 14 Nov 10:48:15 BST 2018 568 290.15 CHIX 18318XJb0r6 Wed 14 Nov 10:47:22 BST 2018 400 290.00 XLON 18318XJb0n1 Wed 14 Nov 10:47:22 BST 2018 540 290.00 CHIX 18318XJb0n2 Wed 14 Nov 10:46:04 BST 2018 734 289.05 CHIX 18318XJb0f2 Wed 14 Nov 10:46:04 BST 2018 1130 289.15 CHIX 18318XJb0ew Wed 14 Nov 10:46:04 BST 2018 2506 289.15 XLON 18318XJb0et Wed 14 Nov 10:46:04 BST 2018 532 289.20 CHIX 18318XJb0er Wed 14 Nov 10:46:04 BST 2018 131 289.20 XLON 18318XJb0eq Wed 14 Nov 10:46:04 BST 2018 2349 289.20 XLON 18318XJb0ep Wed 14 Nov 10:46:04 BST 2018 1800 289.20 XLON 18318XJb0eo Wed 14 Nov 10:46:03 BST 2018 1 289.25 CHIX 18318XJb0en Wed 14 Nov 10:46:03 BST 2018 387 289.25 CHIX 18318XJb0el Wed 14 Nov 10:46:03 BST 2018 308 289.25 CHIX 18318XJb0em Wed 14 Nov 10:46:03 BST 2018 128 289.25 XLON 18318XJb0ej Wed 14 Nov 10:46:03 BST 2018 2 289.25 XLON 18318XJb0ek Wed 14 Nov 10:45:24 BST 2018 1338 289.20 CHIX 18318XJb0ai Wed 14 Nov 10:45:23 BST 2018 633 289.25 CHIX 18318XJb0ah Wed 14 Nov 10:45:23 BST 2018 219 289.25 XLON 18318XJb0ag Wed 14 Nov 10:45:07 BST 2018 30 289.40 CHIX 18318XJb08h Wed 14 Nov 10:45:07 BST 2018 555 289.40 CHIX 18318XJb08g Wed 14 Nov 10:45:07 BST 2018 459 289.40 CHIX 18318XJb08e Wed 14 Nov 10:45:07 BST 2018 432 289.40 CHIX 18318XJb08f Wed 14 Nov 10:45:07 BST 2018 101 289.40 XLON 18318XJb08c Wed 14 Nov 10:45:07 BST 2018 1500 289.40 XLON 18318XJb08a Wed 14 Nov 10:45:07 BST 2018 89 289.40 XLON 18318XJb08b Wed 14 Nov 10:45:07 BST 2018 1004 289.45 XLON 18318XJb088 Wed 14 Nov 10:45:07 BST 2018 26 289.45 XLON 18318XJb089 Wed 14 Nov 10:45:07 BST 2018 541 289.45 CHIX 18318XJb087 Wed 14 Nov 10:44:42 BST 2018 94 289.55 XLON 18318XJb05a Wed 14 Nov 10:44:42 BST 2018 137 289.55 XLON 18318XJb05b Wed 14 Nov 10:44:15 BST 2018 353 289.40 CHIX 18318XJb03n Wed 14 Nov 10:44:01 BST 2018 298 289.40 XLON 18318XJb024 Wed 14 Nov 10:43:26 BST 2018 753 289.45 XLON 18318XJazzv Wed 14 Nov 10:43:26 BST 2018 829 289.45 CHIX 18318XJazzu Wed 14 Nov 10:43:26 BST 2018 1837 289.45 XLON 18318XJazzt Wed 14 Nov 10:41:59 BST 2018 832 289.35 CHIX 18318XJazuh Wed 14 Nov 10:39:29 BST 2018 621 288.90 CHIX 18318XJaziy Wed 14 Nov 10:39:29 BST 2018 1271 288.90 XLON 18318XJazj1 Wed 14 Nov 10:39:27 BST 2018 1 289.05 CHIX 18318XJazir Wed 14 Nov 10:39:27 BST 2018 540 289.05 CHIX 18318XJaziq Wed 14 Nov 10:39:27 BST 2018 559 289.05 CHIX 18318XJazip Wed 14 Nov 10:39:27 BST 2018 1145 289.05 XLON 18318XJazin Wed 14 Nov 10:39:27 BST 2018 429 289.05 XLON 18318XJazio Wed 14 Nov 10:39:25 BST 2018 161 289.10 XLON 18318XJazie Wed 14 Nov 10:39:25 BST 2018 191 289.10 XLON 18318XJazic Wed 14 Nov 10:39:25 BST 2018 1504 289.10 XLON 18318XJazia Wed 14 Nov 10:39:25 BST 2018 333 289.10 CHIX 18318XJazif Wed 14 Nov 10:39:25 BST 2018 247 289.10 CHIX 18318XJazid Wed 14 Nov 10:39:25 BST 2018 680 289.10 CHIX 18318XJazib Wed 14 Nov 10:39:24 BST 2018 541 289.15 CHIX 18318XJazhy Wed 14 Nov 10:39:24 BST 2018 1763 289.20 XLON 18318XJazhz Wed 14 Nov 10:39:24 BST 2018 1106 289.20 XLON 18318XJazi0 Wed 14 Nov 10:39:24 BST 2018 61 289.20 CHIX 18318XJazht Wed 14 Nov 10:39:24 BST 2018 541 289.20 CHIX 18318XJazhu Wed 14 Nov 10:39:24 BST 2018 469 289.20 CHIX 18318XJazhv Wed 14 Nov 10:39:24 BST 2018 488 289.20 CHIX 18318XJazhw Wed 14 Nov 10:39:24 BST 2018 734 289.20 CHIX 18318XJazhs Wed 14 Nov 10:39:24 BST 2018 2619 289.25 XLON 18318XJazhq Wed 14 Nov 10:39:24 BST 2018 1182 289.25 CHIX 18318XJazhp Wed 14 Nov 10:39:21 BST 2018 245 289.30 CHIX 18318XJazhh Wed 14 Nov 10:39:21 BST 2018 541 289.30 CHIX 18318XJazhi Wed 14 Nov 10:39:21 BST 2018 1005 289.30 CHIX 18318XJazhg Wed 14 Nov 10:39:21 BST 2018 639 289.30 CHIX 18318XJazhf Wed 14 Nov 10:39:21 BST 2018 478 289.30 XLON 18318XJazhl Wed 14 Nov 10:39:21 BST 2018 3646 289.30 XLON 18318XJazhj Wed 14 Nov 10:39:21 BST 2018 154 289.30 XLON 18318XJazhk Wed 14 Nov 10:39:11 BST 2018 435 289.40 CHIX 18318XJazh0 Wed 14 Nov 10:39:11 BST 2018 626 289.40 CHIX 18318XJazgz Wed 14 Nov 10:39:11 BST 2018 1331 289.40 XLON 18318XJazgy Wed 14 Nov 10:38:33 BST 2018 541 289.30 CHIX 18318XJazeo Wed 14 Nov 10:38:33 BST 2018 967 289.30 XLON 18318XJazej Wed 14 Nov 10:38:33 BST 2018 2022 289.25 XLON 18318XJazel Wed 14 Nov 10:38:33 BST 2018 913 289.25 CHIX 18318XJazed Wed 14 Nov 10:38:33 BST 2018 1108 289.35 CHIX 18318XJazea Wed 14 Nov 10:38:33 BST 2018 2455 289.35 XLON 18318XJaze7 Wed 14 Nov 10:37:30 BST 2018 541 289.10 CHIX 18318XJazbg Wed 14 Nov 10:37:30 BST 2018 559 289.10 CHIX 18318XJazbh Wed 14 Nov 10:37:30 BST 2018 112 289.10 XLON 18318XJazbf Wed 14 Nov 10:37:30 BST 2018 735 289.10 XLON 18318XJazbe Wed 14 Nov 10:37:27 BST 2018 939 289.20 XLON 18318XJazb3 Wed 14 Nov 10:37:27 BST 2018 541 289.20 CHIX 18318XJazb5 Wed 14 Nov 10:37:00 BST 2018 541 289.05 CHIX 18318XJaz8t Wed 14 Nov 10:37:00 BST 2018 463 289.05 CHIX 18318XJaz8u Wed 14 Nov 10:37:00 BST 2018 761 289.05 XLON 18318XJaz8s Wed 14 Nov 10:37:00 BST 2018 227 289.10 CHIX 18318XJaz8o Wed 14 Nov 10:36:44 BST 2018 51 289.15 CHIX 18318XJaz6o Wed 14 Nov 10:36:44 BST 2018 334 289.15 CHIX 18318XJaz6n Wed 14 Nov 10:36:44 BST 2018 541 289.15 CHIX 18318XJaz6m Wed 14 Nov 10:36:44 BST 2018 804 289.15 XLON 18318XJaz6l Wed 14 Nov 10:35:54 BST 2018 380 289.20 CHIX 18318XJaz2p Wed 14 Nov 10:35:54 BST 2018 270 289.20 CHIX 18318XJaz2q Wed 14 Nov 10:35:54 BST 2018 541 289.20 CHIX 18318XJaz2n Wed 14 Nov 10:35:54 BST 2018 330 289.20 CHIX 18318XJaz2o Wed 14 Nov 10:35:54 BST 2018 227 289.20 CHIX 18318XJaz2m Wed 14 Nov 10:35:54 BST 2018 107 289.20 XLON 18318XJaz2l Wed 14 Nov 10:35:51 BST 2018 518 289.20 XLON 18318XJaz2b Wed 14 Nov 10:35:10 BST 2018 187 289.15 XLON 18318XJaz00 Wed 14 Nov 10:35:10 BST 2018 582 289.15 CHIX 18318XJayzz Wed 14 Nov 10:35:10 BST 2018 1157 289.15 XLON 18318XJayzy Wed 14 Nov 10:35:10 BST 2018 34 289.15 XLON 18318XJayzx Wed 14 Nov 10:34:36 BST 2018 203 289.05 CHIX 18318XJayx7 Wed 14 Nov 10:34:36 BST 2018 298 289.05 CHIX 18318XJayx8 Wed 14 Nov 10:34:36 BST 2018 338 289.05 CHIX 18318XJayx6 Wed 14 Nov 10:34:36 BST 2018 775 289.05 XLON 18318XJayx5 Wed 14 Nov 10:34:36 BST 2018 680 289.10 CHIX 18318XJayx4 Wed 14 Nov 10:34:36 BST 2018 440 289.10 CHIX 18318XJaywl Wed 14 Nov 10:34:36 BST 2018 553 289.10 CHIX 18318XJaywk Wed 14 Nov 10:33:30 BST 2018 565 288.85 CHIX 18318XJaysc Wed 14 Nov 10:33:30 BST 2018 261 288.85 CHIX 18318XJaysa Wed 14 Nov 10:33:30 BST 2018 47 288.85 XLON 18318XJaysb Wed 14 Nov 10:33:30 BST 2018 1830 288.85 XLON 18318XJays9 Wed 14 Nov 10:33:30 BST 2018 267 288.90 CHIX 18318XJays8 Wed 14 Nov 10:33:30 BST 2018 412 288.90 CHIX 18318XJays7 Wed 14 Nov 10:32:25 BST 2018 1021 288.80 XLON 18318XJayob Wed 14 Nov 10:32:25 BST 2018 1 288.85 CHIX 18318XJayoa Wed 14 Nov 10:32:25 BST 2018 541 288.85 CHIX 18318XJayo9 Wed 14 Nov 10:32:25 BST 2018 892 288.85 XLON 18318XJayo8 Wed 14 Nov 10:32:16 BST 2018 542 288.85 CHIX 18318XJaynt Wed 14 Nov 10:32:16 BST 2018 482 288.85 XLON 18318XJayns Wed 14 Nov 10:31:41 BST 2018 296 288.65 CHIX 18318XJaylm Wed 14 Nov 10:31:41 BST 2018 542 288.65 CHIX 18318XJayll Wed 14 Nov 10:31:41 BST 2018 179 288.65 XLON 18318XJayli Wed 14 Nov 10:31:41 BST 2018 582 288.65 XLON 18318XJaylj Wed 14 Nov 10:31:41 BST 2018 137 288.65 XLON 18318XJaylk Wed 14 Nov 10:31:26 BST 2018 733 288.70 CHIX 18318XJayki Wed 14 Nov 10:30:34 BST 2018 155 288.95 CHIX 18318XJayg8 Wed 14 Nov 10:30:34 BST 2018 340 288.90 XLON 18318XJayg7 Wed 14 Nov 10:30:34 BST 2018 1363 288.85 XLON 18318XJayg6 Wed 14 Nov 10:30:34 BST 2018 628 288.85 CHIX 18318XJayg5 Wed 14 Nov 10:30:34 BST 2018 501 288.95 CHIX 18318XJayg4 Wed 14 Nov 10:30:34 BST 2018 963 288.95 CHIX 18318XJayg3 Wed 14 Nov 10:30:34 BST 2018 509 289.00 XLON 18318XJayg2 Wed 14 Nov 10:30:34 BST 2018 542 289.00 CHIX 18318XJayg1 Wed 14 Nov 10:29:59 BST 2018 1899 288.95 XLON 18318XJaycg Wed 14 Nov 10:29:59 BST 2018 1345 288.95 XLON 18318XJaycf Wed 14 Nov 10:29:59 BST 2018 58 289.20 BATE 18318XJayce Wed 14 Nov 10:28:17 BST 2018 1026 288.85 CHIX 18318XJay2j Wed 14 Nov 10:28:17 BST 2018 2274 288.85 XLON 18318XJay2i Wed 14 Nov 10:28:17 BST 2018 397 288.90 CHIX 18318XJay2h Wed 14 Nov 10:27:37 BST 2018 480 289.20 CHIX 18318XJaxya Wed 14 Nov 10:27:37 BST 2018 931 289.30 CHIX 18318XJaxy8 Wed 14 Nov 10:27:37 BST 2018 2063 289.30 XLON 18318XJaxy7 Wed 14 Nov 10:26:54 BST 2018 1985 289.75 XLON 18318XJaxrt Wed 14 Nov 10:26:54 BST 2018 896 289.75 CHIX 18318XJaxrs Wed 14 Nov 10:26:46 BST 2018 702 289.80 CHIX 18318XJaxqy Wed 14 Nov 10:26:46 BST 2018 911 289.80 XLON 18318XJaxqx Wed 14 Nov 10:26:46 BST 2018 188 289.80 CHIX 18318XJaxqw Wed 14 Nov 10:26:46 BST 2018 938 289.80 XLON 18318XJaxqv Wed 14 Nov 10:26:46 BST 2018 122 289.80 XLON 18318XJaxqu Wed 14 Nov 10:26:38 BST 2018 1077 289.95 CHIX 18318XJaxop Wed 14 Nov 10:26:38 BST 2018 1000 289.95 XLON 18318XJaxoo Wed 14 Nov 10:26:38 BST 2018 1387 289.95 XLON 18318XJaxon Wed 14 Nov 10:26:03 BST 2018 2500 289.95 XLON 18318XJaxm1 Wed 14 Nov 10:26:03 BST 2018 284 289.95 XLON 18318XJaxm0 Wed 14 Nov 10:26:03 BST 2018 1257 289.95 CHIX 18318XJaxm2 Wed 14 Nov 10:25:45 BST 2018 671 289.80 CHIX 18318XJaxkg Wed 14 Nov 10:25:45 BST 2018 1486 289.80 XLON 18318XJaxkf Wed 14 Nov 10:25:42 BST 2018 486 289.90 XLON 18318XJaxkd Wed 14 Nov 10:25:34 BST 2018 457 289.85 XLON 18318XJaxj4 Wed 14 Nov 10:25:34 BST 2018 1271 289.85 XLON 18318XJaxj2 Wed 14 Nov 10:25:34 BST 2018 417 289.85 CHIX 18318XJaxj3 Wed 14 Nov 10:25:34 BST 2018 364 289.85 CHIX 18318XJaxj1 Wed 14 Nov 10:25:06 BST 2018 1358 289.70 CHIX 18318XJaxev Wed 14 Nov 10:25:06 BST 2018 3009 289.70 XLON 18318XJaxeu Wed 14 Nov 10:22:49 BST 2018 2954 288.95 XLON 18318XJax0u Wed 14 Nov 10:22:49 BST 2018 1333 288.95 CHIX 18318XJax0t Wed 14 Nov 10:22:28 BST 2018 2000 289.00 XLON 18318XJax03 Wed 14 Nov 10:22:28 BST 2018 876 289.00 XLON 18318XJax02 Wed 14 Nov 10:22:28 BST 2018 67 289.00 XLON 18318XJax01 Wed 14 Nov 10:22:28 BST 2018 284 289.05 CHIX 18318XJax00 Wed 14 Nov 10:20:23 BST 2018 1102 289.60 XLON 18318XJawti Wed 14 Nov 10:20:23 BST 2018 367 289.60 CHIX 18318XJawth Wed 14 Nov 10:20:04 BST 2018 535 289.80 XLON 18318XJawsl Wed 14 Nov 10:20:04 BST 2018 593 289.80 CHIX 18318XJawsk Wed 14 Nov 10:20:04 BST 2018 625 289.80 CHIX 18318XJawsm Wed 14 Nov 10:20:04 BST 2018 784 289.80 XLON 18318XJawsj Wed 14 Nov 10:20:04 BST 2018 1216 289.80 XLON 18318XJawsh Wed 14 Nov 10:19:50 BST 2018 17 290.00 XLON 18318XJawrb Wed 14 Nov 10:19:50 BST 2018 1099 290.00 CHIX 18318XJawra Wed 14 Nov 10:19:50 BST 2018 911 290.00 XLON 18318XJawr9 Wed 14 Nov 10:19:50 BST 2018 1507 290.00 XLON 18318XJawr8 Wed 14 Nov 10:19:46 BST 2018 4012 290.05 XLON 18318XJawr1 Wed 14 Nov 10:19:46 BST 2018 1809 290.05 CHIX 18318XJawr2 Wed 14 Nov 10:19:36 BST 2018 510 290.15 CHIX 18318XJawq6 Wed 14 Nov 10:19:36 BST 2018 690 290.10 XLON 18318XJawq5 Wed 14 Nov 10:19:36 BST 2018 830 290.10 XLON 18318XJawq4 Wed 14 Nov 10:19:36 BST 2018 849 290.10 CHIX 18318XJawq2 Wed 14 Nov 10:19:36 BST 2018 363 290.10 XLON 18318XJawq3 Wed 14 Nov 10:19:36 BST 2018 539 290.15 CHIX 18318XJawq1 Wed 14 Nov 10:19:36 BST 2018 136 290.15 XLON 18318XJawq0 Wed 14 Nov 10:19:36 BST 2018 956 290.15 XLON 18318XJawpz Wed 14 Nov 10:18:22 BST 2018 1 290.15 CHIX 18318XJawjt Wed 14 Nov 10:18:22 BST 2018 915 290.15 CHIX 18318XJawjr Wed 14 Nov 10:18:22 BST 2018 625 290.15 CHIX 18318XJawjs Wed 14 Nov 10:18:22 BST 2018 1182 290.15 XLON 18318XJawjq Wed 14 Nov 10:18:22 BST 2018 843 290.15 XLON 18318XJawjp Wed 14 Nov 10:17:38 BST 2018 1186 290.25 CHIX 18318XJawi8 Wed 14 Nov 10:17:38 BST 2018 50 290.25 XLON 18318XJawi6 Wed 14 Nov 10:17:38 BST 2018 73 290.25 XLON 18318XJawi7 Wed 14 Nov 10:17:38 BST 2018 1884 290.25 XLON 18318XJawi5 Wed 14 Nov 10:17:38 BST 2018 745 290.25 XLON 18318XJawi4 Wed 14 Nov 10:16:48 BST 2018 1481 289.90 XLON 18318XJawe0 Wed 14 Nov 10:16:48 BST 2018 333 289.90 XLON 18318XJawdy Wed 14 Nov 10:16:48 BST 2018 819 289.90 CHIX 18318XJawe1 Wed 14 Nov 10:16:48 BST 2018 1130 290.00 XLON 18318XJawdr Wed 14 Nov 10:16:48 BST 2018 551 290.00 CHIX 18318XJawdt Wed 14 Nov 10:16:48 BST 2018 373 290.00 CHIX 18318XJawdv Wed 14 Nov 10:14:38 BST 2018 304 289.70 CHIX 18318XJaw6w Wed 14 Nov 10:14:37 BST 2018 1837 289.80 CHIX 18318XJaw6r Wed 14 Nov 10:14:37 BST 2018 838 289.80 CHIX 18318XJaw6q Wed 14 Nov 10:14:37 BST 2018 2133 289.80 XLON 18318XJaw6p Wed 14 Nov 10:14:37 BST 2018 3800 289.80 XLON 18318XJaw6o Wed 14 Nov 10:13:22 BST 2018 696 289.75 XLON 18318XJaw2i Wed 14 Nov 10:13:17 BST 2018 695 289.95 CHIX 18318XJaw1z Wed 14 Nov 10:13:17 BST 2018 540 289.95 CHIX 18318XJaw20 Wed 14 Nov 10:13:17 BST 2018 1055 289.95 XLON 18318XJaw1y Wed 14 Nov 10:13:14 BST 2018 1742 290.00 XLON 18318XJaw1x Wed 14 Nov 10:13:14 BST 2018 787 290.00 CHIX 18318XJaw1w Wed 14 Nov 10:13:09 BST 2018 503 290.05 CHIX 18318XJaw1r Wed 14 Nov 10:13:09 BST 2018 1317 290.05 XLON 18318XJaw1o Wed 14 Nov 10:13:09 BST 2018 385 290.05 CHIX 18318XJaw1p Wed 14 Nov 10:13:09 BST 2018 648 290.05 XLON 18318XJaw1n Wed 14 Nov 10:11:56 BST 2018 166 289.85 XLON 18318XJavy4 Wed 14 Nov 10:11:36 BST 2018 927 290.05 XLON 18318XJavxp Wed 14 Nov 10:11:36 BST 2018 540 290.05 CHIX 18318XJavxo Wed 14 Nov 10:11:28 BST 2018 134 290.15 XLON 18318XJavx0 Wed 14 Nov 10:11:28 BST 2018 174 290.15 XLON 18318XJavx1 Wed 14 Nov 10:11:17 BST 2018 616 290.30 CHIX 18318XJavwb Wed 14 Nov 10:11:17 BST 2018 1333 290.30 CHIX 18318XJavwa Wed 14 Nov 10:11:17 BST 2018 1142 290.30 XLON 18318XJavw9 Wed 14 Nov 10:11:17 BST 2018 1333 290.30 XLON 18318XJavw8 Wed 14 Nov 10:11:17 BST 2018 1848 290.30 XLON 18318XJavw7 Wed 14 Nov 10:11:13 BST 2018 1544 290.35 XLON 18318XJavvu Wed 14 Nov 10:11:13 BST 2018 624 290.45 CHIX 18318XJavvt Wed 14 Nov 10:11:13 BST 2018 64 290.45 XLON 18318XJavvs Wed 14 Nov 10:11:13 BST 2018 1283 290.45 XLON 18318XJavvr Wed 14 Nov 10:11:13 BST 2018 14 290.45 XLON 18318XJavvq Wed 14 Nov 10:11:00 BST 2018 539 290.50 CHIX 18318XJavup Wed 14 Nov 10:11:00 BST 2018 713 290.50 XLON 18318XJavuo Wed 14 Nov 10:11:00 BST 2018 539 290.55 CHIX 18318XJavun Wed 14 Nov 10:10:59 BST 2018 538 290.70 CHIX 18318XJavum Wed 14 Nov 10:10:59 BST 2018 538 290.70 CHIX 18318XJavul Wed 14 Nov 10:10:59 BST 2018 943 290.70 XLON 18318XJavuk Wed 14 Nov 10:10:59 BST 2018 371 290.70 XLON 18318XJavui Wed 14 Nov 10:10:59 BST 2018 24 290.70 XLON 18318XJavuj Wed 14 Nov 10:10:38 BST 2018 13 290.80 XLON 18318XJavt9 Wed 14 Nov 10:10:38 BST 2018 538 290.80 CHIX 18318XJavt8 Wed 14 Nov 10:10:38 BST 2018 418 290.80 CHIX 18318XJavt6 Wed 14 Nov 10:10:38 BST 2018 536 290.80 CHIX 18318XJavt7 Wed 14 Nov 10:10:38 BST 2018 414 290.80 XLON 18318XJavt5 Wed 14 Nov 10:10:28 BST 2018 242 290.90 CHIX 18318XJavs9 Wed 14 Nov 10:10:28 BST 2018 538 290.90 CHIX 18318XJavs8 Wed 14 Nov 10:10:28 BST 2018 705 290.90 CHIX 18318XJavs6 Wed 14 Nov 10:10:28 BST 2018 658 290.90 XLON 18318XJavs7 Wed 14 Nov 10:10:28 BST 2018 1561 290.90 XLON 18318XJavs4 Wed 14 Nov 10:10:28 BST 2018 55 290.90 XLON 18318XJavs5 Wed 14 Nov 10:10:22 BST 2018 768 291.00 CHIX 18318XJavrn Wed 14 Nov 10:10:22 BST 2018 1 291.00 XLON 18318XJavro Wed 14 Nov 10:10:22 BST 2018 1701 291.00 XLON 18318XJavrl Wed 14 Nov 10:10:22 BST 2018 12 291.00 XLON 18318XJavrm Wed 14 Nov 10:10:20 BST 2018 409 291.05 CHIX 18318XJavr9 Wed 14 Nov 10:10:20 BST 2018 665 291.05 CHIX 18318XJavr7 Wed 14 Nov 10:10:20 BST 2018 5 291.05 XLON 18318XJavr8 Wed 14 Nov 10:10:20 BST 2018 1471 291.05 XLON 18318XJavr6 Wed 14 Nov 10:10:20 BST 2018 538 291.10 CHIX 18318XJavr5 Wed 14 Nov 10:10:20 BST 2018 642 291.10 XLON 18318XJavr4 Wed 14 Nov 10:09:53 BST 2018 1472 291.00 XLON 18318XJavoq Wed 14 Nov 10:09:28 BST 2018 896 290.70 CHIX 18318XJavns Wed 14 Nov 10:09:28 BST 2018 1985 290.70 XLON 18318XJavnt Wed 14 Nov 10:09:28 BST 2018 187 290.70 XLON 18318XJavnu Wed 14 Nov 10:09:10 BST 2018 1214 290.75 XLON 18318XJavn5 Wed 14 Nov 10:09:06 BST 2018 1121 290.80 XLON 18318XJavms Wed 14 Nov 10:09:06 BST 2018 547 290.80 CHIX 18318XJavmr Wed 14 Nov 10:08:51 BST 2018 763 290.70 XLON 18318XJavjo Wed 14 Nov 10:08:35 BST 2018 130 290.40 XLON 18318XJavf3 Wed 14 Nov 10:08:11 BST 2018 539 290.35 CHIX 18318XJavd3 Wed 14 Nov 10:08:11 BST 2018 127 290.35 XLON 18318XJavd2 Wed 14 Nov 10:08:11 BST 2018 651 290.35 XLON 18318XJavd1 Wed 14 Nov 10:07:35 BST 2018 251 290.10 XLON 18318XJav7z Wed 14 Nov 10:07:35 BST 2018 235 290.10 XLON 18318XJav7r Wed 14 Nov 10:07:35 BST 2018 313 290.10 XLON 18318XJav7o Wed 14 Nov 10:07:35 BST 2018 12 290.10 XLON 18318XJav7k Wed 14 Nov 10:07:35 BST 2018 2 290.10 XLON 18318XJav7l Wed 14 Nov 10:07:35 BST 2018 283 290.10 XLON 18318XJav7j Wed 14 Nov 10:07:35 BST 2018 649 290.10 CHIX 18318XJav7w Wed 14 Nov 10:07:35 BST 2018 713 290.10 CHIX 18318XJav7u Wed 14 Nov 10:07:35 BST 2018 539 290.10 CHIX 18318XJav7y Wed 14 Nov 10:07:35 BST 2018 584 290.10 CHIX 18318XJav7t Wed 14 Nov 10:07:20 BST 2018 575 290.20 CHIX 18318XJav6q Wed 14 Nov 10:07:20 BST 2018 624 290.20 CHIX 18318XJav6p Wed 14 Nov 10:07:20 BST 2018 638 290.20 XLON 18318XJav6o Wed 14 Nov 10:07:20 BST 2018 709 290.20 XLON 18318XJav6n Wed 14 Nov 10:07:03 BST 2018 637 290.25 CHIX 18318XJav5d Wed 14 Nov 10:07:02 BST 2018 539 290.30 CHIX 18318XJav5c Wed 14 Nov 10:07:02 BST 2018 700 290.30 XLON 18318XJav5b Wed 14 Nov 10:07:02 BST 2018 331 290.30 XLON 18318XJav5a Wed 14 Nov 10:07:02 BST 2018 183 290.35 XLON 18318XJav59 Wed 14 Nov 10:07:02 BST 2018 539 290.35 CHIX 18318XJav58 Wed 14 Nov 10:06:54 BST 2018 476 290.35 XLON 18318XJav4m Wed 14 Nov 10:06:49 BST 2018 539 290.40 XLON 18318XJav47 Wed 14 Nov 10:06:49 BST 2018 526 290.40 XLON 18318XJav46 Wed 14 Nov 10:06:49 BST 2018 92 290.40 XLON 18318XJav44 Wed 14 Nov 10:03:49 BST 2018 2685 289.55 XLON 18318XJaurf Wed 14 Nov 10:03:49 BST 2018 1211 289.55 CHIX 18318XJaure Wed 14 Nov 10:03:14 BST 2018 54 289.35 XLON 18318XJaupl Wed 14 Nov 10:03:14 BST 2018 936 289.35 CHIX 18318XJaupk Wed 14 Nov 10:03:14 BST 2018 2075 289.35 XLON 18318XJaupj Wed 14 Nov 10:03:13 BST 2018 626 289.40 CHIX 18318XJaupi Wed 14 Nov 10:03:13 BST 2018 1358 289.40 XLON 18318XJauph Wed 14 Nov 10:02:02 BST 2018 1250 289.25 CHIX 18318XJauk9 Wed 14 Nov 10:02:02 BST 2018 492 289.20 CHIX 18318XJauk8 Wed 14 Nov 10:01:06 BST 2018 1541 289.50 XLON 18318XJauem Wed 14 Nov 10:01:06 BST 2018 696 289.50 CHIX 18318XJauel Wed 14 Nov 10:01:06 BST 2018 1048 289.55 XLON 18318XJauej Wed 14 Nov 10:01:06 BST 2018 13 289.55 XLON 18318XJauek Wed 14 Nov 10:01:06 BST 2018 541 289.55 CHIX 18318XJauei Wed 14 Nov 10:00:10 BST 2018 126 289.40 XLON 18318XJaubx Wed 14 Nov 09:59:28 BST 2018 243 289.35 CHIX 18318XJau9s Wed 14 Nov 09:59:28 BST 2018 712 289.35 CHIX 18318XJau9q Wed 14 Nov 09:59:28 BST 2018 1276 289.40 CHIX 18318XJau9p Wed 14 Nov 09:59:28 BST 2018 2115 289.35 XLON 18318XJau9r Wed 14 Nov 09:59:28 BST 2018 3 289.40 XLON 18318XJau9o Wed 14 Nov 09:59:28 BST 2018 2827 289.40 XLON 18318XJau9n Wed 14 Nov 09:58:09 BST 2018 952 289.30 XLON 18318XJau53 Wed 14 Nov 09:58:09 BST 2018 49 289.30 CHIX 18318XJau54 Wed 14 Nov 09:58:09 BST 2018 673 289.30 CHIX 18318XJau52 Wed 14 Nov 09:58:09 BST 2018 1490 289.30 XLON 18318XJau51 Wed 14 Nov 09:58:09 BST 2018 380 289.30 CHIX 18318XJau50 Wed 14 Nov 09:58:08 BST 2018 499 289.40 XLON 18318XJau4y Wed 14 Nov 09:58:08 BST 2018 541 289.40 CHIX 18318XJau4z Wed 14 Nov 09:57:12 BST 2018 540 290.05 CHIX 18318XJau27 Wed 14 Nov 09:57:12 BST 2018 364 290.05 CHIX 18318XJau28 Wed 14 Nov 09:57:12 BST 2018 833 290.05 CHIX 18318XJau25 Wed 14 Nov 09:57:12 BST 2018 247 290.05 CHIX 18318XJau26 Wed 14 Nov 09:57:12 BST 2018 360 290.05 CHIX 18318XJau23 Wed 14 Nov 09:57:12 BST 2018 539 290.10 CHIX 18318XJau1z Wed 14 Nov 09:57:12 BST 2018 394 290.10 CHIX 18318XJau21 Wed 14 Nov 09:57:12 BST 2018 72 290.05 XLON 18318XJau24 Wed 14 Nov 09:57:12 BST 2018 404 290.05 XLON 18318XJau22 Wed 14 Nov 09:57:12 BST 2018 2643 290.05 XLON 18318XJau20 Wed 14 Nov 09:57:12 BST 2018 88 290.10 XLON 18318XJau1x Wed 14 Nov 09:57:12 BST 2018 1012 290.10 XLON 18318XJau1y Wed 14 Nov 09:57:10 BST 2018 844 290.15 XLON 18318XJau1q Wed 14 Nov 09:57:10 BST 2018 539 290.15 CHIX 18318XJau1r Wed 14 Nov 09:57:10 BST 2018 778 290.20 XLON 18318XJau1n Wed 14 Nov 09:57:10 BST 2018 539 290.20 CHIX 18318XJau1p Wed 14 Nov 09:57:10 BST 2018 484 290.20 CHIX 18318XJau1o Wed 14 Nov 09:57:10 BST 2018 631 290.20 CHIX 18318XJau1m Wed 14 Nov 09:57:08 BST 2018 206 290.25 CHIX 18318XJau1l Wed 14 Nov 09:57:01 BST 2018 134 290.25 XLON 18318XJau11 Wed 14 Nov 09:56:41 BST 2018 401 290.25 CHIX 18318XJatzr Wed 14 Nov 09:56:41 BST 2018 539 290.25 CHIX 18318XJatzq Wed 14 Nov 09:56:41 BST 2018 8 290.25 XLON 18318XJatzp Wed 14 Nov 09:56:41 BST 2018 1090 290.25 XLON 18318XJatzo Wed 14 Nov 09:56:13 BST 2018 361 290.25 XLON 18318XJatxv Wed 14 Nov 09:56:13 BST 2018 539 290.25 CHIX 18318XJatxw Wed 14 Nov 09:56:12 BST 2018 370 290.30 CHIX 18318XJatxt Wed 14 Nov 09:56:12 BST 2018 584 290.30 CHIX 18318XJatxu Wed 14 Nov 09:56:12 BST 2018 179 290.30 XLON 18318XJatxr Wed 14 Nov 09:56:12 BST 2018 1195 290.30 XLON 18318XJatxs Wed 14 Nov 09:56:12 BST 2018 749 290.35 CHIX 18318XJatxq Wed 14 Nov 09:56:12 BST 2018 763 290.35 XLON 18318XJatxp Wed 14 Nov 09:56:12 BST 2018 898 290.35 XLON 18318XJatxo Wed 14 Nov 09:55:56 BST 2018 2263 290.30 XLON 18318XJatw8 Wed 14 Nov 09:55:56 BST 2018 1021 290.30 CHIX 18318XJatw7 Wed 14 Nov 09:54:30 BST 2018 170 290.10 XLON 18318XJatry Wed 14 Nov 09:54:30 BST 2018 444 290.10 CHIX 18318XJatrx Wed 14 Nov 09:54:30 BST 2018 262 290.10 CHIX 18318XJatrw Wed 14 Nov 09:54:19 BST 2018 495 290.10 XLON 18318XJatq9 Wed 14 Nov 09:54:19 BST 2018 539 290.10 CHIX 18318XJatq8 Wed 14 Nov 09:54:10 BST 2018 1955 290.10 XLON 18318XJatpb Wed 14 Nov 09:54:10 BST 2018 82 290.10 XLON 18318XJatpc Wed 14 Nov 09:54:10 BST 2018 882 290.10 CHIX 18318XJatpa Wed 14 Nov 09:53:08 BST 2018 1200 290.10 XLON 18318XJatnb Wed 14 Nov 09:53:08 BST 2018 367 290.05 XLON 18318XJatn8 Wed 14 Nov 09:53:08 BST 2018 1121 290.05 XLON 18318XJatn9 Wed 14 Nov 09:53:08 BST 2018 67 290.05 XLON 18318XJatna Wed 14 Nov 09:53:08 BST 2018 505 290.10 XLON 18318XJatn7 Wed 14 Nov 09:53:08 BST 2018 2283 290.10 XLON 18318XJatn6 Wed 14 Nov 09:53:08 BST 2018 245 290.10 XLON 18318XJatn4 Wed 14 Nov 09:53:08 BST 2018 783 290.10 CHIX 18318XJatn5 Wed 14 Nov 09:53:08 BST 2018 1140 290.10 CHIX 18318XJatn2 Wed 14 Nov 09:53:08 BST 2018 539 290.10 CHIX 18318XJatn3 Wed 14 Nov 09:52:51 BST 2018 175 290.15 XLON 18318XJatm0 Wed 14 Nov 09:52:12 BST 2018 1044 289.95 XLON 18318XJatk3 Wed 14 Nov 09:52:12 BST 2018 540 289.95 CHIX 18318XJatk1 Wed 14 Nov 09:52:12 BST 2018 320 289.95 CHIX 18318XJatk2 Wed 14 Nov 09:51:18 BST 2018 540 289.80 CHIX 18318XJathu Wed 14 Nov 09:51:18 BST 2018 346 289.80 XLON 18318XJaths Wed 14 Nov 09:51:18 BST 2018 35 289.80 XLON 18318XJatht Wed 14 Nov 09:51:17 BST 2018 682 289.85 XLON 18318XJatho Wed 14 Nov 09:51:17 BST 2018 699 289.85 CHIX 18318XJathp Wed 14 Nov 09:51:17 BST 2018 540 289.85 CHIX 18318XJathq Wed 14 Nov 09:51:09 BST 2018 613 289.85 CHIX 18318XJathh Wed 14 Nov 09:50:43 BST 2018 1213 289.80 XLON 18318XJatgt Wed 14 Nov 09:50:43 BST 2018 544 289.80 CHIX 18318XJatgr Wed 14 Nov 09:50:43 BST 2018 1115 289.80 XLON 18318XJatgq Wed 14 Nov 09:49:06 BST 2018 576 289.40 CHIX 18318XJat8a Wed 14 Nov 09:49:06 BST 2018 1181 289.40 XLON 18318XJat89 Wed 14 Nov 09:48:55 BST 2018 431 289.55 XLON 18318XJat7u Wed 14 Nov 09:48:55 BST 2018 541 289.55 CHIX 18318XJat7v Wed 14 Nov 09:47:39 BST 2018 617 289.90 CHIX 18318XJat2x Wed 14 Nov 09:47:39 BST 2018 497 289.90 XLON 18318XJat2w Wed 14 Nov 09:47:39 BST 2018 2128 289.90 XLON 18318XJat2v Wed 14 Nov 09:47:39 BST 2018 567 289.90 CHIX 18318XJat2u Wed 14 Nov 09:47:39 BST 2018 582 290.00 CHIX 18318XJat2t Wed 14 Nov 09:46:19 BST 2018 7060 290.23 CHIX 18318XJaswv Wed 14 Nov 09:46:19 BST 2018 1888 290.30 CHIX 18318XJaswr Wed 14 Nov 09:46:19 BST 2018 389 290.30 XLON 18318XJasws Wed 14 Nov 09:46:19 BST 2018 85 290.30 XLON 18318XJaswt Wed 14 Nov 09:46:19 BST 2018 3800 290.30 XLON 18318XJaswq Wed 14 Nov 09:46:14 BST 2018 314 290.35 CHIX 18318XJasvh Wed 14 Nov 09:46:14 BST 2018 1378 290.40 XLON 18318XJasvf Wed 14 Nov 09:46:14 BST 2018 624 290.40 CHIX 18318XJasvg Wed 14 Nov 09:45:48 BST 2018 615 290.40 CHIX 18318XJastv Wed 14 Nov 09:45:48 BST 2018 1259 290.40 XLON 18318XJastu Wed 14 Nov 09:45:26 BST 2018 527 290.70 CHIX 18318XJasrk Wed 14 Nov 09:44:54 BST 2018 624 290.65 CHIX 18318XJasnc Wed 14 Nov 09:44:54 BST 2018 1328 290.65 XLON 18318XJasnb Wed 14 Nov 09:44:47 BST 2018 87 290.70 XLON 18318XJasmq Wed 14 Nov 09:43:33 BST 2018 580 291.20 CHIX 18318XJasg8 Wed 14 Nov 09:43:33 BST 2018 634 291.20 CHIX 18318XJasg6 Wed 14 Nov 09:43:33 BST 2018 1188 291.20 XLON 18318XJasg7 Wed 14 Nov 09:43:33 BST 2018 210 291.20 XLON 18318XJasg5 Wed 14 Nov 09:43:19 BST 2018 1485 291.40 XLON 18318XJasd3 Wed 14 Nov 09:43:18 BST 2018 671 291.40 CHIX 18318XJasd1 Wed 14 Nov 09:42:31 BST 2018 306 291.70 CHIX 18318XJas9z Wed 14 Nov 09:42:31 BST 2018 744 291.70 XLON 18318XJas9y Wed 14 Nov 09:42:31 BST 2018 1500 291.70 XLON 18318XJas9x Wed 14 Nov 09:42:31 BST 2018 706 291.70 CHIX 18318XJas9w Wed 14 Nov 09:42:27 BST 2018 1471 291.80 XLON 18318XJas9n Wed 14 Nov 09:42:27 BST 2018 665 291.80 CHIX 18318XJas9m Wed 14 Nov 09:42:15 BST 2018 307 292.00 CHIX 18318XJas8s Wed 14 Nov 09:42:15 BST 2018 1046 292.00 CHIX 18318XJas8r Wed 14 Nov 09:42:15 BST 2018 1147 292.00 XLON 18318XJas8q Wed 14 Nov 09:42:15 BST 2018 1169 292.00 XLON 18318XJas8p Wed 14 Nov 09:42:10 BST 2018 439 292.05 CHIX 18318XJas7x Wed 14 Nov 09:41:59 BST 2018 706 292.00 XLON 18318XJas6x Wed 14 Nov 09:41:59 BST 2018 1027 292.00 CHIX 18318XJas6y Wed 14 Nov 09:41:59 BST 2018 1571 292.00 XLON 18318XJas6w Wed 14 Nov 09:41:31 BST 2018 537 291.70 CHIX 18318XJas4g Wed 14 Nov 09:41:31 BST 2018 576 291.70 XLON 18318XJas4f Wed 14 Nov 09:41:23 BST 2018 95 291.75 CHIX 18318XJas3u Wed 14 Nov 09:41:23 BST 2018 739 291.75 XLON 18318XJas3t Wed 14 Nov 09:40:46 BST 2018 536 291.85 CHIX 18318XJas16 Wed 14 Nov 09:40:46 BST 2018 356 291.85 XLON 18318XJas14 Wed 14 Nov 09:40:43 BST 2018 964 292.05 CHIX 18318XJas0d Wed 14 Nov 09:40:43 BST 2018 2138 292.05 XLON 18318XJas0c Wed 14 Nov 09:40:31 BST 2018 413 292.00 CHIX 18318XJarye Wed 14 Nov 09:40:31 BST 2018 1744 292.00 XLON 18318XJaryd Wed 14 Nov 09:40:31 BST 2018 787 292.00 CHIX 18318XJaryc Wed 14 Nov 09:39:54 BST 2018 420 291.70 CHIX 18318XJarv2 Wed 14 Nov 09:39:54 BST 2018 622 291.70 CHIX 18318XJarv0 Wed 14 Nov 09:39:54 BST 2018 277 291.70 CHIX 18318XJarv1 Wed 14 Nov 09:39:54 BST 2018 1341 291.70 XLON 18318XJaruz Wed 14 Nov 09:39:42 BST 2018 666 291.75 CHIX 18318XJartx Wed 14 Nov 09:36:45 BST 2018 184 291.50 XLON 18318XJargz Wed 14 Nov 09:36:45 BST 2018 101 291.50 XLON 18318XJargx Wed 14 Nov 09:36:45 BST 2018 615 291.50 CHIX 18318XJarh0 Wed 14 Nov 09:36:45 BST 2018 819 291.50 CHIX 18318XJargy Wed 14 Nov 09:36:45 BST 2018 785 291.50 CHIX 18318XJargw Wed 14 Nov 09:36:39 BST 2018 2232 291.60 CHIX 18318XJarg0 Wed 14 Nov 09:36:39 BST 2018 4951 291.60 XLON 18318XJarfz Wed 14 Nov 09:36:18 BST 2018 706 291.55 CHIX 18318XJaree Wed 14 Nov 09:36:18 BST 2018 1530 291.60 XLON 18318XJarec Wed 14 Nov 09:36:18 BST 2018 690 291.60 CHIX 18318XJared Wed 14 Nov 09:35:54 BST 2018 500 291.60 CHIX 18318XJarc7 Wed 14 Nov 09:35:54 BST 2018 537 291.60 CHIX 18318XJarc8 Wed 14 Nov 09:35:54 BST 2018 1044 291.60 XLON 18318XJarc6 Wed 14 Nov 09:35:50 BST 2018 2925 291.65 XLON 18318XJarbr Wed 14 Nov 09:35:50 BST 2018 1320 291.65 CHIX 18318XJarbp Wed 14 Nov 09:35:31 BST 2018 1155 291.65 XLON 18318XJar8w Wed 14 Nov 09:35:31 BST 2018 564 291.65 CHIX 18318XJar8v Wed 14 Nov 09:35:31 BST 2018 1048 291.65 XLON 18318XJar8r Wed 14 Nov 09:35:31 BST 2018 536 291.75 CHIX 18318XJar8p Wed 14 Nov 09:35:31 BST 2018 284 291.75 CHIX 18318XJar8q Wed 14 Nov 09:35:31 BST 2018 337 291.75 CHIX 18318XJar8o Wed 14 Nov 09:35:31 BST 2018 225 291.75 CHIX 18318XJar8n Wed 14 Nov 09:35:31 BST 2018 440 291.75 XLON 18318XJar8m Wed 14 Nov 09:35:19 BST 2018 601 291.75 CHIX 18318XJar6o Wed 14 Nov 09:35:19 BST 2018 536 291.85 CHIX 18318XJar6m Wed 14 Nov 09:35:19 BST 2018 536 291.85 CHIX 18318XJar6c Wed 14 Nov 09:35:19 BST 2018 651 291.85 XLON 18318XJar6j Wed 14 Nov 09:35:19 BST 2018 982 291.85 XLON 18318XJar6e Wed 14 Nov 09:35:18 BST 2018 342 291.90 CHIX 18318XJar6b Wed 14 Nov 09:35:15 BST 2018 341 291.90 CHIX 18318XJar5j Wed 14 Nov 09:35:00 BST 2018 536 292.05 CHIX 18318XJar2t Wed 14 Nov 09:35:00 BST 2018 379 292.05 XLON 18318XJar2s Wed 14 Nov 09:34:33 BST 2018 407 291.70 CHIX 18318XJar0o Wed 14 Nov 09:34:32 BST 2018 236 291.70 CHIX 18318XJar0m Wed 14 Nov 09:34:32 BST 2018 372 291.70 CHIX 18318XJar0j Wed 14 Nov 09:34:32 BST 2018 721 291.70 CHIX 18318XJar0h Wed 14 Nov 09:34:32 BST 2018 1596 291.70 XLON 18318XJar0g Wed 14 Nov 09:34:30 BST 2018 691 291.75 CHIX 18318XJar0e Wed 14 Nov 09:34:16 BST 2018 528 291.55 CHIX 18318XJaqyw Wed 14 Nov 09:34:13 BST 2018 507 291.55 CHIX 18318XJaqyr Wed 14 Nov 09:34:13 BST 2018 750 291.55 CHIX 18318XJaqyp Wed 14 Nov 09:34:13 BST 2018 453 291.55 CHIX 18318XJaqyq Wed 14 Nov 09:34:11 BST 2018 998 291.65 CHIX 18318XJaqyb Wed 14 Nov 09:34:11 BST 2018 2213 291.65 XLON 18318XJaqya Wed 14 Nov 09:33:52 BST 2018 3 291.55 XLON 18318XJaqw3 Wed 14 Nov 09:33:51 BST 2018 139 291.55 XLON 18318XJaqw2 Wed 14 Nov 09:33:39 BST 2018 170 291.50 XLON 18318XJaquz Wed 14 Nov 09:33:39 BST 2018 318 291.55 CHIX 18318XJaquy Wed 14 Nov 09:33:33 BST 2018 537 291.55 CHIX 18318XJaqug Wed 14 Nov 09:33:33 BST 2018 689 291.55 XLON 18318XJaquf Wed 14 Nov 09:33:30 BST 2018 34 291.60 CHIX 18318XJaqub Wed 14 Nov 09:33:30 BST 2018 300 291.60 CHIX 18318XJaqua Wed 14 Nov 09:33:25 BST 2018 604 291.60 CHIX 18318XJaqu1 Wed 14 Nov 09:33:25 BST 2018 1236 291.60 XLON 18318XJaqu0 Wed 14 Nov 09:32:52 BST 2018 18 291.25 CHIX 18318XJaqoq Wed 14 Nov 09:30:39 BST 2018 539 290.35 CHIX 18318XJaq9g Wed 14 Nov 09:30:39 BST 2018 539 290.35 CHIX 18318XJaq9i Wed 14 Nov 09:30:39 BST 2018 41 290.35 XLON 18318XJaq9f Wed 14 Nov 09:30:39 BST 2018 580 290.35 XLON 18318XJaq9e Wed 14 Nov 09:30:39 BST 2018 687 290.35 XLON 18318XJaq9h Wed 14 Nov 09:30:31 BST 2018 545 290.45 XLON 18318XJaq8o Wed 14 Nov 09:30:17 BST 2018 157 290.40 XLON 18318XJaq6k Wed 14 Nov 09:30:17 BST 2018 712 290.40 CHIX 18318XJaq6l Wed 14 Nov 09:30:13 BST 2018 139 290.55 XLON 18318XJaq5d Wed 14 Nov 09:29:41 BST 2018 1030 290.35 CHIX 18318XJapy6 Wed 14 Nov 09:29:41 BST 2018 2282 290.35 XLON 18318XJapy5 Wed 14 Nov 09:29:30 BST 2018 72 290.20 CHIX 18318XJapx8 Wed 14 Nov 09:28:41 BST 2018 625 290.05 CHIX 18318XJapt3 Wed 14 Nov 09:28:35 BST 2018 229 290.10 CHIX 18318XJapsn Wed 14 Nov 09:28:29 BST 2018 25 290.20 XLON 18318XJaps9 Wed 14 Nov 09:28:05 BST 2018 453 290.45 XLON 18318XJapq0 Wed 14 Nov 09:28:05 BST 2018 1500 290.45 XLON 18318XJappz Wed 14 Nov 09:28:05 BST 2018 1931 290.35 CHIX 18318XJappy Wed 14 Nov 09:28:05 BST 2018 4284 290.35 XLON 18318XJappx Wed 14 Nov 09:28:05 BST 2018 562 290.40 CHIX 18318XJappw Wed 14 Nov 09:28:05 BST 2018 140 290.45 XLON 18318XJappv Wed 14 Nov 09:28:05 BST 2018 297 290.45 XLON 18318XJappt Wed 14 Nov 09:28:05 BST 2018 67 290.45 XLON 18318XJappu Wed 14 Nov 09:28:05 BST 2018 92 290.45 XLON 18318XJappr Wed 14 Nov 09:28:05 BST 2018 643 290.45 XLON 18318XJappp Wed 14 Nov 09:28:05 BST 2018 643 290.45 CHIX 18318XJappo Wed 14 Nov 09:28:05 BST 2018 573 290.45 CHIX 18318XJappq Wed 14 Nov 09:28:05 BST 2018 751 290.50 CHIX 18318XJappl Wed 14 Nov 09:28:05 BST 2018 779 290.45 XLON 18318XJappn Wed 14 Nov 09:28:05 BST 2018 65 290.50 XLON 18318XJappm Wed 14 Nov 09:28:05 BST 2018 1665 290.50 XLON 18318XJappk Wed 14 Nov 09:27:37 BST 2018 387 290.50 XLON 18318XJapnx Wed 14 Nov 09:27:37 BST 2018 539 290.55 CHIX 18318XJapnw Wed 14 Nov 09:27:37 BST 2018 539 290.55 CHIX 18318XJapnu Wed 14 Nov 09:27:37 BST 2018 470 290.55 CHIX 18318XJapnv Wed 14 Nov 09:27:37 BST 2018 423 290.55 XLON 18318XJapnt Wed 14 Nov 09:27:37 BST 2018 580 290.55 XLON 18318XJapns Wed 14 Nov 09:27:31 BST 2018 725 290.65 CHIX 18318XJapn0 Wed 14 Nov 09:27:31 BST 2018 1605 290.65 XLON 18318XJapmz Wed 14 Nov 09:27:15 BST 2018 539 290.40 CHIX 18318XJapks Wed 14 Nov 09:27:15 BST 2018 959 290.40 XLON 18318XJapkq Wed 14 Nov 09:24:48 BST 2018 690 288.75 XLON 18318XJap4k Wed 14 Nov 09:24:48 BST 2018 542 288.75 CHIX 18318XJap4l Wed 14 Nov 09:24:48 BST 2018 1372 288.80 CHIX 18318XJap4j Wed 14 Nov 09:24:48 BST 2018 849 288.80 XLON 18318XJap4i Wed 14 Nov 09:24:48 BST 2018 2195 288.80 XLON 18318XJap4h Wed 14 Nov 09:24:48 BST 2018 389 288.85 CHIX 18318XJap4g Wed 14 Nov 09:23:10 BST 2018 1981 288.00 CHIX 18318XJaoqn Wed 14 Nov 09:23:10 BST 2018 1598 288.00 XLON 18318XJaoqm Wed 14 Nov 09:23:10 BST 2018 2796 288.00 XLON 18318XJaoql Wed 14 Nov 09:20:55 BST 2018 967 287.85 CHIX 18318XJaoa0 Wed 14 Nov 09:20:55 BST 2018 3200 287.85 XLON 18318XJao9y Wed 14 Nov 09:20:55 BST 2018 873 287.85 CHIX 18318XJao9v Wed 14 Nov 09:20:55 BST 2018 880 287.85 XLON 18318XJao9u Wed 14 Nov 09:20:47 BST 2018 1098 288.00 CHIX 18318XJao8c Wed 14 Nov 09:20:47 BST 2018 2435 288.00 XLON 18318XJao8b Wed 14 Nov 09:20:26 BST 2018 482 287.95 XLON 18318XJao5n Wed 14 Nov 09:20:26 BST 2018 1240 287.95 CHIX 18318XJao5o Wed 14 Nov 09:20:26 BST 2018 594 287.95 CHIX 18318XJao5m Wed 14 Nov 09:20:05 BST 2018 821 288.05 CHIX 18318XJao45 Wed 14 Nov 09:20:05 BST 2018 1819 288.05 XLON 18318XJao44 Wed 14 Nov 09:19:57 BST 2018 1513 288.20 XLON 18318XJao34 Wed 14 Nov 09:19:57 BST 2018 683 288.20 CHIX 18318XJao33 Wed 14 Nov 09:19:43 BST 2018 1817 288.15 XLON 18318XJao0i Wed 14 Nov 09:19:43 BST 2018 444 288.15 CHIX 18318XJao0k Wed 14 Nov 09:19:43 BST 2018 820 288.15 CHIX 18318XJao0j Wed 14 Nov 09:19:20 BST 2018 1428 288.30 XLON 18318XJany7 Wed 14 Nov 09:18:59 BST 2018 94 288.35 XLON 18318XJanw1 Wed 14 Nov 09:18:59 BST 2018 2000 288.35 XLON 18318XJanw0 Wed 14 Nov 09:18:59 BST 2018 735 288.35 XLON 18318XJanvz Wed 14 Nov 09:18:59 BST 2018 1276 288.35 CHIX 18318XJanvy Wed 14 Nov 09:15:44 BST 2018 296 287.65 CHIX 18318XJand4 Wed 14 Nov 09:15:44 BST 2018 1645 287.65 XLON 18318XJand3 Wed 14 Nov 09:15:44 BST 2018 697 287.65 CHIX 18318XJand1 Wed 14 Nov 09:15:44 BST 2018 447 287.65 CHIX 18318XJand2 Wed 14 Nov 09:15:30 BST 2018 718 288.15 XLON 18318XJanbv Wed 14 Nov 09:15:30 BST 2018 543 288.15 CHIX 18318XJanbu Wed 14 Nov 09:15:29 BST 2018 1144 288.20 XLON 18318XJanbq Wed 14 Nov 09:15:29 BST 2018 559 288.20 CHIX 18318XJanbo Wed 14 Nov 09:15:29 BST 2018 268 288.20 CHIX 18318XJanbp Wed 14 Nov 09:15:24 BST 2018 544 288.35 CHIX 18318XJanbj Wed 14 Nov 09:15:24 BST 2018 558 288.35 CHIX 18318XJanbk Wed 14 Nov 09:15:24 BST 2018 205 288.35 CHIX 18318XJanbi Wed 14 Nov 09:15:24 BST 2018 70 288.35 XLON 18318XJanbh Wed 14 Nov 09:15:24 BST 2018 1144 288.35 XLON 18318XJanbf Wed 14 Nov 09:15:24 BST 2018 131 288.35 XLON 18318XJanbg Wed 14 Nov 09:15:24 BST 2018 1661 288.35 XLON 18318XJanbe Wed 14 Nov 09:15:24 BST 2018 2009 288.40 XLON 18318XJanb9 Wed 14 Nov 09:15:24 BST 2018 248 288.40 CHIX 18318XJanbb Wed 14 Nov 09:15:24 BST 2018 360 288.40 CHIX 18318XJanbc Wed 14 Nov 09:15:24 BST 2018 1042 288.40 CHIX 18318XJanba Wed 14 Nov 09:15:24 BST 2018 439 288.40 CHIX 18318XJanbd Wed 14 Nov 09:15:12 BST 2018 300 288.40 XLON 18318XJan9c Wed 14 Nov 09:15:09 BST 2018 729 288.45 XLON 18318XJan97 Wed 14 Nov 09:15:09 BST 2018 1017 288.45 XLON 18318XJan96 Wed 14 Nov 09:15:09 BST 2018 788 288.45 CHIX 18318XJan95 Wed 14 Nov 09:15:09 BST 2018 676 288.50 CHIX 18318XJan8y Wed 14 Nov 09:15:09 BST 2018 2347 288.50 XLON 18318XJan8t Wed 14 Nov 09:15:09 BST 2018 1059 288.50 CHIX 18318XJan8x Wed 14 Nov 09:15:09 BST 2018 404 288.50 CHIX 18318XJan8v Wed 14 Nov 09:14:55 BST 2018 1384 288.50 XLON 18318XJan7r Wed 14 Nov 09:14:55 BST 2018 629 288.50 CHIX 18318XJan7q Wed 14 Nov 09:14:54 BST 2018 740 288.60 CHIX 18318XJan7p Wed 14 Nov 09:14:51 BST 2018 1134 288.60 XLON 18318XJan7l Wed 14 Nov 09:14:51 BST 2018 554 288.60 CHIX 18318XJan7k Wed 14 Nov 09:14:51 BST 2018 252 288.60 CHIX 18318XJan7j Wed 14 Nov 09:14:28 BST 2018 388 288.55 XLON 18318XJan4t Wed 14 Nov 09:14:28 BST 2018 542 288.55 CHIX 18318XJan4s Wed 14 Nov 09:14:26 BST 2018 542 288.60 CHIX 18318XJan4n Wed 14 Nov 09:14:26 BST 2018 1035 288.60 XLON 18318XJan4m Wed 14 Nov 09:13:54 BST 2018 459 288.45 XLON 18318XJan1z Wed 14 Nov 09:13:54 BST 2018 543 288.45 CHIX 18318XJan20 Wed 14 Nov 09:13:17 BST 2018 522 288.30 BATE 18318XJamzl Wed 14 Nov 09:13:17 BST 2018 1500 288.25 XLON 18318XJamzk Wed 14 Nov 09:13:17 BST 2018 914 288.25 CHIX 18318XJamzi Wed 14 Nov 09:13:17 BST 2018 527 288.25 XLON 18318XJamzj Wed 14 Nov 09:13:17 BST 2018 307 288.30 CHIX 18318XJamzh Wed 14 Nov 09:13:17 BST 2018 32 288.30 XLON 18318XJamzg Wed 14 Nov 09:13:12 BST 2018 116 288.40 BATE 18318XJamz3 Wed 14 Nov 09:13:12 BST 2018 836 288.40 BATE 18318XJamz2 Wed 14 Nov 09:13:12 BST 2018 725 288.35 CHIX 18318XJamz1 Wed 14 Nov 09:13:12 BST 2018 47 288.30 XLON 18318XJamz0 Wed 14 Nov 09:13:12 BST 2018 1111 288.30 XLON 18318XJamyz Wed 14 Nov 09:13:12 BST 2018 543 288.30 CHIX 18318XJamyy Wed 14 Nov 09:13:12 BST 2018 543 288.35 CHIX 18318XJamyx Wed 14 Nov 09:13:12 BST 2018 1072 288.35 XLON 18318XJamyw Wed 14 Nov 09:11:23 BST 2018 142 287.80 XLON 18318XJammy Wed 14 Nov 09:11:19 BST 2018 629 287.90 CHIX 18318XJammv Wed 14 Nov 09:11:19 BST 2018 424 287.90 CHIX 18318XJammu Wed 14 Nov 09:11:19 BST 2018 1342 287.90 XLON 18318XJammt Wed 14 Nov 09:11:19 BST 2018 608 287.95 XLON 18318XJamms Wed 14 Nov 09:11:19 BST 2018 1072 288.00 XLON 18318XJammr Wed 14 Nov 09:11:19 BST 2018 691 287.95 CHIX 18318XJammp Wed 14 Nov 09:11:19 BST 2018 544 287.95 CHIX 18318XJammq Wed 14 Nov 09:11:19 BST 2018 543 288.00 CHIX 18318XJammo Wed 14 Nov 09:10:59 BST 2018 549 287.95 CHIX 18318XJaml8 Wed 14 Nov 09:10:59 BST 2018 1124 287.95 XLON 18318XJaml6 Wed 14 Nov 09:10:59 BST 2018 11 287.95 XLON 18318XJaml7 Wed 14 Nov 09:10:35 BST 2018 911 287.90 XLON 18318XJamic Wed 14 Nov 09:10:16 BST 2018 1219 287.90 CHIX 18318XJamg0 Wed 14 Nov 09:10:16 BST 2018 2702 287.90 XLON 18318XJamfz Wed 14 Nov 09:08:31 BST 2018 722 287.30 XLON 18318XJam6r Wed 14 Nov 09:08:31 BST 2018 2548 287.30 XLON 18318XJam6q Wed 14 Nov 09:08:31 BST 2018 1475 287.30 CHIX 18318XJam6p Wed 14 Nov 09:08:30 BST 2018 199 287.50 XLON 18318XJam6o Wed 14 Nov 09:07:45 BST 2018 1222 287.20 CHIX 18318XJam18 Wed 14 Nov 09:07:45 BST 2018 1606 287.20 XLON 18318XJam17 Wed 14 Nov 09:07:45 BST 2018 1102 287.20 XLON 18318XJam16 Wed 14 Nov 09:07:38 BST 2018 1 287.25 CHIX 18318XJam0c Wed 14 Nov 09:07:38 BST 2018 562 287.25 CHIX 18318XJam09 Wed 14 Nov 09:07:38 BST 2018 545 287.25 CHIX 18318XJam08 Wed 14 Nov 09:07:38 BST 2018 294 287.25 CHIX 18318XJam0a Wed 14 Nov 09:07:38 BST 2018 619 287.25 CHIX 18318XJam0b Wed 14 Nov 09:07:38 BST 2018 26 287.25 XLON 18318XJam07 Wed 14 Nov 09:07:38 BST 2018 466 287.25 XLON 18318XJam06 Wed 14 Nov 09:07:32 BST 2018 262 287.30 CHIX 18318XJalz5 Wed 14 Nov 09:07:32 BST 2018 774 287.30 CHIX 18318XJalz4 Wed 14 Nov 09:07:32 BST 2018 424 287.30 CHIX 18318XJalz2 Wed 14 Nov 09:07:32 BST 2018 2655 287.30 XLON 18318XJalyz Wed 14 Nov 09:07:03 BST 2018 651 287.35 CHIX 18318XJalw2 Wed 14 Nov 09:07:03 BST 2018 531 287.35 CHIX 18318XJalw1 Wed 14 Nov 09:07:03 BST 2018 835 287.40 CHIX 18318XJalw0 Wed 14 Nov 09:07:03 BST 2018 1 287.40 XLON 18318XJalvz Wed 14 Nov 09:04:38 BST 2018 545 287.25 CHIX 18318XJal5z Wed 14 Nov 09:04:38 BST 2018 638 287.25 XLON 18318XJal5x Wed 14 Nov 09:04:38 BST 2018 545 287.30 CHIX 18318XJal5v Wed 14 Nov 09:04:38 BST 2018 439 287.30 XLON 18318XJal5u Wed 14 Nov 09:04:38 BST 2018 600 287.35 CHIX 18318XJal5t Wed 14 Nov 09:04:38 BST 2018 2426 287.40 CHIX 18318XJal5s Wed 14 Nov 09:04:38 BST 2018 809 287.40 XLON 18318XJal5r Wed 14 Nov 09:04:38 BST 2018 4575 287.40 XLON 18318XJal5q Wed 14 Nov 09:04:10 BST 2018 662 287.40 CHIX 18318XJal23 Wed 14 Nov 09:04:10 BST 2018 1464 287.40 XLON 18318XJal22 Wed 14 Nov 09:03:52 BST 2018 1087 287.60 CHIX 18318XJakye Wed 14 Nov 09:03:52 BST 2018 2409 287.60 XLON 18318XJakyd Wed 14 Nov 09:03:23 BST 2018 1608 287.70 XLON 18318XJakua Wed 14 Nov 09:03:23 BST 2018 727 287.70 CHIX 18318XJaku8 Wed 14 Nov 09:01:49 BST 2018 2367 287.45 XLON 18318XJakc0 Wed 14 Nov 09:01:49 BST 2018 1068 287.45 CHIX 18318XJakbz Wed 14 Nov 09:00:28 BST 2018 1355 287.50 CHIX 18318XJajve Wed 14 Nov 09:00:28 BST 2018 3005 287.50 XLON 18318XJajvd Wed 14 Nov 09:00:28 BST 2018 339 287.55 CHIX 18318XJajvc Wed 14 Nov 09:00:28 BST 2018 544 287.65 CHIX 18318XJajvb Wed 14 Nov 09:00:28 BST 2018 478 287.65 XLON 18318XJajva Wed 14 Nov 08:59:52 BST 2018 1617 287.80 XLON 18318XJajmy Wed 14 Nov 08:59:52 BST 2018 730 287.80 CHIX 18318XJajmw Wed 14 Nov 08:59:48 BST 2018 1 287.95 CHIX 18318XJajlw Wed 14 Nov 08:59:48 BST 2018 519 287.95 XLON 18318XJajlv Wed 14 Nov 08:59:48 BST 2018 628 287.95 CHIX 18318XJajlu Wed 14 Nov 08:59:48 BST 2018 780 287.95 XLON 18318XJajlt Wed 14 Nov 08:58:11 BST 2018 7941 288.65 XLON 18318XJaizt Wed 14 Nov 08:58:11 BST 2018 3579 288.65 CHIX 18318XJaizs Wed 14 Nov 08:58:02 BST 2018 3456 288.80 XLON 18318XJaixg Wed 14 Nov 08:58:02 BST 2018 1559 288.80 CHIX 18318XJaixe Wed 14 Nov 08:57:30 BST 2018 596 288.60 XLON 18318XJaitq Wed 14 Nov 08:57:30 BST 2018 542 288.60 CHIX 18318XJaito Wed 14 Nov 08:57:30 BST 2018 542 288.60 CHIX 18318XJaitk Wed 14 Nov 08:57:30 BST 2018 800 288.60 XLON 18318XJaitn Wed 14 Nov 08:57:30 BST 2018 19 288.75 XLON 18318XJaitf Wed 14 Nov 08:56:45 BST 2018 542 288.95 CHIX 18318XJaimb Wed 14 Nov 08:56:45 BST 2018 1991 288.95 XLON 18318XJaim8 Wed 14 Nov 08:56:45 BST 2018 899 288.95 CHIX 18318XJaim5 Wed 14 Nov 08:55:47 BST 2018 7500 288.90 XLON 18318XJai7i Wed 14 Nov 08:55:47 BST 2018 3380 288.90 CHIX 18318XJai7k Wed 14 Nov 08:55:47 BST 2018 262 288.90 CHIX 18318XJai7g Wed 14 Nov 08:55:24 BST 2018 641 289.00 CHIX 18318XJai1b Wed 14 Nov 08:54:13 BST 2018 1173 288.85 XLON 18318XJahrz Wed 14 Nov 08:54:07 BST 2018 812 288.95 CHIX 18318XJahrb Wed 14 Nov 08:54:07 BST 2018 1800 288.95 XLON 18318XJahra Wed 14 Nov 08:53:34 BST 2018 4133 289.05 XLON 18318XJahnx Wed 14 Nov 08:53:34 BST 2018 1863 289.05 CHIX 18318XJahnw Wed 14 Nov 08:53:04 BST 2018 728 289.05 CHIX 18318XJahil Wed 14 Nov 08:53:04 BST 2018 1177 289.05 XLON 18318XJahik Wed 14 Nov 08:53:04 BST 2018 436 289.05 XLON 18318XJahij Wed 14 Nov 08:53:04 BST 2018 415 289.10 CHIX 18318XJahih Wed 14 Nov 08:53:04 BST 2018 1317 289.10 CHIX 18318XJahii Wed 14 Nov 08:53:04 BST 2018 1517 289.10 XLON 18318XJahig Wed 14 Nov 08:53:04 BST 2018 501 289.10 XLON 18318XJahif Wed 14 Nov 08:53:04 BST 2018 901 289.10 XLON 18318XJahid Wed 14 Nov 08:53:04 BST 2018 541 289.15 CHIX 18318XJahia Wed 14 Nov 08:53:04 BST 2018 808 289.15 XLON 18318XJahib Wed 14 Nov 08:53:00 BST 2018 75 289.20 CHIX 18318XJahi5 Wed 14 Nov 08:53:00 BST 2018 854 289.20 CHIX 18318XJahi4 Wed 14 Nov 08:53:00 BST 2018 865 289.20 XLON 18318XJahi3 Wed 14 Nov 08:53:00 BST 2018 1194 289.20 XLON 18318XJahi2 Wed 14 Nov 08:52:04 BST 2018 690 289.15 CHIX 18318XJahb1 Wed 14 Nov 08:52:04 BST 2018 541 289.15 CHIX 18318XJahb0 Wed 14 Nov 08:52:04 BST 2018 711 289.15 XLON 18318XJahaz Wed 14 Nov 08:52:04 BST 2018 185 289.20 XLON 18318XJahay Wed 14 Nov 08:52:04 BST 2018 838 289.20 CHIX 18318XJahax Wed 14 Nov 08:51:57 BST 2018 625 289.25 CHIX 18318XJah9y Wed 14 Nov 08:51:57 BST 2018 262 289.25 CHIX 18318XJah9z Wed 14 Nov 08:51:54 BST 2018 541 289.35 CHIX 18318XJah9e Wed 14 Nov 08:51:54 BST 2018 224 289.35 CHIX 18318XJah9f Wed 14 Nov 08:51:54 BST 2018 479 289.35 XLON 18318XJah9c Wed 14 Nov 08:51:54 BST 2018 50 289.35 XLON 18318XJah9d Wed 14 Nov 08:51:41 BST 2018 1172 289.35 XLON 18318XJah7c Wed 14 Nov 08:51:41 BST 2018 702 289.35 XLON 18318XJah7d Wed 14 Nov 08:51:41 BST 2018 572 289.35 CHIX 18318XJah7a Wed 14 Nov 08:51:41 BST 2018 541 289.35 CHIX 18318XJah7b Wed 14 Nov 08:51:06 BST 2018 342 289.20 CHIX 18318XJah51 Wed 14 Nov 08:51:06 BST 2018 850 289.30 CHIX 18318XJah50 Wed 14 Nov 08:51:06 BST 2018 874 289.30 XLON 18318XJah4z Wed 14 Nov 08:51:06 BST 2018 1009 289.30 XLON 18318XJah4y Wed 14 Nov 08:50:22 BST 2018 694 289.20 CHIX 18318XJah2e Wed 14 Nov 08:50:21 BST 2018 1537 289.20 XLON 18318XJah2d Wed 14 Nov 08:49:44 BST 2018 500 289.20 XLON 18318XJagyh Wed 14 Nov 08:49:44 BST 2018 289 289.20 XLON 18318XJagyg Wed 14 Nov 08:49:32 BST 2018 541 289.35 CHIX 18318XJagwq Wed 14 Nov 08:49:32 BST 2018 1059 289.35 XLON 18318XJagwp Wed 14 Nov 08:49:31 BST 2018 427 289.45 CHIX 18318XJagwn Wed 14 Nov 08:49:31 BST 2018 707 289.45 CHIX 18318XJagwo Wed 14 Nov 08:49:31 BST 2018 1563 289.45 XLON 18318XJagwm Wed 14 Nov 08:49:29 BST 2018 472 289.55 XLON 18318XJagwe Wed 14 Nov 08:49:29 BST 2018 541 289.55 CHIX 18318XJagwd Wed 14 Nov 08:49:29 BST 2018 596 289.55 CHIX 18318XJagwc Wed 14 Nov 08:49:17 BST 2018 496 289.65 CHIX 18318XJagvm Wed 14 Nov 08:49:17 BST 2018 392 289.65 CHIX 18318XJagvl Wed 14 Nov 08:49:10 BST 2018 134 289.80 XLON 18318XJagve Wed 14 Nov 08:49:10 BST 2018 1808 289.80 XLON 18318XJagvc Wed 14 Nov 08:49:10 BST 2018 497 289.80 CHIX 18318XJagvd Wed 14 Nov 08:49:10 BST 2018 816 289.80 CHIX 18318XJagvb Wed 14 Nov 08:48:32 BST 2018 540 289.95 CHIX 18318XJagqi Wed 14 Nov 08:48:32 BST 2018 544 289.95 CHIX 18318XJagqj Wed 14 Nov 08:48:32 BST 2018 10 289.95 XLON 18318XJagqh Wed 14 Nov 08:48:32 BST 2018 616 289.95 XLON 18318XJagqg Wed 14 Nov 08:48:22 BST 2018 540 290.00 CHIX 18318XJagpk Wed 14 Nov 08:48:22 BST 2018 540 290.00 CHIX 18318XJagpl Wed 14 Nov 08:48:22 BST 2018 481 290.00 XLON 18318XJagpj Wed 14 Nov 08:48:22 BST 2018 493 290.00 XLON 18318XJagpi Wed 14 Nov 08:45:53 BST 2018 1502 289.75 XLON 18318XJag7y Wed 14 Nov 08:45:53 BST 2018 3167 289.75 XLON 18318XJag7x Wed 14 Nov 08:45:53 BST 2018 2863 289.75 XLON 18318XJag7w Wed 14 Nov 08:45:53 BST 2018 1766 289.80 XLON 18318XJag7t Wed 14 Nov 08:45:53 BST 2018 3395 289.75 CHIX 18318XJag7v Wed 14 Nov 08:45:53 BST 2018 797 289.80 CHIX 18318XJag7u Wed 14 Nov 08:45:31 BST 2018 111 290.00 XLON 18318XJag57 Wed 14 Nov 08:45:17 BST 2018 539 290.25 CHIX 18318XJag40 Wed 14 Nov 08:45:17 BST 2018 733 290.25 XLON 18318XJag3z Wed 14 Nov 08:43:51 BST 2018 27 289.95 XLON 18318XJafsy Wed 14 Nov 08:43:51 BST 2018 1689 290.00 CHIX 18318XJafsw Wed 14 Nov 08:43:51 BST 2018 3743 290.00 XLON 18318XJafsx Wed 14 Nov 08:43:36 BST 2018 978 290.10 CHIX 18318XJafqt Wed 14 Nov 08:43:36 BST 2018 2167 290.10 XLON 18318XJafqs Wed 14 Nov 08:42:24 BST 2018 538 290.85 CHIX 18318XJafkx Wed 14 Nov 08:42:24 BST 2018 799 290.85 XLON 18318XJafkw Wed 14 Nov 08:42:15 BST 2018 3265 291.00 XLON 18318XJafke Wed 14 Nov 08:42:15 BST 2018 2377 291.00 XLON 18318XJafkd Wed 14 Nov 08:42:15 BST 2018 2544 291.00 CHIX 18318XJafkf Wed 14 Nov 08:42:15 BST 2018 852 291.05 CHIX 18318XJafkc Wed 14 Nov 08:42:15 BST 2018 561 291.05 CHIX 18318XJafkb Wed 14 Nov 08:42:15 BST 2018 1889 291.05 XLON 18318XJafka Wed 14 Nov 08:42:15 BST 2018 1356 291.10 XLON 18318XJafk7 Wed 14 Nov 08:42:15 BST 2018 623 291.10 CHIX 18318XJafk9 Wed 14 Nov 08:42:15 BST 2018 371 291.10 CHIX 18318XJafk8 Wed 14 Nov 08:42:07 BST 2018 465 291.15 CHIX 18318XJafjc Wed 14 Nov 08:42:06 BST 2018 2108 291.15 XLON 18318XJafjb Wed 14 Nov 08:41:45 BST 2018 537 291.20 CHIX 18318XJafg7 Wed 14 Nov 08:41:45 BST 2018 441 291.20 CHIX 18318XJafg4 Wed 14 Nov 08:41:45 BST 2018 108 291.20 XLON 18318XJafg0 Wed 14 Nov 08:41:45 BST 2018 698 291.20 XLON 18318XJafg2 Wed 14 Nov 08:41:45 BST 2018 232 291.20 XLON 18318XJaffy Wed 14 Nov 08:41:45 BST 2018 315 291.20 CHIX 18318XJaffw Wed 14 Nov 08:41:45 BST 2018 27 291.20 CHIX 18318XJaffu Wed 14 Nov 08:41:45 BST 2018 618 291.20 CHIX 18318XJaffs Wed 14 Nov 08:41:33 BST 2018 823 291.30 CHIX 18318XJafdt Wed 14 Nov 08:40:26 BST 2018 516 291.30 CHIX 18318XJaf1n Wed 14 Nov 08:40:26 BST 2018 1187 291.30 XLON 18318XJaf1m Wed 14 Nov 08:40:26 BST 2018 396 291.30 CHIX 18318XJaf1l Wed 14 Nov 08:40:26 BST 2018 833 291.30 XLON 18318XJaf1k Wed 14 Nov 08:40:20 BST 2018 1196 291.35 CHIX 18318XJaf1f Wed 14 Nov 08:40:20 BST 2018 172 291.35 XLON 18318XJaf1e Wed 14 Nov 08:40:20 BST 2018 1851 291.35 XLON 18318XJaf1d Wed 14 Nov 08:40:20 BST 2018 800 291.35 XLON 18318XJaf1c Wed 14 Nov 08:40:15 BST 2018 21 291.40 XLON 18318XJaf08 Wed 14 Nov 08:40:15 BST 2018 152 291.40 XLON 18318XJaf06 Wed 14 Nov 08:40:15 BST 2018 1361 291.40 XLON 18318XJaf04 Wed 14 Nov 08:40:15 BST 2018 678 291.40 CHIX 18318XJaf09 Wed 14 Nov 08:40:15 BST 2018 567 291.40 CHIX 18318XJaf07 Wed 14 Nov 08:40:15 BST 2018 684 291.40 CHIX 18318XJaf05 Wed 14 Nov 08:40:15 BST 2018 339 291.40 CHIX 18318XJaf03 Wed 14 Nov 08:39:32 BST 2018 1 291.35 CHIX 18318XJaert Wed 14 Nov 08:39:32 BST 2018 629 291.35 CHIX 18318XJaers Wed 14 Nov 08:39:32 BST 2018 537 291.35 CHIX 18318XJaerq Wed 14 Nov 08:39:32 BST 2018 537 291.35 CHIX 18318XJaerr Wed 14 Nov 08:39:32 BST 2018 215 291.35 XLON 18318XJaerp Wed 14 Nov 08:39:32 BST 2018 561 291.35 XLON 18318XJaero Wed 14 Nov 08:39:32 BST 2018 684 291.35 XLON 18318XJaern Wed 14 Nov 08:39:32 BST 2018 177 291.35 XLON 18318XJaerm Wed 14 Nov 08:39:24 BST 2018 537 291.45 CHIX 18318XJaepe Wed 14 Nov 08:39:24 BST 2018 537 291.45 CHIX 18318XJaepf Wed 14 Nov 08:39:24 BST 2018 837 291.45 XLON 18318XJaepb Wed 14 Nov 08:39:24 BST 2018 33 291.45 XLON 18318XJaepc Wed 14 Nov 08:39:24 BST 2018 618 291.45 XLON 18318XJaepd Wed 14 Nov 08:39:21 BST 2018 537 291.50 CHIX 18318XJaeou Wed 14 Nov 08:39:21 BST 2018 1013 291.50 XLON 18318XJaeot Wed 14 Nov 08:39:21 BST 2018 781 291.55 XLON 18318XJaeop Wed 14 Nov 08:39:21 BST 2018 465 291.55 XLON 18318XJaeoo Wed 14 Nov 08:39:21 BST 2018 537 291.55 CHIX 18318XJaeoq Wed 14 Nov 08:39:21 BST 2018 537 291.55 CHIX 18318XJaeor Wed 14 Nov 08:38:47 BST 2018 638 291.40 CHIX 18318XJaeju Wed 14 Nov 08:38:47 BST 2018 204 291.40 XLON 18318XJaejt Wed 14 Nov 08:38:47 BST 2018 1212 291.40 XLON 18318XJaejs Wed 14 Nov 08:38:47 BST 2018 268 291.40 CHIX 18318XJaejr Wed 14 Nov 08:38:47 BST 2018 324 291.40 CHIX 18318XJaejq Wed 14 Nov 08:38:15 BST 2018 1194 291.10 XLON 18318XJaegs Wed 14 Nov 08:38:15 BST 2018 583 291.10 CHIX 18318XJaegr Wed 14 Nov 08:38:01 BST 2018 273 290.95 XLON 18318XJaeef Wed 14 Nov 08:38:01 BST 2018 622 290.95 XLON 18318XJaeed Wed 14 Nov 08:38:01 BST 2018 4 290.95 XLON 18318XJaeee Wed 14 Nov 08:37:56 BST 2018 538 291.00 CHIX 18318XJaedo Wed 14 Nov 08:37:56 BST 2018 538 291.00 CHIX 18318XJaedp Wed 14 Nov 08:37:56 BST 2018 660 291.00 XLON 18318XJaedm Wed 14 Nov 08:37:56 BST 2018 82 291.00 XLON 18318XJaedn Wed 14 Nov 08:37:56 BST 2018 950 291.00 XLON 18318XJaedl Wed 14 Nov 08:37:43 BST 2018 608 291.00 CHIX 18318XJaebr Wed 14 Nov 08:37:43 BST 2018 1245 291.00 XLON 18318XJaebq Wed 14 Nov 08:37:33 BST 2018 674 291.05 CHIX 18318XJaead Wed 14 Nov 08:37:33 BST 2018 565 291.05 XLON 18318XJaeac Wed 14 Nov 08:37:33 BST 2018 928 291.05 XLON 18318XJaeab Wed 14 Nov 08:37:30 BST 2018 451 291.10 CHIX 18318XJaea5 Wed 14 Nov 08:37:01 BST 2018 538 290.85 CHIX 18318XJae36 Wed 14 Nov 08:37:01 BST 2018 906 290.85 XLON 18318XJae34 Wed 14 Nov 08:37:01 BST 2018 133 290.85 XLON 18318XJae35 Wed 14 Nov 08:37:01 BST 2018 751 290.90 CHIX 18318XJae2y Wed 14 Nov 08:37:01 BST 2018 650 290.90 CHIX 18318XJae2z Wed 14 Nov 08:37:01 BST 2018 917 290.90 XLON 18318XJae32 Wed 14 Nov 08:37:01 BST 2018 1440 290.90 XLON 18318XJae33 Wed 14 Nov 08:37:01 BST 2018 746 290.90 XLON 18318XJae31 Wed 14 Nov 08:35:39 BST 2018 584 290.50 CHIX 18318XJado0 Wed 14 Nov 08:35:39 BST 2018 914 290.55 CHIX 18318XJadny Wed 14 Nov 08:35:39 BST 2018 2027 290.55 XLON 18318XJadnv Wed 14 Nov 08:35:00 BST 2018 982 290.70 XLON 18318XJadl0 Wed 14 Nov 08:35:00 BST 2018 1281 290.70 CHIX 18318XJadl1 Wed 14 Nov 08:35:00 BST 2018 1857 290.70 XLON 18318XJadkz Wed 14 Nov 08:33:22 BST 2018 2432 290.65 XLON 18318XJad61 Wed 14 Nov 08:33:22 BST 2018 3544 290.65 XLON 18318XJad60 Wed 14 Nov 08:33:22 BST 2018 2694 290.65 CHIX 18318XJad5z Wed 14 Nov 08:32:55 BST 2018 551 290.10 CHIX 18318XJad0d Wed 14 Nov 08:32:50 BST 2018 938 290.20 XLON 18318XJacy4 Wed 14 Nov 08:32:50 BST 2018 208 290.20 CHIX 18318XJacy6 Wed 14 Nov 08:32:50 BST 2018 331 290.20 CHIX 18318XJacy1 Wed 14 Nov 08:32:44 BST 2018 186 290.20 XLON 18318XJacvj Wed 14 Nov 08:32:39 BST 2018 539 290.20 CHIX 18318XJactp Wed 14 Nov 08:32:36 BST 2018 247 290.20 XLON 18318XJacsr Wed 14 Nov 08:32:27 BST 2018 206 290.20 XLON 18318XJacrt Wed 14 Nov 08:32:15 BST 2018 322 290.55 CHIX 18318XJacoz Wed 14 Nov 08:32:15 BST 2018 417 290.55 CHIX 18318XJacoy Wed 14 Nov 08:32:15 BST 2018 1636 290.55 XLON 18318XJacox Wed 14 Nov 08:32:15 BST 2018 750 290.55 CHIX 18318XJacow Wed 14 Nov 08:32:15 BST 2018 539 290.55 CHIX 18318XJacov Wed 14 Nov 08:32:15 BST 2018 587 290.55 XLON 18318XJacou Wed 14 Nov 08:32:15 BST 2018 539 290.60 CHIX 18318XJacot Wed 14 Nov 08:32:15 BST 2018 868 290.60 XLON 18318XJacos Wed 14 Nov 08:31:55 BST 2018 200 290.70 XLON 18318XJack0 Wed 14 Nov 08:31:40 BST 2018 1653 290.90 CHIX 18318XJachb Wed 14 Nov 08:31:40 BST 2018 3663 290.90 XLON 18318XJacha Wed 14 Nov 08:31:26 BST 2018 640 291.00 CHIX 18318XJacc8 Wed 14 Nov 08:31:11 BST 2018 669 291.15 CHIX 18318XJac9i Wed 14 Nov 08:31:11 BST 2018 1480 291.15 XLON 18318XJac9h Wed 14 Nov 08:31:05 BST 2018 173 291.20 XLON 18318XJac7o Wed 14 Nov 08:30:52 BST 2018 546 291.45 CHIX 18318XJac1d Wed 14 Nov 08:30:52 BST 2018 1119 291.45 XLON 18318XJac1e Wed 14 Nov 08:30:51 BST 2018 2265 291.50 XLON 18318XJac13 Wed 14 Nov 08:30:50 BST 2018 96 291.55 XLON 18318XJac11 Wed 14 Nov 08:30:42 BST 2018 374 291.50 XLON 18318XJabyu Wed 14 Nov 08:30:37 BST 2018 645 291.65 CHIX 18318XJaby8 Wed 14 Nov 08:30:37 BST 2018 1428 291.65 XLON 18318XJaby7 Wed 14 Nov 08:30:31 BST 2018 666 291.85 CHIX 18318XJabxb Wed 14 Nov 08:30:31 BST 2018 354 291.85 CHIX 18318XJabxc Wed 14 Nov 08:30:31 BST 2018 583 291.85 XLON 18318XJabxa Wed 14 Nov 08:30:31 BST 2018 790 291.85 XLON 18318XJabx8 Wed 14 Nov 08:30:31 BST 2018 100 291.85 XLON 18318XJabx7 Wed 14 Nov 08:30:23 BST 2018 555 291.90 CHIX 18318XJabwh Wed 14 Nov 08:30:23 BST 2018 168 291.90 XLON 18318XJabwg Wed 14 Nov 08:30:23 BST 2018 1136 291.90 XLON 18318XJabwe Wed 14 Nov 08:30:23 BST 2018 18 291.90 XLON 18318XJabwf Wed 14 Nov 08:30:22 BST 2018 536 291.95 CHIX 18318XJabwd Wed 14 Nov 08:30:22 BST 2018 464 291.95 XLON 18318XJabwc Wed 14 Nov 08:30:04 BST 2018 760 292.05 CHIX 18318XJabp9 Wed 14 Nov 08:30:04 BST 2018 1 292.10 CHIX 18318XJabp6 Wed 14 Nov 08:30:04 BST 2018 371 292.05 CHIX 18318XJabpb Wed 14 Nov 08:30:04 BST 2018 535 292.10 CHIX 18318XJabp4 Wed 14 Nov 08:30:04 BST 2018 1684 292.05 XLON 18318XJabp2 Wed 14 Nov 08:30:04 BST 2018 577 292.10 XLON 18318XJaboz Wed 14 Nov 08:29:37 BST 2018 808 291.95 CHIX 18318XJabks Wed 14 Nov 08:29:29 BST 2018 250 292.05 CHIX 18318XJabk8 Wed 14 Nov 08:29:29 BST 2018 621 292.05 CHIX 18318XJabk6 Wed 14 Nov 08:29:29 BST 2018 1296 292.05 XLON 18318XJabk5 Wed 14 Nov 08:29:16 BST 2018 1203 292.20 XLON 18318XJabhn Wed 14 Nov 08:29:16 BST 2018 587 292.20 CHIX 18318XJabhm Wed 14 Nov 08:29:08 BST 2018 1142 292.10 XLON 18318XJabgs Wed 14 Nov 08:29:08 BST 2018 558 292.10 CHIX 18318XJabgt Wed 14 Nov 08:28:38 BST 2018 667 291.85 CHIX 18318XJabe6 Wed 14 Nov 08:28:38 BST 2018 1475 291.85 XLON 18318XJabe5 Wed 14 Nov 08:27:49 BST 2018 536 292.00 CHIX 18318XJab66 Wed 14 Nov 08:27:49 BST 2018 890 292.00 XLON 18318XJab65 Wed 14 Nov 08:27:48 BST 2018 1463 292.10 XLON 18318XJab63 Wed 14 Nov 08:27:48 BST 2018 59 292.10 CHIX 18318XJab62 Wed 14 Nov 08:27:48 BST 2018 447 292.10 CHIX 18318XJab64 Wed 14 Nov 08:27:48 BST 2018 603 292.10 CHIX 18318XJab61 Wed 14 Nov 08:27:30 BST 2018 1 292.25 CHIX 18318XJab4t Wed 14 Nov 08:27:30 BST 2018 805 292.25 CHIX 18318XJab4s Wed 14 Nov 08:27:30 BST 2018 185 292.25 XLON 18318XJab4r Wed 14 Nov 08:27:30 BST 2018 1600 292.25 XLON 18318XJab4q Wed 14 Nov 08:27:21 BST 2018 1360 292.35 XLON 18318XJab40 Wed 14 Nov 08:27:21 BST 2018 620 292.35 CHIX 18318XJab3y Wed 14 Nov 08:27:21 BST 2018 651 292.35 CHIX 18318XJab3z Wed 14 Nov 08:27:18 BST 2018 535 292.45 CHIX 18318XJab36 Wed 14 Nov 08:27:18 BST 2018 864 292.45 XLON 18318XJab35 Wed 14 Nov 08:27:05 BST 2018 607 292.45 CHIX 18318XJab1x Wed 14 Nov 08:27:05 BST 2018 1243 292.45 XLON 18318XJab1w Wed 14 Nov 08:26:46 BST 2018 1283 292.55 XLON 18318XJaaz5 Wed 14 Nov 08:26:46 BST 2018 619 292.55 CHIX 18318XJaaz4 Wed 14 Nov 08:26:29 BST 2018 211 292.50 CHIX 18318XJaay5 Wed 14 Nov 08:26:29 BST 2018 583 292.45 CHIX 18318XJaay4 Wed 14 Nov 08:26:29 BST 2018 645 292.50 CHIX 18318XJaay3 Wed 14 Nov 08:26:29 BST 2018 1194 292.45 XLON 18318XJaay2 Wed 14 Nov 08:26:29 BST 2018 1428 292.50 XLON 18318XJaay1 Wed 14 Nov 08:26:00 BST 2018 481 292.00 XLON 18318XJaavl Wed 14 Nov 08:26:00 BST 2018 36 292.00 CHIX 18318XJaavk Wed 14 Nov 08:26:00 BST 2018 500 292.00 CHIX 18318XJaavj Wed 14 Nov 08:26:00 BST 2018 264 292.10 CHIX 18318XJaavg Wed 14 Nov 08:26:00 BST 2018 265 292.10 CHIX 18318XJaavf Wed 14 Nov 08:26:00 BST 2018 687 292.10 CHIX 18318XJaavd Wed 14 Nov 08:26:00 BST 2018 214 292.10 CHIX 18318XJaave Wed 14 Nov 08:26:00 BST 2018 50 292.10 XLON 18318XJaavc Wed 14 Nov 08:26:00 BST 2018 532 292.10 XLON 18318XJaavb Wed 14 Nov 08:26:00 BST 2018 990 292.10 XLON 18318XJaava Wed 14 Nov 08:25:59 BST 2018 1311 292.15 XLON 18318XJaav9 Wed 14 Nov 08:25:59 BST 2018 620 292.15 CHIX 18318XJaav8 Wed 14 Nov 08:25:57 BST 2018 515 292.20 CHIX 18318XJaav3 Wed 14 Nov 08:25:53 BST 2018 712 292.20 CHIX 18318XJaauw Wed 14 Nov 08:25:53 BST 2018 634 292.25 CHIX 18318XJaauu Wed 14 Nov 08:25:53 BST 2018 137 292.25 XLON 18318XJaaut Wed 14 Nov 08:25:49 BST 2018 344 292.25 XLON 18318XJaauo Wed 14 Nov 08:25:49 BST 2018 1062 292.25 XLON 18318XJaaun Wed 14 Nov 08:25:38 BST 2018 949 292.20 XLON 18318XJaau9 Wed 14 Nov 08:25:38 BST 2018 536 292.20 CHIX 18318XJaau8 Wed 14 Nov 08:25:37 BST 2018 316 292.30 CHIX 18318XJaau6 Wed 14 Nov 08:24:22 BST 2018 544 291.75 CHIX 18318XJaal9 Wed 14 Nov 08:24:22 BST 2018 645 291.75 CHIX 18318XJaal8 Wed 14 Nov 08:24:22 BST 2018 1114 291.75 XLON 18318XJaal7 Wed 14 Nov 08:24:22 BST 2018 1427 291.75 XLON 18318XJaal6 Wed 14 Nov 08:24:11 BST 2018 267 291.80 CHIX 18318XJaak4 Wed 14 Nov 08:24:11 BST 2018 1633 291.80 XLON 18318XJaak3 Wed 14 Nov 08:24:11 BST 2018 737 291.80 CHIX 18318XJaak2 Wed 14 Nov 08:23:44 BST 2018 1 291.60 CHIX 18318XJaaf6 Wed 14 Nov 08:23:44 BST 2018 537 291.60 CHIX 18318XJaaf4 Wed 14 Nov 08:23:44 BST 2018 415 291.60 CHIX 18318XJaaf5 Wed 14 Nov 08:23:44 BST 2018 871 291.60 XLON 18318XJaaf3 Wed 14 Nov 08:23:30 BST 2018 1305 291.70 CHIX 18318XJaadp Wed 14 Nov 08:23:30 BST 2018 293 291.70 XLON 18318XJaado Wed 14 Nov 08:23:30 BST 2018 2600 291.70 XLON 18318XJaadn Wed 14 Nov 08:22:00 BST 2018 2429 291.65 XLON 18318XJaa09 Wed 14 Nov 08:22:00 BST 2018 1096 291.65 CHIX 18318XJaa08 Wed 14 Nov 08:21:27 BST 2018 663 291.35 CHIX 18318XJa9vh Wed 14 Nov 08:21:27 BST 2018 550 291.40 CHIX 18318XJa9vf Wed 14 Nov 08:21:27 BST 2018 1020 291.45 CHIX 18318XJa9ve Wed 14 Nov 08:21:27 BST 2018 1127 291.40 XLON 18318XJa9vg Wed 14 Nov 08:21:27 BST 2018 2260 291.45 XLON 18318XJa9vd Wed 14 Nov 08:21:10 BST 2018 570 291.50 CHIX 18318XJa9tf Wed 14 Nov 08:21:01 BST 2018 694 291.65 CHIX 18318XJa9rm Wed 14 Nov 08:21:01 BST 2018 1537 291.65 XLON 18318XJa9rl Wed 14 Nov 08:20:45 BST 2018 1043 291.50 CHIX 18318XJa9p9 Wed 14 Nov 08:20:45 BST 2018 2313 291.50 XLON 18318XJa9p8 Wed 14 Nov 08:20:43 BST 2018 630 291.60 CHIX 18318XJa9on Wed 14 Nov 08:20:43 BST 2018 749 291.65 CHIX 18318XJa9om Wed 14 Nov 08:20:43 BST 2018 1393 291.60 XLON 18318XJa9ol Wed 14 Nov 08:20:36 BST 2018 899 291.70 XLON 18318XJa9o5 Wed 14 Nov 08:20:36 BST 2018 537 291.70 CHIX 18318XJa9o6 Wed 14 Nov 08:20:36 BST 2018 477 291.75 CHIX 18318XJa9o4 Wed 14 Nov 08:20:25 BST 2018 39 291.80 XLON 18318XJa9mv Wed 14 Nov 08:20:23 BST 2018 902 291.90 XLON 18318XJa9ms Wed 14 Nov 08:20:23 BST 2018 943 291.90 CHIX 18318XJa9mr Wed 14 Nov 08:20:23 BST 2018 1186 291.90 XLON 18318XJa9mq Wed 14 Nov 08:20:22 BST 2018 755 292.00 CHIX 18318XJa9mp Wed 14 Nov 08:20:22 BST 2018 1674 292.00 XLON 18318XJa9mo Wed 14 Nov 08:20:22 BST 2018 536 292.10 CHIX 18318XJa9mn Wed 14 Nov 08:20:22 BST 2018 459 292.10 XLON 18318XJa9mm Wed 14 Nov 08:19:47 BST 2018 947 292.25 XLON 18318XJa9ir Wed 14 Nov 08:19:47 BST 2018 567 292.40 CHIX 18318XJa9io Wed 14 Nov 08:19:47 BST 2018 1160 292.40 XLON 18318XJa9in Wed 14 Nov 08:19:47 BST 2018 596 292.45 XLON 18318XJa9im Wed 14 Nov 08:19:47 BST 2018 685 292.50 CHIX 18318XJa9il Wed 14 Nov 08:19:47 BST 2018 865 292.55 XLON 18318XJa9ij Wed 14 Nov 08:19:47 BST 2018 535 292.55 CHIX 18318XJa9ik Wed 14 Nov 08:19:45 BST 2018 1339 292.60 XLON 18318XJa9ig Wed 14 Nov 08:19:45 BST 2018 755 292.65 CHIX 18318XJa9if Wed 14 Nov 08:19:45 BST 2018 187 292.65 XLON 18318XJa9ie Wed 14 Nov 08:19:45 BST 2018 619 292.60 CHIX 18318XJa9id Wed 14 Nov 08:19:45 BST 2018 804 292.60 CHIX 18318XJa9ic Wed 14 Nov 08:19:45 BST 2018 755 292.65 CHIX 18318XJa9ia Wed 14 Nov 08:19:45 BST 2018 1672 292.65 XLON 18318XJa9ib Wed 14 Nov 08:19:36 BST 2018 848 292.80 XLON 18318XJa9hm Wed 14 Nov 08:19:36 BST 2018 1519 292.80 XLON 18318XJa9ho Wed 14 Nov 08:19:36 BST 2018 535 292.80 CHIX 18318XJa9hl Wed 14 Nov 08:19:36 BST 2018 686 292.80 CHIX 18318XJa9hn Wed 14 Nov 08:19:34 BST 2018 240 292.85 CHIX 18318XJa9hh Wed 14 Nov 08:19:34 BST 2018 329 292.85 CHIX 18318XJa9hg Wed 14 Nov 08:19:25 BST 2018 413 292.80 CHIX 18318XJa9gp Wed 14 Nov 08:19:21 BST 2018 192 292.80 XLON 18318XJa9g7 Wed 14 Nov 08:19:21 BST 2018 535 292.80 CHIX 18318XJa9g6 Wed 14 Nov 08:19:21 BST 2018 1097 292.80 XLON 18318XJa9g2 Wed 14 Nov 08:19:21 BST 2018 63 292.80 XLON 18318XJa9g4 Wed 14 Nov 08:19:15 BST 2018 1255 292.90 XLON 18318XJa9ft Wed 14 Nov 08:19:15 BST 2018 206 292.90 CHIX 18318XJa9fv Wed 14 Nov 08:19:15 BST 2018 613 292.90 CHIX 18318XJa9fu Wed 14 Nov 08:18:56 BST 2018 1720 292.45 XLON 18318XJa9ec Wed 14 Nov 08:18:56 BST 2018 313 292.70 CHIX 18318XJa9ea Wed 14 Nov 08:18:56 BST 2018 248 292.70 CHIX 18318XJa9e9 Wed 14 Nov 08:18:56 BST 2018 535 292.70 CHIX 18318XJa9e8 Wed 14 Nov 08:18:56 BST 2018 535 292.70 CHIX 18318XJa9e7 Wed 14 Nov 08:18:56 BST 2018 1029 292.75 XLON 18318XJa9e5 Wed 14 Nov 08:18:56 BST 2018 535 292.75 CHIX 18318XJa9e6 Wed 14 Nov 08:18:52 BST 2018 1001 292.70 XLON 18318XJa9d8 Wed 14 Nov 08:18:52 BST 2018 582 292.70 XLON 18318XJa9d9 Wed 14 Nov 08:18:10 BST 2018 200 291.90 CHIX 18318XJa99p Wed 14 Nov 08:18:07 BST 2018 400 292.00 XLON 18318XJa99g Wed 14 Nov 08:18:07 BST 2018 1241 292.00 XLON 18318XJa99f Wed 14 Nov 08:18:07 BST 2018 536 292.00 CHIX 18318XJa99e Wed 14 Nov 08:18:07 BST 2018 606 292.00 CHIX 18318XJa99d Wed 14 Nov 08:18:07 BST 2018 335 292.05 CHIX 18318XJa99c Wed 14 Nov 08:18:06 BST 2018 490 292.10 CHIX 18318XJa99b Wed 14 Nov 08:18:00 BST 2018 536 292.10 CHIX 18318XJa98u Wed 14 Nov 08:18:00 BST 2018 514 292.10 XLON 18318XJa98t Wed 14 Nov 08:16:58 BST 2018 665 291.15 CHIX 18318XJa917 Wed 14 Nov 08:16:58 BST 2018 583 291.15 CHIX 18318XJa916 Wed 14 Nov 08:16:58 BST 2018 1135 291.15 XLON 18318XJa918 Wed 14 Nov 08:16:58 BST 2018 59 291.15 XLON 18318XJa915 Wed 14 Nov 08:16:50 BST 2018 733 291.15 CHIX 18318XJa90n Wed 14 Nov 08:16:50 BST 2018 1622 291.15 XLON 18318XJa90m Wed 14 Nov 08:16:45 BST 2018 313 291.15 CHIX 18318XJa8zn Wed 14 Nov 08:16:32 BST 2018 681 291.25 CHIX 18318XJa8yb Wed 14 Nov 08:16:32 BST 2018 537 291.30 CHIX 18318XJa8ya Wed 14 Nov 08:16:32 BST 2018 622 291.30 XLON 18318XJa8y9 Wed 14 Nov 08:16:20 BST 2018 444 291.25 CHIX 18318XJa8xa Wed 14 Nov 08:16:20 BST 2018 801 291.25 CHIX 18318XJa8xb Wed 14 Nov 08:16:20 BST 2018 93 291.25 CHIX 18318XJa8x9 Wed 14 Nov 08:16:20 BST 2018 21 291.25 XLON 18318XJa8x8 Wed 14 Nov 08:16:20 BST 2018 434 291.25 XLON 18318XJa8x7 Wed 14 Nov 08:16:19 BST 2018 697 291.40 CHIX 18318XJa8wo Wed 14 Nov 08:16:19 BST 2018 1543 291.40 XLON 18318XJa8wn Wed 14 Nov 08:16:04 BST 2018 297 291.40 CHIX 18318XJa8v6 Wed 14 Nov 08:16:04 BST 2018 240 291.40 CHIX 18318XJa8v5 Wed 14 Nov 08:16:04 BST 2018 759 291.40 XLON 18318XJa8v4 Wed 14 Nov 08:15:58 BST 2018 468 291.60 CHIX 18318XJa8ty Wed 14 Nov 08:15:58 BST 2018 537 291.60 CHIX 18318XJa8tz Wed 14 Nov 08:15:58 BST 2018 439 291.60 XLON 18318XJa8tx Wed 14 Nov 08:15:58 BST 2018 537 291.65 CHIX 18318XJa8tw Wed 14 Nov 08:15:58 BST 2018 537 291.65 CHIX 18318XJa8tv Wed 14 Nov 08:15:58 BST 2018 88 291.70 CHIX 18318XJa8tt Wed 14 Nov 08:15:58 BST 2018 355 291.65 XLON 18318XJa8ts Wed 14 Nov 08:15:58 BST 2018 351 291.65 XLON 18318XJa8tu Wed 14 Nov 08:15:58 BST 2018 59 291.65 XLON 18318XJa8tq Wed 14 Nov 08:15:58 BST 2018 449 291.70 CHIX 18318XJa8tr Wed 14 Nov 08:15:58 BST 2018 881 291.70 XLON 18318XJa8to Wed 14 Nov 08:15:50 BST 2018 1555 291.85 XLON 18318XJa8t2 Wed 14 Nov 08:15:50 BST 2018 702 291.85 CHIX 18318XJa8t3 Wed 14 Nov 08:15:47 BST 2018 668 291.95 CHIX 18318XJa8sr Wed 14 Nov 08:15:47 BST 2018 536 292.00 CHIX 18318XJa8so Wed 14 Nov 08:15:47 BST 2018 571 292.00 CHIX 18318XJa8sm Wed 14 Nov 08:15:47 BST 2018 524 292.00 XLON 18318XJa8sn Wed 14 Nov 08:15:46 BST 2018 472 292.10 CHIX 18318XJa8sl Wed 14 Nov 08:15:45 BST 2018 536 292.10 CHIX 18318XJa8sk Wed 14 Nov 08:15:45 BST 2018 75 292.10 XLON 18318XJa8sj Wed 14 Nov 08:15:45 BST 2018 900 292.10 XLON 18318XJa8si Wed 14 Nov 08:15:35 BST 2018 572 292.15 XLON 18318XJa8r4 Wed 14 Nov 08:15:35 BST 2018 536 292.15 CHIX 18318XJa8r3 Wed 14 Nov 08:15:21 BST 2018 265 292.05 CHIX 18318XJa8ow Wed 14 Nov 08:15:20 BST 2018 306 292.05 CHIX 18318XJa8ov Wed 14 Nov 08:15:20 BST 2018 284 292.15 BATE 18318XJa8ou Wed 14 Nov 08:15:15 BST 2018 434 292.10 CHIX 18318XJa8oc Wed 14 Nov 08:15:15 BST 2018 264 292.10 CHIX 18318XJa8ob Wed 14 Nov 08:15:15 BST 2018 394 292.10 CHIX 18318XJa8oa Wed 14 Nov 08:15:13 BST 2018 626 292.15 XLON 18318XJa8np Wed 14 Nov 08:15:13 BST 2018 536 292.15 CHIX 18318XJa8no Wed 14 Nov 08:15:02 BST 2018 80 292.10 XLON 18318XJa8kh Wed 14 Nov 08:14:47 BST 2018 324 292.15 CHIX 18318XJa8hw Wed 14 Nov 08:14:35 BST 2018 341 292.25 CHIX 18318XJa8ha Wed 14 Nov 08:14:23 BST 2018 535 292.35 CHIX 18318XJa8gp Wed 14 Nov 08:14:23 BST 2018 535 292.35 CHIX 18318XJa8go Wed 14 Nov 08:14:23 BST 2018 393 292.40 CHIX 18318XJa8gn Wed 14 Nov 08:14:23 BST 2018 832 292.45 CHIX 18318XJa8gm Wed 14 Nov 08:14:23 BST 2018 402 292.35 XLON 18318XJa8gl Wed 14 Nov 08:14:23 BST 2018 759 292.35 XLON 18318XJa8gk Wed 14 Nov 08:14:23 BST 2018 187 292.50 XLON 18318XJa8gj Wed 14 Nov 08:14:20 BST 2018 1845 292.45 XLON 18318XJa8g4 Wed 14 Nov 08:14:19 BST 2018 375 292.45 CHIX 18318XJa8fw Wed 14 Nov 08:14:19 BST 2018 629 292.45 CHIX 18318XJa8fy Wed 14 Nov 08:14:19 BST 2018 535 292.45 CHIX 18318XJa8fx Wed 14 Nov 08:14:19 BST 2018 2 292.45 XLON 18318XJa8fs Wed 14 Nov 08:14:19 BST 2018 371 292.45 XLON 18318XJa8fu Wed 14 Nov 08:14:19 BST 2018 68 292.45 XLON 18318XJa8ft Wed 14 Nov 08:14:19 BST 2018 26 292.45 XLON 18318XJa8fv Wed 14 Nov 08:14:10 BST 2018 67 292.55 CHIX 18318XJa8ef Wed 14 Nov 08:14:10 BST 2018 577 292.55 CHIX 18318XJa8ed Wed 14 Nov 08:14:10 BST 2018 492 292.55 CHIX 18318XJa8ee Wed 14 Nov 08:14:09 BST 2018 541 292.70 CHIX 18318XJa8e9 Wed 14 Nov 08:14:09 BST 2018 535 292.65 CHIX 18318XJa8e8 Wed 14 Nov 08:14:09 BST 2018 636 292.65 XLON 18318XJa8e7 Wed 14 Nov 08:14:00 BST 2018 535 292.60 CHIX 18318XJa8d4 Wed 14 Nov 08:14:00 BST 2018 33 292.60 XLON 18318XJa8d3 Wed 14 Nov 08:14:00 BST 2018 400 292.60 XLON 18318XJa8d2 Wed 14 Nov 08:13:57 BST 2018 707 292.55 XLON 18318XJa8cs Wed 14 Nov 08:13:57 BST 2018 535 292.55 CHIX 18318XJa8ct Wed 14 Nov 08:13:53 BST 2018 599 292.55 CHIX 18318XJa8cj Wed 14 Nov 08:13:53 BST 2018 1228 292.55 XLON 18318XJa8ci Wed 14 Nov 08:13:51 BST 2018 223 292.50 CHIX 18318XJa8cd Wed 14 Nov 08:13:51 BST 2018 620 292.50 CHIX 18318XJa8cc Wed 14 Nov 08:13:51 BST 2018 1291 292.50 XLON 18318XJa8cb Wed 14 Nov 08:13:51 BST 2018 535 292.55 CHIX 18318XJa8ca Wed 14 Nov 08:13:51 BST 2018 574 292.55 CHIX 18318XJa8c9 Wed 14 Nov 08:13:51 BST 2018 210 292.55 XLON 18318XJa8c8 Wed 14 Nov 08:13:51 BST 2018 672 292.55 XLON 18318XJa8c7 Wed 14 Nov 08:13:38 BST 2018 535 292.45 CHIX 18318XJa8aw Wed 14 Nov 08:13:38 BST 2018 1075 292.45 XLON 18318XJa8av Wed 14 Nov 08:13:38 BST 2018 514 292.50 CHIX 18318XJa8at Wed 14 Nov 08:13:31 BST 2018 1063 292.45 XLON 18318XJa88v Wed 14 Nov 08:13:31 BST 2018 535 292.45 CHIX 18318XJa88w Wed 14 Nov 08:13:19 BST 2018 535 292.45 CHIX 18318XJa88c Wed 14 Nov 08:13:19 BST 2018 792 292.45 XLON 18318XJa88b Wed 14 Nov 08:13:19 BST 2018 535 292.50 CHIX 18318XJa88a Wed 14 Nov 08:13:19 BST 2018 103 292.50 XLON 18318XJa889 Wed 14 Nov 08:13:19 BST 2018 438 292.50 XLON 18318XJa888 Wed 14 Nov 08:13:15 BST 2018 407 292.55 CHIX 18318XJa882 Wed 14 Nov 08:13:15 BST 2018 128 292.55 CHIX 18318XJa881 Wed 14 Nov 08:13:11 BST 2018 542 292.55 CHIX 18318XJa87h Wed 14 Nov 08:13:11 BST 2018 1109 292.55 XLON 18318XJa87g Wed 14 Nov 08:13:06 BST 2018 551 292.70 XLON 18318XJa874 Wed 14 Nov 08:13:06 BST 2018 535 292.70 CHIX 18318XJa873 Wed 14 Nov 08:12:33 BST 2018 536 291.95 CHIX 18318XJa83t Wed 14 Nov 08:12:33 BST 2018 862 291.95 XLON 18318XJa83s Wed 14 Nov 08:12:27 BST 2018 536 291.80 CHIX 18318XJa83d Wed 14 Nov 08:12:27 BST 2018 618 291.80 XLON 18318XJa83c Wed 14 Nov 08:12:20 BST 2018 347 291.55 XLON 18318XJa82v Wed 14 Nov 08:12:20 BST 2018 1476 291.55 XLON 18318XJa82u Wed 14 Nov 08:12:20 BST 2018 1265 291.60 XLON 18318XJa82s Wed 14 Nov 08:12:20 BST 2018 824 291.55 CHIX 18318XJa82t Wed 14 Nov 08:12:20 BST 2018 617 291.60 CHIX 18318XJa82r Wed 14 Nov 08:12:19 BST 2018 104 291.70 XLON 18318XJa82q Wed 14 Nov 08:12:19 BST 2018 1608 291.70 XLON 18318XJa82p Wed 14 Nov 08:12:19 BST 2018 727 291.70 CHIX 18318XJa82o Wed 14 Nov 08:12:03 BST 2018 537 291.65 CHIX 18318XJa819 Wed 14 Nov 08:12:03 BST 2018 489 291.65 XLON 18318XJa818 Wed 14 Nov 08:12:02 BST 2018 599 291.70 XLON 18318XJa80m Wed 14 Nov 08:12:02 BST 2018 537 291.70 CHIX 18318XJa80r Wed 14 Nov 08:12:02 BST 2018 536 291.75 CHIX 18318XJa80o Wed 14 Nov 08:12:02 BST 2018 1012 291.75 XLON 18318XJa80k Wed 14 Nov 08:11:57 BST 2018 537 291.70 CHIX 18318XJa7zw Wed 14 Nov 08:11:57 BST 2018 725 291.70 XLON 18318XJa7zv Wed 14 Nov 08:11:39 BST 2018 568 291.40 CHIX 18318XJa7z4 Wed 14 Nov 08:11:39 BST 2018 333 291.40 CHIX 18318XJa7z3 Wed 14 Nov 08:11:39 BST 2018 764 291.45 CHIX 18318XJa7z2 Wed 14 Nov 08:11:39 BST 2018 198 291.45 XLON 18318XJa7z1 Wed 14 Nov 08:11:38 BST 2018 106 291.50 XLON 18318XJa7yw Wed 14 Nov 08:11:38 BST 2018 1430 291.50 XLON 18318XJa7yv Wed 14 Nov 08:11:38 BST 2018 693 291.50 CHIX 18318XJa7yx Wed 14 Nov 08:11:34 BST 2018 594 291.50 CHIX 18318XJa7yq Wed 14 Nov 08:11:34 BST 2018 296 291.50 CHIX 18318XJa7yr Wed 14 Nov 08:11:34 BST 2018 1216 291.50 XLON 18318XJa7yp Wed 14 Nov 08:11:33 BST 2018 66 291.55 CHIX 18318XJa7ym Wed 14 Nov 08:11:23 BST 2018 1225 291.55 XLON 18318XJa7y0 Wed 14 Nov 08:11:23 BST 2018 598 291.55 CHIX 18318XJa7xy Wed 14 Nov 08:11:23 BST 2018 1225 291.55 XLON 18318XJa7xz Wed 14 Nov 08:11:18 BST 2018 611 291.50 CHIX 18318XJa7xm Wed 14 Nov 08:11:12 BST 2018 78 291.55 BATE 18318XJa7xf Wed 14 Nov 08:11:12 BST 2018 310 291.55 CHIX 18318XJa7xe Wed 14 Nov 08:11:12 BST 2018 62 291.55 CHIX 18318XJa7xd Wed 14 Nov 08:11:12 BST 2018 163 291.55 XLON 18318XJa7xb Wed 14 Nov 08:11:12 BST 2018 334 291.50 XLON 18318XJa7xa Wed 14 Nov 08:11:12 BST 2018 1426 291.55 XLON 18318XJa7xc Wed 14 Nov 08:11:09 BST 2018 1145 291.50 XLON 18318XJa7x4 Wed 14 Nov 08:11:09 BST 2018 653 291.30 XLON 18318XJa7x3 Wed 14 Nov 08:11:09 BST 2018 782 291.30 XLON 18318XJa7x2 Wed 14 Nov 08:11:09 BST 2018 102 291.30 XLON 18318XJa7x1 Wed 14 Nov 08:11:09 BST 2018 694 291.30 CHIX 18318XJa7x0 Wed 14 Nov 08:11:09 BST 2018 389 291.35 CHIX 18318XJa7wx Wed 14 Nov 08:11:09 BST 2018 698 291.35 CHIX 18318XJa7wz Wed 14 Nov 08:11:09 BST 2018 1546 291.35 XLON 18318XJa7wy Wed 14 Nov 08:10:30 BST 2018 464 291.20 CHIX 18318XJa7ro Wed 14 Nov 08:10:30 BST 2018 185 291.30 XLON 18318XJa7rn Wed 14 Nov 08:10:30 BST 2018 485 291.20 CHIX 18318XJa7rm Wed 14 Nov 08:10:30 BST 2018 637 291.30 CHIX 18318XJa7rl Wed 14 Nov 08:10:30 BST 2018 537 291.30 CHIX 18318XJa7rk Wed 14 Nov 08:10:30 BST 2018 40 291.30 XLON 18318XJa7rj Wed 14 Nov 08:10:30 BST 2018 735 291.30 XLON 18318XJa7ri Wed 14 Nov 08:10:16 BST 2018 31 291.35 XLON 18318XJa7qj Wed 14 Nov 08:10:13 BST 2018 16 291.35 XLON 18318XJa7q8 Wed 14 Nov 08:10:13 BST 2018 504 291.40 CHIX 18318XJa7q5 Wed 14 Nov 08:10:13 BST 2018 808 291.40 CHIX 18318XJa7q6 Wed 14 Nov 08:09:41 BST 2018 146 291.15 XLON 18318XJa7lu Wed 14 Nov 08:09:16 BST 2018 235 290.85 CHIX 18318XJa7i5 Wed 14 Nov 08:09:13 BST 2018 1863 291.00 XLON 18318XJa7i0 Wed 14 Nov 08:09:13 BST 2018 1577 291.00 XLON 18318XJa7hx Wed 14 Nov 08:09:13 BST 2018 115 291.00 XLON 18318XJa7hz Wed 14 Nov 08:09:13 BST 2018 59 291.00 XLON 18318XJa7hy Wed 14 Nov 08:09:13 BST 2018 713 291.00 CHIX 18318XJa7hw Wed 14 Nov 08:09:13 BST 2018 365 291.05 CHIX 18318XJa7hv Wed 14 Nov 08:08:59 BST 2018 237 291.05 CHIX 18318XJa7fb Wed 14 Nov 08:08:51 BST 2018 538 291.15 CHIX 18318XJa7ee Wed 14 Nov 08:08:51 BST 2018 670 291.15 XLON 18318XJa7ed Wed 14 Nov 08:08:47 BST 2018 35 291.15 XLON 18318XJa7e2 Wed 14 Nov 08:08:45 BST 2018 537 291.35 CHIX 18318XJa7dz Wed 14 Nov 08:08:45 BST 2018 63 291.35 XLON 18318XJa7dy Wed 14 Nov 08:08:45 BST 2018 400 291.35 XLON 18318XJa7dx Wed 14 Nov 08:08:25 BST 2018 5 291.55 XLON 18318XJa7ci Wed 14 Nov 08:08:18 BST 2018 499 291.75 XLON 18318XJa7c8 Wed 14 Nov 08:08:18 BST 2018 536 291.75 CHIX 18318XJa7c9 Wed 14 Nov 08:08:16 BST 2018 102 291.90 XLON 18318XJa7bw Wed 14 Nov 08:08:16 BST 2018 615 291.90 CHIX 18318XJa7bv Wed 14 Nov 08:08:16 BST 2018 297 291.90 CHIX 18318XJa7bu Wed 14 Nov 08:08:16 BST 2018 757 291.90 XLON 18318XJa7bt Wed 14 Nov 08:08:16 BST 2018 138 291.90 XLON 18318XJa7bs Wed 14 Nov 08:08:16 BST 2018 365 291.90 XLON 18318XJa7br Wed 14 Nov 08:08:16 BST 2018 364 292.05 CHIX 18318XJa7bq Wed 14 Nov 08:08:10 BST 2018 28 292.10 XLON 18318XJa7b6 Wed 14 Nov 08:08:09 BST 2018 1 292.15 XLON 18318XJa7b2 Wed 14 Nov 08:08:09 BST 2018 55 292.15 XLON 18318XJa7b1 Wed 14 Nov 08:07:58 BST 2018 115 292.35 XLON 18318XJa79a Wed 14 Nov 08:07:50 BST 2018 359 292.25 XLON 18318XJa78z Wed 14 Nov 08:07:50 BST 2018 7 292.30 XLON 18318XJa78y Wed 14 Nov 08:07:50 BST 2018 183 292.25 CHIX 18318XJa790 Wed 14 Nov 08:07:50 BST 2018 76 292.30 XLON 18318XJa78x Wed 14 Nov 08:07:45 BST 2018 27 292.35 XLON 18318XJa78c Wed 14 Nov 08:07:45 BST 2018 100 292.35 XLON 18318XJa78b Wed 14 Nov 08:07:43 BST 2018 318 292.40 XLON 18318XJa786 Wed 14 Nov 08:07:43 BST 2018 40 292.40 XLON 18318XJa785 Wed 14 Nov 08:07:35 BST 2018 69 292.50 XLON 18318XJa77n Wed 14 Nov 08:06:37 BST 2018 536 292.15 CHIX 18318XJa71e Wed 14 Nov 08:06:37 BST 2018 499 292.15 XLON 18318XJa71d Wed 14 Nov 08:06:37 BST 2018 157 292.15 CHIX 18318XJa71c Wed 14 Nov 08:06:37 BST 2018 311 292.10 XLON 18318XJa71b Wed 14 Nov 08:06:37 BST 2018 536 292.05 CHIX 18318XJa71a Wed 14 Nov 08:06:37 BST 2018 33 292.15 XLON 18318XJa717 Wed 14 Nov 08:06:37 BST 2018 433 292.05 XLON 18318XJa719 Wed 14 Nov 08:06:37 BST 2018 127 292.05 XLON 18318XJa718 Wed 14 Nov 08:06:35 BST 2018 104 292.35 XLON 18318XJa716 Wed 14 Nov 08:06:34 BST 2018 805 292.45 CHIX 18318XJa715 Wed 14 Nov 08:06:34 BST 2018 103 292.45 XLON 18318XJa714 Wed 14 Nov 08:05:22 BST 2018 348 290.65 CHIX 18318XJa6wc Wed 14 Nov 08:05:12 BST 2018 539 290.35 CHIX 18318XJa6vf Wed 14 Nov 08:05:12 BST 2018 551 290.35 XLON 18318XJa6ve Wed 14 Nov 08:04:35 BST 2018 1372 289.35 XLON 18318XJa6u4 Wed 14 Nov 08:04:35 BST 2018 191 289.50 XLON 18318XJa6u3 Wed 14 Nov 08:04:35 BST 2018 191 289.45 XLON 18318XJa6u2 Wed 14 Nov 08:04:35 BST 2018 438 290.00 CHIX 18318XJa6u1 Wed 14 Nov 08:03:35 BST 2018 755 290.10 XLON 18318XJa6na Wed 14 Nov 08:03:35 BST 2018 539 290.10 CHIX 18318XJa6n9 Wed 14 Nov 08:03:26 BST 2018 56 290.10 XLON 18318XJa6n1 Wed 14 Nov 08:03:26 BST 2018 744 290.10 XLON 18318XJa6n2 Wed 14 Nov 08:03:26 BST 2018 315 290.15 CHIX 18318XJa6n0 Wed 14 Nov 08:03:21 BST 2018 22 290.15 XLON 18318XJa6ml Wed 14 Nov 08:03:14 BST 2018 489 290.45 CHIX 18318XJa6li Wed 14 Nov 08:02:40 BST 2018 2872 290.70 XLON 18318XJa6jl Wed 14 Nov 08:02:40 BST 2018 1296 290.70 CHIX 18318XJa6jk Wed 14 Nov 08:01:15 BST 2018 538 290.75 CHIX 18318XJa6dl Wed 14 Nov 08:01:15 BST 2018 382 290.75 XLON 18318XJa6dk Wed 14 Nov 08:00:51 BST 2018 238 290.30 XLON 18318XJa6ax Wed 14 Nov 08:00:51 BST 2018 551 290.30 CHIX 18318XJa6aw Wed 14 Nov 08:00:51 BST 2018 811 290.30 CHIX 18318XJa6av Wed 14 Nov 08:00:50 BST 2018 538 290.90 CHIX 18318XJa6as Wed 14 Nov 08:00:50 BST 2018 486 290.90 XLON 18318XJa6ar Wed 14 Nov 08:00:30 BST 2018 71 291.20 CHIX 18318XJa68w Wed 14 Nov 08:00:30 BST 2018 405 291.20 CHIX 18318XJa68x Wed 14 Nov 08:00:30 BST 2018 334 291.20 CHIX 18318XJa68v Sponsor Absa Bank Limited (acting through its Corporate and Investment Banking Division) Date: 15/11/2018 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.